
<html lang="en"     class="pb-page"  data-request-id="7b2d7e7c-ca97-4b7a-b5e5-6a22b3ae7dc6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.0c01399;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-6;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms" /></meta><meta name="dc.Creator" content="Zsuzsa  Baranyai" /></meta><meta name="dc.Creator" content="Beáta  Biri-Kovács" /></meta><meta name="dc.Creator" content="Martin  Krátký" /></meta><meta name="dc.Creator" content="Bálint  Szeder" /></meta><meta name="dc.Creator" content="Márta L.  Debreczeni" /></meta><meta name="dc.Creator" content="Johanna  Budai" /></meta><meta name="dc.Creator" content="Bence  Kovács" /></meta><meta name="dc.Creator" content="Lilla  Horváth" /></meta><meta name="dc.Creator" content="Edit  Pári" /></meta><meta name="dc.Creator" content="Zsuzsanna  Németh" /></meta><meta name="dc.Creator" content="László  Cervenak" /></meta><meta name="dc.Creator" content="Ferenc  Zsila" /></meta><meta name="dc.Creator" content="Előd  Méhes" /></meta><meta name="dc.Creator" content="Éva  Kiss" /></meta><meta name="dc.Creator" content="Jarmila  Vinšová" /></meta><meta name="dc.Creator" content="Szilvia  Bősze" /></meta><meta name="dc.Description" content="Most therapeutic agents used for treating brain malignancies face hindered transport through the blood–brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed pept..." /></meta><meta name="Description" content="Most therapeutic agents used for treating brain malignancies face hindered transport through the blood–brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed pept..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01399" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01399" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01399" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01399" /></link>
        
    
    

<title>Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01399" /></meta><meta property="og:title" content="Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0016.jpeg" /></meta><meta property="og:description" content="Most therapeutic agents used for treating brain malignancies face hindered transport through the blood–brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple ex vivo and in vitro BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetration ability than daunomycin. These conjugates are promising tools for the delivery systems with tunable features." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01399"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01399">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01399&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01399&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01399&amp;href=/doi/10.1021/acs.jmedchem.0c01399" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2982-3005</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02162" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01448" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based <i>in Vitro</i> Platforms</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zsuzsa Baranyai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zsuzsa Baranyai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zsuzsa++Baranyai">Zsuzsa Baranyai</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2174-6747" title="Orcid link">http://orcid.org/0000-0002-2174-6747</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Beáta Biri-Kovács</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Beáta Biri-Kovács</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div><div class="loa-info-affiliations-info">Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Be%C3%A1ta++Biri-Kov%C3%A1cs">Beáta Biri-Kovács</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5803-9969" title="Orcid link">http://orcid.org/0000-0001-5803-9969</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Krátký</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Krátký</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Kr%C3%A1tk%C3%BD">Martin Krátký</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bálint Szeder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bálint Szeder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Enzymology, Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=B%C3%A1lint++Szeder">Bálint Szeder</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Márta L. Debreczeni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Márta L. Debreczeni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=M%C3%A1rta+L.++Debreczeni">Márta L. Debreczeni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Johanna Budai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Johanna Budai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Johanna++Budai">Johanna Budai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bence Kovács</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bence Kovács</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Ecological Research, Institute of Ecology and Botany, Alkotmány u. 2-4, H-2163 Vácrátót, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bence++Kov%C3%A1cs">Bence Kovács</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lilla Horváth</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lilla Horváth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lilla++Horv%C3%A1th">Lilla Horváth</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edit Pári</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edit Pári</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edit++P%C3%A1ri">Edit Pári</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zsuzsanna Németh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zsuzsanna Németh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zsuzsanna++N%C3%A9meth">Zsuzsanna Németh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">László Cervenak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">László Cervenak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">3rd Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L%C3%A1szl%C3%B3++Cervenak">László Cervenak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ferenc Zsila</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ferenc Zsila</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ferenc++Zsila">Ferenc Zsila</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4853-2810" title="Orcid link">http://orcid.org/0000-0002-4853-2810</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Előd Méhes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Előd Méhes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biological Physics, Institute of Physics, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=El%C5%91d++M%C3%A9hes">Előd Méhes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Éva Kiss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Éva Kiss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C3%89va++Kiss">Éva Kiss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jarmila Vinšová</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jarmila Vinšová</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jarmila++Vin%C5%A1ov%C3%A1">Jarmila Vinšová</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Szilvia Bősze</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Szilvia Bősze</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Eötvös Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f5979a868f90b590998190db9d80"><span class="__cf_email__" data-cfemail="274548545d4267424b5342094f52">[email protected]</span></a>. Phone: +36-372-2500, ext. 1736. Fax: +36-372-26-20.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Szilvia++B%C5%91sze">Szilvia Bősze</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9555-699X" title="Orcid link">http://orcid.org/0000-0001-9555-699X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01399&amp;href=/doi/10.1021%2Facs.jmedchem.0c01399" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2982–3005</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 August 2020</li><li><span class="item_label"><b>Published</b> online</span>15 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01399" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01399</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2982%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZsuzsa%2BBaranyai%252C%2BBe%25C3%25A1ta%2BBiri-Kov%25C3%25A1cs%252C%2BMartin%2BKr%25C3%25A1tk%25C3%25BD%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D6%26contentID%3Dacs.jmedchem.0c01399%26title%3DCellular%2BInternalization%2Band%2BInhibition%2BCapacity%2Bof%2BNew%2BAnti-Glioma%2BPeptide%2BConjugates%253A%2BPhysicochemical%2BCharacterization%2Band%2BEvaluation%2Bon%2BVarious%2BMonolayer-%2Band%2B3D-Spheroid-Based%2Bin%2BVitro%2BPlatforms%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3005%26publicationDate%3DMarch%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01399"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">618</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01399" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cellular Internalization and Inhibition Capacity of New Anti-Glioma Peptide Conjugates: Physicochemical Characterization and Evaluation on Various Monolayer- and 3D-Spheroid-Based in Vitro Platforms&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zsuzsa&quot;,&quot;last_name&quot;:&quot;Baranyai&quot;},{&quot;first_name&quot;:&quot;Beáta&quot;,&quot;last_name&quot;:&quot;Biri-Kovács&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Krátký&quot;},{&quot;first_name&quot;:&quot;Bálint&quot;,&quot;last_name&quot;:&quot;Szeder&quot;},{&quot;first_name&quot;:&quot;Márta&quot;,&quot;last_name&quot;:&quot;L. Debreczeni&quot;},{&quot;first_name&quot;:&quot;Johanna&quot;,&quot;last_name&quot;:&quot;Budai&quot;},{&quot;first_name&quot;:&quot;Bence&quot;,&quot;last_name&quot;:&quot;Kovács&quot;},{&quot;first_name&quot;:&quot;Lilla&quot;,&quot;last_name&quot;:&quot;Horváth&quot;},{&quot;first_name&quot;:&quot;Edit&quot;,&quot;last_name&quot;:&quot;Pári&quot;},{&quot;first_name&quot;:&quot;Zsuzsanna&quot;,&quot;last_name&quot;:&quot;Németh&quot;},{&quot;first_name&quot;:&quot;László&quot;,&quot;last_name&quot;:&quot;Cervenak&quot;},{&quot;first_name&quot;:&quot;Ferenc&quot;,&quot;last_name&quot;:&quot;Zsila&quot;},{&quot;first_name&quot;:&quot;Előd&quot;,&quot;last_name&quot;:&quot;Méhes&quot;},{&quot;first_name&quot;:&quot;Éva&quot;,&quot;last_name&quot;:&quot;Kiss&quot;},{&quot;first_name&quot;:&quot;Jarmila&quot;,&quot;last_name&quot;:&quot;Vinšová&quot;},{&quot;first_name&quot;:&quot;Szilvia&quot;,&quot;last_name&quot;:&quot;Bősze&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2982-3005&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01399&quot;},&quot;abstract&quot;:&quot;Most therapeutic agents used for treating brain malignancies face hindered transport through the blood–brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple ex vivo and in vitro BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetrat&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01399&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01399" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01399&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01399" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01399&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01399" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01399&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01399&amp;href=/doi/10.1021/acs.jmedchem.0c01399" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01399" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01399" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (12 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01399%26sid%3Dliteratum%253Aachs%26pmid%3D33719423%26genre%3Darticle%26aulast%3DBaranyai%26date%3D2021%26atitle%3DCellular%2BInternalization%2Band%2BInhibition%2BCapacity%2Bof%2BNew%2BAnti-Glioma%2BPeptide%2BConjugates%253A%2BPhysicochemical%2BCharacterization%2Band%2BEvaluation%2Bon%2BVarious%2BMonolayer-%2Band%2B3D-Spheroid-Based%2Bin%2BVitro%2BPlatforms%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D6%26spage%3D2982%26epage%3D3005%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/jmcmar.2021.64.issue-6/20210325/jmcmar.2021.64.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Most therapeutic agents used for treating brain malignancies face hindered transport through the blood–brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple <i>ex vivo</i> and <i>in vitro</i> BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetration ability than daunomycin. These conjugates are promising tools for the delivery systems with tunable features.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gliomas are the most common type of primary brain tumors, accounting for 30% of all brain tumors. Gliomas are thought to originate from the neuroglial stem or progenitor cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among the many subtypes, glioblastoma (GBM) is the most aggressive form characterized by poor prognosis and high recurrence rate. Despite the combined treatment of surgery, chemotherapy (mainly with temozolomide), and radiotherapy, the median overall survival is less than 2 years.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> A glioma stem cell (GSC) subpopulation has been identified in glioblastoma, and presumably, these cells are responsible for the resistance to conventional treatments as well as for the high recurrence rate. GSCs are capable of self-renewal and differentiation, and they have high tumorigenicity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Thus, more effective approaches for the treatment of gliomas and GBM are urgently needed.</div><div class="NLM_p">The blood–brain barrier (BBB), a complex neurovascular unit, represents another difficulty in the chemotherapy of gliomas because it prevents therapeutic agents from passing through the endothelium of its capillaries and, therefore, inhibits the delivery of drugs to tumors of the central nervous system (CNS).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> However, the functioning and organization of the BBB can be altered under pathological conditions. Glioblastomas are characterized by various degrees of blood–brain tumor barrier (BBTB) integrity depending on the different tissue regions. In bulky tumor areas, the BBTB integrity is compromised. It can be slightly leaky in more invasive peripheral regions, while in sparsely invaded sectors distant from the tumor bulk it can be intact. Where the BBTB is compromised, the tumor could be more available for drugs; however, the intact BBTB protects regions with isolated tumor cells that can give rise to tumor recurrence.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Current noninvasive strategies to overcome the BBB exploit receptor- and adsorptive-mediated transport systems using carrier molecules and nanotechnology-based drug delivery.<a onclick="showRef(event, 'ref8 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref10 ref11 ref12">(8,10−12)</a></div><div class="NLM_p">Cell-penetrating peptides (CPPs) are promising tools to achieve enhanced drug delivery for antitumor treatment. These are short (usually less than 30 amino acids), positively charged peptides with amphipathic characteristics, and they are capable of rapidly entering cells without cytolytic effects.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> The cationic SynB peptides (e.g., SynB1 and SynB3) belong to the CPP family and are able to cross the cellular membranes of the BBB with high efficiency.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> They are derived from a natural antimicrobial peptide called protegrin-1 (PG1, RGGRLCYCRRRFCVCVGR-NH<sub>2</sub>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> PG1 forms an antiparallel β-sheet, constrained by two disulfide bridges. Eight PG1 peptides aggregate to form a membrane-spanning pore causing cell lysis.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Replacement of the four cysteines with serines leads to linear peptides (SynB1, RGGRLSYSRRRFSTSTGR-NH<sub>2</sub>; SynB3, RRLSYSRRRF-NH<sub>2</sub>, a truncated derivative of SynB1) which are able to cross cell membranes efficiently without any cytolytic effect.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> The transport mechanism of these peptides has been identified as temperature- and energy-dependent adsorptive-mediated transcytosis,<a onclick="showRef(event, 'ref16 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref20 ref21">(16,20,21)</a> which provides the possibility of uptake of cationic molecules at the luminal surface of endothelial cells and then the possibility of exocytosis at the abluminal side.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, it is suggested by <i>in vitro</i> studies that SynB peptides are sequestered within endocytotic vesicles and might be degraded within lysosomal compartments.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Different drugs with poor brain-penetrating ability (such as doxorubicin,<a onclick="showRef(event, 'ref15 ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref23">(15,16,23)</a> paclitaxel,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> benzylpenicillin,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> dalargin,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and morphine-6-glucuronide<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) were conjugated to peptides from the SynB family. The conjugates, in particular, SynB3 conjugates in an <i>in situ</i> brain perfusion method, have shown an increased uptake without compromising the tight junction integrity of the BBB.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Antitumor drug-SynB conjugates (doxorubicin-SynB1,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> 2-pyrrolinodoxorubicin-SynB3,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and paclitaxel-SynB3<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) were able to overcome multidrug resistance <i>in vitro</i>; this finding might be explained by the fact that the conjugated drug is not recognized by the P-glycoprotein efflux pump. Increased <i>in vivo</i> BBB penetration and increased analgesic activity of SynB3-conjugated endomorphin-1 were achieved.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Studies on fluorescently labeled gelatin-siloxane nanoparticles conjugated to SynB1 also showed increased <i>in vitro</i> transport through the BBB and <i>in vivo</i> delivery to the brain.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The BBB transport characteristics (influx and efflux) of five structurally different CPPs (pVEC, SynB3, Tat 47–57, transportan 10 (TP10), TP10-2) were investigated <i>in vivo</i> (intravenous injection into mice) using radiolabeled peptides.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Cationic CPPs like SynB3 showed high brain influx rates, and except for pVEC, all investigated peptides demonstrated a significant efflux from the brain; however, among them, SynB3 had the lowest extent of efflux. According to this study, the estimated cell-penetrating ability of SynB3 is lower than that of pVEC;<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> therefore, despite the higher efflux rate of SynB3, a higher degree of selectivity could be achieved by its application.</div><div class="NLM_p">CPPs provide an effective way of intracellular drug delivery; however, lack of cell-type specificity remains a major disadvantage for their clinical development. A promising strategy to increase the specificity of CPP-based drug delivery toward tumor cells is the conjugation of CPPs to targeting ligands such as homing peptides or tumor-penetrating peptides.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A potential target for achieving the specificity is the neuropilin-1 (NRP-1) transport system. NRP-1 is expressed in most tissues; however, it is upregulated in angiogenic tumor blood vessels (including brain endothelial cells) and usually in tumor cells.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Furthermore, it was reported that NRP-1 is overexpressed in gliomas and NRP-1 expression is increased with the elevation of glioma grade.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> NRP-1 is a transmembrane glycoprotein with multiple domains. It functions as a coreceptor for several extracellular ligands including various forms of vascular endothelial growth factor (VEGF) and class 3 semaphorins.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Among others, NRP-1 plays a crucial role in angiogenesis, axonal guidance, and cell migration.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The ligands of NRP-1 often possess a CendR motif (R/KXXR/K, C-end rule), which was identified as a key aspect for tumor and tissue penetration through the activation of an endocytotic/exocytotic transport named the CendR pathway.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> The C-terminal lysine or arginine is crucial for the activity of the ligands. Blocking the free carboxyl group of this lysine or arginine residue by amidation or elongating the sequence with other amino acids can eliminate the binding and the cellular uptake of the peptide. However, the internal (cryptic) R/KXXR/K motif in the ligand can also be adequate, since it can be exposed and switched on by proteolytic cleavage at the site of action.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The binding of the cargo carrying CendR peptide to NRP-1 initiates an endocytic process that is distinct from the known endocytosis pathways.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This process is presumably followed by the releasing of exosomes containing CendR peptide-conjugated cargo to accomplish cell-to-cell transport and consequently effective tissue penetration (or reaching the tumor side of the endothelium).<a onclick="showRef(event, 'ref33 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref40">(33,40)</a> Successful <i>in vitro</i> and <i>in vivo</i> tumor penetration of drugs or drug-loaded nanoparticles was achieved with the aid of various CendR peptides.<a onclick="showRef(event, 'ref33 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref39 ref40">(33,39,40)</a></div><div class="NLM_p">Tuftsin is a naturally occurring tetrapeptide (human, TKPR; canine, TKPK) produced by enzymatic cleavage of the Fc domain of the heavy chain of immunoglobulin G (IgG). Tuftsin has a wide range of biological activities such as the immunostimulatory effect and antitumor activity through the activation of immunologic effector cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Furthermore, tuftsin binds to NRP-1, it has a highly similar sequence to the C-terminus of VEGF-A165 (DKPRR), and tuftsin competes with it for binding to NRP-1.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> An antagonist analogue of tuftsin, TKPPR, that has a higher affinity for tuftsin receptors on phagocytic cells<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and possesses a CendR motif, binds to NRP-1 approximately 20-fold more avidly than tuftsin.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Moreover, sequential oligopeptides based on tuftsin have been developed and used as effective carriers in monocyte related targeting.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46−50)</a></div><div class="NLM_p">Finding new drugs is also a promising tool in the combat against gliomas. Salicylanilides (2-hydroxy-<i>N</i>-phenylbenzamides) have shown a wide variety of interesting biological activities including antimicrobial and antitumor effects.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> Niclosamide is an oral antihelminthic salicylanilide drug, and recent studies identified it as a potential anticancer agent. However, its poor bioavailability because of its limited water solubility is an obstacle. Niclosamide targets mitochondria by uncoupling oxidative phosphorylation and inducing cell cycle arrest, growth inhibition, and apoptosis. In addition, it also inhibits several signaling pathways (e.g., Wnt/β-catenin, mTORC1, STAT3, NF-κB, Notch).<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> Since the dysfunction of most of these pathways is involved in cancer stem cells, niclosamide is promising at destroying them.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Furthermore, the inhibitory effects of niclosamide on primary human glioblastoma cells were also demonstrated by suppressing signaling pathways. Pre-exposure to niclosamide significantly diminished the malignant potential of glioblastoma cells <i>in vivo</i>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Another study found that niclosamide induced cytotoxicity in human glioblastoma cells (U87) with increased protein ubiquitination, endoplasmic reticulum (ER) stress, and autophagy.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Overall, these findings suggest that salicylanilide derivatives with an effective drug delivery system could be useful therapeutic candidates against GBM.</div><div class="NLM_p last">In this study, we designed drug-peptide conjugates of SynB3 and tuftsin derivatives. Conjugates of tandem peptides composed of both SynB3 and tuftsin derivatives were also used to combine the advantages of these peptides and to develop selective delivery systems. In the case of tandem peptides, we hypothesized that SynB3 derivatives used as cell-penetrating peptides with the ability to cross the BBB are more effective in transferring drugs through the endothelial barrier, whereas tuftsin derivatives as CendR peptides also assist in vascular translocation and they provide target specificity and tumor penetration.<a onclick="showRef(event, 'ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59 ref60 ref61">(57−61)</a> As drug candidates against glioblastoma, we used new salicylanilide derivatives (Sal). A conventional antitumor agent daunomycin (Dau, which has a poor penetration into the brain due to the multidrug resistance mechanism<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>) and the first-line anti-glioblastoma agent temozolomide (TMZ, which is able to cross the BBB, but improved selectivity is needed<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a>) were also applied. Here we report the design, <i>de novo</i> synthesis, chemical characterization, and <i>in vitro</i> evaluation of new salicylanilide derivatives, salicylanilide-, daunomycin-, and temozolomide-peptide conjugates. Secondary structure analysis, lysosomal degradation, cytostatic and cytotoxic activity, cellular uptake, intracellular localization in cell culture monolayers, and penetration ability of conjugates on <i>ex vivo</i> and <i>in vitro</i> BBB models and into three-dimensional (3D) tumor spheroids are presented.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis and Chemical Characterization of Peptide Conjugates</h3><div class="NLM_p">The summarized schematic structures of the compounds used in this study are presented in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Salicylanilide derivatives Sal1, Sal2, and Sal3 were prepared as described before.<a onclick="showRef(event, 'ref50 ref63'); return false;" href="javascript:void(0);" class="ref ref50 ref63">(50,63)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structures of (A) Salicylanilide Derivatives, (B) Daunomycin, and (C) Synthesis of Temozolomide-Carboxylic Acid, (D) Conjugation of Salicylanilide and Daunomycin to (Aminooxy)acetylated Peptide Derivatives to Obtain Drug-Peptide Conjugates with an Oxime Bond, (E) Synthesis of Temozolomide Conjugates to Obtain a Drug-Peptide Conjugate with an Amide Bond, and (F) the Summarized Schematic Structure of the Carrier Peptide Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The carrier peptides were synthesized by solid phase peptide synthesis using the standard Fmoc/<i>t</i>Bu strategy. The synthesis of tuftsin derivatives is presented in our previous work.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> SynB3 and tuftsin derivatives were modified with decanoic acid chains to enhance the lipophilicity, membrane affinity, cell penetration, and endosomal escape properties as well as the encapsulation efficacy of peptides.<a onclick="showRef(event, 'ref50 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref50 ref64 ref65 ref66">(50,64−66)</a> Peptides with an acetylated or free N-terminus were prepared as controls. Fluorescently labeled peptides with 5(6)-carboxyfluorescein at the N-termini (Cf-peptide derivatives) were prepared for the cellular uptake studies. For the conjugation, the N-termini of the peptides were (aminooxy)acetylated (Aoa-derivatives). The C-terminus of the peptides was obtained in amide form; only in the case of TKPPR and SynB3-TKPPR, the C-terminus was obtained in carboxyl form after cleavage from resin.</div><div class="NLM_p">Conjugable salicylanilide Sal3 (<i>N</i>-(4-acetylphenyl)-5-bromo-2-hydroxybenzamide) and daunomycin (Dau) were conjugated to the peptides via an oxime bond, directly or by the insertion of an enzyme cleavable linker (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The oxime bond is stable between pH 3 and 8;<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> the incorporation of a GFLG tetrapeptide between the drug and the carrier moiety might be necessary for sufficient drug release and efficacy. The GFLG linker can be cleaved by the lysosomal cathepsin B that is present at elevated levels in cancer cells.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> The salicylanilide- and daunomycin-peptide conjugates were prepared by oxime bond formation from the appropriate (aminooxy)acetylated peptide and the oxo-group-containing drug molecules as described earlier.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The conjugation was followed by analytical RP-HPLC (<a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>). Although doxorubicin-SynB3 conjugate (an analogue to Dau-SynB3 conjugate) was prepared and evaluated by Rousselle et al.,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the Dau-Aoa-SynB3 conjugate presented here represents a new molecule that is basically different from the doxorubicin-SynB3 not only in the drug molecule (Dau vs doxorubicin) but also in the bond between the drug and peptide (oxime vs amide).</div><div class="NLM_p">The detected metabolites containing the N-terminal amino acid and drug molecule as the smallest lysosomal degradation products were also synthesized using amino acids functionalized with an (aminooxy)acetyl group, and these Aoa-amino acid derivatives were conjugated to Sal3 or Dau as described earlier.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Temozolomide was modified by diazotation and hydrolysis to obtain temozolomide-carboxylic acid (TMZA) (<a class="ref internalNav" href="#notes1" aria-label="Figures S2 and S3">Figures S2 and S3</a>—characterization of TMZA). TMZA was coupled to SynB3 peptide derivatives via an amide bond on the solid phase, and the conjugates were cleaved from the resin<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The peptide derivatives and conjugates were purified using semipreparative RP-HPLC and chemically characterized by mass spectrometry (a mass coinciding with the calculated value) and analytical RP-HPLC (a purity of at least 95%) (<a class="ref internalNav" href="#notes1" aria-label="Table S1, Figure S4">Table S1, Figure S4</a>).</div><div class="NLM_p">The compounds were characterized by their estimated lipophilicity profile by means of their retention time obtained by RP-HPLC and calculated logP values obtained by the Chemicalize online platform (<a href="https://chemicalize.com/app/calculation" class="extLink">https://chemicalize.com/app/calculation</a>, ChemAxonPASS), as detailed in the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information, Figure S5">Supporting Information, Figure S5</a>. The carrier peptides are less lipophilic than the corresponding conjugates, there is no significant difference between the lipophilicity of the corresponding Dau- and Cf-peptides, while the corresponding Sal3-conjugates possess the most lipophilic character.</div><div class="NLM_p last">The stability of the conjugates was investigated under the conditions applied in <i>in vitro</i> studies using analytical RP-HPLC and mass spectrometry. The conjugates were stable in DMSO at 4 °C at least for 4 weeks. Dau-conjugates and Sal3-conjugates were stable in DMEM supplemented with 2.5% FBS (37 °C, 5% CO<sub>2</sub>) at least for 24 h (<a class="ref internalNav" href="#notes1" aria-label="Figure S6">Figure S6</a>). The TMZ-conjugates, TMZ-SynB3 and TMZ-GFLG-SynB3, decomposed in DMEM supplemented with 2.5% FBS with a half-life of 20 min (<a class="ref internalNav" href="#notes1" aria-label="Figure S7">Figure S7</a>). TMZ is a prodrug; it is stable at acidic pH (e.g., in the stomach) but hydrolyzes at physiological pH (pH 7.4, e.g., blood, cell culture medium) to the active and unstable 5-(3-methyl-triazen-1-yl)imidazole-4-carboxamide (MTIC) which rapidly decomposes to form the highly reactive methylating agent methyldiazonium cation and to the inactive 5-amino-1<i>H</i>-imidazole-4-carboxamide (AIC).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Conjugated TMZ possesses the same feature in the cell culture medium, resulting in some inactive AIC-peptide derivatives.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Circular Dichroism Spectroscopic Evaluation of the Secondary Structure of SynB3 and Tuftsin Derivatives</h3><div class="NLM_p">The solution conformation of the acetylated tuftsin-antagonist peptide TKPPR, SynB3, and its tandem TKPPR derivative was studied under different solvent conditions employing CD spectroscopy in the far ultraviolet region. This highly sensitive method is widely used for determining and monitoring the secondary structure of proteins and peptides.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The CD curve of all acetylated peptides measured in water displayed a sole negative band with a minimum between 196 and 204 nm, suggesting the ensemble of various conformers (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). This picture is in line with the cationic nature of SynB peptides where electrostatic repulsions between abundant, positively charged side chains hinder helix formation. The 6 nm red shift in the CD extremum of Ac-TKPPR with respect to the SynB3 spectrum is due to the different excitation energies of imino- and amino acid-containing peptide bonds. Distinct from other residues, proline is an imino acid and makes not a secondary but a tertiary amide bond, the π–π* transition of which is at longer wavelengths.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Due to this reason, the proline residues also affect the λ<sub>min</sub> position of the tandem peptide, shifting it to 199 nm (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). However, in a helix-promoting solvent like trifluoroethanol (TFE), this coil-like CD feature changed considerably to an intense, π–π* type CD couplet and an unresolved broad n−π* component centered around 220 nm (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C). This spectral pattern is indicative of the TFE-induced formation of an organized, right-handed α-helical secondary structure.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Since haloalcohols provide a membrane-mimicking environment,<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> these spectroscopic results predict that upon contact with lipid membranes Ac-SynB3 readily adopts amphipathic helices. Compared to the parent peptide, qualitatively similar spectral alterations were obtained for the Ac-SynB3-TKPPR derivative (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C). Noticeably, however, the magnitude of the positive branch of the CD couplet at 193 nm lags behind that of Ac-SynB3 in both TFE and TFE–H<sub>2</sub>O mixture which refers to the less prone helical folding of the tandem peptide. This conclusion is supported by the CD curves of Ac-TKPPR that exhibited minor variations only upon the addition of TFE (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C). The amplitude of the main band at 203 nm reduced modestly, and a very weak positive peak developed below 190 nm together with a slight intensification of the n−π* signals above 215 nm. According to these observations, the pentapeptide is highly resistant to the helix-promoting effect of TFE that is related to the high abundance of the helix breaker proline residues.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> Thus, its coupling to SynB3 does not improve but rather impairs the overall helical propensity of the hybrid sequence. It is to be noted that the experimental CD spectra of the tandem compound can be approximated as the arithmetic sums of scaled CD curves of native SynB3 and TKPPR measured in the same solvent (data not shown). Therefore, it seems that the original structural properties of the covalently linked components in the hybrid peptide are not much altered and thus display additive CD contributions.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Far-UV CD spectra of SynB3 peptides and TKPPR measured in (A) deionized water, (B) water:TFE 1:1 mixture, and (C) 100% TFE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The outcomes of the above qualitative evaluation were in general agreement with the results of the deconvolution of the CD spectra into major structural components (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The unordered fraction represents a prominent contribution (∼70–80%) for each peptide dissolved in water. Upon rising TFE concentrations, it progressively declines for Ac-SynB3 and the tandem derivative but hardly reduces in Ac-TKPPR. Concomitantly, at the expense of that content, the α-helical component greatly increased in both SynB3 peptides albeit to a lesser extent for the hybrid sequence which exhibits a significant (26%) unordered fraction even in 100% TFE.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Estimation of the Secondary Structure Content (%) of Acetylated SynB3 and TKPPR Peptides<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">H<sub>2</sub>O</th><th class="colsep0 rowsep0" align="center">H<sub>2</sub>O:TFE</th><th class="colsep0 rowsep0" align="center">TFE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Ac-SynB3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-helix</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-sheet</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">disordered</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">turns</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sup>2</sup></td><td class="colsep0 rowsep0" align="left">0.9909</td><td class="colsep0 rowsep0" align="left">0.9340</td><td class="colsep0 rowsep0" align="left">0.9660</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Ac-TKPPR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-helix</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-sheet</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">disordered</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">turns</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sup>2</sup></td><td class="colsep0 rowsep0" align="left">0.9906</td><td class="colsep0 rowsep0" align="left">0.9946</td><td class="colsep0 rowsep0" align="left">0.9960</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center">Ac-SynB3-TKPPR</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α-helix</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-sheet</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">disordered</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">turns</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sup>2</sup></td><td class="colsep0 rowsep0" align="left">0.9940</td><td class="colsep0 rowsep0" align="left">0.9683</td><td class="colsep0 rowsep0" align="left">0.9780</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Far-UV CD spectroscopic data were analyzed by using the MS Excel version of the PEPFIT program.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Lysosomal Digestion Profile of the Conjugates in Rat Liver Lysosomal Homogenate</h3><div class="NLM_p">If the conjugates get into the lysosomes, they can undergo hydrolysis at the lysosomal acidic pH (pH 4.5–5.0) and in the presence of hydrolytic enzymes.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> To identify the smallest drug-containing metabolite, we investigated the digestion profile of the conjugates in rat liver lysosomal homogenate by LC-MS. Analyses (LC-MS chromatogram, mass spectra) of the degradation process are presented in <a class="ref internalNav" href="#notes1" aria-label="Figures S8–S14">Figures S8–S14</a>.</div><div class="NLM_p">The detected main cleavage sites of the conjugates are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A. As was observed in previous studies,<a onclick="showRef(event, 'ref50 ref79'); return false;" href="javascript:void(0);" class="ref ref50 ref79">(50,79)</a> the smallest, drug-containing metabolite is the oxime bonded drug molecule with the N-terminal amino acid of the conjugates that are listed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B. No significant cleavage of the oxime bond and no free salicylanilide or Dau was observed. The degradation of Sal3-Aoa-SynB3 was very fast, and after 4 h, the main metabolite was the smallest one, Sal3-Aoa-Arg-OH. The degradation of Dau-Aoa-SynB3 was also quick with a similar pattern to Sal3-Aoa-SynB3. After 5 min, in both cases, the main metabolite was released by the cleavage of the -<sup>2</sup>Arg-<sup>3</sup>Leu- bond (Sal3-Aoa-RR-OH and Dau-Aoa-RR-OH), but interestingly in the case of Dau-Aoa-SynB3, the degradation of Dau-Aoa-RR-OH into Dau-Aoa-Arg-OH was not complete even after 24 h, as we could find both metabolites. However, it was observed that the -Arg-Leu- bond is a favorable cleavage site in all SynB3-containing conjugates. For the enzyme-labile-linker-containing conjugate, Sal3-Aoa-GFLG-SynB3, the presence of the GFLG linker led to an increased degradation rate as we observed in previous studies.<a onclick="showRef(event, 'ref50 ref79'); return false;" href="javascript:void(0);" class="ref ref50 ref79">(50,79)</a> The smallest drug-containing metabolite already appeared after 5 min in a small amount, and after 1 h, only this metabolite could be detected. However, in the case of Dau-Aoa-GFLG-SynB3, Dau-Aoa-Gly-OH appeared later, after 1 h, in a small amount. The Dau-Aoa-GF-OH was the main metabolite for 8 h, and it was still present after 24 h in a small amount. In the case of Sal3-Aoa-TKPPR<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and Dau-Aoa-TKPPR, the first cleavage site after 5 min was the cleavage of the -<sup>4</sup>Pro-<sup>5</sup>Arg- bond. The detected drug-Aoa-TKPP-OH metabolites turned out to be highly stabile in rat liver lysosomal homogenate; these were the main metabolites after 24 h in both cases. Sal3-Aoa-Thr-OH appeared after 1 h, while Dau-Aoa-Thr-OH only appeared after 24 h in a very small amount, and this might affect the cytostatic activity of both TKPPR conjugates. The Dau-Aoa-SynB3-TKPPR tandem conjugate had the same degradation pattern as Dau-Aoa-SynB3; after 24 h, the released metabolites were Dau-Aoa-RR-OH and Dau-Aoa-Arg-OH. Overall, the type of the conjugated drug also played a role in the release of the smallest, drug-containing metabolites. The resulting two amino acid-containing Dau-metabolites had a slower degradation rate than the corresponding Sal3-metabolites.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Main cleavage sites during the degradation process of new conjugates in rat liver lysosomal homogenate and (B) the smallest, drug-containing metabolites produced from the conjugates (*: results are taken from ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Cytostatic and Cytotoxic Activity</h3><div class="NLM_p">Determination of the <i>in vitro</i> cytostatic (inhibition of cell growth and multiplication) or cytotoxic (direct killing effect, direct decrease in cell viability) effect of the compounds was carried out on different cell cultures using MTT or SYBR-Green assay. The U87 human glioblastoma cell line is a model cell for gliomas. To compare the activity of the compounds, we also used a different brain tumor model, the MDA-MB 435Br brain metastasis cell line.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> MDA-MB 435 was originally classified as a breast cancer cell line,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> but recent findings point to a rather melanocytic origin of this cell line.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In this study, we used a subcell line of MDA-MB 435 that was established from a brain metastasis in nude mice. Human umbilical vein endothelial cells (HUVECs) were used to model tumor related vascular endothelial cells and also healthy, nontumor cells to get insight into the selectivity of the compounds. Furthermore, the MonoMac6 human monocytic cell line was used for modeling phagocytes that eliminate foreign substances such as conjugates from the blood. The HepG2 human hepatocellular carcinoma cell line represents a model to test hepatotoxicity. The cytostasis results on U87 and MDA-MB 435Br and cytotoxicity results on HUVECs of selected compounds after 24 h of treatment are presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> (for statistical analysis, see <a class="ref internalNav" href="#notes1" aria-label="Figures S15 and S16">Figures S15 and S16</a>). The IC<sub>50</sub> values corresponding to all studied compounds on the aforementioned cell cultures, completed with the 3 h cytostatic effect on U87 cells, the 3 and 24 h cytostatic effect on MonoMac6, the 24 h cytostatic effect on HepG2 cells, and the 24 h cytotoxic effect on U87 cells, are summarized in <a class="ref internalNav" href="#notes1" aria-label="Table S2">Table S2</a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> cytostatic activity of the representative compounds on (A) U87 and (B) MDA-MB 435Br cell cultures and (C) cytotoxicity on HUVEC after 24 h treatment. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the case of the U87 cells during a short, 3 h treatment, we observed that free salicylanilides had high cytostatic activity with the exception of the conjugable Sal3 (<a class="ref internalNav" href="#notes1" aria-label="Table S2">Table S2</a>). Salicylanilides (Sal1, Sal2, niclosamide) that both in the salicylic acid ring and in the aniline ring contain halogen substituents are more potent than Sal3 where halogen on the aniline ring was replaced by an acetyl group.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> During the longer, 24 h treatment, the IC<sub>50</sub> values of the salicylanilides decreased and even Sal3 had a high cytostatic activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As expected, Dau had the lowest IC<sub>50</sub> value in the case of all of the examined cell lines. However, under these experimental circumstances, TMZ was ineffective probably due to its rapid decomposition under physiological conditions.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Most of the control peptides had no cytostatic activity on U87 cells, except for the SynB3 derivatives with the decanoic acid side chain modification showing moderate cytostatic activity. These molecules containing a hydrophobic decanoyl side chain and a hydrophilic cationic peptide have an amphipathic characteristic; thus, probably they are more capable of damaging the cell membrane and causing cell death. Importantly, salicylanilide-SynB3 conjugates (Sal3-Aoa-SynB3 and Sal3-Aoa-GFLG-SynB3) had cytostatic activity after 3 h in contrast with the free Sal3. After 24 h treatment, the conjugate with the enzyme labile linker (Sal3-Aoa-GFLG-SynB3) had a similar IC<sub>50</sub> value to the free Sal3 (21.1 ± 1.4 μM vs 17.3 ± 5.4 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The Sal3-tuftsin conjugates were ineffective at the highest measured concentration with the exception of the decanoyl-containing conjugate, Sal3-Aoa-T5(4-dec), which is in correlation with the lysosomal degradation and cellular uptake of these conjugates.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The Dau-SynB3 conjugates showed outstanding cytostatic activity against U87 cells; however, the IC<sub>50</sub> values did not decrease significantly with the longer treatment time (IC<sub>50</sub> between 5.5 and 17.0 μM after 24 h). The Dau-tuftsin conjugates were also ineffective after 3 h with the exception of the decanoyl-containing conjugate, while, after 24 h, they all showed cytostatic activity mostly with similar or slightly higher IC<sub>50</sub> values (6.2–74.7 μM) than the Dau-SynB3 conjugates. The Dau-Aoa-TKPPR conjugate was the least effective among them with a moderate IC<sub>50</sub> value. The tandem conjugates (Dau-Aoa-SynB3-T5, Dau-Aoa-SynB3-TKPPR) had cytostatic activity after 24 h and also after 3 h with IC<sub>50</sub> values between the IC<sub>50</sub> values of Dau-Aoa-SynB3 and the corresponding tuftsin conjugates (Dau-Aoa-T5, Dau-Aoa-TKPPR). The TMZ-conjugates acted similarly as the free TMZ; their rapid decomposition resulted in no cytostatic effect. The smallest metabolites of the salicylanilide conjugates produced during lysosomal degradation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) had no activity on any of the studied cell cultures. In contrast, the metabolites of the Dau-conjugates showed cytostatic activity against U87 cells with the exception of Dau-Aoa-Thr-OH metabolite (<a class="ref internalNav" href="#notes1" aria-label="Table S2">Table S2</a>).</div><div class="NLM_p">The salicylanilides had outstanding activity on the MDA-MB 435Br breast tumor brain metastasis cell line, and the conjugable Sal3 also had a high cytostatic activity after 24 h treatment (IC<sub>50</sub> between 0.6 and 19.5 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The activity of the conjugates showed a similar tendency as in the case of U87 cells but with higher IC<sub>50</sub> values. The most active ones were the Dau-Aoa-GFLG-SynB3 conjugate with the enzyme labile linker and the Dau-Aoa-T5(4-dec) conjugate with the decanoyl side chain; both conjugates have amphipathic characteristics.</div><div class="NLM_p">In the case of HUVECs, Dau and most of the salicylanilides had similar cytotoxic activity with low IC<sub>50</sub> value (6.1–8.6 μM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). In contrast, Sal3, the control peptides, and the Sal3- and Dau-conjugates were not cytotoxic on HUVECs at the highest measured concentration; only Dau-Aoa-GFLG-SynB3 showed a slight cytotoxic effect (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, <a class="ref internalNav" href="#notes1" aria-label="Table S2">Table S2</a>).</div><div class="NLM_p last">Altogether, in the case of the Sal3-SynB3 conjugates and all Dau-peptide conjugates, the <i>in vitro</i> cytostatic and cytotoxic activity against U87 and MDA-MB 435Br is preserved upon conjugation to the peptides through an oxime bond, although the IC<sub>50</sub> values of the conjugates in most cases are higher than the IC<sub>50</sub> values of the free drugs. However, this decrease in activity could be compensated by the possible selectivity and reduction in toxic side effects provided by the conjugation.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> If we compare the lack of cytotoxicity of the conjugates on HUVECs with the good cytostatic and cytotoxic activity on U87 and MDA-MB 435Br tumor cell lines, we can conclude that the conjugates have <i>in vitro</i> selectivity toward the tumor cells.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cellular Internalization of Fluorescently Labeled Carrier Peptides</h3><div class="NLM_p">The pH dependence of the fluorescence intensity of 5(6)-carboxyfluorescein-labeled peptides and daunomycin-conjugates was studied in a pH range between 4.0 and 7.6, representing the pH values of different cellular compartments.<a onclick="showRef(event, 'ref50 ref86'); return false;" href="javascript:void(0);" class="ref ref50 ref86">(50,86)</a> The results are presented in <a class="ref internalNav" href="#notes1" aria-label="Figures S17 and S18">Figures S17 and S18</a>. The fluorescence intensity of Cf-peptides showed pH dependence, while Dau-conjugates showed no significant emission changes. In both cases, the SynB3 derivatives had a slightly lower fluorescence intensity than the tuftsin derivatives and the intensities of the tandem derivatives were between the value of SynB3 and the value of tuftsin derivatives.</div><div class="NLM_p">The <i>in vitro</i> cellular uptake of Cf-peptides was studied on the U87 cell culture using flow cytometry. The cells were treated with the compounds, and after washing and trypsinization, the rate of fluorescence positive, living cells (rate of living Cf+ cells) and the intracellular fluorescence intensity of this population (mean fluorescence intensity of living Cf+ cells) were measured and are related to the cellular uptake rate. A quantified value of the uptake rate, UC<sub>50</sub> (concentration of compounds where the rate of fluorescence positive cells reaches 50%<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a>) can be drawn from the ratio of fluorescence positive cells at different concentrations. Furthermore, from the rate of all living cells at different compound concentrations, the cytotoxicity of the compounds (IC<sub>50</sub> value) can be determined.</div><div class="NLM_p">The surface-bound peptides were removed by treating the cells with trypsin for different incubation times.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> This proteolytic step is used to detach adherent cells from the cell culture plate as well as to digest the cell surface proteins and surface-bound peptides. To detach U87 cells from the wells, in general, 3 min of trypsinization was used. Increasing the treatment time of trypsinization did not result in a significant decrease in fluorescence intensity (<a class="ref internalNav" href="#notes1" aria-label="Figure S19A">Figure S19A</a>). In order to distinguish membrane-bound peptides from internalized ones, trypan blue was also used to quench the external fluorescence. Trypan blue is impermeable for living cells and quenches the extracellular green fluorescence; therefore, only the internal fluorescence can be detected.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> No significant difference was observed after eliminating the cell-surface associated fluorescent signal (<a class="ref internalNav" href="#notes1" aria-label="Figure S19B,C">Figure S19B,C</a>). These results obtained from longer trypsin treatments and trypan blue quenching indicate that the majority of the peptides were internalized rather than associated with the cell membrane.</div><div class="NLM_p">The uptake of all carrier peptides on U87 cells was compared, and cells were treated with up to 50 μM concentrations of the peptides for 3 h. Their uptake was concentration dependent, as we can see in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and with more details in <a class="ref internalNav" href="#notes1" aria-label="Figure S20">Figure S20</a>. At concentrations where nearly 100% of the cells are fluorescence positive (all cells contain fluorescent peptide, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), we can see the differences in the corresponding mean fluorescence intensity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) and also in the determined UC<sub>50</sub> values (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The SynB3 derivatives had a significantly higher uptake rate than the uptake rate in the case of the tuftsin derivatives. This finding is in line with the secondary structure of the peptides, suggesting that upon contact with lipid membranes SynB3 derivatives adopt amphipathic helices while tuftsin derivatives remain disordered. The decanoyl-containing SynB3 derivative (Cf-SynB3K(dec)) had an extremely high internalization rate, but it showed a cytotoxic effect with an IC<sub>50</sub> value of 41.9 μM (<a class="ref internalNav" href="#notes1" aria-label="Figure S20">Figure S20</a>). All of the other carrier peptides showed no cytotoxicity at the highest concentration (50 μM). Among the tuftsin derivatives, the presence of the decanoyl side chain (in Cf-T5(4-dec)) also enhanced the uptake rate but without causing cytotoxicity. Using the tuftsin derivative Cf-TKPPG-OT10 with the same net charge as the cell-penetrating peptide Cf-SynB3 (the net charge at neutral pH is +5 for both) did not result in a similar internalization rate, since Cf-TKPPG-OT10 had as low of an uptake rate as most of the other tuftsin derivatives. The internalization profile of the tandem peptides (Cf-SynB3-T5, Cf-SynB3-TKPPR) was similar to Cf-SynB3. The intracellular fluorescence intensity of the cells treated with these three peptides was the highest in the case of the tandem Cf-SynB3-T5 at 25 and 50 μM. According to the performed statistical analysis (Kruskal–Wallis test with multiple comparisons), the fluorescence intensity profile of Cf-SynB3K(dec) is significantly different from the profile of peptides Cf-T5, Cf-GFLG-T5, Cf-T5(4-dec), and Cf-TKPPR (for details, see <a class="ref internalNav" href="#notes1" aria-label="Table S3">Table S3</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the cellular uptake of the 5(6)-carboxyfluorescein-labeled peptide derivatives on U87 cells at different concentrations using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the peptides. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also studied the time dependence of the internalization rate of the cell-penetrating peptide Cf-SynB3, tuftsin derivative Cf-TKPPR, and their tandem conjugate Cf-SynB3-TKPPR at 25 μM between 5 min and 3 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In the case of Cf-SynB3, the ratio of fluorescence positive cells reached 100% very rapidly and after 5 min there was no significant increase in the mean intracellular fluorescence intensity of the cells. Rapid cellular uptake was observed also in the case of the tandem peptide in the aspect of the percentage of fluorescence positive cells; however, the intracellular fluorescence intensity further increased with time. Even after 3 h, the internalization rate of the tandem peptide remained slightly below the rate of the parent Cf-SynB3. Peptide Cf-TKPPR demonstrated slower cellular uptake it took 3 h to reach 100% of fluorescence positive cells and the corresponding fluorescence intensity is much lower than the intensity of the other two peptides.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time dependence of the cellular internalization of cell-penetrating peptide Cf-SynB3, tuftsin derivative Cf-TKPPR, and their tandem conjugate Cf-SynB3-TKPPR. (A) Comparison of the ratio of the living fluorescence positive U87 cells and (B) mean fluorescence intensity of living, fluorescence positive cells at different incubation times at 25 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cellular Internalization of Dau-Peptide Conjugates</h3><div class="NLM_p">The <i>in vitro</i> cellular uptake of the Dau-peptide conjugates was also compared on the U87 cell culture using flow cytometry. The cells were treated with the compounds for 3 h, and after washing and trypsinization, the intracellular fluorescence intensity of the cells was measured. The uptake of the compounds was concentration dependent on U87 cells, as we can see in <a class="ref internalNav" href="#notes1" aria-label="Figure S21">Figure S21</a>. Results obtained at 25 μM conjugate concentration are shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. The internalization of the free Dau was the highest, as expected. Interestingly, the ratio of the fluorescence positive cells after the treatment with Dau-conjugates was lower than in the case of the treatment with the corresponding Cf-peptides. The ratio of fluorescence positive cells reached nearly 100% in the case of all Cf-peptides at 50 μM concentration. However, the ratio for most of the Dau-conjugates with tuftsin derivatives is below 100% at 50 μM (<a class="ref internalNav" href="#notes1" aria-label="Figure S21">Figure S21</a>). This shows the obvious fact that labeling molecules also have a role in the internalization processes and it can cause a significant difference in the uptake of the same peptide derivative (Dau can also be considered as a labeling molecule).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> However, mostly similar conclusions can be drawn if we compare the different conjugates to each other: the uptake rates of Dau-SynB3-conjugates were significantly higher than the uptake rates of most Dau-tuftsin-conjugates; the rate of the tandem conjugates resembled or was slightly lower than the rate of Dau-Aoa-SynB3. The SynB3-conjugates with high amphipathic characteristics showed a cytotoxic effect: hydrophobic-linker-containing Dau-Aoa-GFLG-SynB3 and hydrophobic-decanoyl-containing Dau-Aoa-SynB3K(dec) had an IC<sub>50</sub> value of 28.2 and 32.0 μM, respectively (<a class="ref internalNav" href="#notes1" aria-label="Figure S21">Figure S21</a>). The uptake of Dau-Aoa-SynB3K(dec) was not outstanding compared to the uptake of its Cf-analogue (Cf-SynB3K(dec)). Interestingly, the uptake of the decanoyl-containing tuftsin conjugate, Dau-Aoa-T5(4-dec), had a similarly high internalization as the Dau-SynB3-conjugates. This salient uptake of Dau-Aoa-T5(4-dec) is reflected in its high cytostatic activity on U87 cells. We also studied the uptake of the smallest, Dau-containing metabolites produced during lysosomal degradation to get a hint about their membrane crossing ability that can be significant in their transport across intracellular membranes (e.g., membranes of lysosomes and cell nuclei). Dau-Aoa-Gly-OH showed the highest internalization rate among these metabolites. This finding is in correlation with its superior cytostatic activity after 3 h in U87 cells among the Dau-metabolites. The uptake of Dau-Aoa-Thr-OH was the lowest among the metabolites; this explains why it showed no cytotoxic activity in U87 cells. Probably this metabolite cannot get sufficiently near its site of action when released from its parent conjugate (Dau-Aoa-TKPPR). Moreover, the very slow release of this metabolite from its parent conjugate observed in rat liver lysosomal homogenate could also be in correlation with the low antitumor efficacy of Dau-Aoa-TKPPR.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the cellular uptake of Dau-peptide conjugates at 25 μM on U87 cells using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the conjugates. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Statistical analysis (Kruskal–Wallis test with multiple comparisons) shows that both the fluorescence intensity profile and percentage of Dau+ cells of Dau-treated cells are significantly different from the profiles of the following conjugates: Dau-Aoa-T5, Dau-Aoa-GFLG-T5, Dau-Aoa-TKPPG-OT10, Dau-Aoa-TKPPR, and Dau-Aoa-Arg-OH (for details, see <a class="ref internalNav" href="#notes1" aria-label="Table S4">Table S4</a>).</div><div class="NLM_p">We also compared the cellular uptake of Dau-Aoa-SynB3, Dau-Aoa-TKPPR, and their tandem conjugate Dau-Aoa-SynB3-TKPPR on the MDA-MB 435Br brain metastasis cell line (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a class="ref internalNav" href="#notes1" aria-label="Figure S22">Figure S22</a>). These cells internalize the SynB3-conjugate and the tandem conjugate to a similar extent. The cellular uptake of the tuftsin conjugate Dau-Aoa-TKPPR is very low (for statistical analysis, see <a class="ref internalNav" href="#notes1" aria-label="Table S5">Table S5</a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the cellular uptake of Dau-peptide conjugates at 25 μM on MDA-MB 435Br cells using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the conjugates. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Selected Dau-conjugates were studied in HUVECs that can be used for modeling tumor related vascular endothelial cells. As can be seen in <a class="ref internalNav" href="#notes1" aria-label="Figure S23">Figure S23</a>, Dau could enter these cells similarly as in the case of U87 cells with a very high uptake rate. Dau-SynB3 conjugates and tandem conjugates showed a superior uptake rate among the conjugates, and interestingly, the internalization rate of the tandem conjugate Dau-Aoa-SynB3-TKPPR was higher than the rate of the Dau-Aoa-SynB3 conjugate (for statistical analysis, see <a class="ref internalNav" href="#notes1" aria-label="Table S6">Table S6</a>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Intracellular Localization of Peptides and Conjugates</h3><div class="NLM_p">Besides the quantitative analysis of the cellular uptake by flow cytometry, the localization of peptides and conjugates was also studied in U87 cells by confocal laser scanning microscopy (CLSM). Different laser intensities were used in the case of compounds with low or high internalization to improve visualization and optimize the image quality; therefore, the CLSM observations cannot be considered as quantitative analysis but provide qualitative information about subcellular localization. Nuclear staining with Hoechst 33342 and lysosome staining with LysoTracker Deep Red (or LysoTracker Red DND-99) was performed in order to get insight into a possible colocalization with nuclei and lysosomes. All of the experiments were carried out with 30 and 90 min of incubation time, and no significant differences were observed between the different treatment periods. Here, only representative images after a 30 min treatment time are shown; images obtained after 90 min incubation time can be found in the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information (Figures S24−S26)">Supporting Information (Figures S24−S26)</a>.</div><div class="NLM_p">First, to rule out fixation artifacts in the cellular distribution of CPPs,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> we compared confocal images of live (unfixed, <a class="ref internalNav" href="#notes1" aria-label="Figure S24">Figure S24</a>) and fixed cells treated with Cf-peptides (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). After 30 min of incubation with Cf-peptides at 25 μM concentration, the U87 cells were directly visualized by CLSM, or the cells were fixed prior to visualization. We did not observe fixation artifacts; distribution of the peptides showed mostly identical patterns in both cases. Cf-SynB3 was located in the cytosol, in the nucleus, and in small, cytosolic compartments (vesicles that could be endosomes). A low lysosomal localization was also detected. This suggests that the uptake of this CPP is complex; not only does direct cell penetration play a role but also vesicular transport can occur.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In the case of Cf-TKPPR, the peptide showed predominant colocalization with lysosomes and no localization in the nucleus. This indicates that this tuftsin derivative mainly internalizes through a form of endocytosis, as expected. The Cf-SynB3-TKPPR tandem peptide could be detected both in the nucleus and in lysosomes; however, it could also be observed in the cytosol and in the proximity of the cell membrane. Presumably, Cf-SynB3-TKPPR follows the internalization mechanisms of both its CPP part and its tuftsin part, and the endolysosomal pathway is more pronounced than in the case of Cf-SynB3.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Localization of Cf-peptides in U87 cells (fixed) by confocal microscopy. Cells were incubated with Cf-labeled peptides (green, 25 μM, 30 min), lysosomes were stained with LysoTracker Deep Red (red), and nuclei were stained with Hoechst 33342 (blue). White arrows indicate examples of nuclear or lysosomal colocalization; yellow arrows indicate vesicular localization. The scale bar represents 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Modification of peptides with fluorophores could differently influence the biological properties of the peptides such as uptake and intracellular distribution.<a onclick="showRef(event, 'ref89 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref89 ref91 ref92">(89,91,92)</a> Hence, Dau can be considered as a fluorophore; therefore, we also investigated the intracellular distribution of Dau-conjugates comparing them with the corresponding Cf-peptides and Dau itself. U87 cells were treated with Dau and Dau-conjugates at 25 μM for 30 min and the cells were fixed prior to visualization (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). As expected, Dau was mainly localized in the nucleus. In the case of the Dau-Aoa-SynB3 conjugate, the Dau signal was mainly in the nucleus and vesicular localization could also be observed; there was no significant lysosomal localization. The Dau signal was mainly in the lysosomes in the case of Dau-Aoa-TKPPR. In the case of the tandem conjugate Dau-Aoa-SynB3-TKPPR, the Dau signal was in the nucleus and in lysosomes. These results showed that the localization patterns of corresponding Cf-peptides and Dau-conjugates are mostly identical. We can conclude that the compounds that contain the SynB3 motif can enter the cell nucleus, proving that the conjugated Dau can reach its site of action; however, conjugation with the peptides decreased the nuclear localization of Dau, and this could explain the reduction of the cytotoxic activity of the conjugates. The main difference between the Cf- and Dau-peptides was that the fluorescence signal in nuclei was more prevalent in the case of Dau-Aoa-SynB3 and Dau-Aoa-SynB3-TKPPR than in the case of the corresponding Cf-peptides (namely, Cf-SynB3 and Cf-SynB3-TKPPR). This phenomenon can be explained by the fact that Dau tends to accumulate in cell nuclei; therefore, these Dau-conjugates or their Dau-containing metabolites can enter cell nuclei and it is preferable, since Dau is a DNA-damage-inducing agent. Taken together with the rapid production of Dau-containing lysosomal metabolites (Dau-Aoa-Arg-OH) from these conjugates, presumably these observations contribute to their high cytostatic activity. In the case of Dau-Aoa-TKPPR, no significant accumulation of the Dau signal in the cell nucleus was observed, neither after a longer, 90 min treatment (<a class="ref internalNav" href="#notes1" aria-label="Figure S26">Figure S26</a>). After the treatment, the Dau-Aoa-TKPPR conjugate was still located in the lysosomes. The lysosomal degradation of this conjugate was slower, and it required more time to release the smallest Dau-containing metabolite. This and the finding of its low uptake rate could also be the reason for the high IC<sub>50</sub> value of this conjugate.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Localization of Dau and Dau-conjugates in U87 cells (fixed) by confocal microscopy. Cells were incubated with Dau or Dau-conjugates (red, 25 μM, 30 min), lysosomes were stained with LysoTracker Deep Red (green), and nuclei were stained with Hoechst 33342 (blue). White arrowheads indicate examples of nuclear or lysosomal colocalization; yellow arrowheads indicate vesicular localization. The scale bar represents 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Penetration Ability of the Conjugates on Lipid Monolayer and Transwell Co-Culture with Noncontact HUVEC-U87 Monolayers as <i>ex Vivo</i> and <i>in Vitro</i> BBB Model</h3><div class="NLM_p">The monomolecular lipid membrane model was used to characterize the interactions between the lipid monolayers and the selected Dau-conjugates (Dau-Aoa-TKPPR, Dau-Aoa-SynB3, and Dau-Aoa-SynB3-TKPPR). The membrane affinity was investigated by using the Langmuir technique employing brain extract polar lipid (BEPL) in chloroform to form a monomolecular lipid layer to mimic the BBB lipid composition (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A). Despite that DPPC and DOPC monolayers are widely used as a simplified model of the mammalian cell membrane, the BEPL mixture was applied in the present membrane affinity measurements as an <i>ex vivo</i> model. This can be considered as a more realistic model to mimic the composition of central nervous system barriers and neuronal membranes.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a></div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. The penetration ability of conjugates was assessed tensiometrically employing a Langmuir balance. (A) Schematic representation of the drug penetration studies using a Langmuir monolayer. (B) The degree of penetration (ΔΠ) of the selected Dau-conjugates into the BEPL monolayer after 30 min of interaction. Error bars represent the confidence intervals (95%) of the determined mean values calculated using Student’s <i>t</i> test from three parallel measurements (<i>p</i> < 0.05). (C) Schematic representation of the Transwell co-culture arrangement with noncontact monolayers as the BBB model containing HUVEC and U87 cells. HUVECs were seeded on the apical side of the TW insert, and U87 cells were seeded on the basolateral chamber employing coverslips. (D) Microscopic images of the HUVEC monolayer on the TW membrane; nuclei were stained with Hoechst 33342 (blue), the cytoplasm of the cells was stained with CMFDA (green), and the scale bar represents 50 μm. (E) CLSM images of U87 cells from the <i>in vitro</i> TW model, where Dau and Dau-conjugates (red, 50 μM, 45 min incubation) were added to the apical chamber. Nuclei of U87 cells from the basolateral chamber on coverslips were stained with Hoechst 33342 (blue); cells were fixed and analyzed by CLSM. The scale bar represents 50 μm. (F) Violin plots of intensity values derived from CLSM images of U87 cells from the <i>in vitro</i> Transwell model, where Dau or Dau-conjugates were added to the apical chamber. The overlaid box-and-whisker plots show the median (horizontal line), the interquartile range (box), and minimum and maximum values (whiskers) of intensity according to the field of view (every inner pixel). (G) The results of the statistical analysis of the mean normalized intensity values of cell clusters treated with Dau or Dau-conjugates. Box-and-whisker plots show the median (horizontal line), the interquartile range (box), and minimum and maximum values (whiskers) of intensity values. Letters demonstrate the results of Tukey’s procedure for all-pairwise comparisons based on the one-way ANOVA (<i>F</i>(3,33) = 134.6; <i>p</i> < 0.001); different letters mean significant differences at <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The change of surface pressure (ΔΠ) detected after 30 min of interaction is plotted for the Dau-conjugates (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). All of the conjugates showed a certain membrane affinity presented by the significant increase of the surface pressure of the lipid monolayer following the appearance of the Dau-conjugate in the subphase. The degree of penetration was quite low for Dau-Aoa-TKPPR while notably higher for conjugates containing the SynB3 sequence. Although all of the three conjugates were highly polar (see calculated LogP (<a class="ref internalNav" href="#notes1" aria-label="Figure S5">Figure S5</a>) and net charges (<a class="ref internalNav" href="#notes1" aria-label="Table S1">Table S1</a>)), the main difference which apparently influences the interaction with the BEPL layer is their charge character. The number of cationic amino acids in the conjugates is 2, 5, and 7 for Dau-Aoa-TKPPR, Dau-Aoa-SynB3, and Dau-Aoa-SynB3-TKPPR, respectively. That order corresponds to the increased interaction with the negatively charged lipid layer resulting in enhanced membrane affinity. The highest degree of penetration was observed for Dau-Aoa-SynB3-TKPPR due to its strong electrostatic attraction with charged membrane components. The membrane affinity was investigated with lipid layers compressed to 25 and also for 30 mN/m. As is expected, the degree of penetration was usually higher into a less compressed (25 mN/m) lipid layer and somewhat smaller due to steric reasons applying a more compressed layer (30 mN/m). A reverse relation was observed in our case for two conjugates, which might support the importance of electrostatic interaction. In the case of more compressed film, the charge density was also increased facilitating the electrostatic attraction of Dau-conjugates. The higher membrane affinity of the SynB3-containing Dau-conjugates observed in lipid monolayer experiments is in harmony with their conformational change in membrane mimetic solvent (i.e., increased α-helix content) determined by CD measurements (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). A similar correlation was found to be valid previously for structural and membrane interaction features of cationic CPPs.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p last">We studied the penetration ability of the conjugates on Transwell (TW) using co-cultured noncontact monolayers of HUVEC and U87 cells as a simple <i>in vitro</i> BBB model (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C,D based on ref <a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a>). Compounds (Dau and conjugates Dau-Aoa-SynB3, Dau-Aoa-TKPPR, and Dau-Aoa-SynB3-TKPPR) were added to the HUVEC-containing apical chamber at 50 μM concentration, and after 45 min or 3 h of incubation, U87 cells from the basolateral chamber were stained and fixed prior to CLSM analysis. As control experiments, treatments without the TW were also carried out (<a class="ref internalNav" href="#notes1" aria-label="Figure S27A,B">Figure S27A,B</a>). The same laser intensities were used in all cases, and the Dau signal in U87 cells was compared based on ImageJ analysis (<a class="ref internalNav" href="#notes1" aria-label="Figure S27C">Figure S27C</a>). Dau and all three conjugates were able to cross the HUVEC monolayer, and they were internalized into U87 cells. According to the Dau signal intensity, the internalization rates followed the same pattern as obtained in the cellular uptake studies (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>E–G); namely, Dau, Dau-Aoa-SynB3 and the tandem conjugate have a higher internalization rate (after crossing the membrane and HUVEC barrier) than the tuftsin conjugate. Similar tendencies were observed after 3 h of incubation (data not shown).</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 3D Tumor Spheroids as Platforms to Study the Penetration Profile of Peptide Carriers</h3><div class="NLM_p">Two-dimensional (2D) monolayer cultures are leading, well-established and reproducible models to assay on <i>in vitro</i> functional responses, structure–activity relations. However, cells grown in 2D form lack cell–cell and cell–extracellular matrix interactions. In comparison with monolayers, three-dimensional (3D) cultures are more analogous to <i>in vivo</i> environments. The 3D platforms can eliminate the species differences in contrast with animal models. Other differences manifest in cell morphology, cell–cell and cell–matrix interactions, gene expression, and differentiation.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a><i>In vitro</i> 3D cell cultures offer more accurate models to mimic multicellular complexity, transport processes, and biochemical factor gradients of solid tumors <i>in vivo</i> than cells in 2D monolayers.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a></div><div class="NLM_p">The poor penetration of drugs into tumor tissues could be associated with low therapeutic efficacy and recurrence of tumors. In our approach, we used a simple, anchorage-independent 3D culture form,<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> a spheroid model for assaying the drug-conjugates. The workflow of the preparation, treatment, imaging, and analysis of 3D tumor spheroids can be seen in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Workflow of preparation, treatment, imaging, and analysis of 3D tumor spheroids. (A) Micromold used for casting of a 3D Petri dish (microtissues), (B) 3D Petri dish in a 35 mm Petri dish, (C) addition of complete cell medium, (D) view of tumor spheroids in a 3D Petri dish, (E) treatment, nucleus staining, and cell fixation performed inside the 3D Petri dish, (F, G) side-view of a tumor spheroid with the position of the scanning plane during CLSM imaging (section z5, corresponding to the z-section captured 50 μm from the surface), (H) position of lines during line scan and position of zones for zonal scan of section z5 of spheroids (two parallel spheroids, 8 lines and 3 zones each), (I) penetration profile by line scan, mean intensity (red line), and SEM (light-red error stripe) averaged from gray values (0–255) of 16 parallel line scans and depth of scanning (black line) along the normalized spheroid diameter, (J) penetration profile by zonal scan; spheroids were separated into a peripheral (zone 1), intermediate (zone 2), and core zone (zone 3), and the relative normalized intensity was determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Penetration Profile of Drug Conjugates in 3D Tumor Spheroids</h3><div class="NLM_p">We compared the penetration ability of Dau and three Dau-peptide conjugates, namely, Dau-Aoa-SynB3, Dau-Aoa-TKPPR, and Dau-Aoa-SynB3-TKPPR. Spheroids formed from U87 glioma cells or MDA-MB 435Br were treated with the compounds for 3 h at 25 μM concentration. Nuclear staining with Hoechst 33342 was also applied. Fixed spheroids were visualized by CLSM. A lower laser intensity was used in the case of Dau and higher but the same intensity in the case of the three Dau-conjugates to improve visualization and to optimize the image quality; therefore, the CLSM observations cannot be considered as quantitative analysis but provide qualitative information about the penetration ability. The U87 and MDA-MB 435Br spheroids had an average diameter of 500 and 400 nm, respectively (<a class="ref internalNav" href="#notes1" aria-label="Figure S28">Figure S28</a>). To compare the penetration profile of the compounds, we have preformed line scan analysis and zonal scan analysis of the spheroids. Spheroids were scanned in the <i>z</i>-direction with a step size of 10 μm (z1–z7). The deepest z-section from the surface of a spheroid presented here is 50 μm (z5). Deeper sections were also recorded; however, a z5 section was chosen as a z-section where the conjugates are securely visible by the objective used during microscopic imaging. For the comparison of sections z1–z7 with line scan analysis, see <a class="ref internalNav" href="#notes1" aria-label="Figure S29">Figure S29</a>. However, at this depth (between 10 μm (z1) and 50 μm (z5)), we managed to observe the differences between the penetration ability of Dau and its conjugates. Two z-sections (z3 with depth of 30 μm and z5 with depth of 50 μm) of U87 and MDA-MB 435Br spheroids are shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A, respectively. The first five z-sections can be seen in <a class="ref internalNav" href="#notes1" aria-label="Figure S30">Figure S30</a> for U87 spheroids and in <a class="ref internalNav" href="#notes1" aria-label="Figure S31">Figure S31</a> for MDA-MB 435Br spheroids. In both cases, we observed that the Dau and even the Hoechst 33342 nuclear stain could not successfully penetrate into deeper layers; they were mostly localized at the spheroid surface. Toward the center of the spheroids, the Dau and Hoechst 33342 signal was gradually decreasing. On the contrary, in the case of the Dau-conjugates, the Dau signal could be observed closer to the center. Line scans of z5-section images (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B and <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B) also confirm these observations, as we can see the differences between the steepness of the mean gray value lines. The mean gray value of the conjugates only slightly decreased toward the middle of the spheroids, while free Dau started with a high mean gray value at the spheroid surface, and this value showed a steeper decrease toward the spheroid center. In the case of zonal scan analysis, the spheroids were divided into different zones (periphery (zone 1), intermediate (zone 2), core (zone 3)) using equal steps from the surface of the spheroids. To have comparable fluorescent intensity values among the treatments and zones, normalized gray value data were standardized as the proportion of the mean normalized intensity in the peripheries (0–100%). The zonal penetration profile comparing the relative normalized intensities also supports the difference between Dau and the Dau-conjugates (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>; for the statistical analysis combining the line and zonal scan data sets, see <a class="ref internalNav" href="#notes1" aria-label="Figure S32 and Table S7">Figure S32 and Table S7</a>). Based on these results, we can conclude that all three conjugates have an improved penetration ability compared to the free Dau on both types of spheroids. Conjugation of Dau to peptide carriers significantly enhanced the <i>in vitro</i> penetration ability on the spheroid model.</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) Representative confocal images of U87 spheroids after 3 h treatment with 25 μM Dau or Dau-peptide conjugates (red). Nuclei were stained with Hoechst 33342 (blue). Z-stack images were obtained starting at the surface of the spheroid with 10 μm intervals for a total of 50 μm into the spheroid; the presented images are from the 30 μm (z3) and 50 μm (z5) depths. The scale bar represents 200 μm. (B) Line scans of spheroids at 50 μm (z5) depth; mean intensities are gray values (0–255) averaged from two parallel spheroids (<i>n</i> = 16 line scans), and error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Representative confocal images of MDA-MB 435Br spheroids after 3 h treatment with 25 μM Dau or Dau-peptide conjugates (red). Nuclei were stained with Hoechst 33342 (blue). Z-stack images were obtained starting at the surface of the spheroid with 10 μm intervals for a total of 50 μm into the spheroid; the presented images are from the 30 μm (z3) and 50 μm (z5) depths. The scale bar represents 200 μm. (B) Line scans of spheroids at 50 μm (z5) depth; mean intensities are gray values (0–255) averaged from two parallel spheroids (<i>n</i> = 16 line scans), and error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Relative normalized intensity of spheroid zone 1, zone 2, and zone 3 displaying the penetration ability of the Dau and Dau-conjugates in (A) U87 spheroids and in (B) MDA-MB 435Br spheroids. Relative normalized intensities of spheroids were extracted at 50 μm (z5) depth, averaged from two parallel spheroids (<i>n</i> = 2); error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Current chemotherapeutics can be very effective on glioma cell growth inhibition, but unfortunately, their cellular internalization rate and BBB penetration ability are limited. Finding new delivery vehicles and strategies to increase drug internalization in the glioma tissue is an urgent need. In this study, we focused on establishing delivery peptides. Therefore, we designed and prepared new peptide conjugates employing different anti-glioma agents such as salicylanilides, Dau, and TMZ. As carrier peptides, derivatives of SynB3 cell-penetrating peptide with the ability to cross the BBB were employed. Tuftsin derivatives were also used as carriers with the aim of targeting the NRP-1 transport system to achieve selectivity and better tumor penetration. Moreover, we combined the two types of carriers to create SynB3-tuftsin tandem peptides to exploit their advantageous properties.</div><div class="NLM_p">As our study demonstrated, the salicylanilide derivatives have good cytostatic activity against U87 cells and the salicylanilide-SynB3 conjugates are also active against this cell culture. Dau-conjugates have superior antitumor activity to Sal3-conjugates. Interestingly, the CendR-motif-containing Dau-Aoa-TKPPR is the least effective among Dau-conjugates with moderate cytostatic activity. The activity of the tandem Dau-conjugates is good; it is between the activity of Dau-Aoa-SynB3 and the corresponding tuftsin conjugates. Importantly, in contrast with the free drugs, the Sal3- and Dau-conjugates proved to be selective for tumor cells, as they show no cytotoxic effect on HUVECs.</div><div class="NLM_p">We revealed further aspects regarding the structure–activity relationship of the conjugates. The secondary structure, cellular uptake, intracellular localization, and release of the smallest, drug-containing metabolite also play an important role in their activity. Specifically, the internalization rate on 2D cell cultures of SynB3 and tandem derivatives is outstanding and significantly higher than the internalization rate of most tuftsin derivatives that is in line with their ability of forming helices upon contact with lipid membranes. The release of the smallest Dau-metabolite from Dau-SynB3 conjugates or Dau-tandem conjugate is fast; moreover, the conjugates or Dau-containing metabolites can be found in the nuclei, at the site of their action. On the other hand, Dau-Aoa-TKPPR shows a low and slow uptake rate, nuclear localization is not observed, and the release of the Dau-metabolite is very slow which contributes to its lower cytostatic activity. This conjugate shows lysosomal localization as a result of endocytosis. The Dau-Aoa-SynB3-TKPPR tandem conjugate follows the internalization mechanisms of both its CPP part and its tuftsin part, since it can be observed in cell nuclei as well as in lysosomes.</div><div class="NLM_p last">To elucidate the penetration ability of the conjugates, <i>ex vivo</i> monolayer using Langmuir balance and <i>in vitro</i> Transwell measurements using co-cultured noncontact monolayers of HUVEC and U87 cells as a simple BBB model were performed. All of the Dau-conjugates show membrane affinity on the BEPL mixture, and they are able to cross the HUVEC monolayer and enter U87 cells. Furthermore, using 3D spheroid cultures for modeling solid tumors <i>in vitro</i>, we have demonstrated that Dau-conjugates have better <i>in vitro</i> tumor penetration ability than the free Dau itself. These experimental setups provided a remarkable difference of the internalization pattern between free Dau and Dau-conjugates on cell monolayers and the spheroid model. To compare the penetration and internalization capacity of the conjugates, we have employed CLSM line and zonal scans as enumeration for differences, but we need to emphasize that these observations can be considered as qualitative information. Taken together, using these peptides as carriers, significantly improved penetration ability can be obtained. The applied cell monolayers, co-culture system, and tumor spheroids were suitable <i>in vitro</i> models in order to find the most promising constructs for <i>in vivo</i> studies. In conclusion, drug-peptide conjugates presented here, in particular Dau-Aoa-SynB3-TKPPR, are promising constructs toward the rational design of glioma targeting using tandem peptide based delivery vehicles to achieve better antitumor efficiency, cellular uptake, and, most importantly, a superior tumor penetration ability.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Materials</h3><div class="NLM_p last">Amino acid derivatives and resins were purchased from Iris Biotech GmBH (Marktredwitz, Germany). Boc-aminooxyacetic acid (Boc-Aoa-OH), 1-hydroxybenzotriazole hydrate (HOBt), <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC), triisopropylsilane (TIS), phenol, thioanisole, 1,2-ethanedithiol (EDT), piperidine, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), <i>N</i>,<i>N</i>-diisopropyl-<i>N</i>-ethylamine (DIEA), benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP), acetic anhydride (Ac<sub>2</sub>O), acetic acid (AcOH), 5(6)-carboxyfluorescein (Cf), temozolomide (TMZ), trifluoroethanol (TFE), and acetonitrile were purchased from Sigma-Aldrich (Budapest, Hungary). Trifluoroacetic acid (TFA), <i>N</i>,<i>N</i>-dimethylformamide (DMF), dichloromethane (DCM), methanol, chloroform, and diethyl ether were purchased from VWR (Budapest, Hungary). Daunomycin hydrochloride was a gift from IVAX (Budapest, Hungary). All reagents and solvents were of analytical grade or highest available purity and were used without further purification. Dulbecco’s Modified Eagle Medium (DMEM) was from Lonza (Basel, Switzerland), and RPMI-1640 medium, fetal bovine serum (FBS), Mowiol 4-88, trypan blue, and trypsin were obtained from Sigma-Aldrich. HPMI buffer (9 mM glucose, 10 mM NaHCO<sub>3</sub>, 119 mM NaCl, 9 mM HEPES, 5 mM KCl, 0.85 mM MgCl<sub>2</sub>, 0.053 mM CaCl<sub>2</sub>, 5 mM Na<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O, pH 7.4) was prepared in-house using components obtained from Sigma-Aldrich.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthetic Procedure</h3><div class="NLM_p">Synthesis and characterization of salicylanilides (Sal1, Sal2, Sal3) is presented in refs <a onclick="showRef(event, 'ref50 ref63'); return false;" href="javascript:void(0);" class="ref ref50 ref63">(50and63)</a>. Temozolomide-carboxylic acid was prepared following a previously described procedure.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a></div><div class="NLM_p">Peptides were synthesized manually on the solid phase (Fmoc-Rink Amide MBHA resin for peptides with C-terminal in amide form and Wang resin for peptides with C-terminal in carboxyl form) using the Fmoc/<i>t</i>Bu strategy with DIC/HOBt coupling reagents, as described previously.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Acetylated derivatives were produced by acetylation of the N-terminal using acetic anhydride/DIEA/DMF (1:1:2 v/v, 60 min). Fluorescently labeled derivatives were prepared with the use of 5(6)-carboxyfluorescein (Cf) with the DIC/HOBt coupling method. In the case of decanoyl-containing peptides, in the required position, lysine was built in as an Fmoc-Lys(Dde)-OH protected form. After the final Fmoc-deprotection, Boc-Aoa-OH or Cf was coupled to the N-terminal of the peptides (DIC/HOBt coupling method) or the N-terminal was acetylated. After the derivatization of the N-terminal, the Dde protecting group was selectively removed with 2% hydrazine hydrate in DMF (v/v) (6 × 2 min); then, decanoic acid was reacted with the free ε-amino group of the Lys residue in the presence of DIC/HOBt coupling reagents. In the case of the decanoyl-containing peptide that has free amino group at the N-terminal (H-SynB3K(dec)), the Dde protecting group was removed and decanoic acid was coupled before the removal of the final N-terminal Fmoc-protecting group. Peptides without Arg were cleaved from the resin with TFA/H<sub>2</sub>O/TIS (95:2.5:2.5 v/v) mixture (2.5 h, RT). After filtration, compounds were precipitated in cold diethyl ether, centrifuged (4000 rpm, 5 min), and freeze-dried from water. Arg-containing peptides were cleaved from the resin with TFA/thioanisole/H<sub>2</sub>O/EDT/phenol (82.5:5:5:2.5:5 v/v/v/v/w) mixture (2.5 h, RT). In the case of SynB3 derivatives (five or six Arg in the sequence) during cleavage, the cleavage product of the Arg side chain protecting group (Pbf) was precipitated. Therefore, diethyl ether was added to the reaction mixture to dissolve the precipitated side chain cleavage product and to precipitate the peptide. This mixture was centrifuged (4000 rpm, 5 min), and the peptide was dissolved in 10% AcOH in water (v/v), filtered off from the resin, and freeze-dried from 10% AcOH in water (v/v). The (aminooxy)acetyl-amino acid derivatives (Aoa-Arg-OH, Aoa-Gly-OH, Aoa-Thr-OH) were synthesized by solid-phase peptide synthesis on Wang resin manually using the Fmoc/<i>t</i>Bu strategy as described previously.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Sal3 and Dau were conjugated to the (aminooxy)acetylated peptides or amino acids through an oxime bond.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Crude Aoa-peptides and Aoa-amino acid derivatives were used for conjugation without purification. The oxime bond formation was carried out under acidic conditions (pH 4.5) in a mixture of 0.2 M sodium acetate buffer and 2-methoxyethanol for Sal3 conjugation, at a peptide concentration of 5–10 mg/mL. Sal3 was used in 10% molar excess as compared to the Aoa-peptides. In the case of Dau-conjugates, oxime bond formation was carried out in 0.2 M ammonium acetate buffer (pH 5.0) with a 10% molar excess of Dau. The reaction mixtures were stirred for 3–72 h at room temperature and monitored by analytical RP-HPLC.</div><div class="NLM_p last">TMZ conjugates were synthesized on the solid phase. Temozolomide-carboxylic acid (TMZA) was coupled to the free N-terminal of the peptides (SynB3 and GFLG-SynB3) on the resin forming amide bond. Four equivalents (calculated to the resin capacity) of TMZA, PyBOP, and DIEA dissolved in DMF was used for coupling for 4 h at RT. The coupling reaction was verified by ninhydrin test, and the conjugates were cleaved from the resin as described above.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)</h3><div class="NLM_p last">The crude peptides and conjugates were purified on a KNAUER 2501 HPLC system (H. Knauer, Bad Homburg, Germany) using a semipreparative Phenomenex Jupiter Proteo C12 column (10 mm, 90 Å, 10 × 250 mm) (Torrance, CA, USA). The applied flow rate was 4 mL/min at ambient temperature, and the peaks were detected at 220 nm. Gradient elution was used with the following eluents: 0.1% TFA/water v/v (eluent A), 0.1% TFA/acetonitrile–water 80:20 v/v (eluent B). Analytical RP-HPLC was performed on an Exformma HPLC system (EX1600 Wufeng Scientific Instruments, Sanghai, China) using a Waters Symmetry C18 column (5 μm, 100 Å, 4.6 mm × 150 mm) with the following gradient: 0–5 min 0% B, 5–15 min 0–60% B, 15–25 min 60–100% B, 25–29 min 100%. The flow rate was 1 mL/min at ambient temperature, and the peaks were detected at 220 nm. All purified compounds demonstrated a single peak on analytical RP-HPLC (purity is >95%).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Electrospray Ionization Mass Spectrometry (ESI-MS)</h3><div class="NLM_p last">Measured monoisotopic or average molecular mass was acquired by a Bruker Esquire 3000+ electrospray ionization (ESI) ion trap mass spectrometer (Bremen, Germany) operating in continuous sample injection mode at 10 μL/min flow rate. Samples were dissolved in acetonitrile–water (50:50, v/v), containing 0.1% acetic acid. Dau-conjugate-containing samples were dissolved in 50 mM NH<sub>4</sub>OAc buffer (pH 6.7)–acetonitrile (50:50, v/v). Mass spectra were recorded in positive ion mode in the 50–1500 <i>m</i>/<i>z</i> range.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Circular Dichroism (CD) Spectroscopy and Secondary Structure Analysis</h3><div class="NLM_p">Peptide samples were dissolved in deionized water and in TFE at 17–170 μM concentrations. Far-UV CD curves were taken on a JASCO J-715 spectropolarimeter at 25 ± 0.2 °C in a 0.1 cm path-length rectangular quartz cuvette (Hellma, USA). Temperature control was provided by a Peltier thermostat. The CD data were monitored in continuous scanning mode between 185 and 260 nm at a rate of 50 nm/min, with a step size of 0.1 nm, response time of 2 s, eight accumulations, and a 2 nm bandwidth. The CD curves were corrected by background contribution of the blank solvent. CD values were plotted in mean residue molar CD units (Δε/residue) calculated by the following equation: Δε = Θ/(32.98<i>cl</i>), where Θ is the measured ellipticity (deg) as a function of wavelength (nm), <i>c</i> is the mean residue molar concentration, and <i>l</i> is the optical path length (cm).</div><div class="NLM_p last">The contribution of the different conformational elements was estimated from the CD spectra by using the MS Excel version of the PEPFIT program developed originally by Reed and Reed.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> The algorithm calculates the percentage of secondary contents (α-helix, β-sheet, disordered, and various turn types) by fitting experimental CD data to the combination of reference spectra. The best fit is defined by the <i>R</i><sup>2</sup> value, where <i>R</i><sup>2</sup> = 1 corresponds to a perfect match.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Lysosomal Digestion Profile of Conjugates in Rat Liver Lysosomal Homogenate and LC-MS Analysis</h3><div class="NLM_p last">The rat liver lysosomal homogenate was prepared as described previously.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The degradation of the conjugates in the rat liver lysosomal homogenate was determined as follows: 90 μL of 50 μM (50 pmoL/μL) conjugate solutions was prepared with 0.2 M sodium acetate buffer, pH 5.0, and the appropriate amount of lysosomal homogenate was added to them to get the conjugates:lysosomal homogenate ratio = 1:1, w/w. The reaction mixtures were incubated at 37 °C, and aliquots of 13 μL were taken after 5 min, 1 h, 2 h, 4 h, 8 h, and 24 h. The reactions were quenched by adding 2 μL of acetic acid and followed by LC-MS analysis. Control experiments were performed with solutions of conjugates in 0.2 M sodium acetate buffer, pH 5.0, with 50 μM conjugate concentration. Lysosomal homogenate control in 0.2 M sodium acetate buffer, pH 5.0, without conjugate was also prepared. Both solutions were incubated at 37 °C for 24 h and also analyzed by LC-MS. LC-MS analyses were performed on a Q Exactive Focus, high resolution and high mass accuracy, hybrid quadrupole-orbitrap mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) using online UHPLC coupling. Separation was performed on a Dionex 3000 UHPLC system using a Supelco 581302-U Ascentis C18 column (2.1 mm × 150 mm, 3 μm, 100 Å). Linear gradient elution (0–2 min 2% B, 2–26 min 2–90% B, 26–27 min 90–100% B) with eluent A (0.1% HCOOH in water, v/v) and eluent B (0.1% HCOOH in acetonitrile–water, 80:20, v/v) was used at a flow rate of 0.2 mL/min at 40 °C. High resolution mass spectra were acquired in the 200–1600 <i>m</i>/<i>z</i> range. LC-MS data were analyzed by Xcalibur software (Thermo Fisher Scientific) and with OriginPro 2018 (OriginLab Corporation, Northampton, MA, USA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Cultures</h3><div class="NLM_p last">The following cell cultures were used for the cytostasis and cytotoxicity studies: U87 (ATCC HTB-14), MDA-MB 435Br (obtained from Janet E. Price),<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> HUVEC (isolated at the 3rd Department of Medicine Research Laboratory, Semmelweis University, Budapest, Hungary), MonoMac6 (DSMZ no.: ACC 124), and HepG2 (ATCC HB-8065). U87 and MDA-MB 435Br were maintained in DMEM medium (Lonza) supplemented with 10% FBS (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) and with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Lonza), 1% nonessential amino acids (Gibco), 1 mM sodium pyruvate (Sigma-Aldrich), 1% penicillin-streptomycin (from 10,000 units of penicillin and 10 mg of streptomycin/mL, Gibco). MonoMac6 and HepG2 were maintained in RPMI-1640 medium (Lonza) containing 10% FBS supplemented with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and 160 μg/mL gentamicin (for MonoMac6), or 1% penicillin-streptomycin (for HepG2). HUVEC was maintained in MCDB medium (90% MCDB-131 (Gibco), 5% FBS, 1% penicillin-streptomycin solution (from 10,000 units of penicillin and 10 mg of streptomycin/mL, Sigma-Aldrich), 1% Chemically Defined Lipid Concentrate from Gibco, 1% HEPES, 1% <span class="smallcaps smallerCapital">l</span>-glutamine solution (from CTS GlutaMAX-I Supplement, Gibco), 1 ng/mL FGF-Basic (Sigma-Aldrich), 0.3% ITS (insulin-transferrin-selenium, Gibco), 2 ng/mL EGF-2 (Gibco), 7.5 U/mL heparin (Sigma-Aldrich), 5 μg/mL <span class="smallcaps smallerCapital">l</span>-ascorbic acid (Sigma-Aldrich), 250 nM hydrocortisone). No mycoplasma contamination was detected in the cell cultures.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Determination of <i>in Vitro</i> Cytostatic and Cytotoxic Activity</h3><div class="NLM_p">U87, MDA-MB 435Br, MonoMac6, and HepG2 were plated on 96-well plates 1 day before the treatment (5000 cells/100 μL of medium/well for cytostasis and 10,000 cells/100 μL of medium/well for cytotoxicity studies). After 24 h of incubation at 37 °C, cells were treated with the compounds dissolved in serum free medium (<i>c</i><sub>DMSO</sub> = 1.0% v/v) at 1.3 × 10<sup>–3</sup> to 100 μM concentration range and incubated for 3 or 24 h (37 °C, 5% CO<sub>2</sub>). Control cells were treated with serum free medium only or with DMSO-containing serum free medium (<i>c</i><sub>DMSO</sub> = 1.0% v/v). After the incubation, cells were washed twice with serum free medium (centrifugation: 1000 rpm, 5 min). To determine the <i>in vitro</i> cytostatic effects, cells were cultured for a further 72 h in serum-containing medium and then the MTT assay was carried out. In the case of cytotoxicity studies, the MTT assay was performed immediately after the washing step. Cell viability was determined with (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. A 45 μL portion of MTT solution (2 mg/mL) was added to each well (final concentration 367 μg/mL), and during 3.5 h of incubation (37 °C, 5% CO<sub>2</sub>), purple formazan crystals were formed by mitochondrial dehydrogenase enzyme present in the living cells. After incubation, cells were centrifuged for 5 min at 2000 rpm and the supernatant was removed. The obtained formazan crystals were dissolved in DMSO, and the optical density (OD) of the samples was determined at 540 and 620 nm using an ELISA Reader (Labsystems iEMS reader, Helsinki, Finland). The OD<sub>620</sub> values were subtracted from the OD<sub>540</sub> values. The percentage of cytostasis or cytotoxicity was calculated using the following equation: cytostatic or cytotoxic effect (%) = 100 × [1 – (OD<sub>treated</sub>/OD<sub>control</sub>)], where OD<sub>treated</sub> and OD<sub>control</sub> correspond to the optical densities of treated and control cells, respectively. In each case, two independent experiments were carried out with four parallel measurements. The 50% inhibitory concentration (IC<sub>50</sub>) values were determined from the dose–response curves. The curves were defined using OriginPro 2018 software.</div><div class="NLM_p last">HUVEC was plated on 0.5% gelatin/PBS (v/v) pretreated 96-well plates 1 day before the experiment in MBCD medium. After 24 h of incubation at 37 °C, the confluent cells were treated with the compounds for 24 h at 3.7–100 μM concentration range. After the incubation, cells were washed with PBS to remove nonadherent cells and then fixed with ice cold methanol/acetone (1:1, v/v) for 5 min and the cell nuclei were stained with SYBR-Green I (Sigma) for 15 min followed by washing with PBS. In each case, two independent experiments were carried out with three parallel measurements. IC<sub>50</sub> was determined by morphological and fluorescent analysis of the cells using CellProfiler software.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cellular Uptake Studies</h3><div class="NLM_p last">Cellular uptake of fluorescent compounds was determined by flow cytometry on U87, MDA-MB 435Br, and HUVEC cell cultures. U87 and MDA-MB 435Br cells were harvested in the logarithmic phase of growth and plated on a 24-well tissue culture plate (10<sup>5</sup> cells/1 mL of medium/well) 24 h prior to the experiment. HUVEC was plated on 0.5% gelatin/PBS (v/v) pretreated 24-well plates 1 day before the experiment in MBCD medium to reach confluence. After 24 h of incubation at 37 °C, U87, MDA-MB 435Br, or HUVEC cells were treated with the compounds dissolved in 500 μL of serum free medium at the 0.1–50 μM concentration range and incubated for 3 h (37 °C, 5% CO<sub>2</sub>). In the case of the time dependence study, U87 cells were incubated for 5 min, 15 min, 30 min, 1 h, 1.5 h, and 3 h. Control cells were treated with serum free medium only. After incubation, cells were centrifuged (1000 rpm, 5 min) and washed with serum free medium, the supernatant was removed, and 100 μL of 0.25% trypsin was added to the cells. After 3 min of incubation at 37 °C, trypsin was inactivated by 800 μL of HPMI medium containing 10% FBS, and the cells were transferred from the plate to the tubes. Cells were centrifuged (1000 rpm, 5 min), and the supernatant was removed. After this procedure, cells were resuspended in 300 μL of HPMI, and their intracellular fluorescence intensity was measured on a BD LSR II flow cytometer (BD Biosciences, San Jose, CA, USA) using a 488 nm laser (Coherent Sapphire, 22 mW) with an FITC channel for Cf-peptides (emission at 505 nm) and PE channel for Dau-conjugates (emission at 550 nm). Data were analyzed with FACSDiva 5.0 software (BD Biosciences, San Jose, CA, USA). All experiments were performed in duplicates. The 50% uptake concentration (UC<sub>50</sub>) values were determined from the curves of the dose rate of fluorescence positive cells. The IC<sub>50</sub> values were determined from the curves of the dose rate of all living cells (including fluorescent positive and negative cells). The curves were defined using OriginPro 2018 software.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Confocal Microscopy Imaging</h3><div class="NLM_p last">Intracellular localization was visualized by confocal microscopy. U87 cells were seeded (75,000 cells/well) in complete DMEM cell culture medium 1 day prior to treatment on cover glasses (Assistent, Karl Hecht GmbH & Co KG, Sondheim/Rhön Germany) and inserted in 24-well plates (Sarstedt, Nümbrecht, Germany). Lysosomes were stained with LysoTracker Deep Red (Invitrogen, Carlsbad, CA, USA) for 30 min (300 nM) in incomplete DMEM, followed by incubation with 25 μM Cf-labeled peptides or Dau-conjugates for 30 or 90 min. Subsequently, cell nuclei were stained with Hoechst 33342 solution (Thermo Fisher Scientific, Waltham, MA, USA) for 10 min (0.2 μM). After each step, cells were washed three times with PBS. Cells were fixed with 4% paraformaldehyde for 15 min (37 °C) and mounted on microscopy slides with Mowiol 4-88. For live cell imaging, U87 cells were seeded (45,000 cells/well) in complete DMEM cell culture medium 1 day prior to treatment in μ-Slide eight-well ibiTreat chambers (Ibidi GmbH, Gräfelfing, Germany). Lysosomes were stained with LysoTracker Red DND-99 (Invitrogen, Carlsbad, CA, USA) for 30 min (300 nM) in incomplete DMEM, followed by incubation with 25 μM Cf-labeled peptides for 30 or 90 min. Subsequently, cell nuclei were stained with Hoechst 33342 solution (0.2 μM) for 10 min. After each step, cells were washed three times with PBS. Imaging was performed on a Zeiss LSM 710 system (Carl Zeiss Microscopy GmbH, Jena, Germany) with a 40× oil immersion objective (40×/1.4 oil DIC M27). The following wavelengths were used for excitation and fluorescence emission detection: for Cf-peptides excitation at 488 nm, detection between 501 and 550 nm; for Dau-conjugates excitation at 458 nm, detection between 541 and 590 nm; for LysoTracker Deep Red excitation at 633 nm, detection between 643 and 797 nm; for LysoTracker Red DND-99 excitation at 543 nm, detection between 560 and 797 nm; for Hoechst 33342 excitation at 405 nm, detection between 410 and 587 nm. Different laser intensities were used in the case of compounds with low or high internalization to improve visualization and optimize the image quality; therefore, the CLSM observations cannot be considered as quantitative analysis but provide qualitative information about subcellular localization. Images were processed with ZEN 3.0 blue lite software (Carl Zeiss Microscopy GmbH).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Membrane Affinity Measurements on Lipid Monolayer as <i>ex vivo</i> BBB Model</h3><div class="NLM_p last">The membrane affinity experiments were performed with a KSV MiniMicro (Finland) instrument at room temperature. The trough was equipped with two polyoxymethylene (POM) barriers while surface pressure was recorded tensiometrically with ±0.5 mN/m accuracy employing previously cleaned filter papers (Whatman Chr1) as Wilhelmy plates. DCM and methanol were used for the cleaning of the trough and barriers, respectively, before each measurement. Double distilled water used as a subphase was checked by its conductivity (<5 mS) and surface tension (>72.0 mN/m at 23 ± 0.5 °C) values. Brain extract polar lipid (BEPL, Avanti Polar Lipids Inc., USA) was applied in chloroform to form a monomolecular lipid layer on the double distilled water subphase in the Langmuir through to mimic the BBB lipid composition. The phospholipid composition (w/w%) of BEPL given by the supplier is 12.6 phosphatidylcholine, 33.1 phosphatidylethanolamine, 4.1 phosphatidylinositol, 18.5 phosphatidylserine, and 0.8 phosphatidic acid, whereas the other 30.9% are unknown. That means that the BEPL monolayer contains a significant amount (at least 23 wt %) of negatively charged lipid components. BEPL was dissolved in chloroform to a concentration of 0.2 mg/mL. After spreading of 50 μL lipid solution, the system was left for 10 min to allow the evaporation of the chloroform before the compression. Surface pressure–area isotherms were recorded two times before each penetration measurement. Compressing the lipid layer to the target pressure (25 or 30 mN/m) following a 5 min relaxation time, the aqueous solution of the Dau-peptide conjugate (concentration of 500 μM) was injected under the lipid monolayer to reach a 5 μM final concentration in the subphase. The changes of the surface pressure as a function of time were recorded for 30 min to detect the interaction/penetration of the Dau-peptide with/into the lipid layer. Three penetration measurements were performed in every case.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Penetration Ability Determination on TW Co-Culture with Noncontact HUVEC-U87 Monolayers as <i>in Vitro</i> BBB Model</h3><div class="NLM_p last">TW system was tested in a number of preliminary experiments in order to optimize seeding procedure, pore size, and coating/non-coating for HUVECs. Cells, HUVEC and U87, were cultured and maintained as described in the <a class="ref internalNav" href="#sec4_7" aria-label="Cell Cultures">Cell Cultures</a> part of the Experimental Section. For barrier seeding, 24-well TW plates of 0.4 μm pore size were used (Corning, United Kingdom). Prior to use, TWs were soaked with PBS  (growth area 0.385 cm<sup>2</sup>). On day one, the apical side of the TW inserts was coated with 0.5% gelatin/PBS (v/v) and incubated for 30 min (37 °C, 5% CO<sub>2</sub>). After incubation, gelatin solution was removed by careful aspiration and 150 μL of HUVEC suspension in complete MBCD medium ((3.0–6.0) × 10<sup>5</sup> cells) was pipetted onto the coated surface of the TW chamber and 500 μL MBCD medium added to the basolateral side. After the cells were cultured at 37 °C for 5–6 h, the apical medium was removed and replaced with fresh MBCD medium in order to avoid nonattached cells. Medium was changed also on day two, and HUVECs were grown up to confluence (which was checked prior to and after the experiments). At confluence, the endothelial cell monolayers were labeled with CellTracker Green (CMFDA (5-chloromethylfluorescein diacetate) dye, Invitrogen, C2925); for this purpose, CMFDA was used as 10 μM solution in serum free MBCD medium. After 30 min of incubation, the cells were washed with serum free MBCD. Cell nuclei of HUVEC monolayers were stained with Hoechst 33342 solution as described earlier. To capture the HUVEC layer, a ZEISS Axio Observer Inverse Imaging Platform (ZEISS) was used (equipped with Led3 470 blue, Led4 555 green; filter set: 25HE). On day three, medium was changed before the Dau-conjugate treatment, as starvation may affect protein expression in the endothelial cell monolayer. U87 cells (10<sup>5</sup> cells/well in complete DMEM) were seeded on day three prior to treatment on cover glasses (Assistent) inserted in the basolateral chambers of 24-well plates. Conjugates (Dau-Aoa-TKPPR, Dau-Aoa-SynB3, and Dau-Aoa-SynB3-TKPPR) were added to the HUVEC-containing apical side at 50 μM concentration, and the system was incubated for 45 min or 3 h (37 °C, 5% CO<sub>2</sub>). After incubation, the TW chamber was removed. Cell nuclei of U87 cells forming the basolateral chamber were stained with Hoechst 33342; cells were fixed with 4% paraformaldehyde and mounted on microscopy slides with Mowiol 4-88 as described above. Fixed U87 cells were studied using confocal microscopy (Zeiss LSM 710). As controls, U87 cells were treated without the presence of the TW inserts. The same wavelengths were used for excitation and fluorescence emission detection for Dau signal and Hoechst 33342 as described above. Laser intensity values were identical. Images were processed with ZEN 3.0 blue lite software. Cell groups were selected on the Dau (red) channel (seven groups in the case of Dau, 10–10 groups in the case of conjugates) with at least 3 cells/group. Selection was carried out manually in NIH ImageJ software based on the occurrence of cell nuclei (blue channel). Histograms and intensity values were obtained, and background corrected normalized fluorescence intensities (CNF) were calculated as follows: CNF = (ID – (<i>A</i> × MFB))/<i>A</i>, where ID is the integrated density, <i>A</i> is the area, and MFB is the mean fluorescence of the background. The obtained intensity in gray values corresponds to the intensity of a given pixel on a scale of 0–255. For visualization of histograms and normalized intensities, “violin plots” were used.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>In Vitro</i> 3D Spheroid Formation and Confocal Microscopy of Spheroids</h3><div class="NLM_p last">Molten agarose (2%, w/v in PBS) was pipetted into a silicon micromold 3D Petri dish (microtissues, Sigma-Aldrich, St. Louis, MO, USA, size L, 5 × 7 array, microwell diameter: 800 μm). After the agarose was gelled, the agarose microwell dish was transferred into a cell culture dish (polystyrene Petri dish, 35 × 10 mm, Sarstedt) and it was equilibrated with serum free DMEM cell culture medium (2 h, 37 °C). Cells were seeded into the agarose microwell dish, and 13 μL of cell suspension (10,000 cells/μL of complete DMEM) was used to fill the microwells under a stereo microscope (YJ-T3C, Ningbo Tianyu Optoelectronic Technology Co., Ltd., Beilun, Ningbo, China); this way, approximately 3500 cells were transferred in one well. Seeded cells were incubated in 2 mL of complete DMEM for 36 h (37 °C, 5% CO<sub>2</sub>), while cell-to-cell adhesion drove the aggregation and formation of spheroids. To monitor the spheroids, bright-field images were captured using an Olympus CX41 microscope (Olympus Corporation, Hamburg, Germany). After 36 h of incubation, spheroids were washed two times with fresh serum free DMEM and they were treated in the microwells with the compounds at 25 μM concentration in 2 mL of serum free DMEM for 3 h (37 °C, 5% CO<sub>2</sub>). After this, spheroids were washed two times with serum free DMEM and two times with PBS to remove the compounds that were not internalized. Nuclei were stained with Hoechst 33342 solution (0.2 μM) for 30 min. Spheroids were fixed with 4% paraformaldehyde for 15 min (37 °C). After each step, spheroids were washed three times with PBS and then harvested and transferred from the agarose microwells into μ-Slide eight-well uncoated chambers (Ibidi). Imaging was performed on a Zeiss LSM 710 system with a 10× dry objective (10×/0.45 M27). The same excitation and emission wavelengths were used as those for the 2D confocal microscopy imaging. Different laser intensities were used in the case of Dau and the Dau-conjugates to improve visualization and to optimize the image quality; therefore, the CLSM observations cannot be considered as quantitative analysis but provide qualitative information about the penetration ability. Z-Stack images were obtained by scanning the spheroids from the bottom of the spheroid with a 10 μm distance between each scanning plane. Images were processed with ZEN 3.0 blue lite software. Line scan and zonal scan analysis of section z5 with a depth of 50 μm was performed by NIH ImageJ software; for each sample, two parallel spheroids were analyzed (8 line scans/spheroid, <i>n</i> = 16 in total, three zones (periphery - zone 1, intermediate - zone 2, core - zone 3) per spheroid, <i>n</i> = 6 in total). Both analyses were carried out using grayscale images; a gray value corresponds to the intensity of a given pixel on a scale of 0 to 255. To average the intensity values from line scans of spheroid sections of slightly different size and shape, all line scan lengths were normalized to 1, yielding normalized diameter. Calculation of average and SEM of multiple curves was carried out using OriginPro 2018 software. In the case of zonal scans, spheroids were selected manually in ImageJ. Selection were scaled to obtain zones, and the scale factors are as follows: 1 for zone 1, 0.67 for zone 2, and 0.33 for zone 3. Intensity values were obtained by ImageJ, and background corrected normalized fluorescence intensities (CNF) were calculated as follows: CNF = (ID – (<i>A</i> × MFB))/<i>A</i>, where ID is the integrated density, <i>A</i> is the area, and MFB is the mean fluorescence of the background. The normalized intensities were standardized as the proportion of the mean intensity in the peripheries (0–100%) and plotted using OriginPro 2018. For statistical analysis, see <a class="ref internalNav" href="#notes1" aria-label="Figure S32 and Table S7">Figure S32 and Table S7</a>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Statistical Analysis</h3><div class="NLM_p last">Due to the variance heterogeneity of the studied groups (i.e., conjugates) and non-normal distribution (based on the performed Bartlett’s test and Shapiro–Wilk normality tests, respectively), Kruskal–Wallis nonparametric tests were used to compare the effects of the conjugates on cellular uptake.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> In the case of a significant treatment effect (a <i>p</i>-value <0.05 was considered as significant), the differences between the conjugates were tested by pairwise multiple comparisons following Dunn’s method. To control the family-wise error rate, <i>p</i>-values of the post hoc tests were adjusted by Holm’s method. For comparison of the cytostatic effect of Dau or Sal3-conjugated peptide derivatives with the corresponding drug alone, Dunnett’s post hoc test with Holm correction was used. ANOVA was used to analyze the treatment effect on the BBB model TW system. All statistical analyses were performed using R version 3.6.1.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> For multiple comparisons package, “PMCMR” was used.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01399" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01399?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01399</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Monitoring of the conjugation reactions, characterization of TMZA, characterization of the compounds, analytical RP-HPLC chromatograms of lead compounds, stability study of the conjugates, digestion profile of conjugates in rat liver lysosomal homogenate and LC-MS analysis, <i>in vitro</i> cytostatic and cytotoxic activity, determination of the pH dependence of the fluorescence intensity, cellular uptake studies, confocal microscopy studies, in vitro BBB model studies, and spheroid studies (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula string (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular formula string (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_003.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_001.pdf">jm0c01399_si_001.pdf (5.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_002.csv">jm0c01399_si_002.csv (15.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_003.xlsx">jm0c01399_si_003.xlsx (14.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01399" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Szilvia Bősze</span> - <span class="hlFld-Affiliation affiliation">Eötvös
Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9555-699X" title="Orcid link">http://orcid.org/0000-0001-9555-699X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#75171a060f1035101901105b1d00"><span class="__cf_email__" data-cfemail="d9bbb6aaa3bc99bcb5adbcf7b1ac">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zsuzsa Baranyai</span> - <span class="hlFld-Affiliation affiliation">Eötvös
Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span>; 
    <span>Present Address:
                        Z.B.: Instituto de Nanociencia y Materiales de Aragón (INMA) - Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Zaragoza, Edificio I+D+i - Campus Río Ebro, C/Mariano Esquillor s/n 50018 Zaragoza, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2174-6747" title="Orcid link">http://orcid.org/0000-0002-2174-6747</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beáta Biri-Kovács</span> - <span class="hlFld-Affiliation affiliation">Eötvös
Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Chemistry, Eötvös Loránd
University, Pázmány Péter Sétány 1/A, H-1117 Budapest, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5803-9969" title="Orcid link">http://orcid.org/0000-0001-5803-9969</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Krátký</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec
Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bálint Szeder</span> - <span class="hlFld-Affiliation affiliation">Institute
of Enzymology, Research Centre for Natural
Sciences, Magyar Tudósok
Körútja 2, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Márta L. Debreczeni</span> - <span class="hlFld-Affiliation affiliation">3rd
Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanna Budai</span> - <span class="hlFld-Affiliation affiliation">Eötvös
Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bence Kovács</span> - <span class="hlFld-Affiliation affiliation">Centre
for
Ecological Research, Institute of Ecology
and Botany, Alkotmány u. 2-4, H-2163 Vácrátót, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lilla Horváth</span> - <span class="hlFld-Affiliation affiliation">Eötvös
Loránd Research Network, Research Group of Peptide Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edit Pári</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zsuzsanna Németh</span> - <span class="hlFld-Affiliation affiliation">3rd
Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">László Cervenak</span> - <span class="hlFld-Affiliation affiliation">3rd
Department of Medicine Research Laboratory, Semmelweis University, Kútvölgyi út 4, H-1125 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferenc Zsila</span> - <span class="hlFld-Affiliation affiliation">Institute
of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4853-2810" title="Orcid link">http://orcid.org/0000-0002-4853-2810</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Előd Méhes</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological Physics, Institute of Physics, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Éva Kiss</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Interfaces and Nanostructures, Institute of Chemistry, Eötvös Loránd University, Pázmány Péter
Sétány 1/A, H-1117 Budapest, Hungary</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jarmila Vinšová</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec
Králové, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research work was financed by the New National Excellence Program of The Ministry of Human Capacities [ÚNKP-17-3 grant]; by the National Research, Development and Innovation Office [NVKP_16-1-2016-0036 grant]; by the ELTE Institutional Excellence Program [NKFIH-1157-8/2019-DT supported by the Hungarian Ministry of Human Capacities]; and by the Czech Science Foundation [grant number 20-19638Y] and cofinanced by the European Regional Development Fund [VEKOP-2.3.3-15-2017-00020] and by EFSA-CDN [No. CZ.02.1.01/0.0/0.0/16_019/0000841]. The authors would like to thank Gitta Schlosser and Arnold Steckel for the help in HRMS measurements, Antal Csámpai for NMR measurements, János Matkó, and Ákos Babitzky for the help in confocal microscopy. Z.B. also would like to thank the Foundation for the Hungarian Peptide and Protein Research, the Hungarian Chemical Society, the Pázmány-Eötvös Foundation for Natural Sciences and Informatics, and the MedInProt Mentor Program (Zsuzsa Baranyai, János Matkó) for the support. B.B.-K. and S.B. acknowledge the support of the ELTE Thematic Excellence Programme supported by the Hungarian Ministry for Innovation and Technology and ELTE Thematic Excellence Programme 2020 supported by the National Research, Development and Innovation Office (TKP2020-IKA-05). E.P. acknowledges the support of the VEKOP-2.3.2-16-2017-00014 grant.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">SynB3</td><td class="NLM_def"><p class="first last">RRLSYSRRRF</p></td></tr><tr><td class="NLM_term">GFLG-SynB3</td><td class="NLM_def"><p class="first last">GFLG-RRLSYSRRRF</p></td></tr><tr><td class="NLM_term">SynB3K</td><td class="NLM_def"><p class="first last">RRLSYSRRRFK</p></td></tr><tr><td class="NLM_term">SynB3K(dec)</td><td class="NLM_def"><p class="first last">RRLSYSRRRFK(decanoyl)</p></td></tr><tr><td class="NLM_term">T5</td><td class="NLM_def"><p class="first last">TKPKG</p></td></tr><tr><td class="NLM_term">GFLG-T5</td><td class="NLM_def"><p class="first last">GFLG-TKPKG</p></td></tr><tr><td class="NLM_term">T5(4-dec)</td><td class="NLM_def"><p class="first last">TKPK(decanoyl)G</p></td></tr><tr><td class="NLM_term">TKPPG-OT10</td><td class="NLM_def"><p class="first last">TKPPG-TKPKG-TKPKG</p></td></tr><tr><td class="NLM_term">H-</td><td class="NLM_def"><p class="first last">free N-terminal</p></td></tr><tr><td class="NLM_term">Ac-</td><td class="NLM_def"><p class="first last">acetylated N-terminal</p></td></tr><tr><td class="NLM_term">Cf-</td><td class="NLM_def"><p class="first last">5(6)-carboxyfluorescein on the N-terminal</p></td></tr><tr><td class="NLM_term">Sal3-Aoa-</td><td class="NLM_def"><p class="first last">salicylanilide conjugated by an oxime bond to the N-terminal of the peptide</p></td></tr><tr><td class="NLM_term">Dau-Aoa-</td><td class="NLM_def"><p class="first last">daunomycin conjugated by an oxime bond to the N-terminal of the peptide</p></td></tr><tr><td class="NLM_term">TMZ-</td><td class="NLM_def"><p class="first last">temozolomide conjugated by an amide bond to the N-terminal of the peptide</p></td></tr><tr><td class="NLM_term">UC<sub>50</sub></td><td class="NLM_def"><p class="first last">compound concentration where the rate of cells displaying fluorescence reaches 50%</p></td></tr><tr><td class="NLM_term">BEPL</td><td class="NLM_def"><p class="first last">brain extract polar lipid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">TW</td><td class="NLM_def"><p class="first last">Transwell</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 104 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span> <span> </span><span class="NLM_article-title">Glioma</span>. <i>Nat. Rev. Dis Primers</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15017</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2015.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fnrdp.2015.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27188790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FgsF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15017&author=M.+Wellerauthor=W.+Wickauthor=K.+Aldapeauthor=M.+Bradaauthor=M.+Bergerauthor=S.+M.+Pfisterauthor=R.+Nishikawaauthor=M.+Rosenthalauthor=P.+Y.+Wenauthor=R.+Stuppauthor=G.+Reifenberger&title=Glioma&doi=10.1038%2Fnrdp.2015.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma</span></div><div class="casAuthors">Weller Michael; Wick Wolfgang; Aldape Ken; Brada Michael; Berger Mitchell; Pfister Stefan M; Pfister Stefan M; Nishikawa Ryo; Rosenthal Mark; Wen Patrick Y; Stupp Roger; Reifenberger Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gliomas are primary brain tumours that are thought to derive from neuroglial stem or progenitor cells.  On the basis of their histological appearance, they have been traditionally classified as astrocytic, oligodendroglial or ependymal tumours and assigned WHO grades I-IV, which indicate different degrees of malignancy.  Tremendous progress in genomic, transcriptomic and epigenetic profiling has resulted in new concepts of classifying and treating gliomas.  Diffusely infiltrating gliomas in adults are now separated into three overarching tumour groups with distinct natural histories, responses to treatment and outcomes: isocitrate dehydrogenase (IDH)-mutant, 1p/19q co-deleted tumours with mostly oligodendroglial morphology that are associated with the best prognosis; IDH-mutant, 1p/19q non-co-deleted tumours with mostly astrocytic histology that are associated with intermediate outcome; and IDH wild-type, mostly higher WHO grade (III or IV) tumours that are associated with poor prognosis.  Gliomas in children are molecularly distinct from those in adults, the majority being WHO grade I pilocytic astrocytomas characterized by circumscribed growth, favourable prognosis and frequent BRAF gene fusions or mutations.  Ependymal tumours can be molecularly subdivided into distinct epigenetic subgroups according to location and prognosis.  Although surgery, radiotherapy and alkylating agent chemotherapy are still the mainstay of treatment, individually tailored strategies based on tumour-intrinsic dominant signalling pathways and antigenic tumour profiles may ultimately improve outcome.  For an illustrated summary of this Primer, visit: http://go.nature.com/TXY7Ri.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp7RmPT9C1joJKJbLTgsvCfW6udTcc2eYgZreOKIOq2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FgsF2ltw%253D%253D&md5=8c80c46f32b00bd1b84c7e7fa31b6977</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2015.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2015.17%26sid%3Dliteratum%253Aachs%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBrada%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DNishikawa%26aufirst%3DR.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DReifenberger%26aufirst%3DG.%26atitle%3DGlioma%26jtitle%3DNat.%2520Rev.%2520Dis%2520Primers%26date%3D2015%26volume%3D1%26spage%3D15017%26doi%3D10.1038%2Fnrdp.2015.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillibert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhermitte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idbaih, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Meco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stragliotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hottinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirson, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavy-Shahaf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paek, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palti, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ram, Z.</span></span> <span> </span><span class="NLM_article-title">Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients with Glioblastoma: A Randomized Clinical Trial</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">2306</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1001/jama.2017.18718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1001%2Fjama.2017.18718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29260225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2017&pages=2306-2316&author=R.+Stuppauthor=S.+Taillibertauthor=A.+Kannerauthor=W.+Readauthor=D.+Steinbergauthor=B.+Lhermitteauthor=S.+Tomsauthor=A.+Idbaihauthor=M.+S.+Ahluwaliaauthor=K.+Finkauthor=F.+Di+Mecoauthor=F.+Liebermanauthor=J.+J.+Zhuauthor=G.+Stragliottoauthor=D.+Tranauthor=S.+Bremauthor=A.+Hottingerauthor=E.+D.+Kirsonauthor=G.+Lavy-Shahafauthor=U.+Weinbergauthor=C.+Y.+Kimauthor=S.+H.+Paekauthor=G.+Nicholasauthor=J.+Brunaauthor=H.+Hirteauthor=M.+Wellerauthor=Y.+Paltiauthor=M.+E.+Hegiauthor=Z.+Ram&title=Effect+of+Tumor-Treating+Fields+Plus+Maintenance+Temozolomide+vs+Maintenance+Temozolomide+Alone+on+Survival+in+Patients+with+Glioblastoma%3A+A+Randomized+Clinical+Trial&doi=10.1001%2Fjama.2017.18718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial</span></div><div class="casAuthors">Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M.; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S.; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D.; Brem, Steven; Hottinger, Andreas F.; Kirson, Eilon D.; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika E.; Ram, Zvi</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2306-2316</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating elec. fields to the tumor.  To investigate whether TTFields improves progression-free and overall survival of patients with glioblastoma, a fatal disease that commonly recurs at the initial tumor site or in the central nervous system.  In this randomized, open-label trial, 695 patients with glioblastoma whose tumor was resected or biopsied and had completed concomitant radiochemotherapy (median time from diagnosis to randomization, 3.8 mo) were enrolled at 83 centers (July 2009-2014) and followed up through Dec. 2016.  A preliminary report from this trial was published in 2015; this report describes the final anal.  Patients were randomized 2:1 to TTFields plus maintenance temozolomide chemotherapy (n = 466) or temozolomide alone (n = 229).  The TTFields, consisting of low-intensity, 200 kHz frequency, alternating elec. fields, was delivered (≥ 18 h/d) via 4 transducer arrays on the shaved scalp and connected to a portable device.  Temozolomide was administered to both groups (150-200 mg/m2) for 5 days per 28-day cycle (6-12 cycles).  Progression-free survival (tested at α = .046).  The secondary end point was overall survival (tested hierarchically at α = .048).  Analyses were performed for the intent-to-treat population.  Adverse events were compared by group.  Results Of the 695 randomized patients (median age, 56 years; IQR, 48-63; 473 men [68%]), 637 (92%) completed the trial.  Median progression-free survival from randomization was 6.7 mo in the TTFields-temozolomide group and 4.0 mo in the temozolomide-alone group (HR, 0.63; 95% CI, 0.52-0.76; P < .001).  Median overall survival was 20.9 mo in the TTFields-temozolomide group vs 16.0 mo in the temozolomide-alone group (HR, 0.63; 95% CI, 0.53-0.76; P < .001).  Systemic adverse event frequency was 48% in the TTFields-temozolomide group and 44% in the temozolomide-alone group.  Mild to moderate skin toxicity underneath the transducer arrays occurred in 52% of patients who received TTFields-temozolomide vs no patients who received temozolomide alone.  In the final anal. of this randomized clin. trial of patients with glioblastoma who had received std. radiochemotherapy, the addn. of TTFields to maintenance temozolomide chemotherapy vs maintenance temozolomide alone, resulted in statistically significant improvement in progression-free survival and overall survival.  These results are consistent with the previous interim anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9S4ay1_W7rVg90H21EOLACvtfcHk0lgwLng7lgUtKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVymtg%253D%253D&md5=9e9104d5f73da7eac08cb8a965b02735</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.2017.18718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2017.18718%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DTaillibert%26aufirst%3DS.%26aulast%3DKanner%26aufirst%3DA.%26aulast%3DRead%26aufirst%3DW.%26aulast%3DSteinberg%26aufirst%3DD.%26aulast%3DLhermitte%26aufirst%3DB.%26aulast%3DToms%26aufirst%3DS.%26aulast%3DIdbaih%26aufirst%3DA.%26aulast%3DAhluwalia%26aufirst%3DM.%2BS.%26aulast%3DFink%26aufirst%3DK.%26aulast%3DDi%2BMeco%26aufirst%3DF.%26aulast%3DLieberman%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%2BJ.%26aulast%3DStragliotto%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DBrem%26aufirst%3DS.%26aulast%3DHottinger%26aufirst%3DA.%26aulast%3DKirson%26aufirst%3DE.%2BD.%26aulast%3DLavy-Shahaf%26aufirst%3DG.%26aulast%3DWeinberg%26aufirst%3DU.%26aulast%3DKim%26aufirst%3DC.%2BY.%26aulast%3DPaek%26aufirst%3DS.%2BH.%26aulast%3DNicholas%26aufirst%3DG.%26aulast%3DBruna%26aufirst%3DJ.%26aulast%3DHirte%26aufirst%3DH.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DPalti%26aufirst%3DY.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DRam%26aufirst%3DZ.%26atitle%3DEffect%2520of%2520Tumor-Treating%2520Fields%2520Plus%2520Maintenance%2520Temozolomide%2520vs%2520Maintenance%2520Temozolomide%2520Alone%2520on%2520Survival%2520in%2520Patients%2520with%2520Glioblastoma%253A%2520A%2520Randomized%2520Clinical%2520Trial%26jtitle%3DJAMA%26date%3D2017%26volume%3D318%26spage%3D2306%26epage%3D2316%26doi%3D10.1001%2Fjama.2017.18718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesakul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muangsin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Current Challenges and Opportunities in Treating Glioblastoma</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">445</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fpr.117.014944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29669750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=412-445&author=A.+Shergalisauthor=A.+Bankheadauthor=U.+Luesakulauthor=N.+Muangsinauthor=N.+Neamati&title=Current+Challenges+and+Opportunities+in+Treating+Glioblastoma&doi=10.1124%2Fpr.117.014944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges and opportunities in treating glioblastoma</span></div><div class="casAuthors">Shergalis, Andrea; Bankhead, Armand; Luesakul, Urarika; Muangsin, Nongnuj; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-445</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has a high mortality rate despite extensive efforts to develop new treatments.  GBM exhibits both intra- and intertumor heterogeneity, lending to resistance and eventual tumor recurrence.  Large-scale genomic and proteomic anal. of GBM tumors has uncovered potential drug targets.  Effective and "druggable" targets must be validated to embark on a robust medicinal chem. campaign culminating in the discovery of clin. candidates.  Here, we review recent developments in GBM drug discovery and delivery.  To identify GBM drug targets, we performed extensive bioinformatics anal. using data from The Cancer Genome Atlas project.  We discovered 20 genes, BOC, CLEC4GP1, ELOVL6, EREG, ESR2, FDCSP, FURIN, FUT8-AS1, GZMB, IRX3, LITAF, NDEL1, NKX3-1, PODNL1, PTPRN, QSOX1, SEMA4F, TH, VEGFC, and C20orf166AS1 that are overexpressed in a subpopulation of GBM patients and correlate with poor survival outcomes.  Importantly, nine of these genes exhibit higher expression in GBM vs. low-grade glioma and may be involved in disease progression.  In this review, we discuss these proteins in the context of GBM disease progression.  We also conducted computational multi-parameter optimization to assess the blood-brain barrier (BBB) permeability of small mols. in clin. trials for GBM treatment.  Drug delivery in the context of GBM is particularly challenging because the BBB hinders small mol. transport.  Therefore, we discuss novel drug delivery methods, including nanoparticles and prodrugs.  Given the aggressive nature of GBM and the complexity of targeting the central nervous system, effective treatment options are a major unmet medical need.  Identification and validation of biomarkers and drug targets assocd. with GBM disease progression present an exciting opportunity to improve treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKoQ_eLuZhn7Vg90H21EOLACvtfcHk0lgwLng7lgUtKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D&md5=80fb3912ca8df56db7b1c146ef45ffef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014944%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DLuesakul%26aufirst%3DU.%26aulast%3DMuangsin%26aufirst%3DN.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DCurrent%2520Challenges%2520and%2520Opportunities%2520in%2520Treating%2520Glioblastoma%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D412%26epage%3D445%26doi%3D10.1124%2Fpr.117.014944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques-Torrejon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, S. M.</span></span> <span> </span><span class="NLM_article-title">Experimental Models and Tools to Tackle Glioblastoma</span>. <i>Dis. Models Mech.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">dmm040386</span>, <span class="refDoi"> DOI: 10.1242/dmm.040386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1242%2Fdmm.040386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31519690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=dmm040386&author=F.+L.+Robertsonauthor=M.+A.+Marques-Torrejonauthor=G.+M.+Morrisonauthor=S.+M.+Pollard&title=Experimental+Models+and+Tools+to+Tackle+Glioblastoma&doi=10.1242%2Fdmm.040386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1242%2Fdmm.040386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.040386%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DF.%2BL.%26aulast%3DMarques-Torrejon%26aufirst%3DM.%2BA.%26aulast%3DMorrison%26aufirst%3DG.%2BM.%26aulast%3DPollard%26aufirst%3DS.%2BM.%26atitle%3DExperimental%2520Models%2520and%2520Tools%2520to%2520Tackle%2520Glioblastoma%26jtitle%3DDis.%2520Models%2520Mech.%26date%3D2019%26volume%3D12%26spage%3Ddmm040386%26doi%3D10.1242%2Fdmm.040386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vollmann-Zwerenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidgens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliciello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span> <span> </span><span class="NLM_article-title">Tumor Cell Invasion in Glioblastoma</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1932</span>, <span class="refDoi"> DOI: 10.3390/ijms21061932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms21061932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVaqt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=1932&author=A.+Vollmann-Zwerenzauthor=V.+Leidgensauthor=G.+Felicielloauthor=C.+A.+Kleinauthor=P.+Hau&title=Tumor+Cell+Invasion+in+Glioblastoma&doi=10.3390%2Fijms21061932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell invasion in glioblastoma</span></div><div class="casAuthors">Vollmann-Zwerenz, Arabel; Leidgens, Verena; Feliciello, Giancarlo; Klein, Christoph A.; Hau, Peter</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1932</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16 mo.  Recent research has revealed novel insights into the outstanding heterogeneity of this type of brain cancer.  However, all GBM subtypes share the hallmark feature of aggressive invasion into the surrounding tissue.  Invasive glioblastoma cells escape surgery and focal therapies and thus represent a major obstacle for curative therapy.  This review aims to provide a comprehensive understanding of glioma invasion mechanisms with respect to tumor-cell-intrinsic properties as well as cues provided by the microenvironment.  We discuss genetic programs that may influence the dissemination and plasticity of GBM cells as well as their different invasion patterns.  We also review how tumor cells shape their microenvironment and how, vice versa, components of the extracellular matrix and factors from non-neoplastic cells influence tumor cell motility.  We further discuss different research platforms for modeling invasion.  Finally, we highlight the importance of accounting for the complex interplay between tumor cell invasion and treatment resistance in glioblastoma when considering new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUBA5r6HWjrVg90H21EOLACvtfcHk0lgwLng7lgUtKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVaqt7%252FJ&md5=3cfa59c863fa23748635d02a67945efb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms21061932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21061932%26sid%3Dliteratum%253Aachs%26aulast%3DVollmann-Zwerenz%26aufirst%3DA.%26aulast%3DLeidgens%26aufirst%3DV.%26aulast%3DFeliciello%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%2BA.%26aulast%3DHau%26aufirst%3DP.%26atitle%3DTumor%2520Cell%2520Invasion%2520in%2520Glioblastoma%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D1932%26doi%3D10.3390%2Fijms21061932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebelt, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shingu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span> <span> </span><span class="NLM_article-title">Glioma Stem Cells: Signaling, Microenvironment, and Therapy</span>. <i>Stem Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">7849890</span>, <span class="refDoi"> DOI: 10.1155/2016/7849890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1155%2F2016%2F7849890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26880988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtVOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=7849890&author=B.+D.+Liebeltauthor=T.+Shinguauthor=X.+Zhouauthor=J.+Renauthor=S.+A.+Shinauthor=J.+Hu&title=Glioma+Stem+Cells%3A+Signaling%2C+Microenvironment%2C+and+Therapy&doi=10.1155%2F2016%2F7849890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma Stem Cells: Signaling, Microenvironment, and Therapy</span></div><div class="casAuthors">Liebelt Brandon D; Shingu Takashi; Zhou Xin; Ren Jiangong; Shin Seul A; Hu Jian</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7849890</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">Glioblastoma remains the most common and devastating primary brain tumor despite maximal therapy with surgery, chemotherapy, and radiation.  The glioma stem cell (GSC) subpopulation has been identified in glioblastoma and likely plays a key role in resistance of these tumors to conventional therapies as well as recurrent disease.  GSCs are capable of self-renewal and differentiation; glioblastoma-derived GSCs are capable of de novo tumor formation when implanted in xenograft models.  Further, GSCs possess unique surface markers, modulate characteristic signaling pathways to promote tumorigenesis, and play key roles in glioma vascular formation.  These features, in addition to microenvironmental factors, present possible targets for specifically directing therapy against the GSC population within glioblastoma.  In this review, the authors summarize the current knowledge of GSC biology and function and the role of GSCs in new vascular formation within glioblastoma and discuss potential therapeutic approaches to target GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFS7HBs9MUiM8MEzWGjS9fW6udTcc2eYzYLIN-7Mcobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtVOisg%253D%253D&md5=7deb1b90f5996939f1079be086436ea7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1155%2F2016%2F7849890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F7849890%26sid%3Dliteratum%253Aachs%26aulast%3DLiebelt%26aufirst%3DB.%2BD.%26aulast%3DShingu%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DS.%2BA.%26aulast%3DHu%26aufirst%3DJ.%26atitle%3DGlioma%2520Stem%2520Cells%253A%2520Signaling%252C%2520Microenvironment%252C%2520and%2520Therapy%26jtitle%3DStem%2520Cells%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D7849890%26doi%3D10.1155%2F2016%2F7849890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patabendige, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolman, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusof, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. J.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Blood-Brain Barrier</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.nbd.2009.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19664713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=13-25&author=N.+J.+Abbottauthor=A.+A.+Patabendigeauthor=D.+E.+Dolmanauthor=S.+R.+Yusofauthor=D.+J.+Begley&title=Structure+and+Function+of+the+Blood-Brain+Barrier&doi=10.1016%2Fj.nbd.2009.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Patabendige, Adjanie A. K.; Dolman, Diana E. M.; Yusof, Siti R.; Begley, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment.  Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier.  The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange.  The structure and function of the BBB is summarized, the phys. barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms.  The roles of assocd. cells are outlined, esp. the end feet of astrocytic glial cells, and pericytes and microglia.  The embryonic development of the BBB, and changes in pathol. are described.  The BBB is subject to short and long-term regulation, which may be disturbed in pathol.  Any program for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLiRwl4gXHmbVg90H21EOLACvtfcHk0liFM5uFOsVcmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P&md5=fa08cd39c1350b4c845121c21a174ad8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DPatabendige%26aufirst%3DA.%2BA.%26aulast%3DDolman%26aufirst%3DD.%2BE.%26aulast%3DYusof%26aufirst%3DS.%2BR.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2009.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yetkin-Arik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gooijer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurdinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, H. E.</span></span> <span> </span><span class="NLM_article-title">Overcoming the Blood-Brain Tumor Barrier for Effective Glioblastoma Treatment</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2015.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.drup.2015.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25791797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmtFGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1-12&author=O.+van%0ATellingenauthor=B.+Yetkin-Arikauthor=M.+C.+de+Gooijerauthor=P.+Wesselingauthor=T.+Wurdingerauthor=H.+E.+de+Vries&title=Overcoming+the+Blood-Brain+Tumor+Barrier+for+Effective+Glioblastoma+Treatment&doi=10.1016%2Fj.drup.2015.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the blood-brain tumor barrier for effective glioblastoma treatment</span></div><div class="casAuthors">van Tellingen O; Yetkin-Arik B; de Gooijer M C; Wesseling P; Wurdinger T; de Vries H E</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gliomas are the most common primary brain tumors.  Particularly in adult patients, the vast majority of gliomas belongs to the heterogeneous group of diffuse gliomas, i.e. glial tumors characterized by diffuse infiltrative growth in the preexistent brain tissue.  Unfortunately, glioblastoma, the most aggressive (WHO grade IV) diffuse glioma is also by far the most frequent one.  After standard treatment, the 2-year overall survival of glioblastoma patients is approximately only 25%.  Advanced knowledge in the molecular pathology underlying malignant transformation has offered new handles and better treatments for several cancer types.  Unfortunately, glioblastoma multiforme (GBM) patients have not yet profited as although numerous experimental drugs have been tested in clinical trials, all failed miserably.  This grim prognosis for GBM is at least partly due to the lack of successful drug delivery across the blood-brain tumor barrier (BBTB).  The human brain comprises over 100 billion capillaries with a total length of 400 miles, a total surface area of 20 m(2) and a median inter-capillary distance of about 50 μm, making it the best perfused organ in the body.  The BBTB encompasses existing and newly formed blood vessels that contribute to the delivery of nutrients and oxygen to the tumor and facilitate glioma cell migration to other parts of the brain.  The high metabolic demands of high-grade glioma create hypoxic areas that trigger increased expression of VEGF and angiogenesis, leading to the formation of abnormal vessels and a dysfunctional BBTB.  Even though the BBTB is considered 'leaky' in the core part of glioblastomas, in large parts of glioblastomas and, even more so, in lower grade diffuse gliomas the BBTB more closely resembles the intact blood-brain barrier (BBB) and prevents efficient passage of cancer therapeutics, including small molecules and antibodies.  Thus, many drugs can still be blocked from reaching the many infiltrative glioblastoma cells that demonstrate 'within-organ-metastasis' away from the core part to brain areas displaying a more organized and less leaky BBTB.  Hence, drug delivery in glioblastoma deserves explicit attention as otherwise new experimental therapies will continue to fail.  In the current review we highlight different aspects of the BBTB in glioma patients and preclinical models and discuss the advantages and drawbacks of drug delivery approaches for the treatment of glioma patients.  We provide an overview on methods to overcome the BBTB, including osmotic blood-brain barrier disruption (BBBD), bradykinin receptor-mediated BBTB opening, inhibition of multidrug efflux transporters, receptor-mediated transport systems and physiological circumvention of the BBTB.  While our knowledge about the molecular biology of glioma cells is rapidly expanding and is, to some extent, already assisting us in the design of tumor-tailored therapeutics, we are still struggling to develop modalities to expose the entire tumor to such therapeutics at pharmacologically meaningful quantities.  Therefore, we must expand our knowledge about the fundamentals of the BBTB as a step toward the design of practical and safe devices and approaches for enhanced drug delivery into the diseased brain area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfxbfaIM8XluRS7coPn-RtfW6udTcc2eYzYLIN-7Mcobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmtFGhtA%253D%253D&md5=dfc68f7c7bc5d75354120d8e929bf2a9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2015.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2015.02.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DYetkin-Arik%26aufirst%3DB.%26aulast%3Dde%2BGooijer%26aufirst%3DM.%2BC.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DWurdinger%26aufirst%3DT.%26aulast%3Dde%2BVries%26aufirst%3DH.%2BE.%26atitle%3DOvercoming%2520the%2520Blood-Brain%2520Tumor%2520Barrier%2520for%2520Effective%2520Glioblastoma%2520Treatment%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2015%26volume%3D19%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.drup.2015.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaria, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parney, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pafundi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laack, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizilbash, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laramy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agar, N. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmquist, W. F.</span></span> <span> </span><span class="NLM_article-title">Is the Blood-Brain Barrier Really Disrupted in All Glioblastomas? A Critical Assessment of Existing Clinical Data</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nox175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1093%2Fneuonc%2Fnox175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29016900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Ogsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=184-191&author=J.+N.+Sarkariaauthor=L.+S.+Huauthor=I.+F.+Parneyauthor=D.+H.+Pafundiauthor=D.+H.+Brinkmannauthor=N.+N.+Laackauthor=C.+Gianniniauthor=T.+C.+Burnsauthor=S.+H.+Kizilbashauthor=J.+K.+Laramyauthor=K.+R.+Swansonauthor=T.+J.+Kaufmannauthor=P.+D.+Brownauthor=N.+Y.+R.+Agarauthor=E.+Galanisauthor=J.+C.+Bucknerauthor=W.+F.+Elmquist&title=Is+the+Blood-Brain+Barrier+Really+Disrupted+in+All+Glioblastomas%3F+A+Critical+Assessment+of+Existing+Clinical+Data&doi=10.1093%2Fneuonc%2Fnox175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data</span></div><div class="casAuthors">Sarkaria, Jann N.; Hu, Leland S.; Parney, Ian F.; Pafundi, Deanna H.; Brinkmann, Debra H.; Laack, Nadia N.; Giannini, Caterina; Burns, Terence C.; Kizilbash, Sani H.; Laramy, Janice K.; Swanson, Kristin R.; Kaufmann, Timothy J.; Brown, Paul D.; Agar, Nathalie Y. R.; Galanis, Evanthia; Buckner, Jan C.; Elmquist, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1523-5866</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) excludes the vast majority of cancer therapeutics from normal brain.  However, the importance of the BBB in limiting drug delivery and efficacy is controversial in high-grade brain tumors, such as glioblastoma (GBM).  The accumulation of normally brain impenetrant radiog. contrast material in essentially all GBM has popularized a belief that the BBB is uniformly disrupted in all GBM patients so that consideration of drug distribution across the BBB is not relevant in designing therapies for GBM.  However, contrary to this view, overwhelming clin. evidence demonstrates that there is also a clin. significant tumor burden with an intact BBB in all GBM, and there is little doubt that drugs with poor BBB permeability do not provide therapeutically effective drug exposures to this fraction of tumor cells.  This review provides an overview of the clin. literature to support a central hypothesis: that all GBM patients have tumor regions with an intact BBB, and cure for GBM will only be possible if these regions of tumor are adequately treated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfa57RTmFi7Vg90H21EOLACvtfcHk0lhxoUusFpEDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Ogsbs%253D&md5=16f3f39fa253e4b5814ca3040c4d661c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnox175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnox175%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DHu%26aufirst%3DL.%2BS.%26aulast%3DParney%26aufirst%3DI.%2BF.%26aulast%3DPafundi%26aufirst%3DD.%2BH.%26aulast%3DBrinkmann%26aufirst%3DD.%2BH.%26aulast%3DLaack%26aufirst%3DN.%2BN.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DT.%2BC.%26aulast%3DKizilbash%26aufirst%3DS.%2BH.%26aulast%3DLaramy%26aufirst%3DJ.%2BK.%26aulast%3DSwanson%26aufirst%3DK.%2BR.%26aulast%3DKaufmann%26aufirst%3DT.%2BJ.%26aulast%3DBrown%26aufirst%3DP.%2BD.%26aulast%3DAgar%26aufirst%3DN.%2BY.%2BR.%26aulast%3DGalanis%26aufirst%3DE.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DIs%2520the%2520Blood-Brain%2520Barrier%2520Really%2520Disrupted%2520in%2520All%2520Glioblastomas%253F%2520A%2520Critical%2520Assessment%2520of%2520Existing%2520Clinical%2520Data%26jtitle%3DNeuro%2520Oncol%26date%3D2018%26volume%3D20%26spage%3D184%26epage%3D191%26doi%3D10.1093%2Fneuonc%2Fnox175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. Q.</span></span> <span> </span><span class="NLM_article-title">Current Approaches to Enhance CNS Delivery of Drugs across the Brain Barriers</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2241</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.2147/IJN.S61288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2147%2FIJN.S61288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24872687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2cjptlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2241-2257&author=C.+T.+Luauthor=Y.+Z.+Zhaoauthor=H.+L.+Wongauthor=J.+Caiauthor=L.+Pengauthor=X.+Q.+Tian&title=Current+Approaches+to+Enhance+CNS+Delivery+of+Drugs+across+the+Brain+Barriers&doi=10.2147%2FIJN.S61288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to enhance CNS delivery of drugs across the brain barriers</span></div><div class="casAuthors">Lu Cui-Tao; Tian Xin-Qiao; Zhao Ying-Zheng; Wong Ho Lun; Cai Jun; Peng Lei</div><div class="citationInfo"><span class="NLM_cas:title">International journal of nanomedicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2241-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although many agents have therapeutic potentials for central nervous system (CNS) diseases, few of these agents have been clinically used because of the brain barriers.  As the protective barrier of the CNS, the blood-brain barrier and the blood-cerebrospinal fluid barrier maintain the brain microenvironment, neuronal activity, and proper functioning of the CNS.  Different strategies for efficient CNS delivery have been studied.  This article reviews the current approaches to open or facilitate penetration across these barriers for enhanced drug delivery to the CNS.  These approaches are summarized into three broad categories: noninvasive, invasive, and miscellaneous techniques.  The progresses made using these approaches are reviewed, and the associated mechanisms and problems are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiAFNhnmth4Q5nADWVYHg1fW6udTcc2eY6C4GgAwVt_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjptlGjsQ%253D%253D&md5=6cf22f5aa89db81ccdf2e57fb40f19b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FIJN.S61288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S61288%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%2BT.%26aulast%3DZhao%26aufirst%3DY.%2BZ.%26aulast%3DWong%26aufirst%3DH.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DX.%2BQ.%26atitle%3DCurrent%2520Approaches%2520to%2520Enhance%2520CNS%2520Delivery%2520of%2520Drugs%2520across%2520the%2520Brain%2520Barriers%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2014%26volume%3D9%26spage%3D2241%26epage%3D2257%26doi%3D10.2147%2FIJN.S61288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohanty, R.</span></span> <span> </span><span class="NLM_article-title">Peptides as Drug Delivery Vehicles across Biological Barriers</span>. <i>J. Pharm. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1007/s40005-017-0374-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs40005-017-0374-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29963321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=89-111&author=D.+Ghoshauthor=X.+Pengauthor=J.+Lealauthor=R.+Mohanty&title=Peptides+as+Drug+Delivery+Vehicles+across+Biological+Barriers&doi=10.1007%2Fs40005-017-0374-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Peptides as drug delivery vehicles across biological barriers</span></div><div class="casAuthors">Ghosh, Debadyuti; Peng, Xiujuan; Leal, Jasmim; Mohanty, Rashmi P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-111</span>CODEN:
                <span class="NLM_cas:coden">JPIOBH</span>;
        ISSN:<span class="NLM_cas:issn">2093-5552</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Peptides are small biol. mols. that are attractive in drug delivery and materials engineering for applications including therapeutics, mol. building blocks and cell-targeting ligands. Peptides are small but can possess complexity and functionality as larger proteins. Due to their intrinsic properties, peptides are able to overcome the physiol. and transport barriers presented by diseases. In this review, we discuss the progress of identifying and using peptides to shuttle across biol. barriers and facilitate transport of drugs and drug delivery systems for improved therapy. Here, the focus of this review is on rationally designed, phage display peptides, and even endogenous peptides as carriers to penetrate biol. barriers, specifically the blood-brain barrier (BBB), the gastrointestinal tract (GI), and the solid tumor microenvironment (T). We will discuss recent advances of peptides as drug carriers in these biol. environments. From these findings, challenges and potential opportunities to iterate and improve peptide-based approaches will be discussed to translate their promise towards the clinic to deliver drugs for therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj-teoIAHcfrVg90H21EOLACvtfcHk0lhxoUusFpEDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7nE&md5=4ab7c6f17bb6f70396dc22418aef1edb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs40005-017-0374-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40005-017-0374-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLeal%26aufirst%3DJ.%26aulast%3DMohanty%26aufirst%3DR.%26atitle%3DPeptides%2520as%2520Drug%2520Delivery%2520Vehicles%2520across%2520Biological%2520Barriers%26jtitle%3DJ.%2520Pharm.%2520Invest.%26date%3D2018%26volume%3D48%26spage%3D89%26epage%3D111%26doi%3D10.1007%2Fs40005-017-0374-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardridge, W. M.</span></span> <span> </span><span class="NLM_article-title">Molecular Trojan Horses for Blood-Brain Barrier Drug Delivery</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.coph.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=16839816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=494-500&author=W.+M.+Pardridge&title=Molecular+Trojan+Horses+for+Blood-Brain+Barrier+Drug+Delivery&doi=10.1016%2Fj.coph.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Trojan horses for blood-brain barrier drug delivery</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">494-500</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides and recombinant proteins such as neurotrophins, enzymes and monoclonal antibodies, have not been developed as new drugs for the brain because these large mol. drugs do not cross the brain capillary wall, which forms the blood-brain barrier (BBB) in vivo.  A new soln. to the brain drug delivery problem is the genetic engineering of recombinant fusion proteins.  The therapeutic peptide or protein drug is fused to a mol. Trojan horse, which is a second peptide or peptidomimetic monoclonal antibody that binds a specific receptor on the BBB.  The Trojan horse enables receptor-mediated delivery of the fusion protein across the BBB so that the protein drug can enter the brain and exert the desired pharmacol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdn5vX2Kb5bVg90H21EOLACvtfcHk0lgs8kQYH3AFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWrsL8%253D&md5=53c63b87e81b4a627df42009338abdb5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DMolecular%2520Trojan%2520Horses%2520for%2520Blood-Brain%2520Barrier%2520Drug%2520Delivery%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D494%26epage%3D500%26doi%3D10.1016%2Fj.coph.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srimanee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.3390/ph5090991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fph5090991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24280701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=991-1007&author=J.+Regbergauthor=A.+Srimaneeauthor=U.+Langel&title=Applications+of+Cell-Penetrating+Peptides+for+Tumor+Targeting+and+Future+Cancer+Therapies&doi=10.3390%2Fph5090991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of cell-penetrating peptides for tumor targeting and future cancer therapies</span></div><div class="casAuthors">Regberg, Jakob; Srimanee, Artita; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">991-1007</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cell-penetrating peptides provide a highly promising strategy for intracellular drug delivery.  One relevant clin. application of cell-penetrating peptides is cancer therapeutics.  Peptide based delivery could increase the uptake of drugs in tumor cells and thereby increase the efficacy of the treatment, either of conventional small mol. drugs or oligonucleotide based therapeutics.  This review is focused on the cancer applications of cell penetrating peptides as delivery systems; different aspects of drug loading, cargoes and delivery are discussed together with methods for targeted delivery, activatable cell-penetrating peptides and transducible agents coupled to cell-penetrating peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq990sv2YeyLbVg90H21EOLACvtfcHk0lgs8kQYH3AFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCkurjP&md5=aabae0f6ae24ed86261fb174a90d4ef5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fph5090991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph5090991%26sid%3Dliteratum%253Aachs%26aulast%3DRegberg%26aufirst%3DJ.%26aulast%3DSrimanee%26aufirst%3DA.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DApplications%2520of%2520Cell-Penetrating%2520Peptides%2520for%2520Tumor%2520Targeting%2520and%2520Future%2520Cancer%2520Therapies%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D991%26epage%3D1007%26doi%3D10.3390%2Fph5090991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oller-Salvia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixido, M.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Shuttle Peptides: An Emerging Paradigm for Brain Delivery</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4690</span>– <span class="NLM_lpage">4707</span>, <span class="refDoi"> DOI: 10.1039/C6CS00076B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1039%2FC6CS00076B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27188322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=4690-4707&author=B.+Oller-Salviaauthor=M.+Sanchez-Navarroauthor=E.+Giraltauthor=M.+Teixido&title=Blood-Brain+Barrier+Shuttle+Peptides%3A+An+Emerging+Paradigm+for+Brain+Delivery&doi=10.1039%2FC6CS00076B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery</span></div><div class="casAuthors">Oller-Salvia, Benjami; Sanchez-Navarro, Macarena; Giralt, Ernest; Teixido, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4690-4707</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain delivery is one of the major challenges in drug development because of the high no. of patients suffering from neural diseases and the low efficiency of the treatments available.  Although the blood-brain barrier (BBB) prevents most drugs from reaching their targets, mol. vectors - known as BBB shuttles - offer great promise to safely overcome this formidable obstacle.  In recent years, peptide shuttles have received growing attention because of their lower cost, reduced immunogenicity, and higher chem. versatility than traditional Trojan horse antibodies and other proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1goQ9PoVFBLVg90H21EOLACvtfcHk0lgs8kQYH3AFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFagtbo%253D&md5=95c266d6b59c001b7ad53dfd01802797</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC6CS00076B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CS00076B%26sid%3Dliteratum%253Aachs%26aulast%3DOller-Salvia%26aufirst%3DB.%26aulast%3DSanchez-Navarro%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26aulast%3DTeixido%26aufirst%3DM.%26atitle%3DBlood-Brain%2520Barrier%2520Shuttle%2520Peptides%253A%2520An%2520Emerging%2520Paradigm%2520for%2520Brain%2520Delivery%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D4690%26epage%3D4707%26doi%3D10.1039%2FC6CS00076B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefauconnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">New Advances in the Transport of Doxorubicin through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1124/mol.57.4.679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fmol.57.4.679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10727512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1ehtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=679-686&author=C.+Rousselleauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=M.+Kaczorekauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=New+Advances+in+the+Transport+of+Doxorubicin+through+the+Blood-Brain+Barrier+by+a+Peptide+Vector-Mediated+Strategy&doi=10.1124%2Fmol.57.4.679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Lefauconnier, Jeanne-Marie; Kaczorek, Michel; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-686</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through the blood-brain barrier (BBB).  To overcome this problem, we have developed a novel method in which short, naturally derived peptides (16-18 amino acids) cross the cellular membranes of the BBB with high efficiency and without compromising its integrity.  The antineoplastic agent doxorubicin (dox) was coupled covalently to two peptides, D-penetratin and SynB1.  The ability of dox to cross the BBB was studied using an in situ rat brain perfusion technique and also by i.v. injection in mice.  In the brain perfusion studies, we first confirmed the very low brain uptake of free radiolabeled dox because of the efflux activity of P-glycoprotein at the BBB.  By contrast, we have demonstrated that when dox is coupled to either the D-penetratin or SynB1 vectors, its uptake was increased by a factor of 6, suggesting that the vectorized dox bypasses P-glycoprotein.  Moreover, using a capillary depletion method, we have shown that vectorization of dox led to a 20-fold increase in the amt. of dox transported into brain parenchyma.  I.v. administration of vectorized dox at a dose of 2.5 mg/kg in mice led to a significant increase in brain dox concns. during the first 30 min of postadministration, compared with free dox.  Addnl., vectorization led to a significant decrease of dox concns. in the heart.  In summary, our results establish that the two peptide vectors used in this study enhance the delivery of dox across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6uZmz-sAHLVg90H21EOLACvtfcHk0lgs8kQYH3AFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1ehtbg%253D&md5=c0d0f5513b7bafbc99c0b35fa54e82c8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.57.4.679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.57.4.679%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DNew%2520Advances%2520in%2520the%2520Transport%2520of%2520Doxorubicin%2520through%2520the%2520Blood-Brain%2520Barrier%2520by%2520a%2520Peptide%2520Vector-Mediated%2520Strategy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D679%26epage%3D686%26doi%3D10.1124%2Fmol.57.4.679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefauconnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Enhanced Delivery of Doxorubicin into the Brain via a Peptide-Vector-Mediated Strategy: Saturation Kinetics and Specificity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=11123372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=124-131&author=C.+Rousselleauthor=M.+Smirnovaauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=A.+Chavanieuauthor=B.+Calasauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Enhanced+Delivery+of+Doxorubicin+into+the+Brain+via+a+Peptide-Vector-Mediated+Strategy%3A+Saturation+Kinetics+and+Specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity</span></div><div class="casAuthors">Rousselle, Christophe; Smirnova, Maria; Clair, Philippe; Lefauconnier, Jeanne-Marie; Chavanieu, Alain; Calas, Bernard; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Doxorubicin delivery to the brain is often restricted because of the poor transport of this therapeutic mol. through the blood-brain barrier (BBB).  To overcome this problem, we have recently developed a technol., Pep:trans, based on short natural-derived peptides that are able to cross efficiently the BBB without compromising its integrity.  In this study, we have used the in situ mouse brain perfusion method to evaluate the brain uptake of free and vectorized doxorubicin.  Doxorubicin was coupled covalently to small peptide vectors: L-SynB1 (18 amino acids), L-SynB3 (10 amino acids), and its enantiomeric form D-SynB3.  We first confirmed the very low brain uptake of free radiolabeled doxorubicin, which is most likely due to the efflux activity of the P-glycoprotein at the level of the BBB.  Vectorization with either L-SynB1, L-SynB3, or D-SynB3 significantly increased the brain uptake of doxorubicin (about 30-fold).  We also investigated the mechanism of transport of vectorized doxorubicin.  We show that vectorized doxorubicin uses a saturable transport mechanism to cross the BBB.  The effect of poly(L-lysine) and protamine, endocytosis inhibitors, on the transport across the brain was also investigated.  Both inhibitors reduced the brain uptake of vectorized doxorubicin in a dose-dependent manner.  These studies indicate that the transport of vectorized doxorubicin appears to occur via an adsorptive-mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-e-bqv26ckLVg90H21EOLACvtfcHk0lj2QjWQV97-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVal&md5=ee2f5ebf25318ab139cf43cc9a0f0359</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DSmirnova%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DChavanieu%26aufirst%3DA.%26aulast%3DCalas%26aufirst%3DB.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DEnhanced%2520Delivery%2520of%2520Doxorubicin%2520into%2520the%2520Brain%2520via%2520a%2520Peptide-Vector-Mediated%2520Strategy%253A%2520Saturation%2520Kinetics%2520and%2520Specificity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D296%26spage%3D124%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokryakov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwig, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panyutich, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shevchenko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleshina, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamova, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneva, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrer, R. I.</span></span> <span> </span><span class="NLM_article-title">Protegrins: Leukocyte Antimicrobial Peptides that Combine Features of Corticostatic Defensins and Tachyplesins</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80175-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2F0014-5793%2893%2980175-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=8335113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK3sXltlGhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1993&pages=231-236&author=V.+N.+Kokryakovauthor=S.+S.+Harwigauthor=E.+A.+Panyutichauthor=A.+A.+Shevchenkoauthor=G.+M.+Aleshinaauthor=O.+V.+Shamovaauthor=H.+A.+Kornevaauthor=R.+I.+Lehrer&title=Protegrins%3A+Leukocyte+Antimicrobial+Peptides+that+Combine+Features+of+Corticostatic+Defensins+and+Tachyplesins&doi=10.1016%2F0014-5793%2893%2980175-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins</span></div><div class="casAuthors">Kokryakov, Vladimir N.; Harwig, Sylvia S. L.; Panyutich, Elena A.; Shevchenko, Andrei A.; Aleshina, Galina M.; Shamova, Olga V.; Korneva, Helen A.; Lehrer, Robert I.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Porcine leukocytes contained three homologous peptides, PG-1, 2 and 3, that manifested potent microbicidal activity against Escherichia coli, Listeria monocytogenes and Candida albicans in vitro.  The peptides (protegrins) were composed of 16 (PG-2) or 18 amino acid residues, and, like tachyplesins (broad-spectrum antibiotic peptides of horseshoe crab hemocytes), they contained two intramol. cystine disulfide bonds.  Considerably smaller than defensins, protegrins nevertheless showed substantial homol. to them, esp. to the corticostatic rabbit defensin, NP-3a.  The relatively simple structure of protegrins should provide useful prototypes for constructing congeners with selectively enhanced host defense activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVa00dACBnS7Vg90H21EOLACvtfcHk0lj2QjWQV97-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlGhsrw%253D&md5=e4d9855d0db677b7abb89bb2933ef803</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980175-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980175-T%26sid%3Dliteratum%253Aachs%26aulast%3DKokryakov%26aufirst%3DV.%2BN.%26aulast%3DHarwig%26aufirst%3DS.%2BS.%26aulast%3DPanyutich%26aufirst%3DE.%2BA.%26aulast%3DShevchenko%26aufirst%3DA.%2BA.%26aulast%3DAleshina%26aufirst%3DG.%2BM.%26aulast%3DShamova%26aufirst%3DO.%2BV.%26aulast%3DKorneva%26aufirst%3DH.%2BA.%26aulast%3DLehrer%26aufirst%3DR.%2BI.%26atitle%3DProtegrins%253A%2520Leukocyte%2520Antimicrobial%2520Peptides%2520that%2520Combine%2520Features%2520of%2520Corticostatic%2520Defensins%2520and%2520Tachyplesins%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D327%26spage%3D231%26epage%3D236%26doi%3D10.1016%2F0014-5793%2893%2980175-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aumelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumestand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Solution Structure of the Antimicrobial Peptide Protegrin-1</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1996.0575p.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1111%2Fj.1432-1033.1996.0575p.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=8647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK28XivVyqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1996&pages=575-583&author=A.+Aumelasauthor=M.+Mangoniauthor=C.+Roumestandauthor=L.+Chicheauthor=E.+Despauxauthor=G.+Grassyauthor=B.+Calasauthor=A.+Chavanieu&title=Synthesis+and+Solution+Structure+of+the+Antimicrobial+Peptide+Protegrin-1&doi=10.1111%2Fj.1432-1033.1996.0575p.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and solution structure of the antimicrobial peptide protegrin-1</span></div><div class="casAuthors">Aumelas, Andre; Mangoni, Matteo; Roumestand, Christian; Chiche, Laurent; Despaux, Ernest; Grassay, Gerard; Calas, Bernard; Chavenieu, Alain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">575-583</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protegrins are members of a family of five Cys-rich, cationic antimicrobial peptides recently isolated from porcine cells.  We have synthesized an 18-amino-acid peptide that corresponds to protegrin-1.  After Cys oxidn., the peptide has bactericidal activity against gram-pos. and gram-neg. bacteria, similar to that described for the natural peptide.  The soln. structure of protegrin-1 was investigated by means of 1H-NMR spectroscopy in water and in (CD3)2SO, with distance-geometry and simulated-annealing calcns.  The C6-C15 and C8-C13 disulfide pattern was detd. on the basis of NMR-derived constraints.  These two parallel disulfide bridges stabilized a β-sheet structure which comprised two antiparallel strands (residues 5-9 and 12-16) linked by a distorted β-turn (residues 9-12).  The N-terminus and C-terminus were essentially disordered.  The distribution of hydrophobic and hydrophilic residues at the peptide surface was found to be a structural feature shared with tachyplesin-1, a related peptide which displays cytolytic activity, and, to a lesser extent, with mammalian defens.  These findings led us to assume that the distribution pattern could be required for the cytolytic activity of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcLR-ARnnnQ7Vg90H21EOLACvtfcHk0lgUyqAmjRlJQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVyqu7g%253D&md5=0d50b05c7f07e307fd5b638f2728d442</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1996.0575p.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1996.0575p.x%26sid%3Dliteratum%253Aachs%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DMangoni%26aufirst%3DM.%26aulast%3DRoumestand%26aufirst%3DC.%26aulast%3DChiche%26aufirst%3DL.%26aulast%3DDespaux%26aufirst%3DE.%26aulast%3DGrassy%26aufirst%3DG.%26aulast%3DCalas%26aufirst%3DB.%26aulast%3DChavanieu%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Solution%2520Structure%2520of%2520the%2520Antimicrobial%2520Peptide%2520Protegrin-1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1996%26volume%3D237%26spage%3D575%26epage%3D583%26doi%3D10.1111%2Fj.1432-1033.1996.0575p.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolintineanu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayyed-Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaznessis, Y. N.</span></span> <span> </span><span class="NLM_article-title">Poisson-Nernst-Planck Models of Nonequilibrium Ion Electrodiffusion through a Protegrin Transmembrane Pore</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1000277</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1000277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pcbi.1000277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19180178" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000277&author=D.+S.+Bolintineanuauthor=A.+Sayyed-Ahmadauthor=H.+T.+Davisauthor=Y.+N.+Kaznessis&title=Poisson-Nernst-Planck+Models+of+Nonequilibrium+Ion+Electrodiffusion+through+a+Protegrin+Transmembrane+Pore&doi=10.1371%2Fjournal.pcbi.1000277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1000277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1000277%26sid%3Dliteratum%253Aachs%26aulast%3DBolintineanu%26aufirst%3DD.%2BS.%26aulast%3DSayyed-Ahmad%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BT.%26aulast%3DKaznessis%26aufirst%3DY.%2BN.%26atitle%3DPoisson-Nernst-Planck%2520Models%2520of%2520Nonequilibrium%2520Ion%2520Electrodiffusion%2520through%2520a%2520Protegrin%2520Transmembrane%2520Pore%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000277%26doi%3D10.1371%2Fjournal.pcbi.1000277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Peptide Delivery to the Brain via Adsorptive-Mediated Endocytosis: Advances with SynB Vectors</span>. <i>AAPS PharmSci</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">E26</span>, <span class="refDoi"> DOI: 10.1208/ps040426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1208%2Fps040426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12645998" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=E26&author=G.+Drinauthor=C.+Rousselleauthor=J.+M.+Scherrmannauthor=A.+R.+Reesauthor=J.+Temsamani&title=Peptide+Delivery+to+the+Brain+via+Adsorptive-Mediated+Endocytosis%3A+Advances+with+SynB+Vectors&doi=10.1208%2Fps040426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1208%2Fps040426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fps040426%26sid%3Dliteratum%253Aachs%26aulast%3DDrin%26aufirst%3DG.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DPeptide%2520Delivery%2520to%2520the%2520Brain%2520via%2520Adsorptive-Mediated%2520Endocytosis%253A%2520Advances%2520with%2520SynB%2520Vectors%26jtitle%3DAAPS%2520PharmSci%26date%3D2002%26volume%3D4%26spage%3DE26%26doi%3D10.1208%2Fps040426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Studies on the Internalization Mechanism of Cationic Cell-Penetrating Peptides</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">31192</span>– <span class="NLM_lpage">31201</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303938200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1074%2Fjbc.M303938200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12783857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFequrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=31192-31201&author=G.+Drinauthor=S.+Cottinauthor=E.+Blancauthor=A.+R.+Reesauthor=J.+Temsamani&title=Studies+on+the+Internalization+Mechanism+of+Cationic+Cell-Penetrating+Peptides&doi=10.1074%2Fjbc.M303938200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the internalization mechanism of cationic cell-penetrating peptides</span></div><div class="casAuthors">Drin, Guillaume; Cottin, Sylvine; Blanc, Emmanuelle; Rees, Anthony R.; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">31192-31201</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A great deal of data has been amassed suggesting that cationic peptides are able to translocate into eucaryotic cells in a temp.-independent manner.  Although such peptides are widely used to promote the intracellular delivery of bioactive mols., the mechanism by which this cell-penetrating activity occurs still remains unclear.  Here, we present an in vitro study of the cellular uptake of peptides, originally deriving from protegrin (the SynB peptide vectors), that have also been shown to enhance the transport of drugs across the blood-brain barrier.  In parallel, we have examd. the internalization process of two lipid-interacting peptides, SynB5 and pAntp-(43-58), the latter corresponding to the translocating segment of the Antennapedia homeodomain.  We report a quant. study of the time- and dose-dependence of internalization and demonstrate that these peptides accumulate inside vesicular structures.  Furthermore, we have examd. the role of endocytotic pathways in this process using a variety of metabolic and endocytosis inhibitors.  We show that the internalization of these peptides is a temp.- and energy-dependent process and that endosomal transport is a key component of the mechanism.  Altogether, our results suggest that SynB and pAntp-(43-58) peptides penetrate into cells by an adsorptive-mediated endocytosis process rather than temp.-independent translocation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOaqOcflsV7Vg90H21EOLACvtfcHk0lgUyqAmjRlJQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFequrw%253D&md5=77b9013a7f7e394c93183f4d992e702f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303938200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303938200%26sid%3Dliteratum%253Aachs%26aulast%3DDrin%26aufirst%3DG.%26aulast%3DCottin%26aufirst%3DS.%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520the%2520Internalization%2520Mechanism%2520of%2520Cationic%2520Cell-Penetrating%2520Peptides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D31192%26epage%3D31201%26doi%3D10.1074%2Fjbc.M303938200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herve, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghinea, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">CNS Delivery via Adsorptive Transcytosis</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1208/s12248-008-9055-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1208%2Fs12248-008-9055-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18726697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=455-472&author=F.+Herveauthor=N.+Ghineaauthor=J.+M.+Scherrmann&title=CNS+Delivery+via+Adsorptive+Transcytosis&doi=10.1208%2Fs12248-008-9055-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CNS delivery via adsorptive transcytosis</span></div><div class="casAuthors">Herve, Francoise; Ghinea, Nicolae; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-472</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Adsorptive-mediated transcytosis (AMT) provides a means for brain delivery of medicines across the blood-brain barrier (BBB).  The BBB is readily equipped for the AMT process: it provides both the potential for binding and uptake of cationic mols. to the luminal surface of endothelial cells, and then for exocytosis at the abluminal surface.  The transcytotic pathways present at the BBB and its morphol. and enzymic properties provide the means for movement of the mols. through the endothelial cytoplasm.  AMT-based drug delivery to the brain was performed using cationic proteins and cell-penetrating peptides (CPPs).  Protein cationization using either synthetic or natural polyamines is discussed and some examples of diamine/polyamine modified proteins that cross BBB are described.  Two main families of CPPs belonging to the Tat-derived peptides and Syn-B vectors have been extensively used in CPP vector-mediated strategies allowing delivery of a large variety of small mols. as well as proteins across cell membranes in vitro and the BBB in vivo.  CPP strategy suffers from several limitations such as toxicity and immunogenicity-like the cationization strategy-as well as the instability of peptide vectors in biol. media.  The review concludes by stressing the need to improve the understanding of AMT mechanisms at BBB and the effectiveness of cationized proteins and CPP-vectorized proteins as neurotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIswum5OkBLVg90H21EOLACvtfcHk0lhFeLhLEayi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVSktLk%253D&md5=a3ba8b01c124c1c9a4234b37003095e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9055-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9055-2%26sid%3Dliteratum%253Aachs%26aulast%3DHerve%26aufirst%3DF.%26aulast%3DGhinea%26aufirst%3DN.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DCNS%2520Delivery%2520via%2520Adsorptive%2520Transcytosis%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D455%26epage%3D472%26doi%3D10.1208%2Fs12248-008-9055-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Doxorubicin-Peptide Conjugates Overcome Multidrug Resistance</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1097/00001813-200102000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F00001813-200102000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=11261883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=107-116&author=M.+Mazelauthor=P.+Clairauthor=C.+Rousselleauthor=P.+Vidalauthor=J.+M.+Scherrmannauthor=D.+Mathieuauthor=J.+Temsamani&title=Doxorubicin-Peptide+Conjugates+Overcome+Multidrug+Resistance&doi=10.1097%2F00001813-200102000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin-peptide conjugates overcome multidrug resistance</span></div><div class="casAuthors">Mazel, Martine; Clair, Philippe; Rousselle, Christophe; Vidal, Pierre; Scherrmann, Jean-Michel; Mathieu, Daniele; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A well-known mechanism leading to the emergence of multidrug-resistant tumor cells is the overexpression of P-glycoprotein (P-gp), which is capable of lowering intracellular drug concns.  To overcome this problem, the authors tested the capability of two peptide vectors that are able to cross cellular membranes to deliver doxorubicin in P-gp-expressing cells.  The antitumor effect of peptide-conjugated doxorubicin was tested in human erythroleukemic (K562/ADR) resistant cells.  The conjugate showed potent dose-dependent inhibition of cell growth against K562/ADR cells as compared with doxorubicin alone.  Doxorubicin exhibited IC50 concns. of 65 μM in the resistant cells, whereas vectorized doxorubicin was more effective with IC50 concns. of 3 μM.  After treatment of the resistant cells with verapamil, the intracellular levels of doxorubicin were markedly increased and consequent cytotoxicity was improved.  In contrast, treatment of resistant cells with verapamil did not cause any further enhancement in the cell uptake nor in the cytotoxic effect of the conjugated doxorubicin, indicating that the conjugate bypasses the P-gp.  Finally, the authors show by the in situ brain perfusion method in P-gp-deficient and competent mice that vectorized doxorubicin bypasses the P-gp present at the luminal site of the blood-brain barrier.  These results indicate that vectorization of doxorubicin with peptide vectors is effective in overcoming multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYybMbjpkTWLVg90H21EOLACvtfcHk0lhFeLhLEayi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVKnsrw%253D&md5=5f324ea8b2e96ce0c66ba4282761b0bb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00001813-200102000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200102000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMazel%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DMathieu%26aufirst%3DD.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DDoxorubicin-Peptide%2520Conjugates%2520Overcome%2520Multidrug%2520Resistance%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2001%26volume%3D12%26spage%3D107%26epage%3D116%26doi%3D10.1097%2F00001813-200102000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnafous, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Peptide-Vector Strategy Bypasses P-Glycoprotein Efflux, and Enhances Brain Transport and Solubility of Paclitaxel</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1097/00001813-200411000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F00001813-200411000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15514563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVeisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=947-954&author=E.+Blancauthor=C.+Bonnafousauthor=P.+Meridaauthor=S.+Cisterninoauthor=P.+Clairauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Peptide-Vector+Strategy+Bypasses+P-Glycoprotein+Efflux%2C+and+Enhances+Brain+Transport+and+Solubility+of+Paclitaxel&doi=10.1097%2F00001813-200411000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel</span></div><div class="casAuthors">Blanc, Emmanuelle; Bonnafous, Cecile; Merida, Peggy; Cisternino, Salvatore; Clair, Philippe; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">947-954</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We present the results obtained with paclitaxel coupled to a peptide-vector SynB3 (PAX-OSUC-SynB3), showing that this peptide-vector enhances the soly. of paclitaxel and its brain uptake in mice using the in situ brain perfusion model.  We also show by the in situ brain perfusion in P-glycoprotein (P-gp)-deficient and wild-type mice that vectorized paclitaxel bypasses the P-gp present at the luminal side of the blood-brain barrier.  The effect of the vectorized paclitaxel on various cancer cells was not significantly different from that of free paclitaxel.  These results indicate that vectorization of paclitaxel may have significant potential for the treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWe1r9wbYN27Vg90H21EOLACvtfcHk0lhFeLhLEayi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVeisrw%253D&md5=13cecce058812f3e3deeda05f0204d56</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2F00001813-200411000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200411000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DCisternino%26aufirst%3DS.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DPeptide-Vector%2520Strategy%2520Bypasses%2520P-Glycoprotein%2520Efflux%252C%2520and%2520Enhances%2520Brain%2520Transport%2520and%2520Solubility%2520of%2520Paclitaxel%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D947%26epage%3D954%26doi%3D10.1097%2F00001813-200411000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Delivery of Benzylpenicillin with a Peptide-Vector-Mediated Strategy</span>. <i>J. Drug Target</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1080/10611860290031886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1080%2F10611860290031886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12164379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlCrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=309-315&author=C.+Rousselleauthor=P.+Clairauthor=J.+Temsamaniauthor=J.+M.+Scherrmann&title=Improved+Brain+Delivery+of+Benzylpenicillin+with+a+Peptide-Vector-Mediated+Strategy&doi=10.1080%2F10611860290031886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Temsamani, Jamal; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-315</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Previous studies from our lab. have demonstrated that the coupling of doxorubicin with SynB1 vector dramatically increases its brain uptake.  In the present study, we have evaluated the broad application of this approach using another mol.: benzylpenicillin (B-Pc).  We, therefore, have coupled the β-lactam antibiotic B-Pc with SynB1 and assessed its ability to cross the blood-brain barrier (BBB) using the in situ rat brain perfusion method.  We first confirmed the very low brain uptake of free radiolabeled B-Pc.  When B-Pc was coupled to SynB1, its uptake in brain was increased by a factor of 7, without compromising the BBB integrity.  The vectorized B-Pc was distributed in all the gray areas assessed (frontal, parietal, and occipital cortex, thalamus, hippocampus, and striatum).  Moreover, using a wash-out procedure and a capillary depletion method, we have shown that the radiolabeled B-Pc was assocd. mainly with brain parenchyma.  In summary, this study demonstrates the successful application of the use of SynB1 vector for the transport of B-Pc across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpnrERGhxq6bVg90H21EOLACvtfcHk0lhHodWUF-V7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlCrt7Y%253D&md5=7dd2678af57ae7643c9cca2fe4aa679e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F10611860290031886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860290031886%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520Brain%2520Delivery%2520of%2520Benzylpenicillin%2520with%2520a%2520Peptide-Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Drug%2520Target%26date%3D2002%26volume%3D10%26spage%3D309%26epage%3D315%26doi%3D10.1080%2F10611860290031886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac-Breton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.048520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fjpet.102.048520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12682214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=371-376&author=C.+Rousselleauthor=P.+Clairauthor=M.+Smirnovaauthor=Y.+Kolesnikovauthor=G.+W.+Pasternakauthor=S.+Gac-Bretonauthor=A.+R.+Reesauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Improved+Brain+Uptake+and+Pharmacological+Activity+of+Dalargin+Using+a+Peptide-Vector-Mediated+Strategy&doi=10.1124%2Fjpet.102.048520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Smirnova, Maria; Kolesnikov, Yuri; Pasternak, Gavril W.; Gac-Breton, Stephanie; Rees, Anthony R.; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">371-376</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The blood-brain barrier restricts the passage of substances into the brain.  Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier.  Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain.  Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacol. effect.  We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin.  We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the obsd. antinociceptive effect of dalargin.  These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah5nliPBGe7Vg90H21EOLACvtfcHk0lhHodWUF-V7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks78%253D&md5=cc48340960c5a65a6aa12e1bf9f2627e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.048520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.048520%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DSmirnova%26aufirst%3DM.%26aulast%3DKolesnikov%26aufirst%3DY.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DGac-Breton%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DImproved%2520Brain%2520Uptake%2520and%2520Pharmacological%2520Activity%2520of%2520Dalargin%2520Using%2520a%2520Peptide-Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D371%26epage%3D376%26doi%3D10.1124%2Fjpet.102.048520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnafous, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisse, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.081000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fjpet.104.081000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15647327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=712-719&author=J.+Temsamaniauthor=C.+Bonnafousauthor=C.+Rousselleauthor=Y.+Fraisseauthor=P.+Clairauthor=L.+A.+Granierauthor=A.+R.+Reesauthor=M.+Kaczorekauthor=J.+M.+Scherrmann&title=Improved+Brain+Uptake+and+Pharmacological+Activity+Profile+of+Morphine-6-Glucuronide+Using+a+Peptide+Vector-Mediated+Strategy&doi=10.1124%2Fjpet.104.081000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity profile of Morphine-6-glucuronide using a peptide vector-mediated strategy</span></div><div class="casAuthors">Temsamani, Jamal; Bonnafous, Cecile; Rousselle, Christophe; Fraisse, Yannik; Clair, Philippe; Granier, Luc-Andre; Rees, Anthony R.; Kaczorek, Michel; Scherrmann, Jean-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine-6-glucuronide (M6G), an active metabolite of morphine, has been shown to have significantly attenuated brain penetration relative to that of morphine.  Recently, we have demonstrated that conjugation of various drugs to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated morphine-6-glucuronide to a peptide vector SynB3 to enhance its brain uptake and its analgesic potency after systemic administration.  We show by in situ brain perfusion that vectorization of M6G (Syn1001) markedly enhances the brain uptake of M6G.  This enhancement results in a significant improvement in the pharmacol. activity of M6G in several models of nociception.  Syn1001 was about 4 times more potent than free M6G (ED50 of 1.87 vs. 8.74 μmol/kg).  Syn1001 showed also a prolonged duration of action compared with free M6G (300 and 120 min, resp.).  Furthermore, the conjugation of M6G results in a lowered respiratory depression, as measured in a rat model.  Taken together, these data strongly support the utility of peptide-mediated strategies for improving the efficacy of drugs such as M6G for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrrHR8h0dYyrVg90H21EOLACvtfcHk0lhHodWUF-V7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D&md5=436b2ad8faf1339f4b459fdac1f6c416</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081000%26sid%3Dliteratum%253Aachs%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DFraisse%26aufirst%3DY.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DGranier%26aufirst%3DL.%2BA.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520Brain%2520Uptake%2520and%2520Pharmacological%2520Activity%2520Profile%2520of%2520Morphine-6-Glucuronide%2520Using%2520a%2520Peptide%2520Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D712%26epage%3D719%26doi%3D10.1124%2Fjpet.104.081000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adenot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahana, R.</span></span> <span> </span><span class="NLM_article-title">Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery</span>. <i>Chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1159/000098422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1159%2F000098422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=17202815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=73-76&author=M.+Adenotauthor=P.+Meridaauthor=R.+Lahana&title=Applications+of+a+Blood-Brain+Barrier+Technology+Platform+to+Predict+CNS+Penetration+of+Various+Chemotherapeutic+Agents.+2.+Cationic+Peptide+Vectors+for+Brain+Delivery&doi=10.1159%2F000098422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents 2. Cationic peptide vectors for brain delivery</span></div><div class="casAuthors">Adenot, M.; Merida, P.; Lahana, R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemotherapy (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-76</span>CODEN:
                <span class="NLM_cas:coden">CHTHBK</span>;
        ISSN:<span class="NLM_cas:issn">0009-3157</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">SynB family peptides conjugated to several drugs have been shown to increase the brain uptake and in vivo activities of these drugs via an adsorptive-mediated transcytosis mechanism.  Based on both in vivo and in vitro exptl. data, a cell uptake component has been added to our computational model of blood-brain barrier.  In situ brain perfusion, in vitro cell model and a computational cell uptake model have been used to discover brain-penetrating properties of SynB peptides and to screen libraries of new rationally designed peptide vectors suitable for brain drug delivery.  Starting from small peptide vectors that enhance the brain transport coeff., the BBB platform has made it possible to design libraries of peptide vectors with enhanced transport properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnQmUfWpl67Vg90H21EOLACvtfcHk0lgz5YGsuOKWsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKktLc%253D&md5=e83393e7ae899ac0692171b73aa737c0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1159%2F000098422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000098422%26sid%3Dliteratum%253Aachs%26aulast%3DAdenot%26aufirst%3DM.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DLahana%26aufirst%3DR.%26atitle%3DApplications%2520of%2520a%2520Blood-Brain%2520Barrier%2520Technology%2520Platform%2520to%2520Predict%2520CNS%2520Penetration%2520of%2520Various%2520Chemotherapeutic%2520Agents.%25202.%2520Cationic%2520Peptide%2520Vectors%2520for%2520Brain%2520Delivery%26jtitle%3DChemotherapy%26date%3D2007%26volume%3D53%26spage%3D73%26epage%3D76%26doi%3D10.1159%2F000098422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castex, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">2-Pyrrolinodoxorubicin and Its Peptide-Vectorized Form Bypass Multidrug Resistance</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1097/01.cad.0000132231.28888.fa</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F01.cad.0000132231.28888.fa" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15205606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=609-617&author=C.+Castexauthor=P.+Meridaauthor=E.+Blancauthor=P.+Clairauthor=A.+R.+Reesauthor=J.+Temsamani&title=2-Pyrrolinodoxorubicin+and+Its+Peptide-Vectorized+Form+Bypass+Multidrug+Resistance&doi=10.1097%2F01.cad.0000132231.28888.fa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance</span></div><div class="casAuthors">Castex, Cedric; Merida, Peggy; Blanc, Emmanuelle; Clair, Philippe; Rees, Anthony R.; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-617</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A well-known mechanism leading to the emergence of multidrug-resistant tumor cells is the overexpression of P-glycoprotein, which is capable of lowering intracellular drug concns.  In the present study, we tested the capability of 2-pyrrolinodoxorubicin (p-DOX), a highly potent deriv. of DOX, to bypass multidrug resistance.  The accumulation, intracellular distribution and cytotoxicity of p-DOX were tested in two cell lines (K562 and A2780) and their DOX-resistant counterparts (K562/ADR and A2780/ADR).  Cellular accumulation and cytotoxicity were dramatically lowered for DOX in resistant cell lines, in comparison with non-resistant cells.  In contrast, cellular accumulation, intracellular distribution and cytotoxicity of p-DOX were independent of the nature of the cell lines.  The p-DOX showed potent dose-dependent inhibition of cell growth against resistant cells as compared with DOX.  After treatment of resistant cells with verapamil, the intracellular levels of DOX were markedly increased and consequent cytotoxicity improved.  In contrast, treatment of resistant cells with verapamil did not cause any further enhancement of cell uptake or an increase in the cytotoxic effect of the deriv. p-DOX, indicating that the compd. bypasses the P-glycoprotein.  Finally, we show that vectorization of p-DOX by a peptide vector (SynB3) which has been shown to enhance the brain uptake of DOX and to decrease its heart accumulation does not affect this property.  These results indicate that p-DOX and its vectorized form are potent and effective in overcoming multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNlCX3bdFL57Vg90H21EOLACvtfcHk0lgz5YGsuOKWsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2ntb0%253D&md5=16c47e8e5d95100495f19749f79d6939</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F01.cad.0000132231.28888.fa&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.cad.0000132231.28888.fa%26sid%3Dliteratum%253Aachs%26aulast%3DCastex%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3D2-Pyrrolinodoxorubicin%2520and%2520Its%2520Peptide-Vectorized%2520Form%2520Bypass%2520Multidrug%2520Resistance%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D609%26epage%3D617%26doi%3D10.1097%2F01.cad.0000132231.28888.fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">The Improved Blood-Brain Barrier Permeability of Endomorphin-1 Using the Cell-Penetrating Peptide SynB3 with Three Different Linkages</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>476</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2014.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ijpharm.2014.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25245547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Shsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=476&publication_year=2014&pages=1-8&author=H.+Liuauthor=W.+Zhangauthor=L.+Maauthor=L.+Fanauthor=F.+Gaoauthor=J.+Niauthor=R.+Wang&title=The+Improved+Blood-Brain+Barrier+Permeability+of+Endomorphin-1+Using+the+Cell-Penetrating+Peptide+SynB3+with+Three+Different+Linkages&doi=10.1016%2Fj.ijpharm.2014.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The improved blood-brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages</span></div><div class="casAuthors">Liu, Hui; Zhang, Wei; Ma, Linnan; Fan, Linlan; Gao, Feiyun; Ni, Jingman; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">476</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endomorphins, although they have high analgesic activity and few undesirable side effects, are not in clin. use because of the blood-brain barrier (BBB).  One promising soln. is to use cell-penetrating peptides (CPPs).  CPPs have the ability to translocate cell membranes and have been successfully applied for delivery of therapeutic mols. across the BBB.  However, little is known about the transport efficiency of different conjugation strategies between cargo and CPPs.  In this study, endomorphin-1 (EM-1) was conjugated with SynB3, an efficient CPP-carrier, via amide, maleimide and disulfide linkages.  The delivery efficiency of three linkers was compared in terms of pharmacodynamics and in vitro metabolic stability.  Near-IR fluorescent and fluorescent microscopy expts. were applied to detect the brain uptake and distribution of CPP delivery qual. and quant.  After the most successful linkage was screened out, the further mechanisms were discussed.  We concluded that compared with the other two linkages, the disulfide bond was the most efficient linkage to deliver EM-1 across the BBB and confirmed that it could be reduced at physiol. conditions in the brain and release its active form.  These findings indicate that for those who need to release a free drug in the brain and maintain activity, a disulfide bond might be the most efficient linkage across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-m2iE0KhOLVg90H21EOLACvtfcHk0lgz5YGsuOKWsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Shsb3F&md5=48e7b5d5fbec399015bc56d0059a6cc0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2014.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2014.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DThe%2520Improved%2520Blood-Brain%2520Barrier%2520Permeability%2520of%2520Endomorphin-1%2520Using%2520the%2520Cell-Penetrating%2520Peptide%2520SynB3%2520with%2520Three%2520Different%2520Linkages%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2014%26volume%3D476%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ijpharm.2014.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Studies on Gelatin-Siloxane Nanoparticles Conjugated with SynB Peptide to Increase Drug Delivery to the Brain</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.2147/IJN.S26541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2147%2FIJN.S26541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22403486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1031-1041&author=X.+H.+Tianauthor=F.+Weiauthor=T.+X.+Wangauthor=P.+Wangauthor=X.+N.+Linauthor=J.+Wangauthor=D.+Wangauthor=L.+Ren&title=In+Vitro+and+in+Vivo+Studies+on+Gelatin-Siloxane+Nanoparticles+Conjugated+with+SynB+Peptide+to+Increase+Drug+Delivery+to+the+Brain&doi=10.2147%2FIJN.S26541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span></div><div class="casAuthors">Tian, Xin-Hua; Wei, Feng; Wang, Tian-Xiao; Wang, Peng; Lin, Xiao-Ning; Wang, Jun; Wang, Dong; Ren, Lei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1031-1041</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Nanobiotechnol. can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful.  Use of nanoparticles is a promising strategy for overcoming the blood-brain barrier and delivering drugs to the brain.  Gelatin-siloxane (GS) nanoparticles modified with Tat peptide can enhance plasmid DNA transfection efficiency compared with a com. reagent.  Methods: SynB-PEG-GS nanoparticles are membrane-penetrable, and can cross the blood-brain barrier and deliver a drug to its target site in the brain.  The efficiency of delivery was investigated in vivo and in vitro using brain capillary endothelial cells, a cocultured blood-brain barrier model, and a normal mouse model.  Results: Our study demonstrated that both SynB-PEG-GS and PEG-GS nanoparticles had a spherical shape and an av. diam. of 150-200 nm.  It was shown by MTT assay that SynB-PEG-GS nanoparticles had good biocompatibility with brain capillary endothelial cells.  Cellular uptake by SynB-PEG-GS nanoparticles was higher than that for PEG-GS nanoparticles for all incubation periods.  The amt. of SynB-PEG-GS nanoparticles crossing the cocultured blood-brain barrier model was significantly higher than that of PEG-GS nanoparticles at all time points measured (P < 0.05).  In animal testing, SynB-PEG-GS nanoparticle levels in the brain were significantly higher than those of PEG-GS nanoparticles at all time points measured (P < 0.01).  In contrast with localization in the brain, PEG-GS nanoparticle levels were significantly higher than those of SynB-PEG-GS nanoparticles (P < 0.01) in the liver.  Conclusion: This study indicates that SynB-PEG-GS nanoparticles have favorable properties with regard to morphol., size distribution, and toxicity.  Moreover, the SynB-PEG-GS nanoparticles exhibited more efficient brain capillary endothelial cell uptake and improved crossing of the blood-brain barrier.  Further, biodistribution studies of rhodamine-loaded nanoparticles demonstrated that modification with the SynB peptide could not only improve the ability of PEG-GS nanoparticles to evade capture in the reticuloendothelial system but also enhance their efficiency in crossing the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQoFHPbbbugLVg90H21EOLACvtfcHk0lgz5YGsuOKWsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D&md5=12c3b0832b6f1ec93b2d528349dc413d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2147%2FIJN.S26541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S26541%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%2BH.%26aulast%3DWei%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%2BX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%2BN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Studies%2520on%2520Gelatin-Siloxane%2520Nanoparticles%2520Conjugated%2520with%2520SynB%2520Peptide%2520to%2520Increase%2520Drug%2520Delivery%2520to%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D1031%26epage%3D1041%26doi%3D10.2147%2FIJN.S26541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynendaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevaert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peremans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burvenich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Spiegeleer, B.</span></span> <span> </span><span class="NLM_article-title">Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0139652</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0139652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pone.0139652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26465925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCmtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=S.+Stalmansauthor=N.+Brackeauthor=E.+Wynendaeleauthor=B.+Gevaertauthor=K.+Peremansauthor=C.+Burvenichauthor=I.+Polisauthor=B.+De+Spiegeleer&title=Cell-Penetrating+Peptides+Selectively+Cross+the+Blood-Brain+Barrier+In+Vivo&doi=10.1371%2Fjournal.pone.0139652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides selectively cross the blood-brain barrier in vivo</span></div><div class="casAuthors">Stalmans, Sofie; Bracke, Nathalie; Wynendaele, Evelien; Gevaert, Bert; Peremans, Kathelijne; Burvenich, Christian; Polis, Ingeborgh; De Spiegeleer, Bart</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0139652/1-e0139652/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers.  CPPs themselves can exert biol. activity and can be formed endogenously.  Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB).  However, comparative, quant. data on the BBB permeability of different CPPs are currently lacking.  Therefore, the in vivo BBB transport characteristics of five chem. diverse CPPs, i.e. pVEC, SynB3, Tat 47'"57, transportan 10 (TP10) and TP10-2, were detd.  The results of the multiple time regression (MTR) anal. revealed that CPPs show divergent BBB influx properties: Tat 47'"57, SynB3, and esp. pVEC showed very high unidirectional influx rates of 4.73 μl/(g × min), 5.63 μl/(g × min) and 6.02 μl/(g × min), resp., while the transportan analogs showed a negligible to low brain influx.  Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma.  Except for pVEC, all peptides showed a significant efflux out of the brain.  Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties.  A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP.  No significant regional differences in brain influx were obsd., with the exception for pVEC, for which the regional variations were only marginal.  The obsd. BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGq6lVzxbIrVg90H21EOLACvtfcHk0ljHQfhyxA4w0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCmtr7J&md5=feaed00f70b3ddae7aca94ec393fba69</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0139652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0139652%26sid%3Dliteratum%253Aachs%26aulast%3DStalmans%26aufirst%3DS.%26aulast%3DBracke%26aufirst%3DN.%26aulast%3DWynendaele%26aufirst%3DE.%26aulast%3DGevaert%26aufirst%3DB.%26aulast%3DPeremans%26aufirst%3DK.%26aulast%3DBurvenich%26aufirst%3DC.%26aulast%3DPolis%26aufirst%3DI.%26aulast%3DDe%2BSpiegeleer%26aufirst%3DB.%26atitle%3DCell-Penetrating%2520Peptides%2520Selectively%2520Cross%2520the%2520Blood-Brain%2520Barrier%2520In%2520Vivo%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0139652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodle, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mixson, A. J.</span></span> <span> </span><span class="NLM_article-title">NRP1 Transport of Cancer Therapeutics Mediated by Tumor-Penetrating Peptides</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1358/dof.2017.042.02.2564106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1358%2Fdof.2017.042.02.2564106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28603338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC1cnntF2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=95-104&author=Q.+Lengauthor=M.+C.+Woodleauthor=A.+J.+Mixson&title=NRP1+Transport+of+Cancer+Therapeutics+Mediated+by+Tumor-Penetrating+Peptides&doi=10.1358%2Fdof.2017.042.02.2564106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides</span></div><div class="casAuthors">Leng Qixin; Mixson A James; Woodle Martin C</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the future</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    </div><div class="casAbstract">Whereas uptake of low molecular weight agents is generally inhibited in tumors due to high interstitial pressure, tumor uptake of macromolecules is increased due to enhanced permeability and retention (EPR).  Small molecule drugs alone or incorporated in nanoparticles (NP) have largely been dependent on such physical tumor uptake (passive) for therapeutic activity.  Although passive targeted NP such as Stealth Liposomal Doxorubicin (Doxil ®) are effective with improved safety, drug delivery to tumors is still significantly limited.  To improve tumor delivery and efficacy, tumor-penetrating peptides (TPP), which contain sequences that target the tumor and activate the neuropilin-1 receptor (NRP1), have either been co-administered with or conjugated to both small and large therapeutic molecules.  In this review, we will discuss TPP-mediated therapeutics which target the NRP1 transport system of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIj3ueQUym6pZoeNcnHOQ9fW6udTcc2eb3XjCflqCmbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnntF2gtA%253D%253D&md5=cbc728c6837a767c635fa10f58118e6a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1358%2Fdof.2017.042.02.2564106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2017.042.02.2564106%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DQ.%26aulast%3DWoodle%26aufirst%3DM.%2BC.%26aulast%3DMixson%26aufirst%3DA.%2BJ.%26atitle%3DNRP1%2520Transport%2520of%2520Cancer%2520Therapeutics%2520Mediated%2520by%2520Tumor-Penetrating%2520Peptides%26jtitle%3DDrugs%2520Future%26date%3D2017%26volume%3D42%26spage%3D95%26epage%3D104%26doi%3D10.1358%2Fdof.2017.042.02.2564106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangalam, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFrance-Corey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanga, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angom, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucchinetti, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span> <span> </span><span class="NLM_article-title">Neuropilin-1 Modulates Interferon-Gamma-Stimulated Signaling in Brain Microvascular Endothelial Cells</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">3911</span>– <span class="NLM_lpage">3921</span>, <span class="refDoi"> DOI: 10.1242/jcs.190702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1242%2Fjcs.190702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27591257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=3911-3921&author=Y.+Wangauthor=Y.+Caoauthor=A.+K.+Mangalamauthor=Y.+Guoauthor=R.+G.+LaFrance-Coreyauthor=J.+D.+Gamezauthor=P.+A.+Atangaauthor=B.+D.+Clarksonauthor=Y.+Zhangauthor=E.+Wangauthor=R.+S.+Angomauthor=K.+Duttaauthor=B.+Jiauthor=I.+Pirkoauthor=C.+F.+Lucchinettiauthor=C.+L.+Howeauthor=D.+Mukhopadhyay&title=Neuropilin-1+Modulates+Interferon-Gamma-Stimulated+Signaling+in+Brain+Microvascular+Endothelial+Cells&doi=10.1242%2Fjcs.190702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells</span></div><div class="casAuthors">Wang, Ying; Cao, Ying; Mangalam, Ashutosh K.; Guo, Yong; LaFrance-Corey, Reghann G.; Gamez, Jeffrey D.; Atanga, Pascal Aliihnui; Clarkson, Benjamin D.; Zhang, Yuebo; Wang, Enfeng; Angom, Ramcharan Singh; Dutta, Kirthica; Ji, Baoan; Pirko, Istvan; Lucchinetti, Claudia F.; Howe, Charles L.; Mukhopadhyay, Debabrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3911-3921</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Inflammatory response of blood-brain barrier (BBB) endothelial cells plays an important role in pathogenesis of many central nervous system inflammatory diseases, including multiple sclerosis; however, the mol. mechanism mediating BBB endothelial cell inflammatory response remains unclear.  In this study, we first obsd. that knockdown of neuropilin-1 (NRP1), a co-receptor of several structurally diverse ligands, suppressed interferon-γ (IFNγ)-induced C-X-C motif chemokine 10 expression and activation of STAT1 in brain microvascular endothelial cells in a Rac1-dependent manner.  Moreover, endothelial-specific NRP1-knockout mice, VECadherin-Cre-ERT2/NRP1flox/flox mice, showed attenuated disease progression during exptl. autoimmune encephalomyelitis, a mouse neuroinflammatory disease model.  Detailed anal. utilizing histol. staining, quant. PCR, flow cytometry and magnetic resonance imaging demonstrated that deletion of endothelial NRP1 suppressed neuron demyelination, altered lymphocyte infiltration, preserved BBB function and decreased activation of the STAT1-CXCL10 pathway.  Furthermore, increased expression of NRP1 was obsd. in endothelial cells of acute multiple sclerosis lesions.  Our data identify a new mol. mechanism of brain microvascular endothelial inflammatory response through NRP1-IFNγ crosstalk that could be a potential target for intervention of endothelial cell dysfunction in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkcM16U07JsrVg90H21EOLACvtfcHk0ljHQfhyxA4w0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ltr8%253D&md5=bd7c8345a1eff1e757c8064934d47d42</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1242%2Fjcs.190702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.190702%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMangalam%26aufirst%3DA.%2BK.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLaFrance-Corey%26aufirst%3DR.%2BG.%26aulast%3DGamez%26aufirst%3DJ.%2BD.%26aulast%3DAtanga%26aufirst%3DP.%2BA.%26aulast%3DClarkson%26aufirst%3DB.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DAngom%26aufirst%3DR.%2BS.%26aulast%3DDutta%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DPirko%26aufirst%3DI.%26aulast%3DLucchinetti%26aufirst%3DC.%2BF.%26aulast%3DHowe%26aufirst%3DC.%2BL.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26atitle%3DNeuropilin-1%2520Modulates%2520Interferon-Gamma-Stimulated%2520Signaling%2520in%2520Brain%2520Microvascular%2520Endothelial%2520Cells%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2016%26volume%3D129%26spage%3D3911%26epage%3D3921%26doi%3D10.1242%2Fjcs.190702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span> <span> </span><span class="NLM_article-title">Neuropilin-1 (NRP-1), a Novel Molecular Target of Glioma</span>. <i>J. Nanosci. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6657</span>– <span class="NLM_lpage">6666</span>, <span class="refDoi"> DOI: 10.1166/jnn.2016.11376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1166%2Fjnn.2016.11376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVCmtr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=6657-6666&author=L.+Chenauthor=Y.+Shiauthor=R.+Qiu&title=Neuropilin-1+%28NRP-1%29%2C+a+Novel+Molecular+Target+of+Glioma&doi=10.1166%2Fjnn.2016.11376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilin-1 (NRP-1), a novel molecular target of glioma</span></div><div class="casAuthors">Chen, Lukui; Shi, Yan; Qiu, Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nanoscience and Nanotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6657-6666</span>CODEN:
                <span class="NLM_cas:coden">JNNOAR</span>;
        ISSN:<span class="NLM_cas:issn">1533-4880</span>.
    
            (<span class="NLM_cas:orgname">American Scientific Publishers</span>)
        </div><div class="casAbstract">This paper reviews the recent studies of Neuropilin-1 (NRP-1) as a novel mol. target of glioma.  In this review, we introduce briefly the properties of the NRP-1.  And then we focused on the role of NRP-1 in gliomas, including relationships of NRP-1 expression and glioma prognosis, NRP-1 signaling and p130Cas tyrosine phosphorylation in gliomas, NRP-1 and LD22-4, Sema3A-NRP-1 signaling in gliomas, NRP-1 in the HGF/SF autocrine pathway, NRP-1 and glioma stem-like cells.  Finally, it is concluded that NRP-1 could potentially act as a novel therapeutical target of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWQq0nHd1p7Vg90H21EOLACvtfcHk0lipHgtHdetASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVCmtr%252FN&md5=ba844732a54937b57ca0696baa382767</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1166%2Fjnn.2016.11376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1166%252Fjnn.2016.11376%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DR.%26atitle%3DNeuropilin-1%2520%2528NRP-1%2529%252C%2520a%2520Novel%2520Molecular%2520Target%2520of%2520Glioma%26jtitle%3DJ.%2520Nanosci.%2520Nanotechnol.%26date%3D2016%26volume%3D16%26spage%3D6657%26epage%3D6666%26doi%3D10.1166%2Fjnn.2016.11376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellet-Many, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachary, I.</span></span> <span> </span><span class="NLM_article-title">Neuropilins: Structure, Function and Role in Disease</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1042/BJ20071639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1042%2FBJ20071639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18363553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslykuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=211-226&author=C.+Pellet-Manyauthor=P.+Frankelauthor=H.+Jiaauthor=I.+Zachary&title=Neuropilins%3A+Structure%2C+Function+and+Role+in+Disease&doi=10.1042%2FBJ20071639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilins: structure, function and role in disease</span></div><div class="casAuthors">Pellet-many, Caroline; Frankel, Paul; Jia, Haiyan; Zachary, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  NRPs (neuropilins) are co-receptors for class 3 semaphorins, polypeptides with key roles in axonal guidance, and for members of the VEGF (vascular endothelial growth factor) family of angiogenic cytokines.  They lack a defined signaling role, but are thought to mediate functional responses as a result of complex formation with other receptors, such as plexins in the case of semaphorins and VEGF receptors (e.g. VEGFR2).  Mutant mouse studies show that NRP1 is essential for neuronal and cardiovascular development, whereas NRP2 has a more restricted role in neuronal patterning and lymphangiogenesis, but recent findings indicate that NRPs may have addnl. biol. roles in other physiol. and disease-related settings.  In particular, NRPs are highly expressed in diverse tumor cell lines and human neoplasms and have been implicated in tumor growth and vascularization in vivo.  However, despite the wealth of information regarding the probable biol. roles of these mols., many aspects of the regulation of cellular function via NRPs remain uncertain, and little is known concerning the mol. mechanisms through which NRPs mediate the functions of their various ligands in different cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNQEjQk8IKgLVg90H21EOLACvtfcHk0lipHgtHdetASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslykuro%253D&md5=566441c07005831d277facaf9a26f0b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1042%2FBJ20071639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071639%26sid%3Dliteratum%253Aachs%26aulast%3DPellet-Many%26aufirst%3DC.%26aulast%3DFrankel%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DNeuropilins%253A%2520Structure%252C%2520Function%2520and%2520Role%2520in%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D211%26epage%3D226%26doi%3D10.1042%2FBJ20071639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotamraju, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">C-End Rule Peptides Mediate Neuropilin-1-Dependent Cell, Vascular, and Tissue Penetration</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">16157</span>– <span class="NLM_lpage">16162</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908201106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1073%2Fpnas.0908201106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19805273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OjsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16157-16162&author=T.+Teesaluauthor=K.+N.+Sugaharaauthor=V.+R.+Kotamrajuauthor=E.+Ruoslahti&title=C-End+Rule+Peptides+Mediate+Neuropilin-1-Dependent+Cell%2C+Vascular%2C+and+Tissue+Penetration&doi=10.1073%2Fpnas.0908201106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration</span></div><div class="casAuthors">Teesalu, Tambet; Sugahara, Kazuki N.; Kotamraju, Venkata Ramana; Erkki Ruoslahti</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16157-16162, S16157/1-S16157/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Screening of phage libraries expressing random peptides for binding to prostate cancer cells primarily yielded peptides that had a C-terminal arginine (or rarely lysine) residue, usually in a consensus context R/KXXR/K.  Phage expressing these sequences and synthetic nanoparticles coated with them bound to and were internalized into cells.  The C-terminal arginine (or lysine) was essential to the activity; adding another amino acid, or even blocking the free carboxyl group of this arginine residue by amidation, eliminated the binding and internalizing activity.  An internal R/KXXR/K can be exposed and switched on by a cleavage by a protease.  The strict requirement for C-terminal exposure of the motif prompted the authors to term the phenomenon the C-end rule (CendR).  Affinity chromatog. showed that the CendR peptides bind to neuropilin-1 (NRP-1) on the target cells.  NRP-1 is a cell-surface receptor that plays an essential role in angiogenesis, regulation of vascular permeability, and the development of the nervous system.  VEGF-A165 and other ligands of NRP-1 possess a C-terminal CendR sequence that interacts with the b1 domain of NRP-1 and causes cellular internalization and vascular leakage.  The authors' CendR peptides have similar effects, particularly when made multivalent through coupling to a particle.  The authors also noted a unique and important activity of these peptides: penetration and transportation through tissues.  The peptides were able to take payloads up to the nanoparticle size scale deep into extravascular tissue.  The authors' observations have implications in drug delivery and penetration of tissue barriers and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6maubmMQubLVg90H21EOLACvtfcHk0ljO-0XRsEjQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OjsbbI&md5=3eb210213cfccc091c4aba949d437b42</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908201106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908201106%26sid%3Dliteratum%253Aachs%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DKotamraju%26aufirst%3DV.%2BR.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DC-End%2520Rule%2520Peptides%2520Mediate%2520Neuropilin-1-Dependent%2520Cell%252C%2520Vascular%252C%2520and%2520Tissue%2520Penetration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16157%26epage%3D16162%26doi%3D10.1073%2Fpnas.0908201106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmali, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotamraju, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agemy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattrey, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2009.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ccr.2009.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19962669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=510-520&author=K.+N.+Sugaharaauthor=T.+Teesaluauthor=P.+P.+Karmaliauthor=V.+R.+Kotamrajuauthor=L.+Agemyauthor=O.+M.+Girardauthor=D.+Hanahanauthor=R.+F.+Mattreyauthor=E.+Ruoslahti&title=Tissue-Penetrating+Delivery+of+Compounds+and+Nanoparticles+into+Tumors&doi=10.1016%2Fj.ccr.2009.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-penetrating delivery of compounds and nanoparticles into tumors</span></div><div class="casAuthors">Sugahara, Kazuki N.; Teesalu, Tambet; Karmali, Priya Prakash; Kotamraju, Venkata Ramana; Agemy, Lilach; Girard, Olivier M.; Hanahan, Douglas; Mattrey, Robert F.; Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Poor penetration of drugs into tumors is a major obstacle in tumor treatment.  We describe a strategy for peptide-mediated delivery of compds. deep into the tumor parenchyma that uses a tumor-homing peptide, iRGD (CRGDK/RGPD/EC).  I.v. injected compds. coupled to iRGD bound to tumor vessels and spread into the extravascular tumor parenchyma, whereas conventional RGD peptides only delivered the cargo to the blood vessels.  IRGD homes to tumors through a three-step process: the RGD motif mediates binding to αv integrins on tumor endothelium and a proteolytic cleavage then exposes a binding motif for neuropilin-1, which mediates penetration into tissue and cells.  Conjugation to iRGD significantly improved the sensitivity of tumor-imaging agents and enhanced the activity of an antitumor drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9SAZVwScjmLVg90H21EOLACvtfcHk0ljO-0XRsEjQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eqsbY%253D&md5=f42c01e8e751526318903d28d70ce4c4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2009.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2009.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DKarmali%26aufirst%3DP.%2BP.%26aulast%3DKotamraju%26aufirst%3DV.%2BR.%26aulast%3DAgemy%26aufirst%3DL.%26aulast%3DGirard%26aufirst%3DO.%2BM.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DMattrey%26aufirst%3DR.%2BF.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTissue-Penetrating%2520Delivery%2520of%2520Compounds%2520and%2520Nanoparticles%2520into%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D510%26epage%3D520%26doi%3D10.1016%2Fj.ccr.2009.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor-Penetrating Peptides</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">216</span>, <span class="refDoi"> DOI: 10.3389/fonc.2013.00216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3389%2Ffonc.2013.00216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=23986882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC3sbjtlGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=216&author=T.+Teesaluauthor=K.+N.+Sugaharaauthor=E.+Ruoslahti&title=Tumor-Penetrating+Peptides&doi=10.3389%2Ffonc.2013.00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-penetrating peptides</span></div><div class="casAuthors">Teesalu Tambet; Sugahara Kazuki N; Ruoslahti Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Tumor-homing peptides can be used to deliver drugs into tumors.  Phage library screening in live mice has recently identified homing peptides that specifically recognize the endothelium of tumor vessels, extravasate, and penetrate deep into the extravascular tumor tissue.  The prototypic peptide of this class, iRGD (CRGDKGPDC), contains the integrin-binding RGD motif.  RGD mediates tumor-homing through binding to αv integrins, which are selectively expressed on various cells in tumors, including tumor endothelial cells.  The tumor-penetrating properties of iRGD are mediated by a second sequence motif, R/KXXR/K.  This C-end Rule (or CendR) motif is active only when the second basic residue is exposed at the C-terminus of the peptide.  Proteolytic processing of iRGD in tumors activates the cryptic CendR motif, which then binds to neuropilin-1 activating an endocytic bulk transport pathway through tumor tissue.  Phage screening has also yielded tumor-penetrating peptides that function like iRGD in activating the CendR pathway, but bind to a different primary receptor.  Moreover, novel tumor-homing peptides can be constructed from tumor-homing motifs, CendR elements and protease cleavage sites.  Pathologies other than tumors can be targeted with tissue-penetrating peptides, and the primary receptor can also be a vascular "zip code" of a normal tissue.  The CendR technology provides a solution to a major problem in tumor therapy, poor penetration of drugs into tumors.  The tumor-penetrating peptides are capable of taking a payload deep into tumor tissue in mice, and they also penetrate into human tumors ex vivo.  Targeting with these peptides specifically increases the accumulation in tumors of a variety of drugs and contrast agents, such as doxorubicin, antibodies, and nanoparticle-based compounds.  Remarkably the drug to be targeted does not have to be coupled to the peptide; the bulk transport system activated by the peptide sweeps along any compound that is present in the blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW6rUhtQrVfgHqQV89nF-2fW6udTcc2eaBItFXImTyMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbjtlGrtg%253D%253D&md5=5bd13d57c5bc6026c30e04de0ab2d087</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00216%26sid%3Dliteratum%253Aachs%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor-Penetrating%2520Peptides%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D216%26doi%3D10.3389%2Ffonc.2013.00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor Penetrating Peptides for Improved Drug Delivery</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.addr.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27040947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=3-12&author=E.+Ruoslahti&title=Tumor+Penetrating+Peptides+for+Improved+Drug+Delivery&doi=10.1016%2Fj.addr.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetrating peptides for improved drug delivery</span></div><div class="casAuthors">Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In vivo screening of phage libraries in tumor-bearing mice has been used to identify peptides that direct phage homing to a tumor.  The power of in vivo phage screening is illustrated by the recent discovery of peptides with unique tumor-penetrating properties.  These peptides activate an endocytic transport pathway related to but distinct from macropinocytosis.  They do so through a complex process that involves binding to a primary, tumor-specific receptor, followed by a proteolytic cleavage, and binding to a second receptor.  The second receptor, neuropilin-1 (or neuropilin-2) activates the transport pathway.  This trans-tissue pathway, dubbed the C-end Rule (CendR) pathway, mediates the extravasation transport through extravascular tumor tissue of payloads ranging from small mol. drugs to nanoparticles.  The CendR technol. provides a soln. to a major problem in tumor therapy, poor penetration of drugs into tumors.  Targeted delivery with tumor-penetrating peptides has been shown to specifically increase the accumulation of drugs, antibodies and nanotherapeutics in exptl. tumors in vivo, and in human tumors ex vivo.  Remarkably the payload does not have to be coupled to the peptide; the peptide activates a bulk transport system that sweeps along a drug present in the blood.  Treatment studies in mice have shown improved anti-tumor efficacy and less damage to normal tissues with drugs ranging from traditional chemotherapeutics to antibodies, and to nanoparticle drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcd2TTUqzLrVg90H21EOLACvtfcHk0ljO-0XRsEjQww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D&md5=83c52c1ec16224278feafb06c8522a1e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor%2520Penetrating%2520Peptides%2520for%2520Improved%2520Drug%2520Delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D3%26epage%3D12%26doi%3D10.1016%2Fj.addr.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aza-Blanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruidiaz, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">An Endocytosis Pathway Initiated through Neuropilin-1 and Regulated by Nutrient Availability</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4904</span>, <span class="refDoi"> DOI: 10.1038/ncomms5904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fncomms5904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25277522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4904&author=H.+B.+Pangauthor=G.+B.+Braunauthor=T.+Frimanauthor=P.+Aza-Blancauthor=M.+E.+Ruidiazauthor=K.+N.+Sugaharaauthor=T.+Teesaluauthor=E.+Ruoslahti&title=An+Endocytosis+Pathway+Initiated+through+Neuropilin-1+and+Regulated+by+Nutrient+Availability&doi=10.1038%2Fncomms5904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability</span></div><div class="casAuthors">Pang, Hong-Bo; Braun, Gary B.; Friman, Tomas; Aza-Blanc, Pedro; Ruidiaz, Manuel E.; Sugahara, Kazuki N.; Teesalu, Tambet; Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4904</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development.  Many growth factors and other signalling mols. bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif).  Peptides with this motif (CendR peptides) are taken up into cells by endocytosis.  Tumor-homing CendR peptides penetrate through tumor tissue and have shown utility in enhancing drug delivery into tumors.  Here we show, using RNAi screening and subsequent validation studies, that NRP1-mediated endocytosis of CendR peptides is distinct from known endocytic pathways.  Ultrastructurally, CendR endocytosis resembles macropinocytosis, but is mechanistically different.  We also show that nutrient-sensing networks such as mTOR signalling regulate CendR endocytosis and subsequent intercellular transport of CendR cargo, both of which are stimulated by nutrient depletion.  As CendR is a bulk transport pathway, our results suggest a role for it in nutrient transport; CendR-enhanced drug delivery then makes use of this natural pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ0RdXrbSNI7Vg90H21EOLACvtfcHk0ljS6Ezn9k5qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgsL7O&md5=2f0e203d82fd281cee230d9e3f201f38</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncomms5904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5904%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DH.%2BB.%26aulast%3DBraun%26aufirst%3DG.%2BB.%26aulast%3DFriman%26aufirst%3DT.%26aulast%3DAza-Blanc%26aufirst%3DP.%26aulast%3DRuidiaz%26aufirst%3DM.%2BE.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DAn%2520Endocytosis%2520Pathway%2520Initiated%2520through%2520Neuropilin-1%2520and%2520Regulated%2520by%2520Nutrient%2520Availability%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4904%26doi%3D10.1038%2Fncomms5904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemion, I. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluczyk, A.</span></span> <span> </span><span class="NLM_article-title">Tuftsin: On the 30-Year Anniversary of Victor Najjar’s Discovery</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(99)00019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2FS0196-9781%2899%2900019-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10465518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=645-674&author=I.+Z.+Siemionauthor=A.+Kluczyk&title=Tuftsin%3A+On+the+30-Year+Anniversary+of+Victor+Najjar%E2%80%99s+Discovery&doi=10.1016%2FS0196-9781%2899%2900019-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin: On the 30-year anniversary of Victor Najjar's discovery</span></div><div class="casAuthors">Siemion, Ignacy Z.; Kluczyk, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">645-674</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 358 refs.  After a short description of the results of Victor Najjar's research on tuftsin and of the discoveries done by other authors in the early stage of tuftsin investigation, the current state of work on tuftsin is presented, based mainly on the literature published in the years 1984-1997.  The mol. structure, protein sequence, antigenic properties, and its effects on phagocytes are reviewed.  Antimicrobial, and antitumor activities of tuftsin and its therapeutic potentials are also summarized.  The presentation follows this order: the occurrence of tuftsin and retro-tuftsin sequences in proteins, their synthesis and biol., the antigenic properties of tuftsin, its influence on phagocytic cells, and other biol. activities of tuftsin, including antimicrobial, antiviral, antitumor and central effects, and the search for tuftsin superactive analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0uIO4JRKgrVg90H21EOLACvtfcHk0ljS6Ezn9k5qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFCjs78%253D&md5=894964c8ade0168d14ea3a094e6259f5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2899%2900019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252899%252900019-4%26sid%3Dliteratum%253Aachs%26aulast%3DSiemion%26aufirst%3DI.%2BZ.%26aulast%3DKluczyk%26aufirst%3DA.%26atitle%3DTuftsin%253A%2520On%2520the%252030-Year%2520Anniversary%2520of%2520Victor%2520Najjar%25E2%2580%2599s%2520Discovery%26jtitle%3DPeptides%26date%3D1999%26volume%3D20%26spage%3D645%26epage%3D674%26doi%3D10.1016%2FS0196-9781%2899%2900019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Wronski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjappan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span> <span> </span><span class="NLM_article-title">Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">5702</span>– <span class="NLM_lpage">5710</span>, <span class="refDoi"> DOI: 10.1074/jbc.M511941200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1074%2Fjbc.M511941200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=16371354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=5702-5710&author=M.+A.+von%0AWronskiauthor=N.+Rajuauthor=R.+Pillaiauthor=N.+J.+Bogdanauthor=E.+R.+Marinelliauthor=P.+Nanjappanauthor=K.+Ramalingamauthor=T.+Arunachalamauthor=S.+Eatonauthor=K.+E.+Linderauthor=F.+Yanauthor=S.+Pochonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=Tuftsin+Binds+Neuropilin-1+through+a+Sequence+Similar+to+That+Encoded+by+Exon+8+of+Vascular+Endothelial+Growth+Factor&doi=10.1074%2Fjbc.M511941200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor</span></div><div class="casAuthors">von Wronski, Mathew A.; Raju, Natarajan; Pillai, Radhakrishna; Bogdan, Nancy J.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Ramalingam, Kondareddiar; Arunachalam, Thangavel; Eaton, Steve; Linder, Karen E.; Yan, Feng; Pochon, Sibylle; Tweedle, Michael F.; Nunn, Adrian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5702-5710</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tuftsin, Thr-Lys-Pro-Arg (TKPR), is an immunostimulatory peptide with reported nervous system effects as well.  The authors unexpectedly found that tuftsin and a higher affinity antagonist, TKPPR, bind selectively to neuropilin-1 and block vascular endothelial growth factor (VEGF) binding to that receptor.  Dimeric and tetrameric forms of TKPPR had greatly increased affinity for neuropilin-1 based on competition binding expts.  On endothelial cells tetrameric TKPPR inhibited the VEGF165-induced autophosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) even though it did not directly inhibit VEGF binding to VEGFR-2.  Homol. between exon 8 of VEGF and TKPPR suggests that the sequence coded for by exon 8 may stabilize VEGF binding to neuropilin-1 to facilitate signaling through VEGFR-2.  Given the overlap between processes involving neuropilin-1 and tuftsin, the authors propose that at least some of the previously reported effects of tuftsin are mediated through neuropilin-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52QmZ9B4Q67Vg90H21EOLACvtfcHk0ljS6Ezn9k5qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVejtLw%253D&md5=c8a2c3233068ab1764befd74f0f7b77e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511941200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511941200%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BWronski%26aufirst%3DM.%2BA.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DPillai%26aufirst%3DR.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DMarinelli%26aufirst%3DE.%2BR.%26aulast%3DNanjappan%26aufirst%3DP.%26aulast%3DRamalingam%26aufirst%3DK.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DS.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DPochon%26aufirst%3DS.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3DTuftsin%2520Binds%2520Neuropilin-1%2520through%2520a%2520Sequence%2520Similar%2520to%2520That%2520Encoded%2520by%2520Exon%25208%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D5702%26epage%3D5710%26doi%3D10.1074%2Fjbc.M511941200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selwood, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsirka, S. E.</span></span> <span> </span><span class="NLM_article-title">Tuftsin Signals through Its Receptor Neuropilin-1 via the Transforming Growth Factor Beta Pathway</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1111/jnc.12404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1111%2Fjnc.12404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24033337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1elurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=394-402&author=J.+C.+Nissenauthor=D.+L.+Selwoodauthor=S.+E.+Tsirka&title=Tuftsin+Signals+through+Its+Receptor+Neuropilin-1+via+the+Transforming+Growth+Factor+Beta+Pathway&doi=10.1111%2Fjnc.12404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway</span></div><div class="casAuthors">Nissen, Jillian C.; Selwood, David L.; Tsirka, Stella E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">394-402</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tuftsin (Thr-Lys-Pro-Arg) is a natural immunomodulating peptide found to stimulate phagocytosis in macrophages/microglia.  Tuftsin binds to the receptor neuropilin-1 (Nrp1) on the surface of cells.  Nrp1 is a single-pass transmembrane protein, but its intracellular C-terminal domain is too small to signal independently.  Instead, it assocs. with a variety of coreceptors.  Despite its long history, the pathway through which tuftsin signals has not been described.  To investigate this question, we employed various inhibitors to Nrp1's coreceptors to det. which route is responsible for tuftsin signaling.  We use the inhibitor EG00229, which prevents tuftsin binding to Nrp1 on the surface of microglia and reverses the anti-inflammatory M2 shift induced by tuftsin.  Furthermore, we demonstrate that blockade of transforming growth factor beta (TGFβ) signaling via TβR1 disrupts the M2 shift similar to EG00229.  We report that tuftsin promotes Smad3 phosphorylation and reduces Akt phosphorylation.  Taken together, our data show that tuftsin signals through Nrp1 and the canonical TGFβ signaling pathway.  Despite the 40-yr history of the tetrapeptide tuftsin (TKPR), a macrophage and microglial activator, its mechanism of action has not been defined.  Here, we report that the tuftsin-mediated anti-inflammatory M2 shift in microglia is caused specifically by tuftsin binding to the receptor neuropilin-1 (Nrp1) and signaling through TGFβ receptor-1, a coreceptor of Nrp1.  We further show that tuftsin signals via the canonical TGFβ pathway and promotes TGFβ release from target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvj4x2zY4f9LVg90H21EOLACvtfcHk0lht9Tdba6TvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1elurzL&md5=f28fda0de3faa05b767b1e8c3b048527</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12404%26sid%3Dliteratum%253Aachs%26aulast%3DNissen%26aufirst%3DJ.%2BC.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DTsirka%26aufirst%3DS.%2BE.%26atitle%3DTuftsin%2520Signals%2520through%2520Its%2520Receptor%2520Neuropilin-1%2520via%2520the%2520Transforming%2520Growth%2520Factor%2520Beta%2520Pathway%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26spage%3D394%26epage%3D402%26doi%3D10.1111%2Fjnc.12404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bump, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wleklik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, V. A.</span></span> <span> </span><span class="NLM_article-title">Isolation and Subunit Composition of Tuftsin Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">7187</span>– <span class="NLM_lpage">7191</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.19.7187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1073%2Fpnas.83.19.7187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=3463958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaL28XlvV2jtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=7187-7191&author=N.+J.+Bumpauthor=J.+Leeauthor=M.+Wleklikauthor=J.+Reichlerauthor=V.+A.+Najjar&title=Isolation+and+Subunit+Composition+of+Tuftsin+Receptor&doi=10.1073%2Fpnas.83.19.7187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and subunit composition of tuftsin receptor</span></div><div class="casAuthors">Bump, Nancy J.; Lee, James; Wleklik, Marek; Reichler, Judith; Najjar, Victor A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7187-91</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Tuftsin (Thr-Lys-Pro-Arg) receptor was purified to apparent homogeneity by affinity chromatog., using a pentapeptide analog (Thr-Lys-Pro-Pro-Arg) that binds the receptor >4 times as avidly as tuftsin.  The analog was covalently linked to a solid support (Affi-Gel 10).  Rabbit peritoneal granulocyte membrane solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate was applied to the affinity column, the column was washed with 0.1 M ammonium carbonate (pH 7.9) and 0.1 M ammonium acetate (pH 5), and bound material was eluted with 20 nM tuftsin or pentapeptide.  The eluate was concd. and subjected to gel filtration; this yielded 1 major peak of [3H]tuftsin-binding activity corresponding to ≈500 kilodaltons (kDa) and a minor peak at ≈250 kDa.  Rechromatog. of either peak resulted in the appearance of the same major and minor peaks.  SDS/PAGE of the affinity-purified material under nonreducing conditions showed only 2 Ag-staining bands.  Electroblotting followed by [3H]tuftsin overlay and fluorog. showed 2 adjacent radioactive bands corresponding in mobility to the Ag-stained bands.  Under reducing conditions, SDS/PAGE yielded mol. mass values of 62 kDa and 52 kDa for the 2 tuftsin receptor subunits.  Electron microscopy revealed a homogeneous population of spherical mols. with diams. of 104 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoajhjEAYhxobVg90H21EOLACvtfcHk0lht9Tdba6TvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvV2jtb4%253D&md5=4c6a22dba5ab81e52372045004a4104b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.19.7187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.19.7187%26sid%3Dliteratum%253Aachs%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWleklik%26aufirst%3DM.%26aulast%3DReichler%26aufirst%3DJ.%26aulast%3DNajjar%26aufirst%3DV.%2BA.%26atitle%3DIsolation%2520and%2520Subunit%2520Composition%2520of%2520Tuftsin%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D7187%26epage%3D7191%26doi%3D10.1073%2Fpnas.83.19.7187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaszi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remenyi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Conformation, and Immunoreactivity of New Carrier Molecules Based on Repeated Tuftsin-Like Sequence</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1002/bip.20024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fbip.20024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15048768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1SlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=645-656&author=G.+Mezoauthor=A.+Kalasziauthor=J.+Remenyiauthor=Z.+Majerauthor=A.+Hilbertauthor=O.+Langauthor=L.+Kohidaiauthor=K.+Barnaauthor=D.+Gaalauthor=F.+Hudecz&title=Synthesis%2C+Conformation%2C+and+Immunoreactivity+of+New+Carrier+Molecules+Based+on+Repeated+Tuftsin-Like+Sequence&doi=10.1002%2Fbip.20024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence</span></div><div class="casAuthors">Mezo, Gabor; Kalaszi, Adrian; Remenyi, Judit; Majer, Zsuzsa; Hilbert, Agnes; Lang, Orsolya; Kohidai, Laszlo; Barna, Krisztina; Gaal, Dezso; Hudecz, Ferenc</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">645-656</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sequential oligopeptides based on a pentapeptide (TKPKG) derived from tuftsin with different lengths were synthesized by stepwise solid phase methodol.  These highly sol. oligomers were nontoxic on mouse spleen cells, and other biol. data suggested that tuftsin-like properties were also presented.  The (TKPKG)n (n=2,4,6,8) oligopeptides were not immunogenic; however, they increased sheep red blood cells (SRBC) antigen specific antibody response in mice, demonstrating their immunostimulatory effect.  Chemotactic activity was also found on J774 monocyte cells, while MRC5 fibroblasts were chemotactically nonresponders to the tested forms of tuftsin.  These oligomers showed unordered and flexible structure by CD measurements, confirmed by computer modeling studies indicating also a fairly good accessibility of the ε-amino group of each lysine residue.  Data suggest that these new oligotuftsin derivs. can be considered as promising carriers for synthetic vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4pdG8kKWvVLVg90H21EOLACvtfcHk0lht9Tdba6TvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1SlsbY%253D&md5=e79fc4c07630c29fb40c0c69771f848e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fbip.20024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20024%26sid%3Dliteratum%253Aachs%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DKalaszi%26aufirst%3DA.%26aulast%3DRemenyi%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DZ.%26aulast%3DHilbert%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DO.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DBarna%26aufirst%3DK.%26aulast%3DGaal%26aufirst%3DD.%26aulast%3DHudecz%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520Conformation%252C%2520and%2520Immunoreactivity%2520of%2520New%2520Carrier%2520Molecules%2520Based%2520on%2520Repeated%2520Tuftsin-Like%2520Sequence%26jtitle%3DBiopolymers%26date%3D2004%26volume%3D73%26spage%3D645%26epage%3D656%26doi%3D10.1002%2Fbip.20024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and In Vitro Activity of Novel Drug Delivery Systems Containing Tuftsin Derivatives and Methotrexate</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2260</span>– <span class="NLM_lpage">2269</span>, <span class="refDoi"> DOI: 10.1021/bc800115w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc800115w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSlsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2260-2269&author=K.+B.+Baiauthor=O.+Langauthor=E.+Orbanauthor=R.+Szaboauthor=L.+Kohidaiauthor=F.+Hudeczauthor=G.+Mezo&title=Design%2C+Synthesis%2C+and+In+Vitro+Activity+of+Novel+Drug+Delivery+Systems+Containing+Tuftsin+Derivatives+and+Methotrexate&doi=10.1021%2Fbc800115w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and In Vitro Activity of Novel Drug Delivery Systems Containing Tuftsin Derivatives and Methotrexate</span></div><div class="casAuthors">Bai, Katalin B.; Lang, Orsolya; Orban, Erika; Szabo, Rita; Kohidai, Laszlo; Hudecz, Ferenc; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2260-2269</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During the past decade, biodegradable polymers or oligopeptides recognized by cell-surface receptors have been shown to increase drug specificity, lowering systemic drug toxicity in contrast to small-size fast-acting drugs.  The goal of the present study was to develop anticancer bioconjugates based on chemotactic drug targeting (CDT).  These constructs are composed of methotrexate (Mtx) attached to a tuftsin-like peptide carrier through an enzyme-labile pentapeptide spacer (GFLGC) and several copies of a chemotactic targeting moiety (H-TKPR, For-TKPR, H-TKPKG, and Ac-TKPKG).  Carriers with targeting moieties in the branches were prepd. by solid-phase synthesis using mixed Boc and Fmoc strategies.  The drug mol. connected to an enzyme-labile spacer was attached to the branched oligopeptide in soln.  In vitro chemotaxis, cellular uptake, and cytotoxicity assays were carried out on the MonoMac6 cell line.  The most effective conjugates with H-TKPR or Ac-TKPKG targeting moieties in the branches, which have the most advantageous chemotactic properties, can be internalized rapidly, and these conjugates trigger higher toxic effect than the free drug (Mtx).  The results suggest that our tuftsin-based drug delivery systems might be potential candidates for targeting cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqArpV5Kz8pz7Vg90H21EOLACvtfcHk0ljCEZGaijBz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSlsrbM&md5=593f340087a796d9c9a11f8156426b8d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbc800115w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800115w%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DK.%2BB.%26aulast%3DLang%26aufirst%3DO.%26aulast%3DOrban%26aufirst%3DE.%26aulast%3DSzabo%26aufirst%3DR.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520In%2520Vitro%2520Activity%2520of%2520Novel%2520Drug%2520Delivery%2520Systems%2520Containing%2520Tuftsin%2520Derivatives%2520and%2520Methotrexate%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2260%26epage%3D2269%26doi%3D10.1021%2Fbc800115w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacsa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grolmusz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vertessy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Enhanced Cellular Uptake of a New, In Silico Identified Antitubercular Candidate by Peptide Conjugation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1021/bc200221t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200221t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=900-907&author=K.+Horvatiauthor=B.+Bacsaauthor=N.+Szaboauthor=S.+Davidauthor=G.+Mezoauthor=V.+Grolmuszauthor=B.+Vertessyauthor=F.+Hudeczauthor=S.+Bosze&title=Enhanced+Cellular+Uptake+of+a+New%2C+In+Silico+Identified+Antitubercular+Candidate+by+Peptide+Conjugation&doi=10.1021%2Fbc200221t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cellular Uptake of a New, in Silico Identified Antitubercular Candidate by Peptide Conjugation</span></div><div class="casAuthors">Horvati, Kata; Bacsa, Bernadett; Szabo, Nora; David, Sandor; Mezo, Gabor; Grolmusz, Vince; Vertessy, Beata; Hudecz, Ferenc; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">900-907</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis is a successful pathogen, and it can survive in infected macrophages in dormant phase for years and decades.  The therapy of tuberculosis takes at least six months, and the slow-growing bacterium is resistant to many antibiotics.  The development of novel antimicrobials to counter the emergence of bacteria resistant to current therapies is urgently needed.  In silico docking methods and structure-based drug design are useful bioinformatics tools for identifying new agents.  A docking expt. to M. tuberculosis dUTPase enzyme, which plays a key role in the bacterial metab., has resulted in 10 new antitubercular drug candidates.  The uptake of antituberculars by infected macrophages is limited by extracellular diffusion.  The optimization of the cellular uptake by drug delivery systems can decrease the used dosages and the length of the therapy, and it can also enhance the bioavailability of the drug mol.  In this study, improved in vitro efficacy was achieved by attaching the TB5 antitubercular drug candidate to peptide carriers.  As drug delivery components, (i) an antimicrobial granulysin peptide and (ii) a receptor specific tuftsin peptide were used.  An efficient synthetic approach was developed to conjugate the in silico identified TB5 coumarone deriv. to the carrier peptides.  The compds. were effective on M. tuberculosis H37Rv culture in vitro; the chem. linkage did not affect the antimycobacterial activity.  Here, we show that the OT20 tuftsin and GranF2 granulysin peptide conjugates have dramatically enhanced uptake into human MonoMac6 cells.  The TB5-OT20 tuftsin conjugate exhibited significant antimycobacterial activity on M. tuberculosis H37Rv infected MonoMac6 cells and inhibited intracellular bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoASABFeIl9gLVg90H21EOLACvtfcHk0ljCEZGaijBz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsbk%253D&md5=48bb5b7404aeacd426efc4b79b48fe4d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbc200221t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200221t%26sid%3Dliteratum%253Aachs%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBacsa%26aufirst%3DB.%26aulast%3DSzabo%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DGrolmusz%26aufirst%3DV.%26aulast%3DVertessy%26aufirst%3DB.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DEnhanced%2520Cellular%2520Uptake%2520of%2520a%2520New%252C%2520In%2520Silico%2520Identified%2520Antitubercular%2520Candidate%2520by%2520Peptide%2520Conjugation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D900%26epage%3D907%26doi%3D10.1021%2Fbc200221t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of New Peptide Conjugates of Antitubercular Drug Candidates-Model Membrane and In Vitro Studies</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2016.07.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.colsurfb.2016.07.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27497074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12kt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2016&pages=106-115&author=A.+Abrahamauthor=Z.+Baranyaiauthor=G.+Gyulaiauthor=E.+Pariauthor=K.+Horvatiauthor=S.+Boszeauthor=E.+Kiss&title=Comparative+Analysis+of+New+Peptide+Conjugates+of+Antitubercular+Drug+Candidates-Model+Membrane+and+In+Vitro+Studies&doi=10.1016%2Fj.colsurfb.2016.07.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of new peptide conjugates of antitubercular drug candidates-Model membrane and in vitro studies</span></div><div class="casAuthors">Abraham, A.; Baranyai, Zs.; Gyulai, G.; Pari, E.; Horvati, K.; Bosze, Sz.; Kiss, E.</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel peptide conjugates of two antitubercular drug candidates were synthesized and characterised using new tuftsin peptide deriv. (OT14) as carrier moiety.  As antitubercular drug candidates two pyridopyrimidine derivs., TB803 (2-allylamino-4-oxopyrido[1,2-a]pyrimidine-3-carbaldehyde) and TB820 (4-oxo-2-(pyrrolidin-1-yl)-pyrido[1,2-a]pyrimidin-3-carbaldehyde) inhibiting vital enzyme of Mycobacterium tuberculosis were applied.  Membrane affinity of the compds. TB803 and TB820 and their peptide conjugates was evaluated using exptl. lipid mono- and bilayer models.  Penetration ability was assessed tensiometrically from Langmuir monolayer study and applying quartz crystal microbalance for the supported lipid bilayer (SLB) system.  Minimal inhibitory concn. (MIC) values remained in a similar micromolar range for both of the conjugates while their cellular uptake rate was improved significantly compared to the drug candidates.  A correlation was found between membrane affinity properties and results of in vitro biol. investigations.  Anal. of phys./structural properties of SLB in contact with bioactive components and visualization of the structural change by at.-force microscopy (AFM) provided information on the type and route of mol. interaction of drug construction with lipid layers.  The possible role of electrostatic interactions between lipid layer and drug candidates was tested in Langmuir-balance expts. using neg. charged lipid mixt. (DPPC + DPPG).  Esp. the peptide conjugates presented increased membrane affinity due to cationic character of the peptide sequence selected for the conjugate formation.  That is supposed to be one reason for the enhanced cellular uptake obsd. in vitro on MonoMac6 cell line.  The conjugation of antitubercular agents to a peptidic carrier is a promising approach to enhance membrane affinity, cellular uptake rate and in vitro selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jYbH0SnJeLVg90H21EOLACvtfcHk0liNeSKqgSMf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12kt7bO&md5=ea785da98804f186c1018d622cd0784e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2016.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2016.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DA.%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DGyulai%26aufirst%3DG.%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DE.%26atitle%3DComparative%2520Analysis%2520of%2520New%2520Peptide%2520Conjugates%2520of%2520Antitubercular%2520Drug%2520Candidates-Model%2520Membrane%2520and%2520In%2520Vitro%2520Studies%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2016%26volume%3D147%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.colsurfb.2016.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosatka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senoner, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Biological Evaluation of New Antimycobacterial Salicylanilide-Tuftsin Conjugates</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejmech.2017.03.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28384546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=152-173&author=Z.+Baranyaiauthor=M.+Kratkyauthor=R.+Vosatkaauthor=E.+Szaboauthor=Z.+Senonerauthor=S.+Davidauthor=J.+Stolarikovaauthor=J.+Vinsovaauthor=S.+Bosze&title=In+Vitro+Biological+Evaluation+of+New+Antimycobacterial+Salicylanilide-Tuftsin+Conjugates&doi=10.1016%2Fj.ejmech.2017.03.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates</span></div><div class="casAuthors">Baranyai, Zsuzsa; Kratky, Martin; Vosatka, Rudolf; Szabo, Eleonora; Senoner, Zsuzsanna; David, Sandor; Stolarikova, Jirina; Vinsova, Jarmila; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-173</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tuberculosis is caused by Mycobacterium tuberculosis, an intracellular pathogen that can survive in host cells, mainly in macrophages.  An increase of multidrug-resistant tuberculosis qualifies this infectious disease as a major public health problem worldwide.  The cellular uptake of the antimycobacterial agents by infected host cells is limited.  The authors' approach is to enhance the cellular uptake of the antituberculars by target cell-directed delivery using drug-peptide conjugates to achieve an increased intracellular efficacy.  In this study, salicylanilide derivs. (2-hydroxy-N-phenylbenzamides) with remarkable antimycobacterial activity were conjugated to macrophage receptor specific tuftsin based peptide carriers through oxime bond directly or by insertion of a GFLG tetrapeptide spacer.  The authors have found that the in vitro antimycobacterial activity of the salicylanilides against M. tuberculosis H37Rv is preserved in the conjugates.  While the free drug was ineffective on infected macrophage model, the conjugates were active against the intracellular bacteria.  The fluorescently labeled peptide carriers that were modified with different fatty acid side chains showed outstanding cellular uptake rate to the macrophage model cells.  The conjugation of the salicylanilides to tuftsin based carriers reduced or abolished the in vitro cytostatic activity of the free drugs with the exception of the palmitoylated conjugates.  The conjugates degraded in the presence of rat liver lysosomal homogenate leading to the formation of an oxime bond-linked salicylanilide-amino acid fragment as the smallest active metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaT-ff9Q5ccbVg90H21EOLACvtfcHk0liNeSKqgSMf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslejtLc%253D&md5=e72e1de7128ca32ee68771705c36b6ae</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.047%26sid%3Dliteratum%253Aachs%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVosatka%26aufirst%3DR.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DSenoner%26aufirst%3DZ.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DStolarikova%26aufirst%3DJ.%26aulast%3DVinsova%26aufirst%3DJ.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DIn%2520Vitro%2520Biological%2520Evaluation%2520of%2520New%2520Antimycobacterial%2520Salicylanilide-Tuftsin%2520Conjugates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D133%26spage%3D152%26epage%3D173%26doi%3D10.1016%2Fj.ejmech.2017.03.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span> <span> </span><span class="NLM_article-title">Salicylanilide Ester Prodrugs as Potential Antimicrobial Agents--a Review</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3494</span>– <span class="NLM_lpage">3505</span>, <span class="refDoi"> DOI: 10.2174/138161211798194521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2174%2F138161211798194521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22074422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3494-3505&author=M.+Kratkyauthor=J.+Vinsova&title=Salicylanilide+Ester+Prodrugs+as+Potential+Antimicrobial+Agents%2D%2Da+Review&doi=10.2174%2F138161211798194521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylanilide ester prodrugs as potential antimicrobial agents - a review</span></div><div class="casAuthors">Kratky, Martin; Vinsova, Jarmila</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3494-3505</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Salicylanilides have been a subject of interest in medicinal chem. as a group with a wide range of biol. activities.  The antibacterial (including antimycobacterial) and antifungal activities have come to be viewed as very significant.  The synthesis of new prodrugs to counter a no. of problematic properties of salicylanilides is a current trend.  This article brings together the known basic facts about these prodrugs, particularly about the different mechanisms of the antimicrobial action of salicylanilides, including salicylanilide toxicity and undesired effects.  The largest part of this group consists of antimicrobial salicylanilide esters with different org. acids, e.g. acetates, carbamates, esters with N-protected amino acids, and mutual antibacterial compds. with known antibacterial agents (β-lactames and linezolid), with the activity and structure-activity relationships of these compds. being of particular interest.  This review summarizes the activity of salicylanilides as potential virulence inhibitors attributable to a blockade of the type III secretion pathway.  Many salicylanilide ester derivs. have been demonstrated an effective and promising treatment against pathogenic fungi and bacteria (esp. against Gram-pos., tuberculous and atypical mycobacterial strains), including strains such as methicillin-resistant Staphylococcus aureus and isoniazid-resistant mycobacteria which are resistant to one or more clin. used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri1EWfwbmF6rVg90H21EOLACvtfcHk0liNeSKqgSMf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGmsA%253D%253D&md5=d3acf1f46dffce26780fc10b1dc8f7c3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F138161211798194521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798194521%26sid%3Dliteratum%253Aachs%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVinsova%26aufirst%3DJ.%26atitle%3DSalicylanilide%2520Ester%2520Prodrugs%2520as%2520Potential%2520Antimicrobial%2520Agents--a%2520Review%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3494%26epage%3D3505%26doi%3D10.2174%2F138161211798194521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arend, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span> <span> </span><span class="NLM_article-title">Multi-Targeted Therapy of Cancer by Niclosamide: A New Application for an Old Drug</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.canlet.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24732808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXms1Gjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=8-14&author=Y.+Liauthor=P.+K.+Liauthor=M.+J.+Robertsauthor=R.+C.+Arendauthor=R.+S.+Samantauthor=D.+J.+Buchsbaum&title=Multi-Targeted+Therapy+of+Cancer+by+Niclosamide%3A+A+New+Application+for+an+Old+Drug&doi=10.1016%2Fj.canlet.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted therapy of cancer by niclosamide: A new application for an old drug</span></div><div class="casAuthors">Li, Yonghe; Li, Pui-Kai; Roberts, Michael J.; Arend, Rebecca C.; Samant, Rajeev S.; Buchsbaum, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rapid development of new anticancer drugs that are safe and effective is a common goal shared by basic scientists, clinicians and patients.  The current review discusses one such agent, namely niclosamide, which has been used in the clinic for the treatment of intestinal parasite infections.  Recent studies repeatedly identified niclosamide as a potential anticancer agent by various high-throughput screening campaigns.  Niclosamide not only inhibits the Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways, but also targets mitochondria in cancer cells to induce cell cycle arrest, growth inhibition and apoptosis.  A no. of studies have established the anticancer activities of niclosamide in both in vitro and in vivo models.  Moreover, the inhibitory effects of niclosamide on cancer stem cells provide further evidence for its consideration as a promising drug for cancer therapy.  This article reviews various aspects of niclosamide as they relate to its efficacy against cancer and assocd. mol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAr8M29D4VSrVg90H21EOLACvtfcHk0liNeSKqgSMf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXms1Gjtbs%253D&md5=0262aa17fe03e265b072f0558e5a2b25</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DRoberts%26aufirst%3DM.%2BJ.%26aulast%3DArend%26aufirst%3DR.%2BC.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26atitle%3DMulti-Targeted%2520Therapy%2520of%2520Cancer%2520by%2520Niclosamide%253A%2520A%2520New%2520Application%2520for%2520an%2520Old%2520Drug%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D349%26spage%3D8%26epage%3D14%26doi%3D10.1016%2Fj.canlet.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premont, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Niclosamide: Beyond an Antihelminthic Drug</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.cellsig.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28389414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt12qurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=89-96&author=W.+Chenauthor=R.+A.+Mookauthor=R.+T.+Premontauthor=J.+Wang&title=Niclosamide%3A+Beyond+an+Antihelminthic+Drug&doi=10.1016%2Fj.cellsig.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Niclosamide: Beyond an antihelminthic drug</span></div><div class="casAuthors">Chen, Wei; Mook, Robert A., Jr.; Premont, Richard T.; Wang, Jiangbo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide.  However recent studies have indicated that niclosamide may have broad clin. applications for the treatment of diseases other than those caused by parasites.  These diseases and symptoms may include cancer, bacterial and viral infection, metabolic diseases such as Type II diabetes, NASH and NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-vs.-host disease, and systemic sclerosis.  Among the underlying mechanisms assocd. with the drug actions of niclosamide are uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways.  Here we provide a brief overview of the biol. activities of niclosamide, its potential clin. applications, and its challenges for use as a new therapy for systemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6P0sW9zodbVg90H21EOLACvtfcHk0lgsNFQs7vxuXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt12qurk%253D&md5=84f8fcc804e57b07dac47376dbffc35b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DPremont%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DNiclosamide%253A%2520Beyond%2520an%2520Antihelminthic%2520Drug%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D41%26spage%3D89%26epage%3D96%26doi%3D10.1016%2Fj.cellsig.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Niclosamide, an Old Antihelminthic Agent, Demonstrates Antitumor Activity by Blocking Multiple Signaling Pathways of Cancer Stem Cells</span>. <i>Aizheng</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.5732/cjc.011.10290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.5732%2Fcjc.011.10290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22237038" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=178-184&author=J.+X.+Panauthor=K.+Dingauthor=C.+Y.+Wang&title=Niclosamide%2C+an+Old+Antihelminthic+Agent%2C+Demonstrates+Antitumor+Activity+by+Blocking+Multiple+Signaling+Pathways+of+Cancer+Stem+Cells&doi=10.5732%2Fcjc.011.10290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.5732%2Fcjc.011.10290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5732%252Fcjc.011.10290%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DNiclosamide%252C%2520an%2520Old%2520Antihelminthic%2520Agent%252C%2520Demonstrates%2520Antitumor%2520Activity%2520by%2520Blocking%2520Multiple%2520Signaling%2520Pathways%2520of%2520Cancer%2520Stem%2520Cells%26jtitle%3DAizheng%26date%3D2012%26volume%3D31%26spage%3D178%26epage%3D184%26doi%3D10.5732%2Fcjc.011.10290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trageser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogolok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinartz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinhaas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimmers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yachnis, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pincus, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steindler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brustle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffler, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer Effects of Niclosamide in Human Glioblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4124</span>– <span class="NLM_lpage">4136</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-2895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1158%2F1078-0432.CCR-12-2895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=23908450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4124-4136&author=A.+Wielandauthor=D.+Trageserauthor=S.+Gogolokauthor=R.+Reinartzauthor=H.+Hoferauthor=M.+Kellerauthor=A.+Leinhaasauthor=R.+Schelleauthor=S.+Normannauthor=L.+Klaasauthor=A.+Wahaauthor=P.+Kochauthor=R.+Fimmersauthor=T.+Pietschauthor=A.+T.+Yachnisauthor=D.+W.+Pincusauthor=D.+A.+Steindlerauthor=O.+Brustleauthor=M.+Simonauthor=M.+Glasauthor=B.+Scheffler&title=Anticancer+Effects+of+Niclosamide+in+Human+Glioblastoma&doi=10.1158%2F1078-0432.CCR-12-2895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Effects of Niclosamide in Human Glioblastoma</span></div><div class="casAuthors">Wieland, Anja; Trageser, Daniel; Gogolok, Sabine; Reinartz, Roman; Hoefer, Heike; Keller, Mihaela; Leinhaas, Anke; Schelle, Ramona; Normann, Sabine; Klaas, Lil; Waha, Andreas; Koch, Philipp; Fimmers, Rolf; Pietsch, Torsten; Yachnis, Anthony T.; Pincus, David W.; Steindler, Dennis A.; Bruestle, Oliver; Simon, Matthias; Glas, Martin; Scheffler, Bjoern</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4124-4136</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma is a highly malignant, invariably fatal brain tumor for which effective pharmacotherapy remains an unmet medical need.  Exptl. Design: Screening of a compd. library of 160 synthetic and natural toxic substances identified the antihelmintic niclosamide as a previously unrecognized candidate for clin. development.  Considering the cellular and interindividual heterogeneity of glioblastoma, a portfolio of short-term expanded primary human glioblastoma cells (pGBM; n = 21), common glioma lines (n = 5), and noncancer human control cells (n = 3) was applied as a discovery platform and for preclin. validation.  Pharmacodynamic anal., study of cell-cycle progression, apoptosis, cell migration, proliferation, and on the frequency of multipotent/self-renewing pGBM cells were conducted in vitro, and orthotopic xenotransplantation was used to confirm anticancer effects in vivo.  Results: Niclosamide led to cytostatic, cytotoxic, and antimigratory effects, strongly reduced the frequencies of multipotent/self-renewing cells in vitro, and after exposure significantly diminished the pGBMs' malignant potential in vivo.  Mechanism of action anal. revealed that niclosamide simultaneously inhibited intracellular WNT/CTNNB1-, NOTCH-, mTOR-, and NF-κB signaling cascades.  Furthermore, combinatorial drug testing established that a heterozygous deletion of the NFKBIA locus in glioblastoma samples could serve as a genomic biomarker for predicting a synergistic activity of niclosamide with temozolomide, the current std. in glioblastoma therapy.  Conclusions: Together, our data advocate the use of pGBMs for exploration of compd. libraries to reveal unexpected leads, for example, niclosamide that might be suited for further development toward personalized clin. application.  Clin Cancer Res; 19(15); 4124-36. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRHeuK52g4rVg90H21EOLACvtfcHk0lgsNFQs7vxuXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amt7%252FN&md5=2df43b45ff14d3e3d4e88abb782ab67b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2895%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DA.%26aulast%3DTrageser%26aufirst%3DD.%26aulast%3DGogolok%26aufirst%3DS.%26aulast%3DReinartz%26aufirst%3DR.%26aulast%3DHofer%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DLeinhaas%26aufirst%3DA.%26aulast%3DSchelle%26aufirst%3DR.%26aulast%3DNormann%26aufirst%3DS.%26aulast%3DKlaas%26aufirst%3DL.%26aulast%3DWaha%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DFimmers%26aufirst%3DR.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DYachnis%26aufirst%3DA.%2BT.%26aulast%3DPincus%26aufirst%3DD.%2BW.%26aulast%3DSteindler%26aufirst%3DD.%2BA.%26aulast%3DBrustle%26aufirst%3DO.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DGlas%26aufirst%3DM.%26aulast%3DScheffler%26aufirst%3DB.%26atitle%3DAnticancer%2520Effects%2520of%2520Niclosamide%2520in%2520Human%2520Glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4124%26epage%3D4136%26doi%3D10.1158%2F1078-0432.CCR-12-2895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsin, A.</span></span> <span> </span><span class="NLM_article-title">Niclosamide Induces Protein Ubiquitination and Inhibits Multiple Pro-Survival Signaling Pathways in the Human Glioblastoma U-87 MG Cell Line</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0184324</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0184324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pone.0184324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28877265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=B.+Chengauthor=L.+D.+Moralesauthor=Y.+Zhangauthor=S.+Mitoauthor=A.+Tsin&title=Niclosamide+Induces+Protein+Ubiquitination+and+Inhibits+Multiple+Pro-Survival+Signaling+Pathways+in+the+Human+Glioblastoma+U-87+MG+Cell+Line&doi=10.1371%2Fjournal.pone.0184324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line</span></div><div class="casAuthors">Cheng, Benxu; Morales, Liza Doreen; Zhang, Yonghong; Mito, Shizue; Tsin, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0184324/1-e0184324/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Glioblastoma is the most common and lethal malignant primary brain tumor for which the development of efficacious chemotherapeutic agents remains an urgent need.  The anti-helminthic drug niclosamide, which has long been in use to treat tapeworm infections, has recently attracted renewed interest due to its apparent anticancer effects in a variety of in vitro and in vivo cancer models.  However, the mechanism(s) of action remains to be elucidated.  In the present study, we found that niclosamide induced cell toxicity in human glioblastoma cells corresponding with increased protein ubiquitination, ER stress and autophagy.  In addn., niclosamide treatment led to down-regulation of Wnt/β-catenin, PI3K/AKT, MAPK/ERK, and STAT3 pro-survival signal transduction pathways to further reduce U-87 MG cell viability.  Taken together, these results provide new insights into the glioblastoma suppressive capabilities of niclosamide, showing that niclosamide can target multiple major cell signaling pathways simultaneously to effectively promote cell death in U- 87 MG cells.  Niclosamide constitutes a new prospect for a therapeutic treatment against human glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIGXP9I-LRrVg90H21EOLACvtfcHk0li5yjrpdnOZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gsbo%253D&md5=3ef37b4ad9f37c0c7fba4d8a48a640ed</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0184324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0184324%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DMorales%26aufirst%3DL.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMito%26aufirst%3DS.%26aulast%3DTsin%26aufirst%3DA.%26atitle%3DNiclosamide%2520Induces%2520Protein%2520Ubiquitination%2520and%2520Inhibits%2520Multiple%2520Pro-Survival%2520Signaling%2520Pathways%2520in%2520the%2520Human%2520Glioblastoma%2520U-87%2520MG%2520Cell%2520Line%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0184324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myrberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Design of a Tumor-Homing Cell-Penetrating Peptide</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1021/bc0701139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc0701139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSku77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=70-75&author=H.+Myrbergauthor=L.+Zhangauthor=M.+Maeauthor=U.+Langel&title=Design+of+a+Tumor-Homing+Cell-Penetrating+Peptide&doi=10.1021%2Fbc0701139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Tumor-Homing Cell-Penetrating Peptide</span></div><div class="casAuthors">Myrberg, Helena; Zhang, Lianglin; Maee, Maarja; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-75</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapy is often limited by toxicity to normal cells.  Therefore, an ideal anticancer drug should discriminate between normal tissue and tumors.  This would require a target receptor mol. mostly present in tumors.  The cyclic peptide cCPGPEGAGC (PEGA) is a homing peptide that has previously been shown to accumulate in breast tumor tissue in mice.  PEGA peptide does not cross the plasma membrane per se; however, when attached to the cell-penetrating peptide pVEC, the conjugate is taken up by different breast cancer cells in vitro.  Addnl., the homing capacity of the PEGA-pVEC is conserved in vivo, where the conjugate mainly accumulates in blood vessels in breast tumor tissue and, consequently is taken up.  Furthermore, the authors show that the efficacy of the anticancer drug, chlorambucil, is increased more than 4 times when the drug is conjugated to the PEGA-pVEC chimeric peptide.  These data demonstrate that combining a homing sequence with a cell-penetrating sequence yields a peptide that combines the desirable properties of the parent peptides.  Such peptides may be useful in diagnostics and delivery of therapeutic agents to an intracellular location in a specific tumor target tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHPDCxMIDgLVg90H21EOLACvtfcHk0li5yjrpdnOZdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSku77O&md5=05c03fbf4f62fb4060f94b210e1a49cc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc0701139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0701139%26sid%3Dliteratum%253Aachs%26aulast%3DMyrberg%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMae%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DDesign%2520of%2520a%2520Tumor-Homing%2520Cell-Penetrating%2520Peptide%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D70%26epage%3D75%26doi%3D10.1021%2Fbc0701139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Maltzhan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karst, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drapkin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span> <span> </span><span class="NLM_article-title">Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene Id4</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">147ra112</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1126%2Fscitranslmed.3003778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22896676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC38fosVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=147ra112&author=Y.+Renauthor=H.+W.+Cheungauthor=G.+von+Maltzhanauthor=A.+Agrawalauthor=G.+S.+Cowleyauthor=B.+A.+Weirauthor=J.+S.+Boehmauthor=P.+Tamayoauthor=A.+M.+Karstauthor=J.+F.+Liuauthor=M.+S.+Hirschauthor=J.+P.+Mesirovauthor=R.+Drapkinauthor=D.+E.+Rootauthor=J.+Loauthor=V.+Fogalauthor=E.+Ruoslahtiauthor=W.+C.+Hahnauthor=S.+N.+Bhatia&title=Targeted+Tumor-Penetrating+siRNA+Nanocomplexes+for+Credentialing+the+Ovarian+Cancer+Oncogene+Id4&doi=10.1126%2Fscitranslmed.3003778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4</span></div><div class="casAuthors">Ren Yin; Cheung Hiu Wing; von Maltzhan Geoffrey; Agrawal Amit; Cowley Glenn S; Weir Barbara A; Boehm Jesse S; Tamayo Pablo; Karst Alison M; Liu Joyce F; Hirsch Michelle S; Mesirov Jill P; Drapkin Ronny; Root David E; Lo Justin; Fogal Valentina; Ruoslahti Erkki; Hahn William C; Bhatia Sangeeta N</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">147</span>),
    <span class="NLM_cas:pages">147ra112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The comprehensive characterization of a large number of cancer genomes will eventually lead to a compendium of genetic alterations in specific cancers.  Unfortunately, the number and complexity of identified alterations complicate endeavors to identify biologically relevant mutations critical for tumor maintenance because many of these targets are not amenable to manipulation by small molecules or antibodies.  RNA interference provides a direct way to study putative cancer targets; however, specific delivery of therapeutics to the tumor parenchyma remains an intractable problem.  We describe a platform for the discovery and initial validation of cancer targets, composed of a systematic effort to identify amplified and essential genes in human cancer cell lines and tumors partnered with a novel modular delivery technology.  We developed a tumor-penetrating nanocomplex (TPN) that comprised small interfering RNA (siRNA) complexed with a tandem tumor-penetrating and membrane-translocating peptide, which enabled the specific delivery of siRNA deep into the tumor parenchyma.  We used TPN in vivo to evaluate inhibitor of DNA binding 4 (ID4) as a novel oncogene.  Treatment of ovarian tumor-bearing mice with ID4-specific TPN suppressed growth of established tumors and significantly improved survival.  These observations not only credential ID4 as an oncogene in 32% of high-grade ovarian cancers but also provide a framework for the identification, validation, and understanding of potential therapeutic cancer targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTi-ecnajvWRH6CEoQgWY10fW6udTcc2eY3CBGs3X8HJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fosVSqtg%253D%253D&md5=19dfb8991167ce0b5fe1ce899d1b985b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003778%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DH.%2BW.%26aulast%3Dvon%2BMaltzhan%26aufirst%3DG.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DKarst%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DFogal%26aufirst%3DV.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26atitle%3DTargeted%2520Tumor-Penetrating%2520siRNA%2520Nanocomplexes%2520for%2520Credentialing%2520the%2520Ovarian%2520Cancer%2520Oncogene%2520Id4%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D147ra112%26doi%3D10.1126%2Fscitranslmed.3003778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisp, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasgow, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellies, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R. Y.</span></span> <span> </span><span class="NLM_article-title">Dual Targeting of Integrin Alphavbeta3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-1067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1158%2F1535-7163.MCT-13-1067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24737028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Ojs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1514-1525&author=J.+L.+Crispauthor=E.+N.+Savariarauthor=H.+L.+Glasgowauthor=L.+G.+Elliesauthor=M.+A.+Whitneyauthor=R.+Y.+Tsien&title=Dual+Targeting+of+Integrin+Alphavbeta3+and+Matrix+Metalloproteinase-2+for+Optical+Imaging+of+Tumors+and+Chemotherapeutic+Delivery&doi=10.1158%2F1535-7163.MCT-13-1067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of Integrin αvβ3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery</span></div><div class="casAuthors">Crisp, Jessica L.; Savariar, Elamprakash N.; Glasgow, Heather L.; Ellies, Lesley G.; Whitney, Michael A.; Tsien, Roger Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1514-1525</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activatable cell-penetrating peptides (ACPP) provide a general strategy for mol. targeting by exploiting the extracellular protease activities assocd. with disease.  Previous work used a matrix metalloproteinase (MMP-2 and 9)-cleavable sequence in the ACPP to target contrast agents for tumor imaging and fluorescence-guided surgery.  To improve specificity and sensitivity for MMP-2, an integrin αvβ3-binding domain, cyclic-RGD, was covalently linked to the ACPP.  This co-targeting strategy relies on the interaction of MMP-2 with integrin αvβ3, which are known to assoc. via the hemopexin domain of MMP-2.  In U87MG glioblastoma cells in culture, dual targeting greatly improved ACPP uptake compared with either MMP or integrin αvβ3 targeting alone.  In vivo, dual-targeted ACPP treatment resulted in tumor contrast of 7.8 ± 1.6, a 10-fold higher tumor fluorescence compared with the neg. control peptide, and increased probe penetration into the core of MDA-MB-231 tumors.  This platform also significantly improved efficacy of the chemotherapeutic monomethylauristatin E (MMAE) in both MDA-MB-231 orthotopic human and syngeneic Py230 murine breast tumors.  Treatment with cyclic-RGD-PLGC(Me)AG-MMAE-ACPP resulted in complete tumor regression in one quarter of MDA-MB-231 tumor-bearing mice, compared with no survival in the control groups.  This rational mechanism for amplified delivery of imaging and potent chemotherapeutic agents avoids the use of antibodies and may be of considerable generality.  Mol Cancer Ther; 13(6); 1514-25. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2Qanxe_4V7Vg90H21EOLACvtfcHk0lj0tMlaukuTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Ojs7s%253D&md5=bc3b4e5c578ee1745e987b9e0d617575</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-1067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-1067%26sid%3Dliteratum%253Aachs%26aulast%3DCrisp%26aufirst%3DJ.%2BL.%26aulast%3DSavariar%26aufirst%3DE.%2BN.%26aulast%3DGlasgow%26aufirst%3DH.%2BL.%26aulast%3DEllies%26aufirst%3DL.%2BG.%26aulast%3DWhitney%26aufirst%3DM.%2BA.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26atitle%3DDual%2520Targeting%2520of%2520Integrin%2520Alphavbeta3%2520and%2520Matrix%2520Metalloproteinase-2%2520for%2520Optical%2520Imaging%2520of%2520Tumors%2520and%2520Chemotherapeutic%2520Delivery%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D1514%26epage%3D1525%26doi%3D10.1158%2F1535-7163.MCT-13-1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span> <span> </span><span class="NLM_article-title">Paclitaxel Loaded Liposomes Decorated with a Multifunctional Tandem Peptide for Glioma Targeting</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4835</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.02.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.biomaterials.2014.02.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24651033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2qtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=4835-4847&author=Y.+Liuauthor=R.+Ranauthor=J.+Chenauthor=Q.+Kuangauthor=J.+Tangauthor=L.+Meiauthor=Q.+Zhangauthor=H.+Gaoauthor=Z.+Zhangauthor=Q.+He&title=Paclitaxel+Loaded+Liposomes+Decorated+with+a+Multifunctional+Tandem+Peptide+for+Glioma+Targeting&doi=10.1016%2Fj.biomaterials.2014.02.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting</span></div><div class="casAuthors">Liu, Yayuan; Ran, Rui; Chen, Jiantao; Kuang, Qifang; Tang, Jie; Mei, Ling; Zhang, Qianyu; Gao, Huile; Zhang, Zhirong; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4835-4847</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The treatment of glioma is a great challenge because of the existence of the blood-brain barrier (BBB).  In order to reduce toxicity to the normal brain tissue and achieve efficient treatment, it is also important for drugs to specifically accumulate in the glioma foci and penetrate into the tumor core after entering into the brain.  In this study, a specific ligand cyclic RGD peptide was conjugated to a cell penetrating peptide R8 to develop a multifunctional peptide R8-RGD.  R8-RGD increased the cellular uptake of liposomes by 2-fold and nearly 30-fold compared to sep. R8 and RGD resp., and displayed effective penetration of three-dimensional glioma spheroids and BBB model in vitro.  In vivo studies showed that R8-RGD-lipo could be efficiently delivered into the brain and selectively accumulated in the glioma foci after systemic administration in C6 glioma bearing mice.  When paclitaxel (PTX) was loaded in liposomes, R8-RGD-lipo could induce the strongest inhibition and apoptosis against C6 cells and finally achieved the longest survival in intracranial C6 glioma bearing mice.  In conclusion, all the results indicated that the tandem peptide R8-RGD was a promising ligand possessing multi functions including BBB transporting, glioma targeting and tumor penetrating.  And R8-RGD-lipo was proved to be a potential anti-glioma drug delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO-NfIUqmT0rVg90H21EOLACvtfcHk0lj0tMlaukuTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2qtLo%253D&md5=d9a0215c7f77ab2c4f7012ba848b3686</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.02.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRan%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DPaclitaxel%2520Loaded%2520Liposomes%2520Decorated%2520with%2520a%2520Multifunctional%2520Tandem%2520Peptide%2520for%2520Glioma%2520Targeting%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D4835%26epage%3D4847%26doi%3D10.1016%2Fj.biomaterials.2014.02.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piarulli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neundorf, I.</span></span> <span> </span><span class="NLM_article-title">Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2011</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2lsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2011-2022&author=L.+Feniauthor=S.+Parenteauthor=C.+Robertauthor=S.+Gazzolaauthor=D.+Arosioauthor=U.+Piarulliauthor=I.+Neundorf&title=Kiss+and+Run%3A+Promoting+Effective+and+Targeted+Cellular+Uptake+of+a+Drug+Delivery+Vehicle+Composed+of+an+Integrin-Targeting+Diketopiperazine+Peptidomimetic+and+a+Cell-Penetrating+Peptide&doi=10.1021%2Facs.bioconjchem.9b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide</span></div><div class="casAuthors">Feni, Lucia; Parente, Sara; Robert, Clemence; Gazzola, Silvia; Arosio, Daniela; Piarulli, Umberto; Neundorf, Ines</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2011-2022</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) have emerged as powerful tools in terms of drug delivery.  Those short, often cationic peptides are characterized by their usually low toxicity and their ability to transport diverse cargos inside almost any kinds of cells.  Still, one major drawback is their nonselective uptake making their application in targeted cancer therapies questionable.  In this work, we aimed to combine the power of a CPP (sC18) with an integrin-targeting unit (c[DKP-f3-RGD]).  The latter is composed of the Arg-Gly-Asp peptide sequence cyclized via a diketopiperazine scaffold and is characterized by its high selectivity toward integrin αvβ3.  The two parts were linked via copper-catalyzed alkyne-azide click reaction (CuAAC), while the CPP was addnl. functionalized with either a fluorescent dye or the anticancer drug daunorubicin.  Both functionalities allowed a careful biol. evaluation of these novel peptide-conjugates regarding their cellular uptake mechanism, as well as cytotoxicity in αvβ3 integrin receptor expressing cells vs. cells that do not express αvβ3.  Our results show that the uptake follows a "kiss-and-run"-like model, in which the conjugates first target and recognize the receptor, but translocate mainly by CPP mediation.  Thereby, we obsd. significantly more pronounced toxic effects in αvβ3 expressing U87 cells compared to HT-29 and MCF-7 cells, when the cells were exposed to the substances with only very short contact times (15 min).  All in all, we present new concepts for the design of cancer selective peptide-drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52geONXxf1rVg90H21EOLACvtfcHk0lj0tMlaukuTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2lsLnL&md5=7fd7487362f162c12a84139697c35575</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00292%26sid%3Dliteratum%253Aachs%26aulast%3DFeni%26aufirst%3DL.%26aulast%3DParente%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DGazzola%26aufirst%3DS.%26aulast%3DArosio%26aufirst%3DD.%26aulast%3DPiarulli%26aufirst%3DU.%26aulast%3DNeundorf%26aufirst%3DI.%26atitle%3DKiss%2520and%2520Run%253A%2520Promoting%2520Effective%2520and%2520Targeted%2520Cellular%2520Uptake%2520of%2520a%2520Drug%2520Delivery%2520Vehicle%2520Composed%2520of%2520an%2520Integrin-Targeting%2520Diketopiperazine%2520Peptidomimetic%2520and%2520a%2520Cell-Penetrating%2520Peptide%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2011%26epage%3D2022%26doi%3D10.1021%2Facs.bioconjchem.9b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkwood, J. M.</span></span> <span> </span><span class="NLM_article-title">Temozolomide, a Novel Alkylating Agent with Activity in the Central Nervous System, May Improve the Treatment of Advanced Metastatic Melanoma</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.5-2-144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1634%2Ftheoncologist.5-2-144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10794805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Wmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=144-151&author=S.+S.+Agarwalaauthor=J.+M.+Kirkwood&title=Temozolomide%2C+a+Novel+Alkylating+Agent+with+Activity+in+the+Central+Nervous+System%2C+May+Improve+the+Treatment+of+Advanced+Metastatic+Melanoma&doi=10.1634%2Ftheoncologist.5-2-144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma</span></div><div class="casAuthors">Agarwala, Sanjiv S.; Kirkwood, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-151</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review with 46 refs.  Temozolomide (TMZ) is the first new chemotherapy agent to be approved for the treatment of high-grade malignant gliomas in more than 20 yr.  This novel oral alkylating agent has demonstrated promising activity not only in brain tumors, but in a variety of solid tumors, including malignant melanoma.  TMZ is 100% bioavailable when taken orally and, because of its small size and lipophilic properties, it is able to cross the blood-brain barrier.  Concns. in the central nervous system are approx. 30% of plasma concns.  Once it has entered the central nervous system, TMZ can be spontaneously converted to the active metabolite.  These pharmacol. properties make it an ideal agent for treating central nervous system malignancies.  In patients with advanced metastatic melanoma, brain metastases are a major cause of treatment failure.  In this setting, TMZ has been shown to be as effective as dacarbazine, with a similar safety profile.  More importantly, there is evidence to suggest that TMZ-treated patients have a lower incidence of central nervous system relapse compared with dacarbazine-treated patients.  Therefore, TMZ is actively being investigated for the treatment and prevention of brain metastases in melanoma patients.  TMZ may become an important part of treatment regimens for advanced metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxC74OlKZMBbVg90H21EOLACvtfcHk0liPWurHI1joEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Wmsr8%253D&md5=43ae5fb41b1efa83547a03072bb9eeee</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.5-2-144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.5-2-144%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwala%26aufirst%3DS.%2BS.%26aulast%3DKirkwood%26aufirst%3DJ.%2BM.%26atitle%3DTemozolomide%252C%2520a%2520Novel%2520Alkylating%2520Agent%2520with%2520Activity%2520in%2520the%2520Central%2520Nervous%2520System%252C%2520May%2520Improve%2520the%2520Treatment%2520of%2520Advanced%2520Metastatic%2520Melanoma%26jtitle%3DOncologist%26date%3D2000%26volume%3D5%26spage%3D144%26epage%3D151%26doi%3D10.1634%2Ftheoncologist.5-2-144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senoner, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Combating Highly Resistant Emerging Pathogen Mycobacterium Abscessus and Mycobacterium Tuberculosis with Novel Salicylanilide Esters and Carbamates</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejmech.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26210507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=692-704&author=Z.+Baranyaiauthor=M.+Kratkyauthor=J.+Vinsovaauthor=N.+Szaboauthor=Z.+Senonerauthor=K.+Horvatiauthor=J.+Stolarikovaauthor=S.+Davidauthor=S.+Bosze&title=Combating+Highly+Resistant+Emerging+Pathogen+Mycobacterium+Abscessus+and+Mycobacterium+Tuberculosis+with+Novel+Salicylanilide+Esters+and+Carbamates&doi=10.1016%2Fj.ejmech.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates</span></div><div class="casAuthors">Baranyai, Zsuzsa; Kratky, Martin; Vinsova, Jarmila; Szabo, Nora; Senoner, Zsuzsanna; Horvati, Kata; Stolarikova, Jirina; David, Sandor; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">692-704</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the Mycobacterium genus over one hundred species are already described and new ones are periodically reported.  Species that form colonies in a week are classified as rapid growers, those requiring longer periods (up to three months) are the mostly pathogenic slow growers.  More recently, new emerging species have been identified to lengthen the list, all rapid growers.  Of these, Mycobacterium abscessus is also an intracellular pathogen and it is the most chemotherapy-resistant rapid-growing mycobacterium.  In addn., the cases of multidrug-resistant Mycobacterium tuberculosis infection are also increasing.  Therefore there is an urgent need to find new active mols. against these threatening strains.  Based on previous results, a series of salicylanilides, salicylanilide 5-chloropyrazinoates and carbamates was designed, synthesized and characterized.  The compds. were evaluated for their in vitro activity on M. abscessus, susceptible M. tuberculosis H37Rv, multidrug-resistant (MDR) M. tuberculosis MDR A8, M. tuberculosis MDR 9449/2006 and on the extremely-resistant Praha 131 (XDR) strains.  All derivs. exhibited a significant activity with min. inhibitory concns. (MICs) in the low micromolar range.  Eight salicylanilide carbamates and two salicylanilide esters exhibited an excellent in vitro activity on M. abscessus with MICs from 0.2 to 2.1 μM, thus being more effective than ciprofloxacin and gentamicin.  This finding is potentially promising, particularly, as M. abscessus is a threateningly chemotherapy-resistant species.  M. tuberculosis H37Rv was inhibited with MICs from 0.2 μM, and eleven compds. have lower MICs than isoniazid.  Salicylanilide esters and carbamates were found that they were effective also on MDR and XDR M. tuberculosis strains with MICs ≥1.0 μM.  The in vitro cytotoxicity (IC50) was also detd. on human MonoMac-6 cells, and selectivity index (SI) of the compds. was established.  In general, salicylanilide derivs. substituted by halogens on both salicyl and aniline rings showed better activity, than 4-benzoylaniline derivs.  The ester or carbamate bond formation of parent salicylanilides mostly retained or improved antimycobacterial potency with moderate selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTzdur-j287Vg90H21EOLACvtfcHk0liPWurHI1joEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltbjL&md5=ee9a776f1ae6887528ea77e115f5f4c0</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVinsova%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DN.%26aulast%3DSenoner%26aufirst%3DZ.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DStolarikova%26aufirst%3DJ.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DCombating%2520Highly%2520Resistant%2520Emerging%2520Pathogen%2520Mycobacterium%2520Abscessus%2520and%2520Mycobacterium%2520Tuberculosis%2520with%2520Novel%2520Salicylanilide%2520Esters%2520and%2520Carbamates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D692%26epage%3D704%26doi%3D10.1016%2Fj.ejmech.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiura, Y.</span></span> <span> </span><span class="NLM_article-title">Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1021/bc015508l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc015508l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1005-1011&author=S.+Futakiauthor=W.+Ohashiauthor=T.+Suzukiauthor=M.+Niwaauthor=S.+Tanakaauthor=K.+Uedaauthor=H.+Harashimaauthor=Y.+Sugiura&title=Stearylated+Arginine-Rich+Peptides%3A+A+New+Class+of+Transfection+Systems&doi=10.1021%2Fbc015508l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems</span></div><div class="casAuthors">Futaki, Shiroh; Ohashi, Wakana; Suzuki, Tomoki; Niwa, Miki; Tanaka, Seigo; Ueda, Kunihiro; Harashima, Hideyoshi; Sugiura, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1005-1011</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Membrane-permeable arginine-rich peptides, such as HIV-1 Tat-(48-60), HIV-1 Rev-(34-50), and flock house virus (FHV) coat-(35-49), have been shown to possess the ability to transfect COS-7 cells with luciferase-coding plasmid as efficiently as polyarginine (MW 5000-15 000) and polylysine (MW 9800).  Not only these virus-derived cationic peptides but also oligoarginines of 4-16 residues were found to be able to transfect cells.  In the case of the Tat, FHV, and octaarginine peptides, N-terminal stearylation of the peptides increases the transfection efficiency by approx. 100 times to reach the same order of magnitude as that of LipofectAMINE, one of the most efficient com. available transfection agents. Also, a certain correlation was obsd. between the transfection efficiency of stearyl-(Arg)n peptides (stearyl-Rn: n = 4, 8, 12, 16) and the membrane permeability of the corresponding (Arg)n peptides (Rn).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_RsRM5TN0krVg90H21EOLACvtfcHk0liPWurHI1joEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVWmtrk%253D&md5=13da6d6a424ef70b2dc1495a20614c50</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbc015508l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc015508l%26sid%3Dliteratum%253Aachs%26aulast%3DFutaki%26aufirst%3DS.%26aulast%3DOhashi%26aufirst%3DW.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNiwa%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DHarashima%26aufirst%3DH.%26aulast%3DSugiura%26aufirst%3DY.%26atitle%3DStearylated%2520Arginine-Rich%2520Peptides%253A%2520A%2520New%2520Class%2520of%2520Transfection%2520Systems%26jtitle%3DBioconjugate%2520Chem.%26date%3D2001%26volume%3D12%26spage%3D1005%26epage%3D1011%26doi%3D10.1021%2Fbc015508l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andaloussi, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghloul, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guterstam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzumanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gait, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallbrink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Pepfect 14, a Novel Cell-Penetrating Peptide for Oligonucleotide Delivery in Solution and as Solid Formulation</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5298</span>, <span class="refDoi"> DOI: 10.1093/nar/gkr072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1093%2Fnar%2Fgkr072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=21345932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=5284-5298&author=K.+Ezzatauthor=S.+E.+Andaloussiauthor=E.+M.+Zaghloulauthor=T.+Lehtoauthor=S.+Lindbergauthor=P.+M.+Morenoauthor=J.+R.+Violaauthor=T.+Magdyauthor=R.+Abdoauthor=P.+Guterstamauthor=R.+Sillardauthor=S.+M.+Hammondauthor=M.+J.+Woodauthor=A.+A.+Arzumanovauthor=M.+J.+Gaitauthor=C.+I.+Smithauthor=M.+Hallbrinkauthor=U.+Langel&title=Pepfect+14%2C+a+Novel+Cell-Penetrating+Peptide+for+Oligonucleotide+Delivery+in+Solution+and+as+Solid+Formulation&doi=10.1093%2Fnar%2Fgkr072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span></div><div class="casAuthors">Ezzat, Kariem; El Andaloussi, Samir; Zaghloul, Eman M.; Lehto, Taavi; Lindberg, Staffan; Moreno, Pedro M. D.; Viola, Joana R.; Magdy, Tarek; Abdo, Rania; Guterstam, Peter; Sillard, Rannar; Hammond, Suzan M.; Wood, Matthew J. A.; Arzumanov, Andrey A.; Gait, Michael J.; Smith, C. I. Edvard; Haellbrink, Mattias; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5284-5298</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splicing.  Recently, several of these debilitating disorders have been shown to be amenable for splice-correcting oligonucleotides (SCOs) that modify splicing patterns and restore the phenotype in exptl. models.  However, translational approaches are required to transform SCOs into usable drug products.  In this study, we present a new cell-penetrating peptide, PepFect14 (PF14), which efficiently delivers SCOs to different cell models including HeLa pLuc705 and mdx mouse myotubes; a cell culture model of Duchenne's muscular dystrophy (DMD).  Non-covalent PF14-SCO nanocomplexes induce splice-correction at rates higher than the com. available lipid-based vector Lipofectamine 2000 (LF2000) and remain active in the presence of serum.  Furthermore, we demonstrate the feasibility of incorporating this delivery system into solid formulations that could be suitable for several therapeutic applications.  Solid dispersion technique is utilized and the formed solid formulations are as active as the freshly prepd. nanocomplexes in soln. even when stored at an elevated temps. for several weeks.  In contrast, LF2000 drastically loses activity after being subjected to same procedure.  This shows that using PF14 is a very promising translational approach for the delivery of SCOs in different pharmaceutical forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamzA5Sq7uFrVg90H21EOLACvtfcHk0lgNDhxtVdVyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D&md5=64e66305efb772c25386977d53802340</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr072%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DAndaloussi%26aufirst%3DS.%2BE.%26aulast%3DZaghloul%26aufirst%3DE.%2BM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DP.%2BM.%26aulast%3DViola%26aufirst%3DJ.%2BR.%26aulast%3DMagdy%26aufirst%3DT.%26aulast%3DAbdo%26aufirst%3DR.%26aulast%3DGuterstam%26aufirst%3DP.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DHammond%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DM.%2BJ.%26aulast%3DArzumanov%26aufirst%3DA.%2BA.%26aulast%3DGait%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26aulast%3DHallbrink%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPepfect%252014%252C%2520a%2520Novel%2520Cell-Penetrating%2520Peptide%2520for%2520Oligonucleotide%2520Delivery%2520in%2520Solution%2520and%2520as%2520Solid%2520Formulation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3D5284%26epage%3D5298%26doi%3D10.1093%2Fnar%2Fgkr072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnoller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribranska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Nanoencapsulation of Antitubercular Drug Isoniazid and Its Lipopeptide Conjugate</span>. <i>J. Dispersion Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1728</span>– <span class="NLM_lpage">1734</span>, <span class="refDoi"> DOI: 10.1080/01932691.2011.616128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1080%2F01932691.2011.616128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGlsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1728-1734&author=E.+Kissauthor=D.+Schnollerauthor=K.+Pribranskaauthor=K.+Hillauthor=C.+B.+Penzesauthor=K.+Horvatiauthor=S.+Bosze&title=Nanoencapsulation+of+Antitubercular+Drug+Isoniazid+and+Its+Lipopeptide+Conjugate&doi=10.1080%2F01932691.2011.616128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoencapsulation of Antitubercular Drug Isoniazid and Its Lipopeptide Conjugate</span></div><div class="casAuthors">Kiss, E.; Schnoeller, D.; Pribranska, K.; Hill, K.; Penzes, Cs. B.; Horvati, K.; Bosze, Sz.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dispersion Science and Technology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1728-1734</span>CODEN:
                <span class="NLM_cas:coden">JDTEDS</span>;
        ISSN:<span class="NLM_cas:issn">0193-2691</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Isoniazid (INH) is a first line drug for treatment of the widespread deadly disease caused by Mycobacterium tuberculosis.  Peptide conjugate of INH was designed and synthesized for targeted and receptor-mediated cellular uptake of INH.  Chem. compn., hydrophobicity (n-octanol/water partition coeff.), and membrane affinity (using a Langmuir lipid monolayer as a model system) of the conjugate were characterized.  Hydrophilicity of the drug was remarkably decreased by the conjugation which resulted in improved interaction with lipid layer and allowed its efficient encapsulation into polylactic/glycolic acid nanoparticles enhancing the bioavailability of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuAf4HLJNJhrVg90H21EOLACvtfcHk0lhLTkwkRIs4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGlsrjL&md5=85496fc2e16555789e7c906a2d365494</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1080%2F01932691.2011.616128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01932691.2011.616128%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DE.%26aulast%3DSchnoller%26aufirst%3DD.%26aulast%3DPribranska%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DK.%26aulast%3DPenzes%26aufirst%3DC.%2BB.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DNanoencapsulation%2520of%2520Antitubercular%2520Drug%2520Isoniazid%2520and%2520Its%2520Lipopeptide%2520Conjugate%26jtitle%3DJ.%2520Dispersion%2520Sci.%2520Technol.%26date%3D2011%26volume%3D32%26spage%3D1728%26epage%3D1734%26doi%3D10.1080%2F01932691.2011.616128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span> <span> </span><span class="NLM_article-title">Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3893</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1021/ja00119a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00119a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=3893-3899&author=J.+Shaoauthor=J.+P.+Tam&title=Unprotected+Peptides+as+Building+Blocks+for+the+Synthesis+of+Peptide+Dendrimers+with+Oxime%2C+Hydrazone%2C+and+Thiazolidine+Linkages&doi=10.1021%2Fja00119a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages</span></div><div class="casAuthors">Shao, Jun; Tam, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3893-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general approach for forming peptide dendrimers with oxime, hydrazone, and thiazolidine linkages was developed using unprotected peptides as building blocks and selective ligation between an aldehyde and a weak base.  To illustrate the generality of this approach, a branched lysine core matrix with an aldehyde was used to ligate four copies of unprotected peptides contg. a weak nucleophilic base such as aminooxy, hydrazide, or cysteine 1,2-aminothiol groups at their N-termini to form synthetic branched proteins.  Various parameters affecting the ligations were studied, and optimal conditions gave 12-27-fold rate increases and shortened the reaction time from 24-60 to 2-8 h.  Among the three reactions studied, ligation by thiazolidine appeared to be superior to ligation by oxime or hydrazone in reaction rate and product stability.  The purified dendrimeric products gave single peaks on reverse phase HPLC and size exclusion HPLC.  Their macromol. structures were also characterized by mass spectrometry and amino acid anal.  CD spectra of the dendrimers showed that they have an increased ordered helical structure.  Ligation reactions using a mutually reactive weak base and aldehyde pair should provide a useful approach for the synthesis of peptide dendrimers and artificial proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9c17gwrdT7Vg90H21EOLACvtfcHk0lhLTkwkRIs4yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVajtb8%253D&md5=6480b4f8c75ce105b1baff1bb3e65075</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja00119a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00119a001%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DJ.%2BP.%26atitle%3DUnprotected%2520Peptides%2520as%2520Building%2520Blocks%2520for%2520the%2520Synthesis%2520of%2520Peptide%2520Dendrimers%2520with%2520Oxime%252C%2520Hydrazone%252C%2520and%2520Thiazolidine%2520Linkages%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D3893%26epage%3D3899%26doi%3D10.1021%2Fja00119a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naqvi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finucane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagra, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishfaq, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosabowski, J.</span></span> <span> </span><span class="NLM_article-title">Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking In Vitro and In Vivo</span>. <i>Cancer Biother. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1089/cbr.2009.0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1089%2Fcbr.2009.0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=20187801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ktl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=89-95&author=S.+A.+Naqviauthor=T.+Matzowauthor=C.+Finucaneauthor=S.+A.+Nagraauthor=M.+M.+Ishfaqauthor=S.+J.+Matherauthor=J.+Sosabowski&title=Insertion+of+a+Lysosomal+Enzyme+Cleavage+Site+into+the+Sequence+of+a+Radiolabeled+Neuropeptide+Influences+Cell+Trafficking+In+Vitro+and+In+Vivo&doi=10.1089%2Fcbr.2009.0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo</span></div><div class="casAuthors">Naqvi Syed Ali Raza; Matzow Torkjel; Finucane Ciara; Nagra Saeed A; Ishfaq Malik M; Mather Stephen J; Sosabowski Jane</div><div class="citationInfo"><span class="NLM_cas:title">Cancer biotherapy & radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Radiolabeled neuropeptides are widely explored for targeting tumours for either imaging or radiotherapeutic purposes.  After binding to their receptors, these peptides are rapidly internalized into lysosomes, where they are degraded by proteolytic enzymes, such as cathepsins.  The aim of this study was to investigate the effect of the inclusion of specific cleavage sites for cathepsin B into the peptide sequence.  The cleavage site, GFLG, together with a series of dipeptides for pharmacokinetic modification of radiometabolites, were, therefore, inserted into a peptide that binds to the gastrin/CCK2 receptor.  The receptor binding of the peptides was explored in AR42J cells, rates of internalization, and externalization of the radionuclide were measured and the nature of the radiometabolites explored.  The effects of the modifications on biodistribution in tumor-bearing mice was explored by high-resolution single-photon emission computed tomography imaging.  Differences in rates of externalization from tumor cells in vitro and in the rates of washout from tumor and kidney in vivo were observed.  These results indicate that insertion of an enzymatic cleavage site, such as that for cathepsin B, into a neuropeptide appears to have an influence on the intracellular processing, which results in a change in the rate of egress of radioactivity from target and nontarget tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKTaXFsO12OJSWdIdmEou5fW6udTcc2eZMLj181sKWNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ktl2itw%253D%253D&md5=dfc6b613726ce09cc9b68291c5a60340</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2009.0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2009.0666%26sid%3Dliteratum%253Aachs%26aulast%3DNaqvi%26aufirst%3DS.%2BA.%26aulast%3DMatzow%26aufirst%3DT.%26aulast%3DFinucane%26aufirst%3DC.%26aulast%3DNagra%26aufirst%3DS.%2BA.%26aulast%3DIshfaq%26aufirst%3DM.%2BM.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DSosabowski%26aufirst%3DJ.%26atitle%3DInsertion%2520of%2520a%2520Lysosomal%2520Enzyme%2520Cleavage%2520Site%2520into%2520the%2520Sequence%2520of%2520a%2520Radiolabeled%2520Neuropeptide%2520Influences%2520Cell%2520Trafficking%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2010%26volume%3D25%26spage%3D89%26epage%3D95%26doi%3D10.1089%2Fcbr.2009.0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vrettos, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzakos, A. G.</span></span> <span> </span><span class="NLM_article-title">On the Design Principles of Peptide-Drug Conjugates for Targeted Drug Delivery to the Malignant Tumor Site</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">930</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.3762/bjoc.14.80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3762%2Fbjoc.14.80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29765474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOnsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=930-954&author=E.+I.+Vrettosauthor=G.+Mezoauthor=A.+G.+Tzakos&title=On+the+Design+Principles+of+Peptide-Drug+Conjugates+for+Targeted+Drug+Delivery+to+the+Malignant+Tumor+Site&doi=10.3762%2Fbjoc.14.80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site</span></div><div class="casAuthors">Vrettos, Eirinaios I.; Mezo, Gabor; Tzakos, Andreas G.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">930-954</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030.  To effectively combat the menace of cancer, a variety of strategies have been exploited.  Among them, the development of peptide-drug conjugates (PDCs) is considered as an inextricable part of this armamentarium and is continuously explored as a viable approach to target malignant tumors.  The general architecture of PDCs consists of three building blocks: the tumor-homing peptide, the cytotoxic agent and the biodegradable connecting linker.  The aim of the current review is to provide a spherical perspective on the basic principles governing PDCs, as also the methodol. to construct them.  We aim to offer basic and integral knowledge on the rational design towards the construction of PDCs through analyzing each building block, as also to highlight the overall progress of this rapidly growing field.  Therefore, we focus on several intriguing examples from the recent literature, including important PDCs that have progressed to phase III clin. trials.  Last, we address possible difficulties that may emerge during the synthesis of PDCs, as also report ways to overcome them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRxpOdZLKXfrVg90H21EOLACvtfcHk0lgkYOHQEeMfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOnsLvP&md5=595fce13e61b3e6f58a8ae6969e8b2c8</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.14.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.14.80%26sid%3Dliteratum%253Aachs%26aulast%3DVrettos%26aufirst%3DE.%2BI.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTzakos%26aufirst%3DA.%2BG.%26atitle%3DOn%2520the%2520Design%2520Principles%2520of%2520Peptide-Drug%2520Conjugates%2520for%2520Targeted%2520Drug%2520Delivery%2520to%2520the%2520Malignant%2520Tumor%2520Site%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D14%26spage%3D930%26epage%3D954%26doi%3D10.3762%2Fbjoc.14.80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. F.</span></span> <span> </span><span class="NLM_article-title">Antitumor Imidazotetrazines. 41. Conjugation of the Antitumor Agents Mitozolomide and Temozolomide to Peptides and Lexitropsins Bearing DNA Major and Minor Groove-Binding Structural Motifs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5458</span>– <span class="NLM_lpage">5470</span>, <span class="refDoi"> DOI: 10.1021/jm020936d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020936d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlyht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5458-5470&author=J.+Arrowsmithauthor=S.+A.+Jenningsauthor=A.+S.+Clarkauthor=M.+F.+Stevens&title=Antitumor+Imidazotetrazines.+41.+Conjugation+of+the+Antitumor+Agents+Mitozolomide+and+Temozolomide+to+Peptides+and+Lexitropsins+Bearing+DNA+Major+and+Minor+Groove-Binding+Structural+Motifs&doi=10.1021%2Fjm020936d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Imidazotetrazines. 41. Conjugation of the Antitumor Agents Mitozolomide and Temozolomide to Peptides and Lexitropsins Bearing DNA Major and Minor Groove-Binding Structural Motifs</span></div><div class="casAuthors">Arrowsmith, Jill; Jennings, Sharon A.; Clark, Alan S.; Stevens, Malcolm F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5458-5470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carboxylic acids derived from the amido groups of the antitumor agents mitozolomide and temozolomide have been conjugated to simple amino acids and peptides by carbodiimide coupling. Solid-state peptide synthesis has been applied to link the acids to DNA major groove-binding peptidic motifs known to adopt α-helical conformations.  Attachment of the acids to pyrrole and imidazole polyamidic lexitropsins gave a series of potential DNA minor groove-binding ligands.  In vitro biol. evaluation of a limited no. of these novel conjugates failed to demonstrate any enhanced growth-inhibitory activity compared to the unconjugated drugs; sites of alkylation at tracts of multiple guanines were also unaffected.  Attachment of addnl. residues at C-8 of the imidazotetrazines did not perturb the chem. of activation of the bicyclic nucleus, and biol. sequelae can be rationalized by invoking the liberation of a common, diffusible, reactive chem. intermediate, the methanediazonium ion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEh6WwILUpnbVg90H21EOLACvtfcHk0lgkYOHQEeMfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlyht74%253D&md5=078cdc0e831e5fe3878d177fc6d5f8e7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm020936d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020936d%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DS.%2BA.%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DStevens%26aufirst%3DM.%2BF.%26atitle%3DAntitumor%2520Imidazotetrazines.%252041.%2520Conjugation%2520of%2520the%2520Antitumor%2520Agents%2520Mitozolomide%2520and%2520Temozolomide%2520to%2520Peptides%2520and%2520Lexitropsins%2520Bearing%2520DNA%2520Major%2520and%2520Minor%2520Groove-Binding%2520Structural%2520Motifs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5458%26epage%3D5470%26doi%3D10.1021%2Fjm020936d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emrick, T.</span></span> <span> </span><span class="NLM_article-title">Versatile Synthesis of Polymer-Temozolomide Conjugates</span>. <i>ACS Macro Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/acsmacrolett.7b00007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmacrolett.7b00007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1agsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=215-218&author=M.+Skinnerauthor=S.+M.+Wardauthor=T.+Emrick&title=Versatile+Synthesis+of+Polymer-Temozolomide+Conjugates&doi=10.1021%2Facsmacrolett.7b00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Versatile Synthesis of Polymer-Temozolomide Conjugates</span></div><div class="casAuthors">Skinner, Matthew; Ward, Sarah M.; Emrick, Todd</div><div class="citationInfo"><span class="NLM_cas:title">ACS Macro Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">AMLCCD</span>;
        ISSN:<span class="NLM_cas:issn">2161-1653</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new and versatile synthesis was developed to produce polymer prodrugs composed of poly(2-methacryloyloxyethyl phosphorylcholine) (polyMPC) conjugated covalently to the glioblastoma drug Temozolomide (TMZ).  Through a controlled free radical copolymn. of a TMZ-substituted methacrylate and MPC, water-sol. polyMPC-TMZ conjugates were realized with TMZ loadings of >50 mol %.  After polymn., the structural fidelity of the pendent TMZ moieties was confirmed by NMR and UV-vis spectroscopy, while mol. wt. estn. by gel permeation chromatog. (GPC) confirmed the desired control over the polymn., with isolated polymer-TMZ conjugates exhibiting narrow mol. wt. distributions.  This synthetic design opens new possibilities for formulating numerous types of polymeric TMZ-based structures that are of interest for treating glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZFjd-Sd5RY7Vg90H21EOLACvtfcHk0lgkYOHQEeMfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1agsLk%253D&md5=b85a474a521c65cb2a8bc409d9a23b7b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facsmacrolett.7b00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmacrolett.7b00007%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DS.%2BM.%26aulast%3DEmrick%26aufirst%3DT.%26atitle%3DVersatile%2520Synthesis%2520of%2520Polymer-Temozolomide%2520Conjugates%26jtitle%3DACS%2520Macro%2520Lett.%26date%3D2017%26volume%3D6%26spage%3D215%26epage%3D218%26doi%3D10.1021%2Facsmacrolett.7b00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toniolo, C. F. F.</span>; <span class="NLM_string-name">Woody, R. W.</span></span> <span> </span><span class="NLM_article-title">Electronic Circular Dichroism of Peptides</span>. In  <i>Comprehensive Chiroptical Spectroscopy: Applications in Stereochemical Analysis of Synthetic Compounds, Natural Products, and Biomolecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berova, N.</span>, <span class="NLM_string-name">Polavarapu, P. L.</span>, <span class="NLM_string-name">Nakanishi, K.</span>, <span class="NLM_string-name">Woody, R. W.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_year">2012</span>; Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">544</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2F9781118120392.ch15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=499-544&author=C.+F.+F.+Toniolo&author=R.+W.+Woodyauthor=N.+Berova&author=P.+L.+Polavarapu&author=K.+Nakanishi&author=R.+W.+Woody&title=Comprehensive+Chiroptical+Spectroscopy%3A+Applications+in+Stereochemical+Analysis+of+Synthetic+Compounds%2C+Natural+Products%2C+and+Biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2F9781118120392.ch15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118120392.ch15%26sid%3Dliteratum%253Aachs%26aulast%3DToniolo%26aufirst%3DC.%2BF.%2BF.%26atitle%3DElectronic%2520Circular%2520Dichroism%2520of%2520Peptides%26btitle%3DComprehensive%2520Chiroptical%2520Spectroscopy%253A%2520Applications%2520in%2520Stereochemical%2520Analysis%2520of%2520Synthetic%2520Compounds%252C%2520Natural%2520Products%252C%2520and%2520Biomolecules%26aulast%3DBerova%26aufirst%3DN.%26pub%3DWiley%26date%3D2012%26volume%3D2%26spage%3D499%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woody, R. W.</span></span> <span> </span><span class="NLM_article-title">Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">8234</span>– <span class="NLM_lpage">8245</span>, <span class="refDoi"> DOI: 10.1021/ja901218m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja901218m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtleltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=8234-8245&author=R.+W.+Woody&title=Circular+Dichroism+Spectrum+of+Peptides+in+the+Poly%28Pro%29II+Conformation&doi=10.1021%2Fja901218m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation</span></div><div class="casAuthors">Woody, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8234-8245</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The poly(Pro)II (PII) conformation is increasingly recognized as an important element in peptide and protein conformation.  CD is one of the most useful methods for detecting and characterizing PII.  Although the std. exciton-based model for predicting peptide CD spectra works well for α-helixes and β-sheets, it fails to reproduce the PII CD spectrum because it does not account for mixing of the nπ* and ππ* transitions with transitions in the deep UV, which is significant for the PII conformation.  In this work, the exciton model is extended to include this mixing, using ab initio-derived bond polarizability tensors to calc. the contributions of the high-energy transitions.  The strong neg. 195-nm and weaker pos. 220-nm CD bands of PII are reproduced for (Ala)n conformers in the PII region of the Ramachandran map.  For the canonical PII conformation from fiber diffraction of poly(Pro)II (-77, +146), the results are poor, but conformations with less neg. φ (∼ -60°) and more pos. ψ (≥160°) give spectra showing the PII characteristics.  The CD of (Pro)n is not reproduced by the calcns., probably because variations in (φ,Ψ), ring puckering, and cis-trans isomerism are not included in the model The extended model also gives improved results for α-helical polypeptides, leading to increased amplitude for the 205-nm band and decreased amplitude for a neg. band predicted near 180 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFoF4RrL40KLVg90H21EOLACvtfcHk0lh9ZYAI1UC_Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtleltrs%253D&md5=8ff00394c461ee2a815ededda8168a06</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja901218m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja901218m%26sid%3Dliteratum%253Aachs%26aulast%3DWoody%26aufirst%3DR.%2BW.%26atitle%3DCircular%2520Dichroism%2520Spectrum%2520of%2520Peptides%2520in%2520the%2520Poly%2528Pro%2529II%2520Conformation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D8234%26epage%3D8245%26doi%3D10.1021%2Fja901218m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zsila, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uray, K.</span></span> <span> </span><span class="NLM_article-title">Tailoring Uptake Efficacy of HSV-1 gD Derived Carrier Peptides</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">721</span>, <span class="refDoi"> DOI: 10.3390/biom10050721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fbiom10050721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFChsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=721&author=S.+Boszeauthor=F.+Zsilaauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=Z.+Majerauthor=F.+Hudeczauthor=K.+Uray&title=Tailoring+Uptake+Efficacy+of+HSV-1+gD+Derived+Carrier+Peptides&doi=10.3390%2Fbiom10050721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Tailoring uptake efficacy of HSV-1 gD tailoring uptake efficacy of Hsv-1 GD derived carrier peptides</span></div><div class="casAuthors">Bosze, Szilvia; Zsila, Ferenc; Biri-Kovacs, Beata; Szeder, Balint; Majer, Zsuzsa; Hudecz, Ferenc; Uray, Katalin</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Regions of the Herpes simplex virus-1 (HSV-1) glycoprotein D (gD) were chosen to design carrier peptides based on the known tertiary structure of the virus entry receptor complexes.  These complexes consist of the following: HSV-1 gD-nectin-1 and HSV-1 gD-herpesvirus entry mediator (HVEM).  Three sets of peptides were synthesized with sequences covering the (i) N-terminal HVEM- and nectin-1 binding region -5-42, (ii) the 181-216 medium region contg. nectin-1 binding sequences and (iii) the C-terminal nectin-1 binding region 214-255.  The carrier candidates were prepd. with acetylated and 5(6)-carboxyfluorescein labeled N-termini.  The peptides were chem. characterised and their conformational features in soln. were also detd.  In vitro internalisation profile and intracellular localisation were evaluated on SH-SY5Y neuroblastoma cells.  Peptide originated from the C-terminal region 224-247 of the HSV-1 gD showed remarkable internalisation compared to the other peptides with low to moderate entry.  Electronic CD secondary structure studies of the peptides revealed that the most effectively internalised peptides exhibit high helical propensity at increasing TFE concns.  We proved that oligopeptides derived from the nectin-1 binding region are promising candidates-with possibility of Lys237Arg and/or Trp241Phe substitutions-for side-reaction free conjugation of bioactive compds.-drugs or gene therapy agents-as cargos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpFf4GZ9IzLVg90H21EOLACvtfcHk0lh9ZYAI1UC_Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFChsbrI&md5=18b7b467a6a4c6389fde07fda20fe931</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3390%2Fbiom10050721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10050721%26sid%3Dliteratum%253Aachs%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DZsila%26aufirst%3DF.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DMajer%26aufirst%3DZ.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DUray%26aufirst%3DK.%26atitle%3DTailoring%2520Uptake%2520Efficacy%2520of%2520HSV-1%2520gD%2520Derived%2520Carrier%2520Peptides%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26spage%3D721%26doi%3D10.3390%2Fbiom10050721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span> <span> </span><span class="NLM_article-title">About TFE: Old and New Findings</span>. <i>Curr. Protein Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.2174/1389203720666190214152439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2174%2F1389203720666190214152439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30767740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVGht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=425-451&author=M.+Vincenziauthor=F.+A.+Mercurioauthor=M.+Leone&title=About+TFE%3A+Old+and+New+Findings&doi=10.2174%2F1389203720666190214152439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">About TFE: Old and New Findings</span></div><div class="casAuthors">Vincenzi, Marian; Mercurio, Flavia A.; Leone, Marilisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-451</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The fluorinated alc. 2,2,2-Trifluoroethanol (TFE) has been implemented for many decades now in conformational studies of proteins and peptides.  In peptides, which are often disordered in aq. solns., TFE acts as secondary structure stabilizer and primarily induces an α -helical conformation.  The exact mechanism through which TFE plays its stabilizing roles is still debated and direct and indirect routes, relying either on straight interaction between TFE and mols. or indirect pathways based on perturbation of solvation sphere, have been proposed.  Another still unanswered question is the capacity of TFE to favor in peptides a bioactive or a native-like conformation rather than simply stimulate the raise of secondary structure elements that reflect only the inherent propensity of a specific amino-acid sequence.  In protein studies, TFE destroys unique protein tertiary structure and often leads to the formation of non-native secondary structure elements, but, interestingly, gives some hints about early folding intermediates.  In this review, we will summarize proposed mechanisms of TFE actions.  We will also describe several examples, in which TFE has been successfully used to reveal structural properties of different mol. systems, including antimicrobial and aggregation-prone peptides, as well as globular folded and intrinsically disordered proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTMk3S3Vx6LVg90H21EOLACvtfcHk0lh9ZYAI1UC_Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVGht7fI&md5=4ebf31c9bc3368a1c51d07586b69dfec</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F1389203720666190214152439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203720666190214152439%26sid%3Dliteratum%253Aachs%26aulast%3DVincenzi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DF.%2BA.%26aulast%3DLeone%26aufirst%3DM.%26atitle%3DAbout%2520TFE%253A%2520Old%2520and%2520New%2520Findings%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D425%26epage%3D451%26doi%3D10.2174%2F1389203720666190214152439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2</span>. <i>Probiotics Antimicrob. Proteins</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/s12602-017-9335-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs12602-017-9335-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29043494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=118-127&author=J.+Yanauthor=X.+Liangauthor=C.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=K.+Wangauthor=L.+Zhao&title=Influence+of+Proline+Substitution+on+the+Bioactivity+of+Mammalian-Derived+Antimicrobial+Peptide+NK-2&doi=10.1007%2Fs12602-017-9335-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2</span></div><div class="casAuthors">Yan, Jiexi; Liang, Xiaolei; Liu, Chang; Cheng, Yuemei; Zhou, Lanxia; Wang, Kairong; Zhao, Li</div><div class="citationInfo"><span class="NLM_cas:title">Probiotics and Antimicrobial Proteins</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-127</span>CODEN:
                <span class="NLM_cas:coden">PAPREP</span>;
        ISSN:<span class="NLM_cas:issn">1867-1306</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Multidrug-resistant bacteria are emerging as a global threat, making the search for alternative compds. urgent.  Antimicrobial peptides (AMPs) became a promising hotspot due to their distinct action mechanism and possibility to be used as an alternative or complement to traditional antibiotics.  However, gaining a better understanding about the relationship between antimicrobial peptides structure and its bioactivity is crucial for the development of next generation of antimicrobial agents.  NK-2, derived from mammalian protein NK-lysin, has potent antitumor and bactericidal abilities.  As proline was considered to be an effective α-helix breaker due to its restricted conformation, to better comprehend the effects of proline in the structure-activity relationship of NK-2, we constructed two NK-2 analogs.  We examd. the biol. activities of NK-2 and its proline substitution analogs and analyzed the resulting conformational changes.  Our results showed that introducing proline into the primary sequence of NK-2 significantly decreased the antitumor, antibacterial, and cytotoxic effects, as well as DNA binding activity by changing the α-helix content.  However, α-helical content was not the only detg. factor, the position of proline inserted was also crit.  This study will allow for clearer insight into the role of proline in structure and bioactivity of NK-2 and provide a foundation for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXX60Rzle7qLVg90H21EOLACvtfcHk0lj47PjqsgAYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsr3P&md5=494febc701ee5a918b7a91427c7725f3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs12602-017-9335-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12602-017-9335-1%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DInfluence%2520of%2520Proline%2520Substitution%2520on%2520the%2520Bioactivity%2520of%2520Mammalian-Derived%2520Antimicrobial%2520Peptide%2520NK-2%26jtitle%3DProbiotics%2520Antimicrob.%2520Proteins%26date%3D2018%26volume%3D10%26spage%3D118%26epage%3D127%26doi%3D10.1007%2Fs12602-017-9335-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitaku, S.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Secondary Structure Breakers in Soluble Proteins</span>. <i>Biophysics (Biophys. Soc. Jpn.)</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.2142/biophysics.1.55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2142%2Fbiophysics.1.55" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2lurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=55-65&author=K.+Imaiauthor=S.+Mitaku&title=Mechanisms+of+Secondary+Structure+Breakers+in+Soluble+Proteins&doi=10.2142%2Fbiophysics.1.55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of secondary structure breakers in soluble proteins</span></div><div class="casAuthors">Imai, Kenichiro; Mitaku, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Biophysics (Biophysical Society of Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">BBSJC3</span>;
        ISSN:<span class="NLM_cas:issn">1349-2942</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society of Japan</span>)
        </div><div class="casAbstract">The sequences of proteins contain various signals for structural stability and function.  Membrane proteins, for example, have clear signals for helical structure characterized by a cluster of hydrophobic residues sandwiched between clusters of amphiphilic residues.  However, the distinct physicochem. signals for secondary structures in sol. proteins remain unclear.  Therefore, despite a long history of investigation, the accuracy of secondary structure prediction is not sufficiently high.  In contrast, very clear signals for secondary structure breakpoints (breakers) have been established.  These signals include the presence of Pro residues, Gly residues, or clusters of a combination of Pro and Gly residues.  Pro residues are too rigid to be incorporated into a secondary structure, whereas Gly residues are so flexible that the local structure becomes unstable in a cluster.  Breaking signals of secondary structure put strong limitations on the tertiary structures of proteins.  Here, in addn. to Pro and Gly clusters, clusters of residues with amphiphilic side-chains which have both a polar group and a flexible hydrocarbon (e.g., Arg, Lys, His, Glu, and Gln residues) were found to be a novel type of secondary structure breaker.  These secondary structure breakers were found to depend on specific environmental factors.  Such conditions included the av. hydrophobicity, the helical periodicity, the d. of Ser and Thr residues, and the presence of Trp and Tyr clusters.  Principal component anal. of environmental factors was conducted in order to identify candidate breakers in the secondary structure breaking regions.  Predicted breakers were located in breaking regions with an accuracy of 72%.  Taking the loop core into consideration, almost 90% of the predicted breakers were located in the loop segments.  When the migration effect of the breaking point was taken into account, the loop segments with the predicted breakers covered 2/3 of all loop segments.  The possibility of secondary structure prediction based on secondary structure breakers was discussed.  By combining the effects of primary factors (Pro, Gly, and amphiphilic residues) and several environmental factors, a method was developed for accurately predicting secondary structure breakers.  The system of this method is available on the Internet at the URL: http://bp.nuap.nagoya-u.ac.jp/sosui/sosuibreaker/sosuibreaker_submit.html.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27FHdHa66O7Vg90H21EOLACvtfcHk0lj47PjqsgAYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2lurrL&md5=47a29e985cace9329e2aea0e723ac67d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.2142%2Fbiophysics.1.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2142%252Fbiophysics.1.55%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DK.%26aulast%3DMitaku%26aufirst%3DS.%26atitle%3DMechanisms%2520of%2520Secondary%2520Structure%2520Breakers%2520in%2520Soluble%2520Proteins%26jtitle%3DBiophysics%2520%2528Biophys.%2520Soc.%2520Jpn.%2529%26date%3D2005%26volume%3D1%26spage%3D55%26epage%3D65%26doi%3D10.2142%2Fbiophysics.1.55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mindell, J. A.</span></span> <span> </span><span class="NLM_article-title">Lysosomal Acidification Mechanisms</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-012110-142317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1146%2Fannurev-physiol-012110-142317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22335796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFynsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=69-86&author=J.+A.+Mindell&title=Lysosomal+Acidification+Mechanisms&doi=10.1146%2Fannurev-physiol-012110-142317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal acidification mechanisms</span></div><div class="casAuthors">Mindell, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-86</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysosomes, the terminal organelles on the endocytic pathway, digest macromols. and make their components available to the cell as nutrients.  Hydrolytic enzymes specific to a wide range of targets reside within the lysosome; these enzymes are activated by the highly acidic pH (between 4.5 and 5.0) in the organelles' interior.  Lysosomes generate and maintain their pH gradients by using the activity of a proton-pumping V-type ATPase, which uses metabolic energy in the form of ATP to pump protons into the lysosome lumen.  Because this activity separates elec. charge and generates a transmembrane voltage, another ion must move to dissipate this voltage for net pumping to occur.  This so-called counterion may be either a cation (moving out of the lysosome) or an anion (moving into the lysosome).  Recent data support the involvement of ClC-7, a Cl-/H+ antiporter, in this process, although many open questions remain as to this transporter's involvement.  Although functional results also point to a cation transporter, its mol. identity remains uncertain.  Both the V-ATPase and the counterion transporter are likely to be important players in the mechanisms detg. the steady-state pH of the lysosome interior.  Exciting new results suggest that lysosomal pH may be dynamically regulated in some cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhQ7yyHPp6nrVg90H21EOLACvtfcHk0lj47PjqsgAYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFynsbo%253D&md5=c9a157aa4b4c9c432ee4e26e4d3bdd13</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-012110-142317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-012110-142317%26sid%3Dliteratum%253Aachs%26aulast%3DMindell%26aufirst%3DJ.%2BA.%26atitle%3DLysosomal%2520Acidification%2520Mechanisms%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2012%26volume%3D74%26spage%3D69%26epage%3D86%26doi%3D10.1146%2Fannurev-physiol-012110-142317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansorge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M?ller, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manea, M.</span></span> <span> </span><span class="NLM_article-title">In Vitro Degradation and Antitumor Activity of Oxime Bond-Linked Daunorubicin-GnRH-III Bioconjugates and DNA-Binding Properties of Daunorubicin-Amino Acid Metabolites</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1007/s00726-010-0766-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs00726-010-0766-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=20953647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=469-483&author=E.+Orbanauthor=G.+Mezoauthor=P.+Schlageauthor=G.+Csikauthor=Z.+Kulicauthor=P.+Ansorgeauthor=E.+Fellingerauthor=H.+M.+M%3Fllerauthor=M.+Manea&title=In+Vitro+Degradation+and+Antitumor+Activity+of+Oxime+Bond-Linked+Daunorubicin-GnRH-III+Bioconjugates+and+DNA-Binding+Properties+of+Daunorubicin-Amino+Acid+Metabolites&doi=10.1007%2Fs00726-010-0766-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites</span></div><div class="casAuthors">Orban, Erika; Mezo, Gabor; Schlage, Pascal; Csik, Gabriella; Kulic, Zarko; Ansorge, Philipp; Fellinger, Erzsebet; Moeller, Heiko Michael; Manea, Marilena</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-483</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Bioconjugates with receptor-mediated tumor-targeting functions and carrying cytotoxic agents should enable the specific delivery of chemotherapeutics to malignant tissues, thus increasing their local efficacy while limiting the peripheral toxicity.  In the present study, gonadotropin-releasing hormone III (GnRH-III; Glp-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2) was employed as a targeting moiety to which daunorubicin was attached via oxime bond, either directly or by insertion of a GFLG or YRRL tetrapeptide spacer.  The in vitro antitumor activity of the bioconjugates was detd. on MCF-7 human breast and HT-29 human colon cancer cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.  Their degrdn./stability (1) in human serum, (2) in the presence of cathepsin B and (3) in rat liver lysosomal homogenate was analyzed by liq. chromatog. in combination with mass spectrometry.  The results show that (1) all synthesized bioconjugates have in vitro antitumor effect, (2) they are stable in human serum at least for 24 h, except for the compd. contg. an YRRL spacer and (3) they are hydrolyzed by cathepsin B and in the lysosomal homogenate.  To investigate the relationship between the in vitro antitumor activity and the structure of the bioconjugates, the smallest metabolites produced in the lysosomal homogenate were synthesized and their binding to DNA was assessed by fluorescence spectroscopy.  Our data indicate that the incorporation of a peptide spacer in the structure of oxime bond-linked daunorubicin-GnRH-III bioconjugates is not required for their antitumor activity.  Moreover, the antitumor activity is influenced by the structure of the metabolites (daunorubicin-amino acid derivs.) and their DNA-binding properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1eA6n7rBhLVg90H21EOLACvtfcHk0lj47PjqsgAYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsb4%253D&md5=0b6f89a0f7f9a916ea0f9de7e377f99f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs00726-010-0766-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-010-0766-1%26sid%3Dliteratum%253Aachs%26aulast%3DOrban%26aufirst%3DE.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DSchlage%26aufirst%3DP.%26aulast%3DCsik%26aufirst%3DG.%26aulast%3DKulic%26aufirst%3DZ.%26aulast%3DAnsorge%26aufirst%3DP.%26aulast%3DFellinger%26aufirst%3DE.%26aulast%3DM%253Fller%26aufirst%3DH.%2BM.%26aulast%3DManea%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Degradation%2520and%2520Antitumor%2520Activity%2520of%2520Oxime%2520Bond-Linked%2520Daunorubicin-GnRH-III%2520Bioconjugates%2520and%2520DNA-Binding%2520Properties%2520of%2520Daunorubicin-Amino%2520Acid%2520Metabolites%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D41%26spage%3D469%26epage%3D483%26doi%3D10.1007%2Fs00726-010-0766-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyzos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, L. M.</span></span> <span> </span><span class="NLM_article-title">Tumorigenicity and Metastasis of Human Breast Carcinoma Cell Lines in Nude Mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=2297709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADyaK3c7isVansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=717-721&author=J.+E.+Priceauthor=A.+Polyzosauthor=R.+D.+Zhangauthor=L.+M.+Daniels&title=Tumorigenicity+and+Metastasis+of+Human+Breast+Carcinoma+Cell+Lines+in+Nude+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice</span></div><div class="casAuthors">Price J E; Polyzos A; Zhang R D; Daniels L M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-21</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">There are few reports describing experimental models of the growth and metastasis of human breast carcinomas.  This article discusses the tumorigenic and metastatic properties of two estrogen receptor-negative breast carcinomas injected into nude mice.  Tumor growth in the mammary fatpad (m.f.p.) and the subcutis was compared in female nude mice.  The injection of 10(5) viable cells of two human breast carcinoma cell lines (MDA-MB-231 and MDA-MB-435) gave a 100% tumor take rate in the m.f.p., whereas only 40% of the s.c. injections produced tumors and these occurred several weeks after the appearance of the m.f.p. tumors.  Thus, the m.f.p. of nude mice is a favorable site for the growth of human breast carcinomas.  MDA-MB-435 tumors produced distant metastases in 80% to 100% of recipients.  The most common sites for metastasis were the lymph nodes and lungs, with a lower incidence of metastases in muscle (chest wall and thigh), heart, and brain.  New variant cell lines were isolated from metastases in the lungs, brain, and heart.  All the cell lines were tumorigenic in the m.f.p., and the lung- and heart-derived metastasis lines produced slightly more lung metastases than the original cell line.  However, the brain metastasis variant produced significantly fewer lung metastases.  Intravenous inoculation of the spontaneous metastasis-derived cell lines produced few lung colonies.  Only cell variants isolated from experimental lung metastases showed enhanced lung colonization potential when reinjected i.v.  Our results suggest that the estrogen receptor-negative MDA-MB-435 cell line injected in the m.f.p. of nude mice could be a valuable tool for analysis of the cellular and molecular basis of the metastasis of advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCYThNdIE9DEH3Rlp_k91zfW6udTcc2eYjLVcj52aNr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7isVansA%253D%253D&md5=7e2d4690d050a7d5fcbf5114220dca42</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DJ.%2BE.%26aulast%3DPolyzos%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%2BD.%26aulast%3DDaniels%26aufirst%3DL.%2BM.%26atitle%3DTumorigenicity%2520and%2520Metastasis%2520of%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Lines%2520in%2520Nude%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D717%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cailleau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciger, Q. V.</span></span> <span> </span><span class="NLM_article-title">Long-Term Human Breast Carcinoma Cell Lines of Metastatic Origin: Preliminary Characterization</span>. <i>In Vitro</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1007/BF02616120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2FBF02616120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=730202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADyaE1M%252FoslCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1978&pages=911-915&author=R.+Cailleauauthor=M.+Oliveauthor=Q.+V.+Cruciger&title=Long-Term+Human+Breast+Carcinoma+Cell+Lines+of+Metastatic+Origin%3A+Preliminary+Characterization&doi=10.1007%2FBF02616120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization</span></div><div class="casAuthors">Cailleau R; Olive M; Cruciger Q V</div><div class="citationInfo"><span class="NLM_cas:title">In vitro</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-5</span>
        ISSN:<span class="NLM_cas:issn">0073-5655</span>.
    </div><div class="casAbstract">Nineteen human breast carcinoma cell lines have been established as continuous cultures during the past 6 years in our laboratory.  This preliminary report is designed to list the lines by their designated code numbers (MDA-MB) and present a brief summary of their morphological, cytogenetic and biochemical characteristics.  Sixteen of our lines were obtained from pleural effusions, two from brain metastases, and one from pericardial fluid.  All lines have been shown to be distinct entities and are uncontaminated by HeLa cells or each other.  A lq marker chromosome is present in all but one of the lines examined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwc_MDwhbdp5agfuraLLzSfW6udTcc2eYjLVcj52aNr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FoslCqtQ%253D%253D&md5=f7f96fa1a76a2728e60c1c369157d9ba</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2FBF02616120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02616120%26sid%3Dliteratum%253Aachs%26aulast%3DCailleau%26aufirst%3DR.%26aulast%3DOlive%26aufirst%3DM.%26aulast%3DCruciger%26aufirst%3DQ.%2BV.%26atitle%3DLong-Term%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Lines%2520of%2520Metastatic%2520Origin%253A%2520Preliminary%2520Characterization%26jtitle%3DIn%2520Vitro%26date%3D1978%26volume%3D14%26spage%3D911%26epage%3D915%26doi%3D10.1007%2FBF02616120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirks, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faries, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varella-Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nims, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capes-Davis, A.</span></span> <span> </span><span class="NLM_article-title">Authentication of M14 Melanoma Cell Line Proves Misidentification of MDA-MB-435 Breast Cancer Cell Line</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1002/ijc.31067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fijc.31067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28940260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1alsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2018&pages=561-572&author=C.+Korchauthor=E.+M.+Hallauthor=W.+G.+Dirksauthor=M.+Ewingauthor=M.+Fariesauthor=M.+Varella-Garciaauthor=S.+Robinsonauthor=D.+Stortsauthor=J.+A.+Turnerauthor=Y.+Wangauthor=E.+C.+Burnettauthor=L.+Healyauthor=D.+Knissauthor=R.+M.+Neveauthor=R.+W.+Nimsauthor=Y.+A.+Reidauthor=W.+A.+Robinsonauthor=A.+Capes-Davis&title=Authentication+of+M14+Melanoma+Cell+Line+Proves+Misidentification+of+MDA-MB-435+Breast+Cancer+Cell+Line&doi=10.1002%2Fijc.31067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line</span></div><div class="casAuthors">Korch, Christopher; Hall, Erin M.; Dirks, Wilhelm G.; Ewing, Margaret; Faries, Mark; Varella-Garcia, Marileila; Robinson, Steven; Storts, Douglas; Turner, Jacqueline A.; Wang, Ying; Burnett, Edward C.; Healy, Lyn; Kniss, Douglas; Neve, Richard M.; Nims, Raymond W.; Reid, Yvonne A.; Robinson, William A.; Capes-Davis, Amanda</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A variety of anal. approaches have indicated that melanoma cell line UCLA-SO-M14 (M14) and breast carcinoma cell line MDA-MB-435 originate from a common donor.  This indicates that at some point in the past, one of these cell lines became misidentified, meaning that it ceased to correspond to the reported donor and instead became falsely identified (through cross-contamination or other means) as a cell line from a different donor.  Initial studies concluded that MDA-MB-435 was the misidentified cell line and M14 was the authentic cell line, although contradictory evidence has been published, resulting in further confusion.  To address this question, we obtained early samples of the melanoma cell line (M14), a lymphoblastoid cell line from the same donor (ML14), and donor serum preserved at the originator's institution.  M14 samples were cryopreserved in Dec. 1975, before MDA-MB-435 cells were established in culture.  Through a series of mol. characterizations, including short tandem repeat (STR) profiling and cytogenetic anal., we demonstrated that later samples of M14 and MDA-MB-435 correspond to samples of M14 frozen in 1975, to the lymphoblastoid cell line ML14, and to the melanoma donor's STR profile, sex and blood type.  This work demonstrates conclusively that M14 is the authentic cell line and MDA-MB-435 is misidentified.  With clear provenance information and authentication testing of early samples, it is possible to resolve debates regarding the origins of problematic cell lines that are widely used in cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbh0oUjT06OLVg90H21EOLACvtfcHk0lhfcZUWHcF5Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1alsLzL&md5=e2b359c4465cc1cb89cc694d0f17f800</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fijc.31067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31067%26sid%3Dliteratum%253Aachs%26aulast%3DKorch%26aufirst%3DC.%26aulast%3DHall%26aufirst%3DE.%2BM.%26aulast%3DDirks%26aufirst%3DW.%2BG.%26aulast%3DEwing%26aufirst%3DM.%26aulast%3DFaries%26aufirst%3DM.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DStorts%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBurnett%26aufirst%3DE.%2BC.%26aulast%3DHealy%26aufirst%3DL.%26aulast%3DKniss%26aufirst%3DD.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DNims%26aufirst%3DR.%2BW.%26aulast%3DReid%26aufirst%3DY.%2BA.%26aulast%3DRobinson%26aufirst%3DW.%2BA.%26aulast%3DCapes-Davis%26aufirst%3DA.%26atitle%3DAuthentication%2520of%2520M14%2520Melanoma%2520Cell%2520Line%2520Proves%2520Misidentification%2520of%2520MDA-MB-435%2520Breast%2520Cancer%2520Cell%2520Line%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2018%26volume%3D142%26spage%3D561%26epage%3D572%26doi%3D10.1002%2Fijc.31067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapuvari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span> <span> </span><span class="NLM_article-title">Improved in Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4763</span>, <span class="refDoi"> DOI: 10.3390/ijms20194763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms20194763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVWgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=4763&author=I.+Randelovicauthor=S.+Schusterauthor=B.+Kapuvariauthor=G.+Fossatiauthor=C.+Steinkuhlerauthor=G.+Mezoauthor=J.+Tovari&title=Improved+in+Vivo+Anti-Tumor+and+Anti-Metastatic+Effect+of+GnRH-III-Daunorubicin+Analogs+on+Colorectal+and+Breast+Carcinoma+Bearing+Mice&doi=10.3390%2Fijms20194763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Improved in vivo anti-tumor and anti-metastatic effect of GnRH-III-daunorubicin analogs on colorectal and breast carcinoma bearing mice</span></div><div class="casAuthors">Randelovic, Ivan; Schuster, Sabine; Kapuvari, Bence; Fossati, Gianluca; Steinkuhler, Christian; Mezo, Gabor; Tovari, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4763</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Among various homing devices, gonadotropin-releasing hormone-III (GnRH-III) peptide represents a suitable targeting moiety for drug delivery systems.  The anti-tumor activity of the previously developed GnRH-III-[4Lys(Bu),8Lys(Dau = Aoa)] conjugate and the novel synthesized GnRH-III-[2ΔHis,3d-Tic,4Lys(Bu),8Lys(Dau = Aoa)] conjugate, contg. the anti-cancer drug daunorubicin, were evaluated.  Here, we demonstrate that both GnRH-III-Dau conjugates possess an efficient growth inhibitory effect on more than 20 cancer cell lines, whereby the biol. activity is strongly connected to the expression of gonadotropin-releasing hormone receptors (GnRH-R).  The novel conjugate showed a higher in vitro anti-proliferative activity and a higher uptake capacity.  Moreover, the treatment with GnRH-III-Dau conjugates cause a significant in vivo tumor growth and metastases inhibitory effect in three different orthotopic models, including 4T1 mice and MDA-MB-231 human breast carcinoma, as well as HT-29 human colorectal cancer bearing BALB/s and SCID mice, while toxic side-effects were substantially reduced in comparison to the treatment with the free drug.  These findings illustrate that our novel lead compd. is a highly promising candidate for targeted tumor therapy in both colon cancer and metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2QyO2YJrgdbVg90H21EOLACvtfcHk0lg9rtrD0QNYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVWgs74%253D&md5=068322b233f70d77d0ac12ded68b4e63</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fijms20194763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20194763%26sid%3Dliteratum%253Aachs%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DKapuvari%26aufirst%3DB.%26aulast%3DFossati%26aufirst%3DG.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTovari%26aufirst%3DJ.%26atitle%3DImproved%2520in%2520Vivo%2520Anti-Tumor%2520and%2520Anti-Metastatic%2520Effect%2520of%2520GnRH-III-Daunorubicin%2520Analogs%2520on%2520Colorectal%2520and%2520Breast%2520Carcinoma%2520Bearing%2520Mice%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D4763%26doi%3D10.3390%2Fijms20194763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripodi, A. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span> <span> </span><span class="NLM_article-title">In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1879</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1007/s12253-019-00773-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs12253-019-00773-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31820302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCjs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1879-1892&author=A.+A.+P.+Tripodiauthor=I.+Randelovicauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=G.+Mezoauthor=J.+Tovari&title=In+Vivo+Tumor+Growth+Inhibition+and+Antiangiogenic+Effect+of+Cyclic+NGR+Peptide-Daunorubicin+Conjugates+Developed+for+Targeted+Drug+Delivery&doi=10.1007%2Fs12253-019-00773-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery</span></div><div class="casAuthors">Tripodi, Andrea Angelo Pierluigi; Randjelovic, Ivan; Biri-Kovacs, Beata; Szeder, Balint; Mezo, Gabor; Tovari, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1879-1892</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Among various homing devices, peptides contg. the NGR tripeptide sequence represent a promising approach to selectively recognize CD13 receptor isoforms on the surface of tumor cells.  They have been successfully used for the delivery of various chemotherapeutic drugs to tumor vessels.  Here, we report on the murine plasma stability, in vitro and in vivo antitumor activity of our recently described bioconjugates contg. daunorubicin as payload.  Furthermore, CD13 expression of KS Kaposi's Sarcoma cell line and HT-29 human colon carcinoma cell line was investigated.  Flow cytometry studies confirm the fast cellular uptake resulting in the rapid delivery of the active metabolite Dau = Aoa-Gly-OH to tumor cells.  The increased in vitro antitumor effect might be explained by the faster rearrangement from NGR to isoDGR in case of conjugate 2 (Dau = Aoa-GFLGK(c[NleNGRE]-GG)-NH2) in comparison with conjugate 1 (Dau = Aoa-GFLGK(c[KNGRE]-GG)-NH2).  Nevertheless, results indicated that both conjugates showed significant effect on inhibition of proliferation in the primary tumor and also on blood vessel formation making them a potential candidate for targeting angiogenesis processes in tumors where CD13 and integrins are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuuR3Awl8OLVg90H21EOLACvtfcHk0lg9rtrD0QNYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCjs7zE&md5=9587fd214003a7c590147b47ad499c1d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs12253-019-00773-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-019-00773-3%26sid%3Dliteratum%253Aachs%26aulast%3DTripodi%26aufirst%3DA.%2BA.%2BP.%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTovari%26aufirst%3DJ.%26atitle%3DIn%2520Vivo%2520Tumor%2520Growth%2520Inhibition%2520and%2520Antiangiogenic%2520Effect%2520of%2520Cyclic%2520NGR%2520Peptide-Daunorubicin%2520Conjugates%2520Developed%2520for%2520Targeted%2520Drug%2520Delivery%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2020%26volume%3D26%26spage%3D1879%26epage%3D1892%26doi%3D10.1007%2Fs12253-019-00773-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dokus, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to Panc-1 Pancreatic Cancer</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">576</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics12060576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fpharmaceutics12060576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFGnsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=576&author=L.+E.+Dokusauthor=E.+Lajkoauthor=I.+Randelovicauthor=D.+Mezoauthor=G.+Schlosserauthor=L.+Kohidaiauthor=J.+Tovariauthor=G.+Mezo&title=Phage+Display-Based+Homing+Peptide-Daunomycin+Conjugates+for+Selective+Drug+Targeting+to+Panc-1+Pancreatic+Cancer&doi=10.3390%2Fpharmaceutics12060576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to PANC-1 pancreatic cancer</span></div><div class="casAuthors">Dokus, Levente E.; Lajko, Eszter; Randelovic, Ivan; Mezo, Diana; Schlosser, Gitta; Kohidai, Laszlo; Tovari, Jozsef; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and dangerous cancerous diseases, leading to a high rate of mortality.  Therefore, the development of new, more efficient treatment approaches is necessary to cure this illness.  Peptide-based drug targeting provides a new tool for this purpose.  Previously, a hexapeptide Cys-Lys-Ala-Ala-Lys-Asn (CKAAKN) was applied efficiently as the homing device for drug-loaded nanostructures in PDAC cells.  In this research, Cys was replaced by Ser in the sequence and this new SKAAKN targeting moiety was used in conjugates contg. daunomycin (Dau).  Five different structures were developed and tested.  The results indicated that linear versions with one Dau were not effective on PANC-1 cells in vitro; however, branched conjugates with two Dau mols. showed significant antitumor activity.  Differences in the antitumor effect of the conjugates could be explained with the different cellular uptake and lysosomal degrdn.  The most efficient conjugate was Dau=Aoa-GFLG-K(Dau=Aoa)SKAAKN-OH (conjugate 4) that also showed significant tumor growth inhibition on s.c. implanted PANC-1 tumor-bearing mice with negligible side effects.  Our novel results suggest that peptide-based drug delivery systems could be a promising tool for the treatment of pancreatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHefZ-MzGahLVg90H21EOLACvtfcHk0lg9rtrD0QNYWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFGnsbzP&md5=bb8a2a924ee2244cc4e62d8e3d5b6e55</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics12060576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics12060576%26sid%3Dliteratum%253Aachs%26aulast%3DDokus%26aufirst%3DL.%2BE.%26aulast%3DLajko%26aufirst%3DE.%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DMezo%26aufirst%3DD.%26aulast%3DSchlosser%26aufirst%3DG.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DTovari%26aufirst%3DJ.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DPhage%2520Display-Based%2520Homing%2520Peptide-Daunomycin%2520Conjugates%2520for%2520Selective%2520Drug%2520Targeting%2520to%2520Panc-1%2520Pancreatic%2520Cancer%26jtitle%3DPharmaceutics%26date%3D2020%26volume%3D12%26spage%3D576%26doi%3D10.3390%2Fpharmaceutics12060576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, J.</span></span> <span> </span><span class="NLM_article-title">Sensors and Regulators of Intracellular Ph</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1038/nrm2820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fnrm2820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19997129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=50-61&author=J.+R.+Caseyauthor=S.+Grinsteinauthor=J.+Orlowski&title=Sensors+and+Regulators+of+Intracellular+Ph&doi=10.1038%2Fnrm2820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Sensors and regulators of intracellular pH</span></div><div class="casAuthors">Casey, Joseph R.; Grinstein, Sergio; Orlowski, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-61</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protons dictate the charge and structure of macromols. and are used as energy currency by eukaryotic cells.  The unique function of individual organelles therefore depends on the establishment and stringent maintenance of a distinct pH.  This, in turn, requires a means to sense the prevailing pH and to respond to deviations from the norm with effective mechanisms to transport, produce, or consume proton equiv.  A dynamic, finely tuned balance between proton-extruding and proton-importing processes underlies pH homeostasis not only in the cytosol, but in other cellular compartments as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0tc-Hhm3bxLVg90H21EOLACvtfcHk0lifxwewU0tPgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqtL3K&md5=e2812e3d37793d358456b4f3e0ee3f8c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnrm2820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2820%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%26aufirst%3DJ.%2BR.%26aulast%3DGrinstein%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DJ.%26atitle%3DSensors%2520and%2520Regulators%2520of%2520Intracellular%2520Ph%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D50%26epage%3D61%26doi%3D10.1038%2Fnrm2820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adorjan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship of HER2 Receptor Targeting Peptide and Its Derivatives in Targeted Tumor Therapy</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">183</span>, <span class="refDoi"> DOI: 10.3390/biom10020183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fbiom10020183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslCjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=183&author=B.+Biri-Kovacsauthor=A.+Adorjanauthor=I.+Szaboauthor=B.+Szederauthor=S.+Boszeauthor=G.+Mezo&title=Structure-Activity+Relationship+of+HER2+Receptor+Targeting+Peptide+and+Its+Derivatives+in+Targeted+Tumor+Therapy&doi=10.3390%2Fbiom10020183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of HER2 receptor targeting peptide and its derivatives in targeted tumor therapy</span></div><div class="casAuthors">Biri-Kovacs, Beata; Adorjan, Afrodite; Szabo, Ildiko; Szeder, Balint; Bosze, Szilvia; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Human epidermal growth factor (HER2) is a transmembrane tyrosine kinase receptor that is frequently overexpressed in breast cancer.  Its increased level prognoses a poor patient outcome and a high mortality rate.  Despite the widening spectrum of therapies that are becoming available to treat HER2+ breast cancer, its side effects and resistance still make this protein a valuable object of research in targeted tumor therapy.  The role of tumor-targeting peptides has become more and more prominent in the last few decades due to their simple synthesis and pharmakokinetic properties.  Here, we examine two fluorescently-labeled HER2-specific peptides and their combined analogs that are developed to target the extracellular region of HER2.  The peptides are investigated on breast cancer cell lines with different HER2 expression profiles.  Moreover, their extracellular localization and specificity are confirmed by flow cytometry and confocal microscopy.  Therefore, a new, combined HER2 binding conjugate is obtained that interacts with HER2-overexpressing cells with high affinity and specificity.  Furthermore, secondary structure prediction reveals that the a-helical content of the peptides is assocd. with their receptor recognition.  This highly specific conjugate can be used as a starting point for diagnostical or drug-targeting purposes in upcoming studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Rnc3wzfxF7Vg90H21EOLACvtfcHk0lifxwewU0tPgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslCjurc%253D&md5=49813039f8199847316480ac4abb74d0</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3390%2Fbiom10020183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10020183%26sid%3Dliteratum%253Aachs%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DAdorjan%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DI.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520HER2%2520Receptor%2520Targeting%2520Peptide%2520and%2520Its%2520Derivatives%2520in%2520Targeted%2520Tumor%2520Therapy%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26spage%3D183%26doi%3D10.3390%2Fbiom10020183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joliot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallerla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagan, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative Fluorescence Spectroscopy and Flow Cytometry Analyses of Cell-Penetrating Peptides Internalization Pathways: Optimization, Pitfalls, Comparison with Mass Spectrometry Quantification</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36938</span>, <span class="refDoi"> DOI: 10.1038/srep36938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fsrep36938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27841303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGitr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36938&author=F.+Illienauthor=N.+Rodriguezauthor=M.+Amouraauthor=A.+Joliotauthor=M.+Pallerlaauthor=S.+Cribierauthor=F.+Burlinaauthor=S.+Sagan&title=Quantitative+Fluorescence+Spectroscopy+and+Flow+Cytometry+Analyses+of+Cell-Penetrating+Peptides+Internalization+Pathways%3A+Optimization%2C+Pitfalls%2C+Comparison+with+Mass+Spectrometry+Quantification&doi=10.1038%2Fsrep36938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantification</span></div><div class="casAuthors">Illien, Francoise; Rodriguez, Nicolas; Amoura, Mehdi; Joliot, Alain; Pallerla, Manjula; Cribier, Sophie; Burlina, Fabienne; Sagan, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36938</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of cell-penetrating peptides entry into cells is unclear, preventing the development of more efficient vectors for biotechnol. or therapeutic purposes.  Here, we developed a protocol relying on fluorometry to distinguish endocytosis from direct membrane translocation, using Penetratin, TAT and R9.  The quantities of internalized CPPs measured by fluorometry in cell lysates converge with those obtained by our previously reported mass spectrometry quantification method.  By contrast, flow cytometry quantification faces several limitations due to fluorescence quenching processes that depend on the cell line and occur at peptide/cell ratio >6.108 for CF-Penetratin.  The anal. of cellular internalization of a doubly labeled fluorescent and biotinylated Penetratin analog by the two independent techniques, fluorometry and mass spectrometry, gave consistent results at the quant. and qual. levels.  Both techniques revealed the use of two alternative translocation and endocytosis pathways, whose relative efficacy depends on cell-surface sugars and peptide concn.  We confirmed that Penetratin translocates at low concn. and uses endocytosis at high μM concns.  We further demonstrate that the hydrophobic/hydrophilic nature of the N-terminal extremity impacts on the internalization efficiency of CPPs.  We expect these results and the assocd. protocols to help unraveling the translocation pathway to the cytosol of cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwTCm2jxX937Vg90H21EOLACvtfcHk0lifxwewU0tPgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGitr%252FN&md5=ee292e6cfee9f70ab9630d2413258ac5</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fsrep36938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36938%26sid%3Dliteratum%253Aachs%26aulast%3DIllien%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DN.%26aulast%3DAmoura%26aufirst%3DM.%26aulast%3DJoliot%26aufirst%3DA.%26aulast%3DPallerla%26aufirst%3DM.%26aulast%3DCribier%26aufirst%3DS.%26aulast%3DBurlina%26aufirst%3DF.%26aulast%3DSagan%26aufirst%3DS.%26atitle%3DQuantitative%2520Fluorescence%2520Spectroscopy%2520and%2520Flow%2520Cytometry%2520Analyses%2520of%2520Cell-Penetrating%2520Peptides%2520Internalization%2520Pathways%253A%2520Optimization%252C%2520Pitfalls%252C%2520Comparison%2520with%2520Mass%2520Spectrometry%2520Quantification%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36938%26doi%3D10.1038%2Fsrep36938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Membrane Affinity and Fluorescent Labelling: Comparative Study of Monolayer Interaction, Cellular Uptake and Cytotoxicity Profile of Carboxyfluorescein-Conjugated Cationic Peptides</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1007/s00726-018-2630-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs00726-018-2630-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30099595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFSqtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1557-1571&author=E.+Kissauthor=G.+Gyulaiauthor=E.+Pariauthor=K.+Horvatiauthor=S.+Bosze&title=Membrane+Affinity+and+Fluorescent+Labelling%3A+Comparative+Study+of+Monolayer+Interaction%2C+Cellular+Uptake+and+Cytotoxicity+Profile+of+Carboxyfluorescein-Conjugated+Cationic+Peptides&doi=10.1007%2Fs00726-018-2630-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane affinity and fluorescent labelling: comparative study of monolayer interaction, cellular uptake and cytotoxicity profile of carboxyfluorescein-conjugated cationic peptides</span></div><div class="casAuthors">Kiss, Eva; Gyulai, Gergo; Pari, Edit; Horvati, Kata; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1557-1571</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">Fluorescent labeling is a common approach to reveal the mol. details of cellular uptake, internalisation, transport, distribution processes in biol. systems.  A representative set of seven cationic peptides-including cell-penetrating peptides as well as antimicrobial peptides and synthetic derivs.-was selected for our comparative study.  Membrane affinity of the peptides and their 5(6)-carboxyfluorescein (Cf) derivs. was detd. quant. and compared applying Langmuir monolayer of zwitterionic (DPPC) and neg. charged (DPPC + DPPG) lipids as cell membrane models.  The interaction with neutral lipid layer is mainly governed by the overall hydrophobicity of the mol. which is remarkably increased by Cf-conjugation for the most hydrophobic Magainin, Melittin and Transportan.  A significantly enhanced membrane affinity was detected in neg. charged lipid model monolayer for all of the peptides since the combination of electrostatic and hydrophobic interaction is active in that case.  This effect might also responsible for the obsd. high in vitro internalisation rate of Penetratin and Dhvar4, while according to in vitro studies they did not cause damage of cell membrane.  From the expts. with the given seven cationic peptides, it can be concluded that the Cf-conjugation alters the degree of membrane interaction of such peptides which are moderately hydrophobic and highly charged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNxF1mGvPJbVg90H21EOLACvtfcHk0lifxwewU0tPgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFSqtrnI&md5=82f6c7e49bb7cc951e52c6963fd47775</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1007%2Fs00726-018-2630-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-018-2630-7%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DE.%26aulast%3DGyulai%26aufirst%3DG.%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DMembrane%2520Affinity%2520and%2520Fluorescent%2520Labelling%253A%2520Comparative%2520Study%2520of%2520Monolayer%2520Interaction%252C%2520Cellular%2520Uptake%2520and%2520Cytotoxicity%2520Profile%2520of%2520Carboxyfluorescein-Conjugated%2520Cationic%2520Peptides%26jtitle%3DAmino%2520Acids%26date%3D2018%26volume%3D50%26spage%3D1557%26epage%3D1571%26doi%3D10.1007%2Fs00726-018-2630-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ü.</span></span> <i>CPP, Cell-Penetrating Peptides</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">2019</span>; pp  <span class="NLM_fpage">XII</span>, 470.<span class="refDoi"> DOI: 10.1007/978-981-13-8747-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2F978-981-13-8747-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=XII&author=%C3%9C.+Langel&title=CPP%2C+Cell-Penetrating+Peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8747-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-981-13-8747-0%26sid%3Dliteratum%253Aachs%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26btitle%3DCPP%252C%2520Cell-Penetrating%2520Peptides%26pub%3DSpringer%26date%3D2019%26spage%3DXII%26doi%3D10.1007%2F978-981-13-8747-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staerk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H. M.</span></span> <span> </span><span class="NLM_article-title">Fluorophore Labeling of a Cell-Penetrating Peptide Induces Differential Effects on Its Cellular Distribution and Affects Cell Viability</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1859</i></span>,  <span class="NLM_fpage">2483</span>– <span class="NLM_lpage">2494</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2017.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.bbamem.2017.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28919344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SitLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1859&publication_year=2017&pages=2483-2494&author=D.+Birchauthor=M.+V.+Christensenauthor=D.+Staerkauthor=H.+Franzykauthor=H.+M.+Nielsen&title=Fluorophore+Labeling+of+a+Cell-Penetrating+Peptide+Induces+Differential+Effects+on+Its+Cellular+Distribution+and+Affects+Cell+Viability&doi=10.1016%2Fj.bbamem.2017.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorophore labeling of a cell-penetrating peptide induces differential effects on its cellular distribution and affects cell viability</span></div><div class="casAuthors">Birch, Ditlev; Christensen, Malene Vinther; Staerk, Dan; Franzyk, Henrik; Nielsen, Hanne Moerck</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1859</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2483-2494</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-penetrating peptides constitute efficient delivery vectors, and studies of their uptake and mechanism of translocation typically involve fluorophore-labeled conjugates.  In the present study, the influence of a no. of specific fluorophores on the physico-chem. properties and uptake-related characteristics of penetratin were studied.  An array of seven fluorophores belonging to distinct structural classes was examd., and the impact of fluorophore labeling on intracellular distribution and cytotoxicity was correlated to the physico-chem. properties of the conjugates.  Exposure of several mammalian cell types to fluorophore-penetratin conjugates revealed a strong structure-dependent redn. in viability (1.5- to 20-fold lower IC50 values as compared to those of non-labeled penetratin).  Also, the degree of less severe effects on membrane integrity, as well as intracellular distribution patterns differed among the conjugates.  Overall, neutral hydrophobic fluorophores or neg. charged fluorophores conferred less cytotoxicity as compared to the effect exerted by pos. charged, hydrophobic fluorophores.  The latter conjugates, however, exhibited less membrane assocn. and more clearly defined intracellular distribution patterns.  Thus, selection of the appropriate flurophore is crit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuUABBhzCZLVg90H21EOLACvtfcHk0lj6drZj4uCPqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SitLjE&md5=fecd160ea4a85fb30ff21a78ec68db30</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2017.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2017.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DD.%26aulast%3DChristensen%26aufirst%3DM.%2BV.%26aulast%3DStaerk%26aufirst%3DD.%26aulast%3DFranzyk%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DH.%2BM.%26atitle%3DFluorophore%2520Labeling%2520of%2520a%2520Cell-Penetrating%2520Peptide%2520Induces%2520Differential%2520Effects%2520on%2520Its%2520Cellular%2520Distribution%2520and%2520Affects%2520Cell%2520Viability%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2017%26volume%3D1859%26spage%3D2483%26epage%3D2494%26doi%3D10.1016%2Fj.bbamem.2017.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Ardoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lostale-Seijo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, J.</span></span> <span> </span><span class="NLM_article-title">Where in the Cell Is Our Cargo? Methods Currently Used to Study Intracellular Cytosolic Localisation</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1002/cbic.201800390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fcbic.201800390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30178574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CgsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=488-498&author=A.+Mendez-Ardoyauthor=I.+Lostale-Seijoauthor=J.+Montenegro&title=Where+in+the+Cell+Is+Our+Cargo%3F+Methods+Currently+Used+to+Study+Intracellular+Cytosolic+Localisation&doi=10.1002%2Fcbic.201800390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Where in the Cell Is our Cargo? Methods Currently Used To Study Intracellular Cytosolic Localisation</span></div><div class="casAuthors">Mendez-Ardoy, Alejandro; Lostale-Seijo, Irene; Montenegro, Javier</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-498</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The internalisation and delivery of active substances into cells is a field of growing interest for chem. biol. and therapeutics.  As we move from small-mol.-based drugs towards bigger cargos, such as antibodies, enzymes, nucleases or nucleic acids, the development of efficient delivery systems becomes crit. for their practical application.  Different strategies and synthetic carriers have been developed; these include cationic lipids, gold nanoparticles, polymers, cell-penetrating peptides (CPPs), protein surface modification etc.  However, all of these methodologies still present limitations relating to the precise targeting of the different intracellular compartments and, in particular, difficulties in access to the cellular cytosol.  Addnl., the precise quantification of the cellular uptake of a compd. is not enough to demonstrate delivery and/or functional activity.  Therefore, methods to det. cellular distributions of cargos and carriers are of crit. importance for identifying the barriers that are blocking the activity.  Herein we survey the different techniques that can currently be used to track and to monitor the subcellular localisation of the synthetic compds. that we deliver inside cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgcISUGrv1x7Vg90H21EOLACvtfcHk0lj6drZj4uCPqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CgsrjE&md5=63251bf2420cf2977e977c52207d25b4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800390%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Ardoy%26aufirst%3DA.%26aulast%3DLostale-Seijo%26aufirst%3DI.%26aulast%3DMontenegro%26aufirst%3DJ.%26atitle%3DWhere%2520in%2520the%2520Cell%2520Is%2520Our%2520Cargo%253F%2520Methods%2520Currently%2520Used%2520to%2520Study%2520Intracellular%2520Cytosolic%2520Localisation%26jtitle%3DChemBioChem%26date%3D2019%26volume%3D20%26spage%3D488%26epage%3D498%26doi%3D10.1002%2Fcbic.201800390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, F.</span></span> <span> </span><span class="NLM_article-title">Lipid Matrix Plays a Role in Abeta Fibril Kinetics and Morphology</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2011.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.febslet.2011.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=21320494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsF2jurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=749-754&author=M.+A.+Saniauthor=J.+D.+Gehmanauthor=F.+Separovic&title=Lipid+Matrix+Plays+a+Role+in+Abeta+Fibril+Kinetics+and+Morphology&doi=10.1016%2Fj.febslet.2011.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid matrix plays a role in Abeta fibril kinetics and morphology</span></div><div class="casAuthors">Sani, Marc-Antoine; Gehman, John D.; Separovic, Frances</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-754</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While neuronal membranes are proposed to be the primary target of amyloid plaques, the effect of phospholipids on fibril formation kinetics and morphol. has not yet been resolved.  We report that interaction of various compns. with neuronal mimics promoted different processes of fibril formation; neg. charged surfaces increased the lag time and elongation rate in thioflavin T assays, while brain total lipid ext. had an opposite effect compared to that in the absence of lipid.  Electron microscopy showed thin and elongated fibrils when the peptide was incubated with anionic lipids, while neutral surfaces promoted coarse and small fibrils.  CD and thioflavin T assays confirmed an initially unstructured peptide, and measured its transition to an aggregated beta-sheet conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfD1-zxKZgg7Vg90H21EOLACvtfcHk0lj6drZj4uCPqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsF2jurk%253D&md5=ac9e49ee4e1078f6f543df0eab649d10</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%2BA.%26aulast%3DGehman%26aufirst%3DJ.%2BD.%26aulast%3DSeparovic%26aufirst%3DF.%26atitle%3DLipid%2520Matrix%2520Plays%2520a%2520Role%2520in%2520Abeta%2520Fibril%2520Kinetics%2520and%2520Morphology%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D749%26epage%3D754%26doi%3D10.1016%2Fj.febslet.2011.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandrino, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochelavicius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobre, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, O. N.,  Jr</span></span> <span> </span><span class="NLM_article-title">The Prion Fragment Prp106–127 Adopts a Secondary Structure Typical of Aggregated Fibrils in Langmuir Monolayers of Brain Lipid Extract</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">104930</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2020.104930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.chemphyslip.2020.104930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=32470442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2020&pages=104930&author=B.+Sandrinoauthor=K.+Jochelaviciusauthor=D.+Volpatiauthor=S.+C.+Barbosaauthor=T.+M.+Nobreauthor=O.+N.+Oliveira&title=The+Prion+Fragment+Prp106%E2%80%93127+Adopts+a+Secondary+Structure+Typical+of+Aggregated+Fibrils+in+Langmuir+Monolayers+of+Brain+Lipid+Extract&doi=10.1016%2Fj.chemphyslip.2020.104930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The prion fragment PrP106-127 adopts a secondary structure typical of aggregated fibrils in langmuir monolayers of brain lipid extract</span></div><div class="casAuthors">Sandrino, B.; Jochelavicius, K.; Volpati, D.; Barbosa, S. C.; Nobre, T. M.; Oliveira, O. N. Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104930</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Understanding protein aggregation is essential to unveil mol. mechanisms assocd. with neurodegenerative diseases such as Alzheimer's, Huntington's and spongiform encephalopathy, particularly to det. the role of interaction with cell membranes.  In this study, we employ Langmuir monolayers as cell membrane models to mimic interaction with the peptide KTNMHKHMAGAAAAGAVVGGLG-OH, a fragment from the human prion protein including residues 106-127, believed to be involved in protein aggregation.  Using in situ polarization-modulated IR reflection adsorption spectroscopy (PM-IRRAS) for Langmuir monolayers and FTIR for solid films, we found that PrP106-127 adopts mainly β-sheets, random coils and β-turns in Langmuir monolayers and in Langmuir-Blodgett (LB) and cast films.  This also applies to monolayers and solid films made with PrP106-127 and a brain total lipid ext. (BTLE).  In contrast, some α-helixes are obsd. in the secondary structure of PrP106-127 in monolayers, and esp. in solid films, of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC).  In summary, in a model representing brain cells (BTLE), the secondary structure of PrP106-127 is typical of fiber aggregates, while aggregation is unlikely if PrP106-127 interacts with a membrane model (DOPC) characteristic of mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kGwa2c5JGrVg90H21EOLACvtfcHk0lhjUue5y33ROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjsL%252FP&md5=17e9082ed9a3e424d4f5b833d14ca1be</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2020.104930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2020.104930%26sid%3Dliteratum%253Aachs%26aulast%3DSandrino%26aufirst%3DB.%26aulast%3DJochelavicius%26aufirst%3DK.%26aulast%3DVolpati%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%2BC.%26aulast%3DNobre%26aufirst%3DT.%2BM.%26aulast%3DOliveira%26aufirst%3DO.%2BN.%26atitle%3DThe%2520Prion%2520Fragment%2520Prp106%25E2%2580%2593127%2520Adopts%2520a%2520Secondary%2520Structure%2520Typical%2520of%2520Aggregated%2520Fibrils%2520in%2520Langmuir%2520Monolayers%2520of%2520Brain%2520Lipid%2520Extract%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2020%26volume%3D230%26spage%3D104930%26doi%3D10.1016%2Fj.chemphyslip.2020.104930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zsila, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span> <span> </span><span class="NLM_article-title">Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2197</span>, <span class="refDoi"> DOI: 10.3390/ijms21062197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms21062197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVejsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=2197&author=E.+Pariauthor=K.+Horvatiauthor=S.+Boszeauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=F.+Zsilaauthor=E.+Kiss&title=Drug+Conjugation+Induced+Modulation+of+Structural+and+Membrane+Interaction+Features+of+Cationic+Cell-Permeable+Peptides&doi=10.3390%2Fijms21062197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Drug conjugation induced modulation of structural and membrane interaction features of cationic cell-permeable peptides</span></div><div class="casAuthors">Pari, Edit; Horvati, Kata; Bosze, Szilvia; Biri-Kovacs, Beata; Szeder, Balint; Zsila, Ferenc; Kiss, Eva</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2197</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cell-penetrating peptides might have great potential for enhancing the therapeutic effect of drug mols. against such dangerous pathogens as Mycobacterium tuberculosis (Mtb), which causes a major health problem worldwide.  A set of cationic cell-penetration peptides with various hydrophobicity were selected and synthesized as drug carrier of isoniazid (INH), a first-line antibacterial agent against tuberculosis.  Mol. interactions between the peptides and their INH-conjugates with cell-membrane-forming lipid layers composed of DPPC and mycolic acid (a characteristic component of Mtb cell wall) were evaluated, using the Langmuir balance technique.  Secondary structure of the INH conjugates was analyzed and compared to that of the native peptides by CD spectroscopic expts. performed in aq. and membrane mimetic environment.  A correlation was found between the conjugation induced conformational and membrane affinity changes of the INH-peptide conjugates.  The degree and mode of interaction were also characterized by AFM imaging of penetrated lipid layers.  In vitro biol. evaluation was performed with Penetratin and Transportan conjugates.  Results showed similar internalization rate into EBC-1 human squamous cell carcinoma, but markedly different subcellular localization and activity on intracellular Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwni53JmX97Vg90H21EOLACvtfcHk0lhjUue5y33ROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVejsb7L&md5=d5de492802b38dc4263265d408372c79</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.3390%2Fijms21062197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21062197%26sid%3Dliteratum%253Aachs%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DZsila%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DE.%26atitle%3DDrug%2520Conjugation%2520Induced%2520Modulation%2520of%2520Structural%2520and%2520Membrane%2520Interaction%2520Features%2520of%2520Cationic%2520Cell-Permeable%2520Peptides%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D2197%26doi%3D10.3390%2Fijms21062197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bicker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortuna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcão, A.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Models and Their Relevance for a Successful Development of CNS Drug Delivery Systems: A Review</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejpb.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24686194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=409-432&author=J.+Bickerauthor=G.+Alvesauthor=A.+Fortunaauthor=A.+Falc%C3%A3o&title=Blood-Brain+Barrier+Models+and+Their+Relevance+for+a+Successful+Development+of+CNS+Drug+Delivery+Systems%3A+A+Review&doi=10.1016%2Fj.ejpb.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review</span></div><div class="casAuthors">Bicker, Joana; Alves, Gilberto; Fortuna, Ana; Falcao, Amilcar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-432</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the research and development of new drugs directed at the central nervous system, there is a considerable attrition rate caused by their hampered access to the brain by the blood-brain barrier.  Throughout the years, several in vitro models have been developed in an attempt to mimic crit. functionalities of the blood-brain barrier and reliably predict the permeability of drug candidates.  However, the current challenge lies in developing a model that retains fundamental blood-brain barrier characteristics and simultaneously remains compatible with the high throughput demands of pharmaceutical industries.  This review firstly describes the roles of all elements of the neurovascular unit and their influence on drug brain penetration.  In vitro models, including non-cell based and cell-based models, and in vivo models are herein presented, with a particular emphasis on their methodol. aspects.  Lastly, their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-OEiYO0znrVg90H21EOLACvtfcHk0lhjUue5y33ROw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D&md5=73c2d2182182626c039ccb469b65eec4</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBicker%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DFortuna%26aufirst%3DA.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26atitle%3DBlood-Brain%2520Barrier%2520Models%2520and%2520Their%2520Relevance%2520for%2520a%2520Successful%2520Development%2520of%2520CNS%2520Drug%2520Delivery%2520Systems%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D87%26spage%3D409%26epage%3D432%26doi%3D10.1016%2Fj.ejpb.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cukierman, E.</span></span> <span> </span><span class="NLM_article-title">Modeling Tissue Morphogenesis and Cancer in 3D</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.cell.2007.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=17719539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVels77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=601-610&author=K.+M.+Yamadaauthor=E.+Cukierman&title=Modeling+Tissue+Morphogenesis+and+Cancer+in+3D&doi=10.1016%2Fj.cell.2007.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling tissue morphogenesis and cancer in 3D</span></div><div class="casAuthors">Yamada, Kenneth M.; Cukierman, Edna</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Three-dimensional (3D) in vitro models span the gap between two-dimensional cell cultures and whole-animal systems.  By mimicking features of the in vivo environment and taking advantage of the same tools used to study cells in traditional cell culture, 3D models provide unique perspectives on the behavior of stem cells, developing tissues and organs, and tumors.  These models may help to accelerate translational research in cancer biol. and tissue engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorQ_LEDS99G7Vg90H21EOLACvtfcHk0lho-UCASxVFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVels77F&md5=6822cdd35eeb4b3413fd4ea9ad66b689</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BM.%26aulast%3DCukierman%26aufirst%3DE.%26atitle%3DModeling%2520Tissue%2520Morphogenesis%2520and%2520Cancer%2520in%25203D%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D601%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, S. A.</span></span> <span> </span><span class="NLM_article-title">Three-Dimensional In Vitro Cell Culture Models in Drug Discovery and Drug Repositioning</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">6</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3389%2Ffphar.2018.00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29410625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKrs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=6&author=S.+A.+Langhans&title=Three-Dimensional+In+Vitro+Cell+Culture+Models+in+Drug+Discovery+and+Drug+Repositioning&doi=10.3389%2Ffphar.2018.00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional in vitro cell culture models in drug discovery and drug repositioning</span></div><div class="casAuthors">Langhans, Sigrid A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6/1-6/14</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Drug development is a lengthy and costly process that proceeds through several stages from target identification to lead discovery and optimization, preclin. validation and clin. trials culminating in approval for clin. use.  An important step in this process is high-throughput screening (HTS) of small compd. libraries for lead identification.  Currently, themajority of cell-based HTS is being carried out on cultured cells propagated in two-dimensions (2D) on plastic surfaces optimized for tissue culture.  At the same time, compelling evidence suggests that cells cultured in these non-physiol. conditions are not representative of cells residing in the complex microenvironment of a tissue.  This discrepancy is thought to be a significant contributor to the high failure rate in drug discovery, where only a low percentage of drugs investigated ever make it through the gamut of testing and approval to the market.  Thus, three-dimensional (3D) cell culture technologies that more closely resemble in vivo cell environments are now being pursued with intensity as they are expected to accommodate better precision in drug discovery.  Here we will review common approaches to 3D culture, discuss the significance of 3D cultures in drug resistance and drug repositioning and address some of the challenges of applying 3D cell cultures to high-throughput drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw5NAwsfOLKrVg90H21EOLACvtfcHk0lho-UCASxVFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKrs7%252FP&md5=79c9604de826fc9e3850978df741468f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00006%26sid%3Dliteratum%253Aachs%26aulast%3DLanghans%26aufirst%3DS.%2BA.%26atitle%3DThree-Dimensional%2520In%2520Vitro%2520Cell%2520Culture%2520Models%2520in%2520Drug%2520Discovery%2520and%2520Drug%2520Repositioning%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D6%26doi%3D10.3389%2Ffphar.2018.00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, T. A.</span></span> <span> </span><span class="NLM_article-title">A Set of Constructed Type Spectra for the Practical Estimation of Peptide Secondary Structure from Circular Dichroism</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1006/abio.1997.2355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1006%2Fabio.1997.2355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=9398343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK2sXnvVOjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1997&pages=36-40&author=J.+Reedauthor=T.+A.+Reed&title=A+Set+of+Constructed+Type+Spectra+for+the+Practical+Estimation+of+Peptide+Secondary+Structure+from+Circular+Dichroism&doi=10.1006%2Fabio.1997.2355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism</span></div><div class="casAuthors">Reed, Jennifer; Reed, Thomas Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-40</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">While reliable methods have been developed for the estn. of globular protein secondary structure content from their far UV CD spectra, these are not suitable for the anal. of simple peptides.  Model peptides have been measured in purely α-helical, β-sheet, and coil form, and are often used for fitting the CD spectra of peptides, but these are mainly derived from homopolymers and exhibit side-chain-dependent characteristics that do not accurately represent the situation in natural sequences.  We have attempted to reduce the side-chain bias inherent in these spectra by constructing a series of frequency-weighted "av." spectra from all available data on model peptides.  These have proved quite satisfactory in estg. the secondary structure of a no. of peptides.  A computer program incorporating these spectra has been developed for practical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSVhnf5TB-LVg90H21EOLACvtfcHk0lho-UCASxVFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvVOjtbY%253D&md5=7e0175339e8fc187b56d7b6331354ef7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1006%2Fabio.1997.2355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1997.2355%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DT.%2BA.%26atitle%3DA%2520Set%2520of%2520Constructed%2520Type%2520Spectra%2520for%2520the%2520Practical%2520Estimation%2520of%2520Peptide%2520Secondary%2520Structure%2520from%2520Circular%2520Dichroism%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D254%26spage%3D36%26epage%3D40%26doi%3D10.1006%2Fabio.1997.2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolios, N.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Conformational Properties of a Novel T-Cell Antigen Receptor Transmembrane Peptide in Model Membranes</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1002/psc.987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fpsc.987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18240131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=714-724&author=M.+A.+Amonauthor=M.+Aliauthor=V.+Benderauthor=K.+Hallauthor=M.+I.+Aguilarauthor=J.+Aldrich-Wrightauthor=N.+Manolios&title=Kinetic+and+Conformational+Properties+of+a+Novel+T-Cell+Antigen+Receptor+Transmembrane+Peptide+in+Model+Membranes&doi=10.1002%2Fpsc.987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes</span></div><div class="casAuthors">Amon, Michael A.; Ali, Marina; Bender, Veronika; Hall, Kristopher; Aguilar, Marie-Isabel; Aldrich-Wright, Janice; Manolios, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">714-724</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Core peptide (CP; GLRILLLKV) is a 9-amino acid peptide derived from the transmembrane sequence of the T-cell antigen receptor (TCR) α-subunit.  CP inhibits T-cell activation both in vitro and in vivo by disruption of the TCR at the membrane level.  To elucidate CP interactions with lipids, surface plasmon resonance (SPR) and CD were used to examine CP binding and secondary structure in the presence of either the anionic dimyristoyl-L-α-phosphatidyl-DL-glycerol (DMPG), or the zwitterionic dimyristoyl-L-α-phosphatidyl choline (DMPC).  Using lipid monolayers and bilayers, SPR expts. demonstrated that irreversible peptide-lipid binding required the hydrophobic interior provided by a membrane bilayer.  The importance of electrostatic interactions between CP and phospholipids was highlighted on lipid monolayers as CP bound reversibly to anionic DMPG monolayers, with no detectable binding obsd. on neutral DMPC monolayers.  CD revealed a dose-dependent conformational change of CP from a dominantly random coil structure to that of β-structure as the concn. of lipid increased relative to CP.  This occurred only in the presence of the anionic DMPG at a lipid: peptide molar ratio of 1.6: 1 as no conformational change was obsd. when the zwitterionic DMPC was tested up to a lipid: peptide ratio of 8.4: 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ZRRmn2yl8LVg90H21EOLACvtfcHk0lik0igApvTIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSktLg%253D&md5=ddb04ab43e3d6c4bd32e9b728d601135</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fpsc.987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.987%26sid%3Dliteratum%253Aachs%26aulast%3DAmon%26aufirst%3DM.%2BA.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DAguilar%26aufirst%3DM.%2BI.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%26aulast%3DManolios%26aufirst%3DN.%26atitle%3DKinetic%2520and%2520Conformational%2520Properties%2520of%2520a%2520Novel%2520T-Cell%2520Antigen%2520Receptor%2520Transmembrane%2520Peptide%2520in%2520Model%2520Membranes%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2008%26volume%3D14%26spage%3D714%26epage%3D724%26doi%3D10.1002%2Fpsc.987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggiali, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kievit, R.</span></span> <span> </span><span class="NLM_article-title">Raincloud Plots: A Multi-Platform Tool for Robust Data Visualization [Version 1; Peer Review: 2 Approved]</span>. <i>Wellcome Open Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.12688/wellcomeopenres.15191.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.12688%2Fwellcomeopenres.15191.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31069261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=63&author=M.+Allenauthor=D.+Poggialiauthor=K.+Whitakerauthor=T.+Marshallauthor=R.+Kievit&title=Raincloud+Plots%3A+A+Multi-Platform+Tool+for+Robust+Data+Visualization+%5BVersion+1%3B+Peer+Review%3A+2+Approved%5D&doi=10.12688%2Fwellcomeopenres.15191.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Raincloud plots: a multi-platform tool for robust data visualization</span></div><div class="casAuthors">Allen Micah; Allen Micah; Whitaker Kirstie; Allen Micah; Poggiali Davide; Poggiali Davide; Whitaker Kirstie; Marshall Tom Rhys; Marshall Tom Rhys; Kievit Rogier A; Kievit Rogier A</div><div class="citationInfo"><span class="NLM_cas:title">Wellcome open research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn">2398-502X</span>.
    </div><div class="casAbstract">Across scientific disciplines, there is a rapidly growing recognition of the need for more statistically robust, transparent approaches to data visualization.  Complementary to this, many scientists have called for plotting tools that accurately and transparently convey key aspects of statistical effects and raw data with minimal distortion.  Previously common approaches, such as plotting conditional mean or median barplots together with error-bars have been criticized for distorting effect size, hiding underlying patterns in the raw data, and obscuring the assumptions upon which the most commonly used statistical tests are based.  Here we describe a data visualization approach which overcomes these issues, providing maximal statistical information while preserving the desired 'inference at a glance' nature of barplots and other similar visualization devices.  These "raincloud plots" can visualize raw data, probability density, and key summary statistics such as median, mean, and relevant confidence intervals in an appealing and flexible format with minimal redundancy.  In this tutorial paper, we provide basic demonstrations of the strength of raincloud plots and similar approaches, outline potential modifications for their optimal use, and provide open-source code for their streamlined implementation in R, Python and Matlab ( https://github.com/RainCloudPlots/RainCloudPlots).  Readers can investigate the R and Python tutorials interactively in the browser using Binder by Project Jupyter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvxyxWUQf3XoJKJbLTgsvCfW6udTcc2eZX5zf8IRIkOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jvVeitQ%253D%253D&md5=a24a8c463d5b6536940d02728e19c898</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.12688%2Fwellcomeopenres.15191.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Fwellcomeopenres.15191.1%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DPoggiali%26aufirst%3DD.%26aulast%3DWhitaker%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DT.%26aulast%3DKievit%26aufirst%3DR.%26atitle%3DRaincloud%2520Plots%253A%2520A%2520Multi-Platform%2520Tool%2520for%2520Robust%2520Data%2520Visualization%2520%255BVersion%25201%253B%2520Peer%2520Review%253A%25202%2520Approved%255D%26jtitle%3DWellcome%2520Open%2520Res.%26date%3D2019%26volume%3D4%26spage%3D63%26doi%3D10.12688%2Fwellcomeopenres.15191.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zar, J. H.</span></span> In  <i>Biostatistical Analysis</i>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, J. H.</span></span>, Ed.; <span class="NLM_publisher-name">Pearson Educations</span>: <span class="NLM_publisher-loc">Upper Saddle River, NJ</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+H.+Zarauthor=J.+H.+Zar&title=Biostatistical+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZar%26aufirst%3DJ.%2BH.%26btitle%3DBiostatistical%2520Analysis%26aulast%3DZar%26aufirst%3DJ.%2BH.%26pub%3DPearson%2520Educations%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">R Core Team</span>. <span> </span><span class="NLM_article-title">The R Project for Statistical
Computing</span>. <a href="https://www.r-project.org/" class="extLink">https://www.r-project.org/</a> (accessed Feb 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=R+Core+Team.+The+R+Project+for+Statistical%0AComputing.+https%3A%2F%2Fwww.r-project.org%2F+%28accessed+Feb+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520R%2520Project%2520for%2520Statistical%250AComputing" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohlert, T.</span></span> <span> </span><span class="NLM_article-title">The Pairwise Multiple Comparison of Mean Ranks Package (Pmcmr)</span>. <a href="https://cran.r-project.org/web/packages/PMCMR/vignettes/PMCMR.pdf" class="extLink">https://cran.r-project.org/web/packages/PMCMR/vignettes/PMCMR.pdf</a> (accessed Feb 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pohlert%2C+T.+The+Pairwise+Multiple+Comparison+of+Mean+Ranks+Package+%28Pmcmr%29.+https%3A%2F%2Fcran.r-project.org%2Fweb%2Fpackages%2FPMCMR%2Fvignettes%2FPMCMR.pdf+%28accessed+Feb+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPohlert%26aufirst%3DT.%26atitle%3DThe%2520Pairwise%2520Multiple%2520Comparison%2520of%2520Mean%2520Ranks%2520Package%2520%2528Pmcmr%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structures of (A) Salicylanilide Derivatives, (B) Daunomycin, and (C) Synthesis of Temozolomide-Carboxylic Acid, (D) Conjugation of Salicylanilide and Daunomycin to (Aminooxy)acetylated Peptide Derivatives to Obtain Drug-Peptide Conjugates with an Oxime Bond, (E) Synthesis of Temozolomide Conjugates to Obtain a Drug-Peptide Conjugate with an Amide Bond, and (F) the Summarized Schematic Structure of the Carrier Peptide Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Far-UV CD spectra of SynB3 peptides and TKPPR measured in (A) deionized water, (B) water:TFE 1:1 mixture, and (C) 100% TFE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Main cleavage sites during the degradation process of new conjugates in rat liver lysosomal homogenate and (B) the smallest, drug-containing metabolites produced from the conjugates (*: results are taken from ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> cytostatic activity of the representative compounds on (A) U87 and (B) MDA-MB 435Br cell cultures and (C) cytotoxicity on HUVEC after 24 h treatment. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the cellular uptake of the 5(6)-carboxyfluorescein-labeled peptide derivatives on U87 cells at different concentrations using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the peptides. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time dependence of the cellular internalization of cell-penetrating peptide Cf-SynB3, tuftsin derivative Cf-TKPPR, and their tandem conjugate Cf-SynB3-TKPPR. (A) Comparison of the ratio of the living fluorescence positive U87 cells and (B) mean fluorescence intensity of living, fluorescence positive cells at different incubation times at 25 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the cellular uptake of Dau-peptide conjugates at 25 μM on U87 cells using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the conjugates. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the cellular uptake of Dau-peptide conjugates at 25 μM on MDA-MB 435Br cells using flow cytometry (3 h incubation time). (A) The ratio of living, fluorescence positive cells, (B) mean intracellular fluorescence intensity of living, fluorescence positive cells, and (C) quantified value of the uptake rate (UC<sub>50</sub>) of the conjugates. Experiments were carried out in duplicates; error bars represent standard deviation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Localization of Cf-peptides in U87 cells (fixed) by confocal microscopy. Cells were incubated with Cf-labeled peptides (green, 25 μM, 30 min), lysosomes were stained with LysoTracker Deep Red (red), and nuclei were stained with Hoechst 33342 (blue). White arrows indicate examples of nuclear or lysosomal colocalization; yellow arrows indicate vesicular localization. The scale bar represents 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Localization of Dau and Dau-conjugates in U87 cells (fixed) by confocal microscopy. Cells were incubated with Dau or Dau-conjugates (red, 25 μM, 30 min), lysosomes were stained with LysoTracker Deep Red (green), and nuclei were stained with Hoechst 33342 (blue). White arrowheads indicate examples of nuclear or lysosomal colocalization; yellow arrowheads indicate vesicular localization. The scale bar represents 10 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. The penetration ability of conjugates was assessed tensiometrically employing a Langmuir balance. (A) Schematic representation of the drug penetration studies using a Langmuir monolayer. (B) The degree of penetration (ΔΠ) of the selected Dau-conjugates into the BEPL monolayer after 30 min of interaction. Error bars represent the confidence intervals (95%) of the determined mean values calculated using Student’s <i>t</i> test from three parallel measurements (<i>p</i> < 0.05). (C) Schematic representation of the Transwell co-culture arrangement with noncontact monolayers as the BBB model containing HUVEC and U87 cells. HUVECs were seeded on the apical side of the TW insert, and U87 cells were seeded on the basolateral chamber employing coverslips. (D) Microscopic images of the HUVEC monolayer on the TW membrane; nuclei were stained with Hoechst 33342 (blue), the cytoplasm of the cells was stained with CMFDA (green), and the scale bar represents 50 μm. (E) CLSM images of U87 cells from the <i>in vitro</i> TW model, where Dau and Dau-conjugates (red, 50 μM, 45 min incubation) were added to the apical chamber. Nuclei of U87 cells from the basolateral chamber on coverslips were stained with Hoechst 33342 (blue); cells were fixed and analyzed by CLSM. The scale bar represents 50 μm. (F) Violin plots of intensity values derived from CLSM images of U87 cells from the <i>in vitro</i> Transwell model, where Dau or Dau-conjugates were added to the apical chamber. The overlaid box-and-whisker plots show the median (horizontal line), the interquartile range (box), and minimum and maximum values (whiskers) of intensity according to the field of view (every inner pixel). (G) The results of the statistical analysis of the mean normalized intensity values of cell clusters treated with Dau or Dau-conjugates. Box-and-whisker plots show the median (horizontal line), the interquartile range (box), and minimum and maximum values (whiskers) of intensity values. Letters demonstrate the results of Tukey’s procedure for all-pairwise comparisons based on the one-way ANOVA (<i>F</i>(3,33) = 134.6; <i>p</i> < 0.001); different letters mean significant differences at <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Workflow of preparation, treatment, imaging, and analysis of 3D tumor spheroids. (A) Micromold used for casting of a 3D Petri dish (microtissues), (B) 3D Petri dish in a 35 mm Petri dish, (C) addition of complete cell medium, (D) view of tumor spheroids in a 3D Petri dish, (E) treatment, nucleus staining, and cell fixation performed inside the 3D Petri dish, (F, G) side-view of a tumor spheroid with the position of the scanning plane during CLSM imaging (section z5, corresponding to the z-section captured 50 μm from the surface), (H) position of lines during line scan and position of zones for zonal scan of section z5 of spheroids (two parallel spheroids, 8 lines and 3 zones each), (I) penetration profile by line scan, mean intensity (red line), and SEM (light-red error stripe) averaged from gray values (0–255) of 16 parallel line scans and depth of scanning (black line) along the normalized spheroid diameter, (J) penetration profile by zonal scan; spheroids were separated into a peripheral (zone 1), intermediate (zone 2), and core zone (zone 3), and the relative normalized intensity was determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) Representative confocal images of U87 spheroids after 3 h treatment with 25 μM Dau or Dau-peptide conjugates (red). Nuclei were stained with Hoechst 33342 (blue). Z-stack images were obtained starting at the surface of the spheroid with 10 μm intervals for a total of 50 μm into the spheroid; the presented images are from the 30 μm (z3) and 50 μm (z5) depths. The scale bar represents 200 μm. (B) Line scans of spheroids at 50 μm (z5) depth; mean intensities are gray values (0–255) averaged from two parallel spheroids (<i>n</i> = 16 line scans), and error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Representative confocal images of MDA-MB 435Br spheroids after 3 h treatment with 25 μM Dau or Dau-peptide conjugates (red). Nuclei were stained with Hoechst 33342 (blue). Z-stack images were obtained starting at the surface of the spheroid with 10 μm intervals for a total of 50 μm into the spheroid; the presented images are from the 30 μm (z3) and 50 μm (z5) depths. The scale bar represents 200 μm. (B) Line scans of spheroids at 50 μm (z5) depth; mean intensities are gray values (0–255) averaged from two parallel spheroids (<i>n</i> = 16 line scans), and error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/medium/jm0c01399_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Relative normalized intensity of spheroid zone 1, zone 2, and zone 3 displaying the penetration ability of the Dau and Dau-conjugates in (A) U87 spheroids and in (B) MDA-MB 435Br spheroids. Relative normalized intensities of spheroids were extracted at 50 μm (z5) depth, averaged from two parallel spheroids (<i>n</i> = 2); error stripes correspond to SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c01399/20210319/images/large/jm0c01399_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01399&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 104 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wick, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldape, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span> <span> </span><span class="NLM_article-title">Glioma</span>. <i>Nat. Rev. Dis Primers</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">15017</span>, <span class="refDoi"> DOI: 10.1038/nrdp.2015.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fnrdp.2015.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27188790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FgsF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=15017&author=M.+Wellerauthor=W.+Wickauthor=K.+Aldapeauthor=M.+Bradaauthor=M.+Bergerauthor=S.+M.+Pfisterauthor=R.+Nishikawaauthor=M.+Rosenthalauthor=P.+Y.+Wenauthor=R.+Stuppauthor=G.+Reifenberger&title=Glioma&doi=10.1038%2Fnrdp.2015.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma</span></div><div class="casAuthors">Weller Michael; Wick Wolfgang; Aldape Ken; Brada Michael; Berger Mitchell; Pfister Stefan M; Pfister Stefan M; Nishikawa Ryo; Rosenthal Mark; Wen Patrick Y; Stupp Roger; Reifenberger Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gliomas are primary brain tumours that are thought to derive from neuroglial stem or progenitor cells.  On the basis of their histological appearance, they have been traditionally classified as astrocytic, oligodendroglial or ependymal tumours and assigned WHO grades I-IV, which indicate different degrees of malignancy.  Tremendous progress in genomic, transcriptomic and epigenetic profiling has resulted in new concepts of classifying and treating gliomas.  Diffusely infiltrating gliomas in adults are now separated into three overarching tumour groups with distinct natural histories, responses to treatment and outcomes: isocitrate dehydrogenase (IDH)-mutant, 1p/19q co-deleted tumours with mostly oligodendroglial morphology that are associated with the best prognosis; IDH-mutant, 1p/19q non-co-deleted tumours with mostly astrocytic histology that are associated with intermediate outcome; and IDH wild-type, mostly higher WHO grade (III or IV) tumours that are associated with poor prognosis.  Gliomas in children are molecularly distinct from those in adults, the majority being WHO grade I pilocytic astrocytomas characterized by circumscribed growth, favourable prognosis and frequent BRAF gene fusions or mutations.  Ependymal tumours can be molecularly subdivided into distinct epigenetic subgroups according to location and prognosis.  Although surgery, radiotherapy and alkylating agent chemotherapy are still the mainstay of treatment, individually tailored strategies based on tumour-intrinsic dominant signalling pathways and antigenic tumour profiles may ultimately improve outcome.  For an illustrated summary of this Primer, visit: http://go.nature.com/TXY7Ri.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp7RmPT9C1joJKJbLTgsvCfW6udTcc2eZ_7pnm-XIVNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FgsF2ltw%253D%253D&md5=8c80c46f32b00bd1b84c7e7fa31b6977</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2015.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2015.17%26sid%3Dliteratum%253Aachs%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DAldape%26aufirst%3DK.%26aulast%3DBrada%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DNishikawa%26aufirst%3DR.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DReifenberger%26aufirst%3DG.%26atitle%3DGlioma%26jtitle%3DNat.%2520Rev.%2520Dis%2520Primers%26date%3D2015%26volume%3D1%26spage%3D15017%26doi%3D10.1038%2Fnrdp.2015.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taillibert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhermitte, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idbaih, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahluwalia, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Meco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stragliotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hottinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirson, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavy-Shahaf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paek, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirte, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palti, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ram, Z.</span></span> <span> </span><span class="NLM_article-title">Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients with Glioblastoma: A Randomized Clinical Trial</span>. <i>JAMA</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">2306</span>– <span class="NLM_lpage">2316</span>, <span class="refDoi"> DOI: 10.1001/jama.2017.18718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1001%2Fjama.2017.18718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29260225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVymtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2017&pages=2306-2316&author=R.+Stuppauthor=S.+Taillibertauthor=A.+Kannerauthor=W.+Readauthor=D.+Steinbergauthor=B.+Lhermitteauthor=S.+Tomsauthor=A.+Idbaihauthor=M.+S.+Ahluwaliaauthor=K.+Finkauthor=F.+Di+Mecoauthor=F.+Liebermanauthor=J.+J.+Zhuauthor=G.+Stragliottoauthor=D.+Tranauthor=S.+Bremauthor=A.+Hottingerauthor=E.+D.+Kirsonauthor=G.+Lavy-Shahafauthor=U.+Weinbergauthor=C.+Y.+Kimauthor=S.+H.+Paekauthor=G.+Nicholasauthor=J.+Brunaauthor=H.+Hirteauthor=M.+Wellerauthor=Y.+Paltiauthor=M.+E.+Hegiauthor=Z.+Ram&title=Effect+of+Tumor-Treating+Fields+Plus+Maintenance+Temozolomide+vs+Maintenance+Temozolomide+Alone+on+Survival+in+Patients+with+Glioblastoma%3A+A+Randomized+Clinical+Trial&doi=10.1001%2Fjama.2017.18718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial</span></div><div class="casAuthors">Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M.; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S.; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D.; Brem, Steven; Hottinger, Andreas F.; Kirson, Eilon D.; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika E.; Ram, Zvi</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2306-2316</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">1538-3598</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating elec. fields to the tumor.  To investigate whether TTFields improves progression-free and overall survival of patients with glioblastoma, a fatal disease that commonly recurs at the initial tumor site or in the central nervous system.  In this randomized, open-label trial, 695 patients with glioblastoma whose tumor was resected or biopsied and had completed concomitant radiochemotherapy (median time from diagnosis to randomization, 3.8 mo) were enrolled at 83 centers (July 2009-2014) and followed up through Dec. 2016.  A preliminary report from this trial was published in 2015; this report describes the final anal.  Patients were randomized 2:1 to TTFields plus maintenance temozolomide chemotherapy (n = 466) or temozolomide alone (n = 229).  The TTFields, consisting of low-intensity, 200 kHz frequency, alternating elec. fields, was delivered (≥ 18 h/d) via 4 transducer arrays on the shaved scalp and connected to a portable device.  Temozolomide was administered to both groups (150-200 mg/m2) for 5 days per 28-day cycle (6-12 cycles).  Progression-free survival (tested at α = .046).  The secondary end point was overall survival (tested hierarchically at α = .048).  Analyses were performed for the intent-to-treat population.  Adverse events were compared by group.  Results Of the 695 randomized patients (median age, 56 years; IQR, 48-63; 473 men [68%]), 637 (92%) completed the trial.  Median progression-free survival from randomization was 6.7 mo in the TTFields-temozolomide group and 4.0 mo in the temozolomide-alone group (HR, 0.63; 95% CI, 0.52-0.76; P < .001).  Median overall survival was 20.9 mo in the TTFields-temozolomide group vs 16.0 mo in the temozolomide-alone group (HR, 0.63; 95% CI, 0.53-0.76; P < .001).  Systemic adverse event frequency was 48% in the TTFields-temozolomide group and 44% in the temozolomide-alone group.  Mild to moderate skin toxicity underneath the transducer arrays occurred in 52% of patients who received TTFields-temozolomide vs no patients who received temozolomide alone.  In the final anal. of this randomized clin. trial of patients with glioblastoma who had received std. radiochemotherapy, the addn. of TTFields to maintenance temozolomide chemotherapy vs maintenance temozolomide alone, resulted in statistically significant improvement in progression-free survival and overall survival.  These results are consistent with the previous interim anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9S4ay1_W7rVg90H21EOLACvtfcHk0ljFcDx5DokKKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVymtg%253D%253D&md5=9e9104d5f73da7eac08cb8a965b02735</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.2017.18718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2017.18718%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DTaillibert%26aufirst%3DS.%26aulast%3DKanner%26aufirst%3DA.%26aulast%3DRead%26aufirst%3DW.%26aulast%3DSteinberg%26aufirst%3DD.%26aulast%3DLhermitte%26aufirst%3DB.%26aulast%3DToms%26aufirst%3DS.%26aulast%3DIdbaih%26aufirst%3DA.%26aulast%3DAhluwalia%26aufirst%3DM.%2BS.%26aulast%3DFink%26aufirst%3DK.%26aulast%3DDi%2BMeco%26aufirst%3DF.%26aulast%3DLieberman%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%2BJ.%26aulast%3DStragliotto%26aufirst%3DG.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DBrem%26aufirst%3DS.%26aulast%3DHottinger%26aufirst%3DA.%26aulast%3DKirson%26aufirst%3DE.%2BD.%26aulast%3DLavy-Shahaf%26aufirst%3DG.%26aulast%3DWeinberg%26aufirst%3DU.%26aulast%3DKim%26aufirst%3DC.%2BY.%26aulast%3DPaek%26aufirst%3DS.%2BH.%26aulast%3DNicholas%26aufirst%3DG.%26aulast%3DBruna%26aufirst%3DJ.%26aulast%3DHirte%26aufirst%3DH.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DPalti%26aufirst%3DY.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DRam%26aufirst%3DZ.%26atitle%3DEffect%2520of%2520Tumor-Treating%2520Fields%2520Plus%2520Maintenance%2520Temozolomide%2520vs%2520Maintenance%2520Temozolomide%2520Alone%2520on%2520Survival%2520in%2520Patients%2520with%2520Glioblastoma%253A%2520A%2520Randomized%2520Clinical%2520Trial%26jtitle%3DJAMA%26date%3D2017%26volume%3D318%26spage%3D2306%26epage%3D2316%26doi%3D10.1001%2Fjama.2017.18718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesakul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muangsin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Current Challenges and Opportunities in Treating Glioblastoma</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">445</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fpr.117.014944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29669750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=412-445&author=A.+Shergalisauthor=A.+Bankheadauthor=U.+Luesakulauthor=N.+Muangsinauthor=N.+Neamati&title=Current+Challenges+and+Opportunities+in+Treating+Glioblastoma&doi=10.1124%2Fpr.117.014944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges and opportunities in treating glioblastoma</span></div><div class="casAuthors">Shergalis, Andrea; Bankhead, Armand; Luesakul, Urarika; Muangsin, Nongnuj; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-445</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has a high mortality rate despite extensive efforts to develop new treatments.  GBM exhibits both intra- and intertumor heterogeneity, lending to resistance and eventual tumor recurrence.  Large-scale genomic and proteomic anal. of GBM tumors has uncovered potential drug targets.  Effective and "druggable" targets must be validated to embark on a robust medicinal chem. campaign culminating in the discovery of clin. candidates.  Here, we review recent developments in GBM drug discovery and delivery.  To identify GBM drug targets, we performed extensive bioinformatics anal. using data from The Cancer Genome Atlas project.  We discovered 20 genes, BOC, CLEC4GP1, ELOVL6, EREG, ESR2, FDCSP, FURIN, FUT8-AS1, GZMB, IRX3, LITAF, NDEL1, NKX3-1, PODNL1, PTPRN, QSOX1, SEMA4F, TH, VEGFC, and C20orf166AS1 that are overexpressed in a subpopulation of GBM patients and correlate with poor survival outcomes.  Importantly, nine of these genes exhibit higher expression in GBM vs. low-grade glioma and may be involved in disease progression.  In this review, we discuss these proteins in the context of GBM disease progression.  We also conducted computational multi-parameter optimization to assess the blood-brain barrier (BBB) permeability of small mols. in clin. trials for GBM treatment.  Drug delivery in the context of GBM is particularly challenging because the BBB hinders small mol. transport.  Therefore, we discuss novel drug delivery methods, including nanoparticles and prodrugs.  Given the aggressive nature of GBM and the complexity of targeting the central nervous system, effective treatment options are a major unmet medical need.  Identification and validation of biomarkers and drug targets assocd. with GBM disease progression present an exciting opportunity to improve treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKoQ_eLuZhn7Vg90H21EOLACvtfcHk0lhoIUL-qiVqhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D&md5=80fb3912ca8df56db7b1c146ef45ffef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014944%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DLuesakul%26aufirst%3DU.%26aulast%3DMuangsin%26aufirst%3DN.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DCurrent%2520Challenges%2520and%2520Opportunities%2520in%2520Treating%2520Glioblastoma%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D412%26epage%3D445%26doi%3D10.1124%2Fpr.117.014944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques-Torrejon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, S. M.</span></span> <span> </span><span class="NLM_article-title">Experimental Models and Tools to Tackle Glioblastoma</span>. <i>Dis. Models Mech.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">dmm040386</span>, <span class="refDoi"> DOI: 10.1242/dmm.040386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1242%2Fdmm.040386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31519690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=dmm040386&author=F.+L.+Robertsonauthor=M.+A.+Marques-Torrejonauthor=G.+M.+Morrisonauthor=S.+M.+Pollard&title=Experimental+Models+and+Tools+to+Tackle+Glioblastoma&doi=10.1242%2Fdmm.040386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1242%2Fdmm.040386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.040386%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DF.%2BL.%26aulast%3DMarques-Torrejon%26aufirst%3DM.%2BA.%26aulast%3DMorrison%26aufirst%3DG.%2BM.%26aulast%3DPollard%26aufirst%3DS.%2BM.%26atitle%3DExperimental%2520Models%2520and%2520Tools%2520to%2520Tackle%2520Glioblastoma%26jtitle%3DDis.%2520Models%2520Mech.%26date%3D2019%26volume%3D12%26spage%3Ddmm040386%26doi%3D10.1242%2Fdmm.040386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vollmann-Zwerenz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidgens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliciello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span> <span> </span><span class="NLM_article-title">Tumor Cell Invasion in Glioblastoma</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1932</span>, <span class="refDoi"> DOI: 10.3390/ijms21061932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms21061932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVaqt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=1932&author=A.+Vollmann-Zwerenzauthor=V.+Leidgensauthor=G.+Felicielloauthor=C.+A.+Kleinauthor=P.+Hau&title=Tumor+Cell+Invasion+in+Glioblastoma&doi=10.3390%2Fijms21061932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell invasion in glioblastoma</span></div><div class="casAuthors">Vollmann-Zwerenz, Arabel; Leidgens, Verena; Feliciello, Giancarlo; Klein, Christoph A.; Hau, Peter</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1932</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Glioblastoma (GBM) is a particularly devastating tumor with a median survival of about 16 mo.  Recent research has revealed novel insights into the outstanding heterogeneity of this type of brain cancer.  However, all GBM subtypes share the hallmark feature of aggressive invasion into the surrounding tissue.  Invasive glioblastoma cells escape surgery and focal therapies and thus represent a major obstacle for curative therapy.  This review aims to provide a comprehensive understanding of glioma invasion mechanisms with respect to tumor-cell-intrinsic properties as well as cues provided by the microenvironment.  We discuss genetic programs that may influence the dissemination and plasticity of GBM cells as well as their different invasion patterns.  We also review how tumor cells shape their microenvironment and how, vice versa, components of the extracellular matrix and factors from non-neoplastic cells influence tumor cell motility.  We further discuss different research platforms for modeling invasion.  Finally, we highlight the importance of accounting for the complex interplay between tumor cell invasion and treatment resistance in glioblastoma when considering new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcUBA5r6HWjrVg90H21EOLACvtfcHk0lhoIUL-qiVqhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVaqt7%252FJ&md5=3cfa59c863fa23748635d02a67945efb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms21061932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21061932%26sid%3Dliteratum%253Aachs%26aulast%3DVollmann-Zwerenz%26aufirst%3DA.%26aulast%3DLeidgens%26aufirst%3DV.%26aulast%3DFeliciello%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DC.%2BA.%26aulast%3DHau%26aufirst%3DP.%26atitle%3DTumor%2520Cell%2520Invasion%2520in%2520Glioblastoma%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D1932%26doi%3D10.3390%2Fijms21061932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liebelt, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shingu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span> <span> </span><span class="NLM_article-title">Glioma Stem Cells: Signaling, Microenvironment, and Therapy</span>. <i>Stem Cells Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">7849890</span>, <span class="refDoi"> DOI: 10.1155/2016/7849890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1155%2F2016%2F7849890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26880988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtVOisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=7849890&author=B.+D.+Liebeltauthor=T.+Shinguauthor=X.+Zhouauthor=J.+Renauthor=S.+A.+Shinauthor=J.+Hu&title=Glioma+Stem+Cells%3A+Signaling%2C+Microenvironment%2C+and+Therapy&doi=10.1155%2F2016%2F7849890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Glioma Stem Cells: Signaling, Microenvironment, and Therapy</span></div><div class="casAuthors">Liebelt Brandon D; Shingu Takashi; Zhou Xin; Ren Jiangong; Shin Seul A; Hu Jian</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells international</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7849890</span>
        ISSN:<span class="NLM_cas:issn">1687-966X</span>.
    </div><div class="casAbstract">Glioblastoma remains the most common and devastating primary brain tumor despite maximal therapy with surgery, chemotherapy, and radiation.  The glioma stem cell (GSC) subpopulation has been identified in glioblastoma and likely plays a key role in resistance of these tumors to conventional therapies as well as recurrent disease.  GSCs are capable of self-renewal and differentiation; glioblastoma-derived GSCs are capable of de novo tumor formation when implanted in xenograft models.  Further, GSCs possess unique surface markers, modulate characteristic signaling pathways to promote tumorigenesis, and play key roles in glioma vascular formation.  These features, in addition to microenvironmental factors, present possible targets for specifically directing therapy against the GSC population within glioblastoma.  In this review, the authors summarize the current knowledge of GSC biology and function and the role of GSCs in new vascular formation within glioblastoma and discuss potential therapeutic approaches to target GSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFS7HBs9MUiM8MEzWGjS9fW6udTcc2eY_iNEHs2adiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtVOisg%253D%253D&md5=7deb1b90f5996939f1079be086436ea7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1155%2F2016%2F7849890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F7849890%26sid%3Dliteratum%253Aachs%26aulast%3DLiebelt%26aufirst%3DB.%2BD.%26aulast%3DShingu%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DS.%2BA.%26aulast%3DHu%26aufirst%3DJ.%26atitle%3DGlioma%2520Stem%2520Cells%253A%2520Signaling%252C%2520Microenvironment%252C%2520and%2520Therapy%26jtitle%3DStem%2520Cells%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D7849890%26doi%3D10.1155%2F2016%2F7849890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patabendige, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolman, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusof, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. J.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Blood-Brain Barrier</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.nbd.2009.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19664713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=13-25&author=N.+J.+Abbottauthor=A.+A.+Patabendigeauthor=D.+E.+Dolmanauthor=S.+R.+Yusofauthor=D.+J.+Begley&title=Structure+and+Function+of+the+Blood-Brain+Barrier&doi=10.1016%2Fj.nbd.2009.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Patabendige, Adjanie A. K.; Dolman, Diana E. M.; Yusof, Siti R.; Begley, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment.  Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier.  The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange.  The structure and function of the BBB is summarized, the phys. barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms.  The roles of assocd. cells are outlined, esp. the end feet of astrocytic glial cells, and pericytes and microglia.  The embryonic development of the BBB, and changes in pathol. are described.  The BBB is subject to short and long-term regulation, which may be disturbed in pathol.  Any program for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLiRwl4gXHmbVg90H21EOLACvtfcHk0ljvgfDsEQl_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P&md5=fa08cd39c1350b4c845121c21a174ad8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DPatabendige%26aufirst%3DA.%2BA.%26aulast%3DDolman%26aufirst%3DD.%2BE.%26aulast%3DYusof%26aufirst%3DS.%2BR.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2009.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yetkin-Arik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gooijer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurdinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, H. E.</span></span> <span> </span><span class="NLM_article-title">Overcoming the Blood-Brain Tumor Barrier for Effective Glioblastoma Treatment</span>. <i>Drug Resist. Updates</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.drup.2015.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.drup.2015.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25791797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmtFGhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1-12&author=O.+van%0ATellingenauthor=B.+Yetkin-Arikauthor=M.+C.+de+Gooijerauthor=P.+Wesselingauthor=T.+Wurdingerauthor=H.+E.+de+Vries&title=Overcoming+the+Blood-Brain+Tumor+Barrier+for+Effective+Glioblastoma+Treatment&doi=10.1016%2Fj.drup.2015.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the blood-brain tumor barrier for effective glioblastoma treatment</span></div><div class="casAuthors">van Tellingen O; Yetkin-Arik B; de Gooijer M C; Wesseling P; Wurdinger T; de Vries H E</div><div class="citationInfo"><span class="NLM_cas:title">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Gliomas are the most common primary brain tumors.  Particularly in adult patients, the vast majority of gliomas belongs to the heterogeneous group of diffuse gliomas, i.e. glial tumors characterized by diffuse infiltrative growth in the preexistent brain tissue.  Unfortunately, glioblastoma, the most aggressive (WHO grade IV) diffuse glioma is also by far the most frequent one.  After standard treatment, the 2-year overall survival of glioblastoma patients is approximately only 25%.  Advanced knowledge in the molecular pathology underlying malignant transformation has offered new handles and better treatments for several cancer types.  Unfortunately, glioblastoma multiforme (GBM) patients have not yet profited as although numerous experimental drugs have been tested in clinical trials, all failed miserably.  This grim prognosis for GBM is at least partly due to the lack of successful drug delivery across the blood-brain tumor barrier (BBTB).  The human brain comprises over 100 billion capillaries with a total length of 400 miles, a total surface area of 20 m(2) and a median inter-capillary distance of about 50 μm, making it the best perfused organ in the body.  The BBTB encompasses existing and newly formed blood vessels that contribute to the delivery of nutrients and oxygen to the tumor and facilitate glioma cell migration to other parts of the brain.  The high metabolic demands of high-grade glioma create hypoxic areas that trigger increased expression of VEGF and angiogenesis, leading to the formation of abnormal vessels and a dysfunctional BBTB.  Even though the BBTB is considered 'leaky' in the core part of glioblastomas, in large parts of glioblastomas and, even more so, in lower grade diffuse gliomas the BBTB more closely resembles the intact blood-brain barrier (BBB) and prevents efficient passage of cancer therapeutics, including small molecules and antibodies.  Thus, many drugs can still be blocked from reaching the many infiltrative glioblastoma cells that demonstrate 'within-organ-metastasis' away from the core part to brain areas displaying a more organized and less leaky BBTB.  Hence, drug delivery in glioblastoma deserves explicit attention as otherwise new experimental therapies will continue to fail.  In the current review we highlight different aspects of the BBTB in glioma patients and preclinical models and discuss the advantages and drawbacks of drug delivery approaches for the treatment of glioma patients.  We provide an overview on methods to overcome the BBTB, including osmotic blood-brain barrier disruption (BBBD), bradykinin receptor-mediated BBTB opening, inhibition of multidrug efflux transporters, receptor-mediated transport systems and physiological circumvention of the BBTB.  While our knowledge about the molecular biology of glioma cells is rapidly expanding and is, to some extent, already assisting us in the design of tumor-tailored therapeutics, we are still struggling to develop modalities to expose the entire tumor to such therapeutics at pharmacologically meaningful quantities.  Therefore, we must expand our knowledge about the fundamentals of the BBTB as a step toward the design of practical and safe devices and approaches for enhanced drug delivery into the diseased brain area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfxbfaIM8XluRS7coPn-RtfW6udTcc2eY_iNEHs2adiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmtFGhtA%253D%253D&md5=dfc68f7c7bc5d75354120d8e929bf2a9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2015.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2015.02.002%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BTellingen%26aufirst%3DO.%26aulast%3DYetkin-Arik%26aufirst%3DB.%26aulast%3Dde%2BGooijer%26aufirst%3DM.%2BC.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DWurdinger%26aufirst%3DT.%26aulast%3Dde%2BVries%26aufirst%3DH.%2BE.%26atitle%3DOvercoming%2520the%2520Blood-Brain%2520Tumor%2520Barrier%2520for%2520Effective%2520Glioblastoma%2520Treatment%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2015%26volume%3D19%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.drup.2015.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarkaria, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parney, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pafundi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laack, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizilbash, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laramy, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agar, N. Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmquist, W. F.</span></span> <span> </span><span class="NLM_article-title">Is the Blood-Brain Barrier Really Disrupted in All Glioblastomas? A Critical Assessment of Existing Clinical Data</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nox175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1093%2Fneuonc%2Fnox175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29016900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Ogsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=184-191&author=J.+N.+Sarkariaauthor=L.+S.+Huauthor=I.+F.+Parneyauthor=D.+H.+Pafundiauthor=D.+H.+Brinkmannauthor=N.+N.+Laackauthor=C.+Gianniniauthor=T.+C.+Burnsauthor=S.+H.+Kizilbashauthor=J.+K.+Laramyauthor=K.+R.+Swansonauthor=T.+J.+Kaufmannauthor=P.+D.+Brownauthor=N.+Y.+R.+Agarauthor=E.+Galanisauthor=J.+C.+Bucknerauthor=W.+F.+Elmquist&title=Is+the+Blood-Brain+Barrier+Really+Disrupted+in+All+Glioblastomas%3F+A+Critical+Assessment+of+Existing+Clinical+Data&doi=10.1093%2Fneuonc%2Fnox175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data</span></div><div class="casAuthors">Sarkaria, Jann N.; Hu, Leland S.; Parney, Ian F.; Pafundi, Deanna H.; Brinkmann, Debra H.; Laack, Nadia N.; Giannini, Caterina; Burns, Terence C.; Kizilbash, Sani H.; Laramy, Janice K.; Swanson, Kristin R.; Kaufmann, Timothy J.; Brown, Paul D.; Agar, Nathalie Y. R.; Galanis, Evanthia; Buckner, Jan C.; Elmquist, William F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1523-5866</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) excludes the vast majority of cancer therapeutics from normal brain.  However, the importance of the BBB in limiting drug delivery and efficacy is controversial in high-grade brain tumors, such as glioblastoma (GBM).  The accumulation of normally brain impenetrant radiog. contrast material in essentially all GBM has popularized a belief that the BBB is uniformly disrupted in all GBM patients so that consideration of drug distribution across the BBB is not relevant in designing therapies for GBM.  However, contrary to this view, overwhelming clin. evidence demonstrates that there is also a clin. significant tumor burden with an intact BBB in all GBM, and there is little doubt that drugs with poor BBB permeability do not provide therapeutically effective drug exposures to this fraction of tumor cells.  This review provides an overview of the clin. literature to support a central hypothesis: that all GBM patients have tumor regions with an intact BBB, and cure for GBM will only be possible if these regions of tumor are adequately treated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMfa57RTmFi7Vg90H21EOLACvtfcHk0ljunF-WSDqkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Ogsbs%253D&md5=16f3f39fa253e4b5814ca3040c4d661c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnox175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnox175%26sid%3Dliteratum%253Aachs%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DHu%26aufirst%3DL.%2BS.%26aulast%3DParney%26aufirst%3DI.%2BF.%26aulast%3DPafundi%26aufirst%3DD.%2BH.%26aulast%3DBrinkmann%26aufirst%3DD.%2BH.%26aulast%3DLaack%26aufirst%3DN.%2BN.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DT.%2BC.%26aulast%3DKizilbash%26aufirst%3DS.%2BH.%26aulast%3DLaramy%26aufirst%3DJ.%2BK.%26aulast%3DSwanson%26aufirst%3DK.%2BR.%26aulast%3DKaufmann%26aufirst%3DT.%2BJ.%26aulast%3DBrown%26aufirst%3DP.%2BD.%26aulast%3DAgar%26aufirst%3DN.%2BY.%2BR.%26aulast%3DGalanis%26aufirst%3DE.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DIs%2520the%2520Blood-Brain%2520Barrier%2520Really%2520Disrupted%2520in%2520All%2520Glioblastomas%253F%2520A%2520Critical%2520Assessment%2520of%2520Existing%2520Clinical%2520Data%26jtitle%3DNeuro%2520Oncol%26date%3D2018%26volume%3D20%26spage%3D184%26epage%3D191%26doi%3D10.1093%2Fneuonc%2Fnox175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. Q.</span></span> <span> </span><span class="NLM_article-title">Current Approaches to Enhance CNS Delivery of Drugs across the Brain Barriers</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2241</span>– <span class="NLM_lpage">2257</span>, <span class="refDoi"> DOI: 10.2147/IJN.S61288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2147%2FIJN.S61288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24872687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC2cjptlGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2241-2257&author=C.+T.+Luauthor=Y.+Z.+Zhaoauthor=H.+L.+Wongauthor=J.+Caiauthor=L.+Pengauthor=X.+Q.+Tian&title=Current+Approaches+to+Enhance+CNS+Delivery+of+Drugs+across+the+Brain+Barriers&doi=10.2147%2FIJN.S61288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Current approaches to enhance CNS delivery of drugs across the brain barriers</span></div><div class="casAuthors">Lu Cui-Tao; Tian Xin-Qiao; Zhao Ying-Zheng; Wong Ho Lun; Cai Jun; Peng Lei</div><div class="citationInfo"><span class="NLM_cas:title">International journal of nanomedicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2241-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although many agents have therapeutic potentials for central nervous system (CNS) diseases, few of these agents have been clinically used because of the brain barriers.  As the protective barrier of the CNS, the blood-brain barrier and the blood-cerebrospinal fluid barrier maintain the brain microenvironment, neuronal activity, and proper functioning of the CNS.  Different strategies for efficient CNS delivery have been studied.  This article reviews the current approaches to open or facilitate penetration across these barriers for enhanced drug delivery to the CNS.  These approaches are summarized into three broad categories: noninvasive, invasive, and miscellaneous techniques.  The progresses made using these approaches are reviewed, and the associated mechanisms and problems are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiAFNhnmth4Q5nADWVYHg1fW6udTcc2eZpXmUal9fWrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjptlGjsQ%253D%253D&md5=6cf22f5aa89db81ccdf2e57fb40f19b0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FIJN.S61288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S61288%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%2BT.%26aulast%3DZhao%26aufirst%3DY.%2BZ.%26aulast%3DWong%26aufirst%3DH.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DX.%2BQ.%26atitle%3DCurrent%2520Approaches%2520to%2520Enhance%2520CNS%2520Delivery%2520of%2520Drugs%2520across%2520the%2520Brain%2520Barriers%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2014%26volume%3D9%26spage%3D2241%26epage%3D2257%26doi%3D10.2147%2FIJN.S61288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohanty, R.</span></span> <span> </span><span class="NLM_article-title">Peptides as Drug Delivery Vehicles across Biological Barriers</span>. <i>J. Pharm. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1007/s40005-017-0374-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs40005-017-0374-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29963321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2018&pages=89-111&author=D.+Ghoshauthor=X.+Pengauthor=J.+Lealauthor=R.+Mohanty&title=Peptides+as+Drug+Delivery+Vehicles+across+Biological+Barriers&doi=10.1007%2Fs40005-017-0374-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Peptides as drug delivery vehicles across biological barriers</span></div><div class="casAuthors">Ghosh, Debadyuti; Peng, Xiujuan; Leal, Jasmim; Mohanty, Rashmi P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-111</span>CODEN:
                <span class="NLM_cas:coden">JPIOBH</span>;
        ISSN:<span class="NLM_cas:issn">2093-5552</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Peptides are small biol. mols. that are attractive in drug delivery and materials engineering for applications including therapeutics, mol. building blocks and cell-targeting ligands. Peptides are small but can possess complexity and functionality as larger proteins. Due to their intrinsic properties, peptides are able to overcome the physiol. and transport barriers presented by diseases. In this review, we discuss the progress of identifying and using peptides to shuttle across biol. barriers and facilitate transport of drugs and drug delivery systems for improved therapy. Here, the focus of this review is on rationally designed, phage display peptides, and even endogenous peptides as carriers to penetrate biol. barriers, specifically the blood-brain barrier (BBB), the gastrointestinal tract (GI), and the solid tumor microenvironment (T). We will discuss recent advances of peptides as drug carriers in these biol. environments. From these findings, challenges and potential opportunities to iterate and improve peptide-based approaches will be discussed to translate their promise towards the clinic to deliver drugs for therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj-teoIAHcfrVg90H21EOLACvtfcHk0ljunF-WSDqkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7nE&md5=4ab7c6f17bb6f70396dc22418aef1edb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs40005-017-0374-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40005-017-0374-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DLeal%26aufirst%3DJ.%26aulast%3DMohanty%26aufirst%3DR.%26atitle%3DPeptides%2520as%2520Drug%2520Delivery%2520Vehicles%2520across%2520Biological%2520Barriers%26jtitle%3DJ.%2520Pharm.%2520Invest.%26date%3D2018%26volume%3D48%26spage%3D89%26epage%3D111%26doi%3D10.1007%2Fs40005-017-0374-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardridge, W. M.</span></span> <span> </span><span class="NLM_article-title">Molecular Trojan Horses for Blood-Brain Barrier Drug Delivery</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.coph.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=16839816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=494-500&author=W.+M.+Pardridge&title=Molecular+Trojan+Horses+for+Blood-Brain+Barrier+Drug+Delivery&doi=10.1016%2Fj.coph.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Trojan horses for blood-brain barrier drug delivery</span></div><div class="casAuthors">Pardridge, William M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">494-500</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides and recombinant proteins such as neurotrophins, enzymes and monoclonal antibodies, have not been developed as new drugs for the brain because these large mol. drugs do not cross the brain capillary wall, which forms the blood-brain barrier (BBB) in vivo.  A new soln. to the brain drug delivery problem is the genetic engineering of recombinant fusion proteins.  The therapeutic peptide or protein drug is fused to a mol. Trojan horse, which is a second peptide or peptidomimetic monoclonal antibody that binds a specific receptor on the BBB.  The Trojan horse enables receptor-mediated delivery of the fusion protein across the BBB so that the protein drug can enter the brain and exert the desired pharmacol. effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdn5vX2Kb5bVg90H21EOLACvtfcHk0ljunF-WSDqkXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWrsL8%253D&md5=53c63b87e81b4a627df42009338abdb5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DMolecular%2520Trojan%2520Horses%2520for%2520Blood-Brain%2520Barrier%2520Drug%2520Delivery%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D494%26epage%3D500%26doi%3D10.1016%2Fj.coph.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srimanee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">991</span>– <span class="NLM_lpage">1007</span>, <span class="refDoi"> DOI: 10.3390/ph5090991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fph5090991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24280701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCkurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=991-1007&author=J.+Regbergauthor=A.+Srimaneeauthor=U.+Langel&title=Applications+of+Cell-Penetrating+Peptides+for+Tumor+Targeting+and+Future+Cancer+Therapies&doi=10.3390%2Fph5090991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of cell-penetrating peptides for tumor targeting and future cancer therapies</span></div><div class="casAuthors">Regberg, Jakob; Srimanee, Artita; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">991-1007</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cell-penetrating peptides provide a highly promising strategy for intracellular drug delivery.  One relevant clin. application of cell-penetrating peptides is cancer therapeutics.  Peptide based delivery could increase the uptake of drugs in tumor cells and thereby increase the efficacy of the treatment, either of conventional small mol. drugs or oligonucleotide based therapeutics.  This review is focused on the cancer applications of cell penetrating peptides as delivery systems; different aspects of drug loading, cargoes and delivery are discussed together with methods for targeted delivery, activatable cell-penetrating peptides and transducible agents coupled to cell-penetrating peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq990sv2YeyLbVg90H21EOLACvtfcHk0lj79T5o8dx0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCkurjP&md5=aabae0f6ae24ed86261fb174a90d4ef5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fph5090991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph5090991%26sid%3Dliteratum%253Aachs%26aulast%3DRegberg%26aufirst%3DJ.%26aulast%3DSrimanee%26aufirst%3DA.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DApplications%2520of%2520Cell-Penetrating%2520Peptides%2520for%2520Tumor%2520Targeting%2520and%2520Future%2520Cancer%2520Therapies%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D991%26epage%3D1007%26doi%3D10.3390%2Fph5090991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oller-Salvia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Navarro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixido, M.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Shuttle Peptides: An Emerging Paradigm for Brain Delivery</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4690</span>– <span class="NLM_lpage">4707</span>, <span class="refDoi"> DOI: 10.1039/C6CS00076B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1039%2FC6CS00076B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27188322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=4690-4707&author=B.+Oller-Salviaauthor=M.+Sanchez-Navarroauthor=E.+Giraltauthor=M.+Teixido&title=Blood-Brain+Barrier+Shuttle+Peptides%3A+An+Emerging+Paradigm+for+Brain+Delivery&doi=10.1039%2FC6CS00076B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery</span></div><div class="casAuthors">Oller-Salvia, Benjami; Sanchez-Navarro, Macarena; Giralt, Ernest; Teixido, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4690-4707</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain delivery is one of the major challenges in drug development because of the high no. of patients suffering from neural diseases and the low efficiency of the treatments available.  Although the blood-brain barrier (BBB) prevents most drugs from reaching their targets, mol. vectors - known as BBB shuttles - offer great promise to safely overcome this formidable obstacle.  In recent years, peptide shuttles have received growing attention because of their lower cost, reduced immunogenicity, and higher chem. versatility than traditional Trojan horse antibodies and other proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1goQ9PoVFBLVg90H21EOLACvtfcHk0lj79T5o8dx0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFagtbo%253D&md5=95c266d6b59c001b7ad53dfd01802797</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1039%2FC6CS00076B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CS00076B%26sid%3Dliteratum%253Aachs%26aulast%3DOller-Salvia%26aufirst%3DB.%26aulast%3DSanchez-Navarro%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DE.%26aulast%3DTeixido%26aufirst%3DM.%26atitle%3DBlood-Brain%2520Barrier%2520Shuttle%2520Peptides%253A%2520An%2520Emerging%2520Paradigm%2520for%2520Brain%2520Delivery%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D4690%26epage%3D4707%26doi%3D10.1039%2FC6CS00076B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefauconnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">New Advances in the Transport of Doxorubicin through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1124/mol.57.4.679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fmol.57.4.679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10727512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3cXit1ehtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=679-686&author=C.+Rousselleauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=M.+Kaczorekauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=New+Advances+in+the+Transport+of+Doxorubicin+through+the+Blood-Brain+Barrier+by+a+Peptide+Vector-Mediated+Strategy&doi=10.1124%2Fmol.57.4.679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Lefauconnier, Jeanne-Marie; Kaczorek, Michel; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">679-686</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many therapeutic drugs are excluded from entering the brain, due to their lack of transport through the blood-brain barrier (BBB).  To overcome this problem, we have developed a novel method in which short, naturally derived peptides (16-18 amino acids) cross the cellular membranes of the BBB with high efficiency and without compromising its integrity.  The antineoplastic agent doxorubicin (dox) was coupled covalently to two peptides, D-penetratin and SynB1.  The ability of dox to cross the BBB was studied using an in situ rat brain perfusion technique and also by i.v. injection in mice.  In the brain perfusion studies, we first confirmed the very low brain uptake of free radiolabeled dox because of the efflux activity of P-glycoprotein at the BBB.  By contrast, we have demonstrated that when dox is coupled to either the D-penetratin or SynB1 vectors, its uptake was increased by a factor of 6, suggesting that the vectorized dox bypasses P-glycoprotein.  Moreover, using a capillary depletion method, we have shown that vectorization of dox led to a 20-fold increase in the amt. of dox transported into brain parenchyma.  I.v. administration of vectorized dox at a dose of 2.5 mg/kg in mice led to a significant increase in brain dox concns. during the first 30 min of postadministration, compared with free dox.  Addnl., vectorization led to a significant decrease of dox concns. in the heart.  In summary, our results establish that the two peptide vectors used in this study enhance the delivery of dox across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6uZmz-sAHLVg90H21EOLACvtfcHk0lj79T5o8dx0Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXit1ehtbg%253D&md5=c0d0f5513b7bafbc99c0b35fa54e82c8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fmol.57.4.679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.57.4.679%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DNew%2520Advances%2520in%2520the%2520Transport%2520of%2520Doxorubicin%2520through%2520the%2520Blood-Brain%2520Barrier%2520by%2520a%2520Peptide%2520Vector-Mediated%2520Strategy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D679%26epage%3D686%26doi%3D10.1124%2Fmol.57.4.679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefauconnier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Enhanced Delivery of Doxorubicin into the Brain via a Peptide-Vector-Mediated Strategy: Saturation Kinetics and Specificity</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=11123372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=124-131&author=C.+Rousselleauthor=M.+Smirnovaauthor=P.+Clairauthor=J.+M.+Lefauconnierauthor=A.+Chavanieuauthor=B.+Calasauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Enhanced+Delivery+of+Doxorubicin+into+the+Brain+via+a+Peptide-Vector-Mediated+Strategy%3A+Saturation+Kinetics+and+Specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity</span></div><div class="casAuthors">Rousselle, Christophe; Smirnova, Maria; Clair, Philippe; Lefauconnier, Jeanne-Marie; Chavanieu, Alain; Calas, Bernard; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">124-131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Doxorubicin delivery to the brain is often restricted because of the poor transport of this therapeutic mol. through the blood-brain barrier (BBB).  To overcome this problem, we have recently developed a technol., Pep:trans, based on short natural-derived peptides that are able to cross efficiently the BBB without compromising its integrity.  In this study, we have used the in situ mouse brain perfusion method to evaluate the brain uptake of free and vectorized doxorubicin.  Doxorubicin was coupled covalently to small peptide vectors: L-SynB1 (18 amino acids), L-SynB3 (10 amino acids), and its enantiomeric form D-SynB3.  We first confirmed the very low brain uptake of free radiolabeled doxorubicin, which is most likely due to the efflux activity of the P-glycoprotein at the level of the BBB.  Vectorization with either L-SynB1, L-SynB3, or D-SynB3 significantly increased the brain uptake of doxorubicin (about 30-fold).  We also investigated the mechanism of transport of vectorized doxorubicin.  We show that vectorized doxorubicin uses a saturable transport mechanism to cross the BBB.  The effect of poly(L-lysine) and protamine, endocytosis inhibitors, on the transport across the brain was also investigated.  Both inhibitors reduced the brain uptake of vectorized doxorubicin in a dose-dependent manner.  These studies indicate that the transport of vectorized doxorubicin appears to occur via an adsorptive-mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-e-bqv26ckLVg90H21EOLACvtfcHk0lgYlXFRVmt2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVal&md5=ee2f5ebf25318ab139cf43cc9a0f0359</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DSmirnova%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DLefauconnier%26aufirst%3DJ.%2BM.%26aulast%3DChavanieu%26aufirst%3DA.%26aulast%3DCalas%26aufirst%3DB.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DEnhanced%2520Delivery%2520of%2520Doxorubicin%2520into%2520the%2520Brain%2520via%2520a%2520Peptide-Vector-Mediated%2520Strategy%253A%2520Saturation%2520Kinetics%2520and%2520Specificity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D296%26spage%3D124%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokryakov, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwig, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panyutich, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shevchenko, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleshina, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamova, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneva, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehrer, R. I.</span></span> <span> </span><span class="NLM_article-title">Protegrins: Leukocyte Antimicrobial Peptides that Combine Features of Corticostatic Defensins and Tachyplesins</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>327</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80175-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2F0014-5793%2893%2980175-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=8335113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK3sXltlGhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=1993&pages=231-236&author=V.+N.+Kokryakovauthor=S.+S.+Harwigauthor=E.+A.+Panyutichauthor=A.+A.+Shevchenkoauthor=G.+M.+Aleshinaauthor=O.+V.+Shamovaauthor=H.+A.+Kornevaauthor=R.+I.+Lehrer&title=Protegrins%3A+Leukocyte+Antimicrobial+Peptides+that+Combine+Features+of+Corticostatic+Defensins+and+Tachyplesins&doi=10.1016%2F0014-5793%2893%2980175-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins</span></div><div class="casAuthors">Kokryakov, Vladimir N.; Harwig, Sylvia S. L.; Panyutich, Elena A.; Shevchenko, Andrei A.; Aleshina, Galina M.; Shamova, Olga V.; Korneva, Helen A.; Lehrer, Robert I.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Porcine leukocytes contained three homologous peptides, PG-1, 2 and 3, that manifested potent microbicidal activity against Escherichia coli, Listeria monocytogenes and Candida albicans in vitro.  The peptides (protegrins) were composed of 16 (PG-2) or 18 amino acid residues, and, like tachyplesins (broad-spectrum antibiotic peptides of horseshoe crab hemocytes), they contained two intramol. cystine disulfide bonds.  Considerably smaller than defensins, protegrins nevertheless showed substantial homol. to them, esp. to the corticostatic rabbit defensin, NP-3a.  The relatively simple structure of protegrins should provide useful prototypes for constructing congeners with selectively enhanced host defense activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVa00dACBnS7Vg90H21EOLACvtfcHk0lgYlXFRVmt2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlGhsrw%253D&md5=e4d9855d0db677b7abb89bb2933ef803</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980175-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980175-T%26sid%3Dliteratum%253Aachs%26aulast%3DKokryakov%26aufirst%3DV.%2BN.%26aulast%3DHarwig%26aufirst%3DS.%2BS.%26aulast%3DPanyutich%26aufirst%3DE.%2BA.%26aulast%3DShevchenko%26aufirst%3DA.%2BA.%26aulast%3DAleshina%26aufirst%3DG.%2BM.%26aulast%3DShamova%26aufirst%3DO.%2BV.%26aulast%3DKorneva%26aufirst%3DH.%2BA.%26aulast%3DLehrer%26aufirst%3DR.%2BI.%26atitle%3DProtegrins%253A%2520Leukocyte%2520Antimicrobial%2520Peptides%2520that%2520Combine%2520Features%2520of%2520Corticostatic%2520Defensins%2520and%2520Tachyplesins%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D327%26spage%3D231%26epage%3D236%26doi%3D10.1016%2F0014-5793%2893%2980175-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aumelas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roumestand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Despaux, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Solution Structure of the Antimicrobial Peptide Protegrin-1</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>237</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1996.0575p.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1111%2Fj.1432-1033.1996.0575p.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=8647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK28XivVyqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1996&pages=575-583&author=A.+Aumelasauthor=M.+Mangoniauthor=C.+Roumestandauthor=L.+Chicheauthor=E.+Despauxauthor=G.+Grassyauthor=B.+Calasauthor=A.+Chavanieu&title=Synthesis+and+Solution+Structure+of+the+Antimicrobial+Peptide+Protegrin-1&doi=10.1111%2Fj.1432-1033.1996.0575p.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and solution structure of the antimicrobial peptide protegrin-1</span></div><div class="casAuthors">Aumelas, Andre; Mangoni, Matteo; Roumestand, Christian; Chiche, Laurent; Despaux, Ernest; Grassay, Gerard; Calas, Bernard; Chavenieu, Alain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">575-583</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protegrins are members of a family of five Cys-rich, cationic antimicrobial peptides recently isolated from porcine cells.  We have synthesized an 18-amino-acid peptide that corresponds to protegrin-1.  After Cys oxidn., the peptide has bactericidal activity against gram-pos. and gram-neg. bacteria, similar to that described for the natural peptide.  The soln. structure of protegrin-1 was investigated by means of 1H-NMR spectroscopy in water and in (CD3)2SO, with distance-geometry and simulated-annealing calcns.  The C6-C15 and C8-C13 disulfide pattern was detd. on the basis of NMR-derived constraints.  These two parallel disulfide bridges stabilized a β-sheet structure which comprised two antiparallel strands (residues 5-9 and 12-16) linked by a distorted β-turn (residues 9-12).  The N-terminus and C-terminus were essentially disordered.  The distribution of hydrophobic and hydrophilic residues at the peptide surface was found to be a structural feature shared with tachyplesin-1, a related peptide which displays cytolytic activity, and, to a lesser extent, with mammalian defens.  These findings led us to assume that the distribution pattern could be required for the cytolytic activity of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcLR-ARnnnQ7Vg90H21EOLACvtfcHk0lgYlXFRVmt2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVyqu7g%253D&md5=0d50b05c7f07e307fd5b638f2728d442</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1996.0575p.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1996.0575p.x%26sid%3Dliteratum%253Aachs%26aulast%3DAumelas%26aufirst%3DA.%26aulast%3DMangoni%26aufirst%3DM.%26aulast%3DRoumestand%26aufirst%3DC.%26aulast%3DChiche%26aufirst%3DL.%26aulast%3DDespaux%26aufirst%3DE.%26aulast%3DGrassy%26aufirst%3DG.%26aulast%3DCalas%26aufirst%3DB.%26aulast%3DChavanieu%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Solution%2520Structure%2520of%2520the%2520Antimicrobial%2520Peptide%2520Protegrin-1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1996%26volume%3D237%26spage%3D575%26epage%3D583%26doi%3D10.1111%2Fj.1432-1033.1996.0575p.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolintineanu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sayyed-Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaznessis, Y. N.</span></span> <span> </span><span class="NLM_article-title">Poisson-Nernst-Planck Models of Nonequilibrium Ion Electrodiffusion through a Protegrin Transmembrane Pore</span>. <i>PLoS Comput. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1000277</span>, <span class="refDoi"> DOI: 10.1371/journal.pcbi.1000277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pcbi.1000277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19180178" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000277&author=D.+S.+Bolintineanuauthor=A.+Sayyed-Ahmadauthor=H.+T.+Davisauthor=Y.+N.+Kaznessis&title=Poisson-Nernst-Planck+Models+of+Nonequilibrium+Ion+Electrodiffusion+through+a+Protegrin+Transmembrane+Pore&doi=10.1371%2Fjournal.pcbi.1000277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1000277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1000277%26sid%3Dliteratum%253Aachs%26aulast%3DBolintineanu%26aufirst%3DD.%2BS.%26aulast%3DSayyed-Ahmad%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BT.%26aulast%3DKaznessis%26aufirst%3DY.%2BN.%26atitle%3DPoisson-Nernst-Planck%2520Models%2520of%2520Nonequilibrium%2520Ion%2520Electrodiffusion%2520through%2520a%2520Protegrin%2520Transmembrane%2520Pore%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000277%26doi%3D10.1371%2Fjournal.pcbi.1000277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Peptide Delivery to the Brain via Adsorptive-Mediated Endocytosis: Advances with SynB Vectors</span>. <i>AAPS PharmSci</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">E26</span>, <span class="refDoi"> DOI: 10.1208/ps040426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1208%2Fps040426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12645998" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=E26&author=G.+Drinauthor=C.+Rousselleauthor=J.+M.+Scherrmannauthor=A.+R.+Reesauthor=J.+Temsamani&title=Peptide+Delivery+to+the+Brain+via+Adsorptive-Mediated+Endocytosis%3A+Advances+with+SynB+Vectors&doi=10.1208%2Fps040426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1208%2Fps040426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fps040426%26sid%3Dliteratum%253Aachs%26aulast%3DDrin%26aufirst%3DG.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DPeptide%2520Delivery%2520to%2520the%2520Brain%2520via%2520Adsorptive-Mediated%2520Endocytosis%253A%2520Advances%2520with%2520SynB%2520Vectors%26jtitle%3DAAPS%2520PharmSci%26date%3D2002%26volume%3D4%26spage%3DE26%26doi%3D10.1208%2Fps040426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Studies on the Internalization Mechanism of Cationic Cell-Penetrating Peptides</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">31192</span>– <span class="NLM_lpage">31201</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303938200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1074%2Fjbc.M303938200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12783857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFequrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=31192-31201&author=G.+Drinauthor=S.+Cottinauthor=E.+Blancauthor=A.+R.+Reesauthor=J.+Temsamani&title=Studies+on+the+Internalization+Mechanism+of+Cationic+Cell-Penetrating+Peptides&doi=10.1074%2Fjbc.M303938200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the internalization mechanism of cationic cell-penetrating peptides</span></div><div class="casAuthors">Drin, Guillaume; Cottin, Sylvine; Blanc, Emmanuelle; Rees, Anthony R.; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">31192-31201</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A great deal of data has been amassed suggesting that cationic peptides are able to translocate into eucaryotic cells in a temp.-independent manner.  Although such peptides are widely used to promote the intracellular delivery of bioactive mols., the mechanism by which this cell-penetrating activity occurs still remains unclear.  Here, we present an in vitro study of the cellular uptake of peptides, originally deriving from protegrin (the SynB peptide vectors), that have also been shown to enhance the transport of drugs across the blood-brain barrier.  In parallel, we have examd. the internalization process of two lipid-interacting peptides, SynB5 and pAntp-(43-58), the latter corresponding to the translocating segment of the Antennapedia homeodomain.  We report a quant. study of the time- and dose-dependence of internalization and demonstrate that these peptides accumulate inside vesicular structures.  Furthermore, we have examd. the role of endocytotic pathways in this process using a variety of metabolic and endocytosis inhibitors.  We show that the internalization of these peptides is a temp.- and energy-dependent process and that endosomal transport is a key component of the mechanism.  Altogether, our results suggest that SynB and pAntp-(43-58) peptides penetrate into cells by an adsorptive-mediated endocytosis process rather than temp.-independent translocation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOaqOcflsV7Vg90H21EOLACvtfcHk0lg2-8v0tFuSGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFequrw%253D&md5=77b9013a7f7e394c93183f4d992e702f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303938200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303938200%26sid%3Dliteratum%253Aachs%26aulast%3DDrin%26aufirst%3DG.%26aulast%3DCottin%26aufirst%3DS.%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520the%2520Internalization%2520Mechanism%2520of%2520Cationic%2520Cell-Penetrating%2520Peptides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D31192%26epage%3D31201%26doi%3D10.1074%2Fjbc.M303938200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herve, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghinea, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">CNS Delivery via Adsorptive Transcytosis</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1208/s12248-008-9055-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1208%2Fs12248-008-9055-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18726697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=455-472&author=F.+Herveauthor=N.+Ghineaauthor=J.+M.+Scherrmann&title=CNS+Delivery+via+Adsorptive+Transcytosis&doi=10.1208%2Fs12248-008-9055-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">CNS delivery via adsorptive transcytosis</span></div><div class="casAuthors">Herve, Francoise; Ghinea, Nicolae; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-472</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Adsorptive-mediated transcytosis (AMT) provides a means for brain delivery of medicines across the blood-brain barrier (BBB).  The BBB is readily equipped for the AMT process: it provides both the potential for binding and uptake of cationic mols. to the luminal surface of endothelial cells, and then for exocytosis at the abluminal surface.  The transcytotic pathways present at the BBB and its morphol. and enzymic properties provide the means for movement of the mols. through the endothelial cytoplasm.  AMT-based drug delivery to the brain was performed using cationic proteins and cell-penetrating peptides (CPPs).  Protein cationization using either synthetic or natural polyamines is discussed and some examples of diamine/polyamine modified proteins that cross BBB are described.  Two main families of CPPs belonging to the Tat-derived peptides and Syn-B vectors have been extensively used in CPP vector-mediated strategies allowing delivery of a large variety of small mols. as well as proteins across cell membranes in vitro and the BBB in vivo.  CPP strategy suffers from several limitations such as toxicity and immunogenicity-like the cationization strategy-as well as the instability of peptide vectors in biol. media.  The review concludes by stressing the need to improve the understanding of AMT mechanisms at BBB and the effectiveness of cationized proteins and CPP-vectorized proteins as neurotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIswum5OkBLVg90H21EOLACvtfcHk0lg2-8v0tFuSGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVSktLk%253D&md5=a3ba8b01c124c1c9a4234b37003095e2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9055-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9055-2%26sid%3Dliteratum%253Aachs%26aulast%3DHerve%26aufirst%3DF.%26aulast%3DGhinea%26aufirst%3DN.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DCNS%2520Delivery%2520via%2520Adsorptive%2520Transcytosis%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D455%26epage%3D472%26doi%3D10.1208%2Fs12248-008-9055-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathieu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Doxorubicin-Peptide Conjugates Overcome Multidrug Resistance</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1097/00001813-200102000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F00001813-200102000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=11261883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=107-116&author=M.+Mazelauthor=P.+Clairauthor=C.+Rousselleauthor=P.+Vidalauthor=J.+M.+Scherrmannauthor=D.+Mathieuauthor=J.+Temsamani&title=Doxorubicin-Peptide+Conjugates+Overcome+Multidrug+Resistance&doi=10.1097%2F00001813-200102000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Doxorubicin-peptide conjugates overcome multidrug resistance</span></div><div class="casAuthors">Mazel, Martine; Clair, Philippe; Rousselle, Christophe; Vidal, Pierre; Scherrmann, Jean-Michel; Mathieu, Daniele; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A well-known mechanism leading to the emergence of multidrug-resistant tumor cells is the overexpression of P-glycoprotein (P-gp), which is capable of lowering intracellular drug concns.  To overcome this problem, the authors tested the capability of two peptide vectors that are able to cross cellular membranes to deliver doxorubicin in P-gp-expressing cells.  The antitumor effect of peptide-conjugated doxorubicin was tested in human erythroleukemic (K562/ADR) resistant cells.  The conjugate showed potent dose-dependent inhibition of cell growth against K562/ADR cells as compared with doxorubicin alone.  Doxorubicin exhibited IC50 concns. of 65 μM in the resistant cells, whereas vectorized doxorubicin was more effective with IC50 concns. of 3 μM.  After treatment of the resistant cells with verapamil, the intracellular levels of doxorubicin were markedly increased and consequent cytotoxicity was improved.  In contrast, treatment of resistant cells with verapamil did not cause any further enhancement in the cell uptake nor in the cytotoxic effect of the conjugated doxorubicin, indicating that the conjugate bypasses the P-gp.  Finally, the authors show by the in situ brain perfusion method in P-gp-deficient and competent mice that vectorized doxorubicin bypasses the P-gp present at the luminal site of the blood-brain barrier.  These results indicate that vectorization of doxorubicin with peptide vectors is effective in overcoming multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYybMbjpkTWLVg90H21EOLACvtfcHk0lg2-8v0tFuSGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVKnsrw%253D&md5=5f324ea8b2e96ce0c66ba4282761b0bb</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2F00001813-200102000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200102000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMazel%26aufirst%3DM.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DVidal%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DMathieu%26aufirst%3DD.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DDoxorubicin-Peptide%2520Conjugates%2520Overcome%2520Multidrug%2520Resistance%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2001%26volume%3D12%26spage%3D107%26epage%3D116%26doi%3D10.1097%2F00001813-200102000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnafous, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisternino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Peptide-Vector Strategy Bypasses P-Glycoprotein Efflux, and Enhances Brain Transport and Solubility of Paclitaxel</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1097/00001813-200411000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F00001813-200411000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15514563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVeisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=947-954&author=E.+Blancauthor=C.+Bonnafousauthor=P.+Meridaauthor=S.+Cisterninoauthor=P.+Clairauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Peptide-Vector+Strategy+Bypasses+P-Glycoprotein+Efflux%2C+and+Enhances+Brain+Transport+and+Solubility+of+Paclitaxel&doi=10.1097%2F00001813-200411000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel</span></div><div class="casAuthors">Blanc, Emmanuelle; Bonnafous, Cecile; Merida, Peggy; Cisternino, Salvatore; Clair, Philippe; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">947-954</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We present the results obtained with paclitaxel coupled to a peptide-vector SynB3 (PAX-OSUC-SynB3), showing that this peptide-vector enhances the soly. of paclitaxel and its brain uptake in mice using the in situ brain perfusion model.  We also show by the in situ brain perfusion in P-glycoprotein (P-gp)-deficient and wild-type mice that vectorized paclitaxel bypasses the P-gp present at the luminal side of the blood-brain barrier.  The effect of the vectorized paclitaxel on various cancer cells was not significantly different from that of free paclitaxel.  These results indicate that vectorization of paclitaxel may have significant potential for the treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWe1r9wbYN27Vg90H21EOLACvtfcHk0lh0mTwZ1y0guA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVeisrw%253D&md5=13cecce058812f3e3deeda05f0204d56</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1097%2F00001813-200411000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-200411000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DCisternino%26aufirst%3DS.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DPeptide-Vector%2520Strategy%2520Bypasses%2520P-Glycoprotein%2520Efflux%252C%2520and%2520Enhances%2520Brain%2520Transport%2520and%2520Solubility%2520of%2520Paclitaxel%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D947%26epage%3D954%26doi%3D10.1097%2F00001813-200411000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Delivery of Benzylpenicillin with a Peptide-Vector-Mediated Strategy</span>. <i>J. Drug Target</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1080/10611860290031886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1080%2F10611860290031886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12164379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlCrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=309-315&author=C.+Rousselleauthor=P.+Clairauthor=J.+Temsamaniauthor=J.+M.+Scherrmann&title=Improved+Brain+Delivery+of+Benzylpenicillin+with+a+Peptide-Vector-Mediated+Strategy&doi=10.1080%2F10611860290031886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Temsamani, Jamal; Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-315</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Previous studies from our lab. have demonstrated that the coupling of doxorubicin with SynB1 vector dramatically increases its brain uptake.  In the present study, we have evaluated the broad application of this approach using another mol.: benzylpenicillin (B-Pc).  We, therefore, have coupled the β-lactam antibiotic B-Pc with SynB1 and assessed its ability to cross the blood-brain barrier (BBB) using the in situ rat brain perfusion method.  We first confirmed the very low brain uptake of free radiolabeled B-Pc.  When B-Pc was coupled to SynB1, its uptake in brain was increased by a factor of 7, without compromising the BBB integrity.  The vectorized B-Pc was distributed in all the gray areas assessed (frontal, parietal, and occipital cortex, thalamus, hippocampus, and striatum).  Moreover, using a wash-out procedure and a capillary depletion method, we have shown that the radiolabeled B-Pc was assocd. mainly with brain parenchyma.  In summary, this study demonstrates the successful application of the use of SynB1 vector for the transport of B-Pc across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpnrERGhxq6bVg90H21EOLACvtfcHk0lh0mTwZ1y0guA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlCrt7Y%253D&md5=7dd2678af57ae7643c9cca2fe4aa679e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F10611860290031886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10611860290031886%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520Brain%2520Delivery%2520of%2520Benzylpenicillin%2520with%2520a%2520Peptide-Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Drug%2520Target%26date%3D2002%26volume%3D10%26spage%3D309%26epage%3D315%26doi%3D10.1080%2F10611860290031886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasternak, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gac-Breton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.048520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fjpet.102.048520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=12682214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=371-376&author=C.+Rousselleauthor=P.+Clairauthor=M.+Smirnovaauthor=Y.+Kolesnikovauthor=G.+W.+Pasternakauthor=S.+Gac-Bretonauthor=A.+R.+Reesauthor=J.+M.+Scherrmannauthor=J.+Temsamani&title=Improved+Brain+Uptake+and+Pharmacological+Activity+of+Dalargin+Using+a+Peptide-Vector-Mediated+Strategy&doi=10.1124%2Fjpet.102.048520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy</span></div><div class="casAuthors">Rousselle, Christophe; Clair, Philippe; Smirnova, Maria; Kolesnikov, Yuri; Pasternak, Gavril W.; Gac-Breton, Stephanie; Rees, Anthony R.; Scherrmann, Jean-Michel; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">371-376</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The blood-brain barrier restricts the passage of substances into the brain.  Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier.  Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain.  Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacol. effect.  We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin.  We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the obsd. antinociceptive effect of dalargin.  These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah5nliPBGe7Vg90H21EOLACvtfcHk0lh0mTwZ1y0guA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ks78%253D&md5=cc48340960c5a65a6aa12e1bf9f2627e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.048520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.048520%26sid%3Dliteratum%253Aachs%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DSmirnova%26aufirst%3DM.%26aulast%3DKolesnikov%26aufirst%3DY.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26aulast%3DGac-Breton%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3DImproved%2520Brain%2520Uptake%2520and%2520Pharmacological%2520Activity%2520of%2520Dalargin%2520Using%2520a%2520Peptide-Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D371%26epage%3D376%26doi%3D10.1124%2Fjpet.102.048520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnafous, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousselle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisse, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczorek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherrmann, J. M.</span></span> <span> </span><span class="NLM_article-title">Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.081000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1124%2Fjpet.104.081000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15647327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=712-719&author=J.+Temsamaniauthor=C.+Bonnafousauthor=C.+Rousselleauthor=Y.+Fraisseauthor=P.+Clairauthor=L.+A.+Granierauthor=A.+R.+Reesauthor=M.+Kaczorekauthor=J.+M.+Scherrmann&title=Improved+Brain+Uptake+and+Pharmacological+Activity+Profile+of+Morphine-6-Glucuronide+Using+a+Peptide+Vector-Mediated+Strategy&doi=10.1124%2Fjpet.104.081000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improved brain uptake and pharmacological activity profile of Morphine-6-glucuronide using a peptide vector-mediated strategy</span></div><div class="casAuthors">Temsamani, Jamal; Bonnafous, Cecile; Rousselle, Christophe; Fraisse, Yannik; Clair, Philippe; Granier, Luc-Andre; Rees, Anthony R.; Kaczorek, Michel; Scherrmann, Jean-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine-6-glucuronide (M6G), an active metabolite of morphine, has been shown to have significantly attenuated brain penetration relative to that of morphine.  Recently, we have demonstrated that conjugation of various drugs to peptide vectors significantly enhances their brain uptake.  In this study, we have conjugated morphine-6-glucuronide to a peptide vector SynB3 to enhance its brain uptake and its analgesic potency after systemic administration.  We show by in situ brain perfusion that vectorization of M6G (Syn1001) markedly enhances the brain uptake of M6G.  This enhancement results in a significant improvement in the pharmacol. activity of M6G in several models of nociception.  Syn1001 was about 4 times more potent than free M6G (ED50 of 1.87 vs. 8.74 μmol/kg).  Syn1001 showed also a prolonged duration of action compared with free M6G (300 and 120 min, resp.).  Furthermore, the conjugation of M6G results in a lowered respiratory depression, as measured in a rat model.  Taken together, these data strongly support the utility of peptide-mediated strategies for improving the efficacy of drugs such as M6G for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrrHR8h0dYyrVg90H21EOLACvtfcHk0lif1BdVCi_i9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsLY%253D&md5=436b2ad8faf1339f4b459fdac1f6c416</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081000%26sid%3Dliteratum%253Aachs%26aulast%3DTemsamani%26aufirst%3DJ.%26aulast%3DBonnafous%26aufirst%3DC.%26aulast%3DRousselle%26aufirst%3DC.%26aulast%3DFraisse%26aufirst%3DY.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DGranier%26aufirst%3DL.%2BA.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DKaczorek%26aufirst%3DM.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520Brain%2520Uptake%2520and%2520Pharmacological%2520Activity%2520Profile%2520of%2520Morphine-6-Glucuronide%2520Using%2520a%2520Peptide%2520Vector-Mediated%2520Strategy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D712%26epage%3D719%26doi%3D10.1124%2Fjpet.104.081000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adenot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahana, R.</span></span> <span> </span><span class="NLM_article-title">Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery</span>. <i>Chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1159/000098422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1159%2F000098422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=17202815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=73-76&author=M.+Adenotauthor=P.+Meridaauthor=R.+Lahana&title=Applications+of+a+Blood-Brain+Barrier+Technology+Platform+to+Predict+CNS+Penetration+of+Various+Chemotherapeutic+Agents.+2.+Cationic+Peptide+Vectors+for+Brain+Delivery&doi=10.1159%2F000098422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents 2. Cationic peptide vectors for brain delivery</span></div><div class="casAuthors">Adenot, M.; Merida, P.; Lahana, R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemotherapy (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-76</span>CODEN:
                <span class="NLM_cas:coden">CHTHBK</span>;
        ISSN:<span class="NLM_cas:issn">0009-3157</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">SynB family peptides conjugated to several drugs have been shown to increase the brain uptake and in vivo activities of these drugs via an adsorptive-mediated transcytosis mechanism.  Based on both in vivo and in vitro exptl. data, a cell uptake component has been added to our computational model of blood-brain barrier.  In situ brain perfusion, in vitro cell model and a computational cell uptake model have been used to discover brain-penetrating properties of SynB peptides and to screen libraries of new rationally designed peptide vectors suitable for brain drug delivery.  Starting from small peptide vectors that enhance the brain transport coeff., the BBB platform has made it possible to design libraries of peptide vectors with enhanced transport properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplnQmUfWpl67Vg90H21EOLACvtfcHk0lif1BdVCi_i9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKktLc%253D&md5=e83393e7ae899ac0692171b73aa737c0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1159%2F000098422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000098422%26sid%3Dliteratum%253Aachs%26aulast%3DAdenot%26aufirst%3DM.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DLahana%26aufirst%3DR.%26atitle%3DApplications%2520of%2520a%2520Blood-Brain%2520Barrier%2520Technology%2520Platform%2520to%2520Predict%2520CNS%2520Penetration%2520of%2520Various%2520Chemotherapeutic%2520Agents.%25202.%2520Cationic%2520Peptide%2520Vectors%2520for%2520Brain%2520Delivery%26jtitle%3DChemotherapy%26date%3D2007%26volume%3D53%26spage%3D73%26epage%3D76%26doi%3D10.1159%2F000098422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castex, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temsamani, J.</span></span> <span> </span><span class="NLM_article-title">2-Pyrrolinodoxorubicin and Its Peptide-Vectorized Form Bypass Multidrug Resistance</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1097/01.cad.0000132231.28888.fa</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1097%2F01.cad.0000132231.28888.fa" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15205606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvV2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=609-617&author=C.+Castexauthor=P.+Meridaauthor=E.+Blancauthor=P.+Clairauthor=A.+R.+Reesauthor=J.+Temsamani&title=2-Pyrrolinodoxorubicin+and+Its+Peptide-Vectorized+Form+Bypass+Multidrug+Resistance&doi=10.1097%2F01.cad.0000132231.28888.fa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance</span></div><div class="casAuthors">Castex, Cedric; Merida, Peggy; Blanc, Emmanuelle; Clair, Philippe; Rees, Anthony R.; Temsamani, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-617</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A well-known mechanism leading to the emergence of multidrug-resistant tumor cells is the overexpression of P-glycoprotein, which is capable of lowering intracellular drug concns.  In the present study, we tested the capability of 2-pyrrolinodoxorubicin (p-DOX), a highly potent deriv. of DOX, to bypass multidrug resistance.  The accumulation, intracellular distribution and cytotoxicity of p-DOX were tested in two cell lines (K562 and A2780) and their DOX-resistant counterparts (K562/ADR and A2780/ADR).  Cellular accumulation and cytotoxicity were dramatically lowered for DOX in resistant cell lines, in comparison with non-resistant cells.  In contrast, cellular accumulation, intracellular distribution and cytotoxicity of p-DOX were independent of the nature of the cell lines.  The p-DOX showed potent dose-dependent inhibition of cell growth against resistant cells as compared with DOX.  After treatment of resistant cells with verapamil, the intracellular levels of DOX were markedly increased and consequent cytotoxicity improved.  In contrast, treatment of resistant cells with verapamil did not cause any further enhancement of cell uptake or an increase in the cytotoxic effect of the deriv. p-DOX, indicating that the compd. bypasses the P-glycoprotein.  Finally, we show that vectorization of p-DOX by a peptide vector (SynB3) which has been shown to enhance the brain uptake of DOX and to decrease its heart accumulation does not affect this property.  These results indicate that p-DOX and its vectorized form are potent and effective in overcoming multidrug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNlCX3bdFL57Vg90H21EOLACvtfcHk0lif1BdVCi_i9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvV2ntb0%253D&md5=16c47e8e5d95100495f19749f79d6939</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F01.cad.0000132231.28888.fa&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.cad.0000132231.28888.fa%26sid%3Dliteratum%253Aachs%26aulast%3DCastex%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DP.%26aulast%3DBlanc%26aufirst%3DE.%26aulast%3DClair%26aufirst%3DP.%26aulast%3DRees%26aufirst%3DA.%2BR.%26aulast%3DTemsamani%26aufirst%3DJ.%26atitle%3D2-Pyrrolinodoxorubicin%2520and%2520Its%2520Peptide-Vectorized%2520Form%2520Bypass%2520Multidrug%2520Resistance%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2004%26volume%3D15%26spage%3D609%26epage%3D617%26doi%3D10.1097%2F01.cad.0000132231.28888.fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">The Improved Blood-Brain Barrier Permeability of Endomorphin-1 Using the Cell-Penetrating Peptide SynB3 with Three Different Linkages</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>476</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2014.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ijpharm.2014.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25245547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Shsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=476&publication_year=2014&pages=1-8&author=H.+Liuauthor=W.+Zhangauthor=L.+Maauthor=L.+Fanauthor=F.+Gaoauthor=J.+Niauthor=R.+Wang&title=The+Improved+Blood-Brain+Barrier+Permeability+of+Endomorphin-1+Using+the+Cell-Penetrating+Peptide+SynB3+with+Three+Different+Linkages&doi=10.1016%2Fj.ijpharm.2014.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The improved blood-brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages</span></div><div class="casAuthors">Liu, Hui; Zhang, Wei; Ma, Linnan; Fan, Linlan; Gao, Feiyun; Ni, Jingman; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">476</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endomorphins, although they have high analgesic activity and few undesirable side effects, are not in clin. use because of the blood-brain barrier (BBB).  One promising soln. is to use cell-penetrating peptides (CPPs).  CPPs have the ability to translocate cell membranes and have been successfully applied for delivery of therapeutic mols. across the BBB.  However, little is known about the transport efficiency of different conjugation strategies between cargo and CPPs.  In this study, endomorphin-1 (EM-1) was conjugated with SynB3, an efficient CPP-carrier, via amide, maleimide and disulfide linkages.  The delivery efficiency of three linkers was compared in terms of pharmacodynamics and in vitro metabolic stability.  Near-IR fluorescent and fluorescent microscopy expts. were applied to detect the brain uptake and distribution of CPP delivery qual. and quant.  After the most successful linkage was screened out, the further mechanisms were discussed.  We concluded that compared with the other two linkages, the disulfide bond was the most efficient linkage to deliver EM-1 across the BBB and confirmed that it could be reduced at physiol. conditions in the brain and release its active form.  These findings indicate that for those who need to release a free drug in the brain and maintain activity, a disulfide bond might be the most efficient linkage across the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd-m2iE0KhOLVg90H21EOLACvtfcHk0li1pR7QtLHRJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Shsb3F&md5=48e7b5d5fbec399015bc56d0059a6cc0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2014.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2014.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DNi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DThe%2520Improved%2520Blood-Brain%2520Barrier%2520Permeability%2520of%2520Endomorphin-1%2520Using%2520the%2520Cell-Penetrating%2520Peptide%2520SynB3%2520with%2520Three%2520Different%2520Linkages%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2014%26volume%3D476%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.ijpharm.2014.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Studies on Gelatin-Siloxane Nanoparticles Conjugated with SynB Peptide to Increase Drug Delivery to the Brain</span>. <i>Int. J. Nanomed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1031</span>– <span class="NLM_lpage">1041</span>, <span class="refDoi"> DOI: 10.2147/IJN.S26541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2147%2FIJN.S26541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22403486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1031-1041&author=X.+H.+Tianauthor=F.+Weiauthor=T.+X.+Wangauthor=P.+Wangauthor=X.+N.+Linauthor=J.+Wangauthor=D.+Wangauthor=L.+Ren&title=In+Vitro+and+in+Vivo+Studies+on+Gelatin-Siloxane+Nanoparticles+Conjugated+with+SynB+Peptide+to+Increase+Drug+Delivery+to+the+Brain&doi=10.2147%2FIJN.S26541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain</span></div><div class="casAuthors">Tian, Xin-Hua; Wei, Feng; Wang, Tian-Xiao; Wang, Peng; Lin, Xiao-Ning; Wang, Jun; Wang, Dong; Ren, Lei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1031-1041</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Nanobiotechnol. can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful.  Use of nanoparticles is a promising strategy for overcoming the blood-brain barrier and delivering drugs to the brain.  Gelatin-siloxane (GS) nanoparticles modified with Tat peptide can enhance plasmid DNA transfection efficiency compared with a com. reagent.  Methods: SynB-PEG-GS nanoparticles are membrane-penetrable, and can cross the blood-brain barrier and deliver a drug to its target site in the brain.  The efficiency of delivery was investigated in vivo and in vitro using brain capillary endothelial cells, a cocultured blood-brain barrier model, and a normal mouse model.  Results: Our study demonstrated that both SynB-PEG-GS and PEG-GS nanoparticles had a spherical shape and an av. diam. of 150-200 nm.  It was shown by MTT assay that SynB-PEG-GS nanoparticles had good biocompatibility with brain capillary endothelial cells.  Cellular uptake by SynB-PEG-GS nanoparticles was higher than that for PEG-GS nanoparticles for all incubation periods.  The amt. of SynB-PEG-GS nanoparticles crossing the cocultured blood-brain barrier model was significantly higher than that of PEG-GS nanoparticles at all time points measured (P < 0.05).  In animal testing, SynB-PEG-GS nanoparticle levels in the brain were significantly higher than those of PEG-GS nanoparticles at all time points measured (P < 0.01).  In contrast with localization in the brain, PEG-GS nanoparticle levels were significantly higher than those of SynB-PEG-GS nanoparticles (P < 0.01) in the liver.  Conclusion: This study indicates that SynB-PEG-GS nanoparticles have favorable properties with regard to morphol., size distribution, and toxicity.  Moreover, the SynB-PEG-GS nanoparticles exhibited more efficient brain capillary endothelial cell uptake and improved crossing of the blood-brain barrier.  Further, biodistribution studies of rhodamine-loaded nanoparticles demonstrated that modification with the SynB peptide could not only improve the ability of PEG-GS nanoparticles to evade capture in the reticuloendothelial system but also enhance their efficiency in crossing the blood-brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQoFHPbbbugLVg90H21EOLACvtfcHk0li1pR7QtLHRJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFWrsLc%253D&md5=12c3b0832b6f1ec93b2d528349dc413d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2147%2FIJN.S26541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S26541%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DX.%2BH.%26aulast%3DWei%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%2BX.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DX.%2BN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Studies%2520on%2520Gelatin-Siloxane%2520Nanoparticles%2520Conjugated%2520with%2520SynB%2520Peptide%2520to%2520Increase%2520Drug%2520Delivery%2520to%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D1031%26epage%3D1041%26doi%3D10.2147%2FIJN.S26541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wynendaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevaert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peremans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burvenich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Spiegeleer, B.</span></span> <span> </span><span class="NLM_article-title">Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0139652</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0139652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pone.0139652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26465925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCmtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=S.+Stalmansauthor=N.+Brackeauthor=E.+Wynendaeleauthor=B.+Gevaertauthor=K.+Peremansauthor=C.+Burvenichauthor=I.+Polisauthor=B.+De+Spiegeleer&title=Cell-Penetrating+Peptides+Selectively+Cross+the+Blood-Brain+Barrier+In+Vivo&doi=10.1371%2Fjournal.pone.0139652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides selectively cross the blood-brain barrier in vivo</span></div><div class="casAuthors">Stalmans, Sofie; Bracke, Nathalie; Wynendaele, Evelien; Gevaert, Bert; Peremans, Kathelijne; Burvenich, Christian; Polis, Ingeborgh; De Spiegeleer, Bart</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0139652/1-e0139652/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers.  CPPs themselves can exert biol. activity and can be formed endogenously.  Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB).  However, comparative, quant. data on the BBB permeability of different CPPs are currently lacking.  Therefore, the in vivo BBB transport characteristics of five chem. diverse CPPs, i.e. pVEC, SynB3, Tat 47'"57, transportan 10 (TP10) and TP10-2, were detd.  The results of the multiple time regression (MTR) anal. revealed that CPPs show divergent BBB influx properties: Tat 47'"57, SynB3, and esp. pVEC showed very high unidirectional influx rates of 4.73 μl/(g × min), 5.63 μl/(g × min) and 6.02 μl/(g × min), resp., while the transportan analogs showed a negligible to low brain influx.  Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma.  Except for pVEC, all peptides showed a significant efflux out of the brain.  Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties.  A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP.  No significant regional differences in brain influx were obsd., with the exception for pVEC, for which the regional variations were only marginal.  The obsd. BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGq6lVzxbIrVg90H21EOLACvtfcHk0li1pR7QtLHRJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCmtr7J&md5=feaed00f70b3ddae7aca94ec393fba69</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0139652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0139652%26sid%3Dliteratum%253Aachs%26aulast%3DStalmans%26aufirst%3DS.%26aulast%3DBracke%26aufirst%3DN.%26aulast%3DWynendaele%26aufirst%3DE.%26aulast%3DGevaert%26aufirst%3DB.%26aulast%3DPeremans%26aufirst%3DK.%26aulast%3DBurvenich%26aufirst%3DC.%26aulast%3DPolis%26aufirst%3DI.%26aulast%3DDe%2BSpiegeleer%26aufirst%3DB.%26atitle%3DCell-Penetrating%2520Peptides%2520Selectively%2520Cross%2520the%2520Blood-Brain%2520Barrier%2520In%2520Vivo%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0139652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodle, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mixson, A. J.</span></span> <span> </span><span class="NLM_article-title">NRP1 Transport of Cancer Therapeutics Mediated by Tumor-Penetrating Peptides</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1358/dof.2017.042.02.2564106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1358%2Fdof.2017.042.02.2564106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28603338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC1cnntF2gtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=95-104&author=Q.+Lengauthor=M.+C.+Woodleauthor=A.+J.+Mixson&title=NRP1+Transport+of+Cancer+Therapeutics+Mediated+by+Tumor-Penetrating+Peptides&doi=10.1358%2Fdof.2017.042.02.2564106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides</span></div><div class="casAuthors">Leng Qixin; Mixson A James; Woodle Martin C</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the future</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    </div><div class="casAbstract">Whereas uptake of low molecular weight agents is generally inhibited in tumors due to high interstitial pressure, tumor uptake of macromolecules is increased due to enhanced permeability and retention (EPR).  Small molecule drugs alone or incorporated in nanoparticles (NP) have largely been dependent on such physical tumor uptake (passive) for therapeutic activity.  Although passive targeted NP such as Stealth Liposomal Doxorubicin (Doxil ®) are effective with improved safety, drug delivery to tumors is still significantly limited.  To improve tumor delivery and efficacy, tumor-penetrating peptides (TPP), which contain sequences that target the tumor and activate the neuropilin-1 receptor (NRP1), have either been co-administered with or conjugated to both small and large therapeutic molecules.  In this review, we will discuss TPP-mediated therapeutics which target the NRP1 transport system of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIj3ueQUym6pZoeNcnHOQ9fW6udTcc2eaDyIu9TCe3Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnntF2gtA%253D%253D&md5=cbc728c6837a767c635fa10f58118e6a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1358%2Fdof.2017.042.02.2564106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2017.042.02.2564106%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DQ.%26aulast%3DWoodle%26aufirst%3DM.%2BC.%26aulast%3DMixson%26aufirst%3DA.%2BJ.%26atitle%3DNRP1%2520Transport%2520of%2520Cancer%2520Therapeutics%2520Mediated%2520by%2520Tumor-Penetrating%2520Peptides%26jtitle%3DDrugs%2520Future%26date%3D2017%26volume%3D42%26spage%3D95%26epage%3D104%26doi%3D10.1358%2Fdof.2017.042.02.2564106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangalam, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFrance-Corey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atanga, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angom, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucchinetti, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, D.</span></span> <span> </span><span class="NLM_article-title">Neuropilin-1 Modulates Interferon-Gamma-Stimulated Signaling in Brain Microvascular Endothelial Cells</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">3911</span>– <span class="NLM_lpage">3921</span>, <span class="refDoi"> DOI: 10.1242/jcs.190702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1242%2Fjcs.190702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27591257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2016&pages=3911-3921&author=Y.+Wangauthor=Y.+Caoauthor=A.+K.+Mangalamauthor=Y.+Guoauthor=R.+G.+LaFrance-Coreyauthor=J.+D.+Gamezauthor=P.+A.+Atangaauthor=B.+D.+Clarksonauthor=Y.+Zhangauthor=E.+Wangauthor=R.+S.+Angomauthor=K.+Duttaauthor=B.+Jiauthor=I.+Pirkoauthor=C.+F.+Lucchinettiauthor=C.+L.+Howeauthor=D.+Mukhopadhyay&title=Neuropilin-1+Modulates+Interferon-Gamma-Stimulated+Signaling+in+Brain+Microvascular+Endothelial+Cells&doi=10.1242%2Fjcs.190702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells</span></div><div class="casAuthors">Wang, Ying; Cao, Ying; Mangalam, Ashutosh K.; Guo, Yong; LaFrance-Corey, Reghann G.; Gamez, Jeffrey D.; Atanga, Pascal Aliihnui; Clarkson, Benjamin D.; Zhang, Yuebo; Wang, Enfeng; Angom, Ramcharan Singh; Dutta, Kirthica; Ji, Baoan; Pirko, Istvan; Lucchinetti, Claudia F.; Howe, Charles L.; Mukhopadhyay, Debabrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3911-3921</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Inflammatory response of blood-brain barrier (BBB) endothelial cells plays an important role in pathogenesis of many central nervous system inflammatory diseases, including multiple sclerosis; however, the mol. mechanism mediating BBB endothelial cell inflammatory response remains unclear.  In this study, we first obsd. that knockdown of neuropilin-1 (NRP1), a co-receptor of several structurally diverse ligands, suppressed interferon-γ (IFNγ)-induced C-X-C motif chemokine 10 expression and activation of STAT1 in brain microvascular endothelial cells in a Rac1-dependent manner.  Moreover, endothelial-specific NRP1-knockout mice, VECadherin-Cre-ERT2/NRP1flox/flox mice, showed attenuated disease progression during exptl. autoimmune encephalomyelitis, a mouse neuroinflammatory disease model.  Detailed anal. utilizing histol. staining, quant. PCR, flow cytometry and magnetic resonance imaging demonstrated that deletion of endothelial NRP1 suppressed neuron demyelination, altered lymphocyte infiltration, preserved BBB function and decreased activation of the STAT1-CXCL10 pathway.  Furthermore, increased expression of NRP1 was obsd. in endothelial cells of acute multiple sclerosis lesions.  Our data identify a new mol. mechanism of brain microvascular endothelial inflammatory response through NRP1-IFNγ crosstalk that could be a potential target for intervention of endothelial cell dysfunction in neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkcM16U07JsrVg90H21EOLACvtfcHk0lhhtiMcIOGcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ltr8%253D&md5=bd7c8345a1eff1e757c8064934d47d42</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1242%2Fjcs.190702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.190702%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMangalam%26aufirst%3DA.%2BK.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DLaFrance-Corey%26aufirst%3DR.%2BG.%26aulast%3DGamez%26aufirst%3DJ.%2BD.%26aulast%3DAtanga%26aufirst%3DP.%2BA.%26aulast%3DClarkson%26aufirst%3DB.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DAngom%26aufirst%3DR.%2BS.%26aulast%3DDutta%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DPirko%26aufirst%3DI.%26aulast%3DLucchinetti%26aufirst%3DC.%2BF.%26aulast%3DHowe%26aufirst%3DC.%2BL.%26aulast%3DMukhopadhyay%26aufirst%3DD.%26atitle%3DNeuropilin-1%2520Modulates%2520Interferon-Gamma-Stimulated%2520Signaling%2520in%2520Brain%2520Microvascular%2520Endothelial%2520Cells%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2016%26volume%3D129%26spage%3D3911%26epage%3D3921%26doi%3D10.1242%2Fjcs.190702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span> <span> </span><span class="NLM_article-title">Neuropilin-1 (NRP-1), a Novel Molecular Target of Glioma</span>. <i>J. Nanosci. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6657</span>– <span class="NLM_lpage">6666</span>, <span class="refDoi"> DOI: 10.1166/jnn.2016.11376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1166%2Fjnn.2016.11376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVCmtr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=6657-6666&author=L.+Chenauthor=Y.+Shiauthor=R.+Qiu&title=Neuropilin-1+%28NRP-1%29%2C+a+Novel+Molecular+Target+of+Glioma&doi=10.1166%2Fjnn.2016.11376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilin-1 (NRP-1), a novel molecular target of glioma</span></div><div class="casAuthors">Chen, Lukui; Shi, Yan; Qiu, Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nanoscience and Nanotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6657-6666</span>CODEN:
                <span class="NLM_cas:coden">JNNOAR</span>;
        ISSN:<span class="NLM_cas:issn">1533-4880</span>.
    
            (<span class="NLM_cas:orgname">American Scientific Publishers</span>)
        </div><div class="casAbstract">This paper reviews the recent studies of Neuropilin-1 (NRP-1) as a novel mol. target of glioma.  In this review, we introduce briefly the properties of the NRP-1.  And then we focused on the role of NRP-1 in gliomas, including relationships of NRP-1 expression and glioma prognosis, NRP-1 signaling and p130Cas tyrosine phosphorylation in gliomas, NRP-1 and LD22-4, Sema3A-NRP-1 signaling in gliomas, NRP-1 in the HGF/SF autocrine pathway, NRP-1 and glioma stem-like cells.  Finally, it is concluded that NRP-1 could potentially act as a novel therapeutical target of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmWQq0nHd1p7Vg90H21EOLACvtfcHk0lhhtiMcIOGcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVCmtr%252FN&md5=ba844732a54937b57ca0696baa382767</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1166%2Fjnn.2016.11376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1166%252Fjnn.2016.11376%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DR.%26atitle%3DNeuropilin-1%2520%2528NRP-1%2529%252C%2520a%2520Novel%2520Molecular%2520Target%2520of%2520Glioma%26jtitle%3DJ.%2520Nanosci.%2520Nanotechnol.%26date%3D2016%26volume%3D16%26spage%3D6657%26epage%3D6666%26doi%3D10.1166%2Fjnn.2016.11376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pellet-Many, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachary, I.</span></span> <span> </span><span class="NLM_article-title">Neuropilins: Structure, Function and Role in Disease</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1042/BJ20071639</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1042%2FBJ20071639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18363553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjslykuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=211-226&author=C.+Pellet-Manyauthor=P.+Frankelauthor=H.+Jiaauthor=I.+Zachary&title=Neuropilins%3A+Structure%2C+Function+and+Role+in+Disease&doi=10.1042%2FBJ20071639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropilins: structure, function and role in disease</span></div><div class="casAuthors">Pellet-many, Caroline; Frankel, Paul; Jia, Haiyan; Zachary, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  NRPs (neuropilins) are co-receptors for class 3 semaphorins, polypeptides with key roles in axonal guidance, and for members of the VEGF (vascular endothelial growth factor) family of angiogenic cytokines.  They lack a defined signaling role, but are thought to mediate functional responses as a result of complex formation with other receptors, such as plexins in the case of semaphorins and VEGF receptors (e.g. VEGFR2).  Mutant mouse studies show that NRP1 is essential for neuronal and cardiovascular development, whereas NRP2 has a more restricted role in neuronal patterning and lymphangiogenesis, but recent findings indicate that NRPs may have addnl. biol. roles in other physiol. and disease-related settings.  In particular, NRPs are highly expressed in diverse tumor cell lines and human neoplasms and have been implicated in tumor growth and vascularization in vivo.  However, despite the wealth of information regarding the probable biol. roles of these mols., many aspects of the regulation of cellular function via NRPs remain uncertain, and little is known concerning the mol. mechanisms through which NRPs mediate the functions of their various ligands in different cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNQEjQk8IKgLVg90H21EOLACvtfcHk0lhhtiMcIOGcqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjslykuro%253D&md5=566441c07005831d277facaf9a26f0b7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1042%2FBJ20071639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071639%26sid%3Dliteratum%253Aachs%26aulast%3DPellet-Many%26aufirst%3DC.%26aulast%3DFrankel%26aufirst%3DP.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DZachary%26aufirst%3DI.%26atitle%3DNeuropilins%253A%2520Structure%252C%2520Function%2520and%2520Role%2520in%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D211%26epage%3D226%26doi%3D10.1042%2FBJ20071639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotamraju, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">C-End Rule Peptides Mediate Neuropilin-1-Dependent Cell, Vascular, and Tissue Penetration</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">16157</span>– <span class="NLM_lpage">16162</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908201106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1073%2Fpnas.0908201106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19805273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OjsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16157-16162&author=T.+Teesaluauthor=K.+N.+Sugaharaauthor=V.+R.+Kotamrajuauthor=E.+Ruoslahti&title=C-End+Rule+Peptides+Mediate+Neuropilin-1-Dependent+Cell%2C+Vascular%2C+and+Tissue+Penetration&doi=10.1073%2Fpnas.0908201106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration</span></div><div class="casAuthors">Teesalu, Tambet; Sugahara, Kazuki N.; Kotamraju, Venkata Ramana; Erkki Ruoslahti</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16157-16162, S16157/1-S16157/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Screening of phage libraries expressing random peptides for binding to prostate cancer cells primarily yielded peptides that had a C-terminal arginine (or rarely lysine) residue, usually in a consensus context R/KXXR/K.  Phage expressing these sequences and synthetic nanoparticles coated with them bound to and were internalized into cells.  The C-terminal arginine (or lysine) was essential to the activity; adding another amino acid, or even blocking the free carboxyl group of this arginine residue by amidation, eliminated the binding and internalizing activity.  An internal R/KXXR/K can be exposed and switched on by a cleavage by a protease.  The strict requirement for C-terminal exposure of the motif prompted the authors to term the phenomenon the C-end rule (CendR).  Affinity chromatog. showed that the CendR peptides bind to neuropilin-1 (NRP-1) on the target cells.  NRP-1 is a cell-surface receptor that plays an essential role in angiogenesis, regulation of vascular permeability, and the development of the nervous system.  VEGF-A165 and other ligands of NRP-1 possess a C-terminal CendR sequence that interacts with the b1 domain of NRP-1 and causes cellular internalization and vascular leakage.  The authors' CendR peptides have similar effects, particularly when made multivalent through coupling to a particle.  The authors also noted a unique and important activity of these peptides: penetration and transportation through tissues.  The peptides were able to take payloads up to the nanoparticle size scale deep into extravascular tissue.  The authors' observations have implications in drug delivery and penetration of tissue barriers and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6maubmMQubLVg90H21EOLACvtfcHk0lhrYwSNCAjqJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OjsbbI&md5=3eb210213cfccc091c4aba949d437b42</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908201106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908201106%26sid%3Dliteratum%253Aachs%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DKotamraju%26aufirst%3DV.%2BR.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DC-End%2520Rule%2520Peptides%2520Mediate%2520Neuropilin-1-Dependent%2520Cell%252C%2520Vascular%252C%2520and%2520Tissue%2520Penetration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16157%26epage%3D16162%26doi%3D10.1073%2Fpnas.0908201106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmali, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotamraju, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agemy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattrey, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2009.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ccr.2009.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19962669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=510-520&author=K.+N.+Sugaharaauthor=T.+Teesaluauthor=P.+P.+Karmaliauthor=V.+R.+Kotamrajuauthor=L.+Agemyauthor=O.+M.+Girardauthor=D.+Hanahanauthor=R.+F.+Mattreyauthor=E.+Ruoslahti&title=Tissue-Penetrating+Delivery+of+Compounds+and+Nanoparticles+into+Tumors&doi=10.1016%2Fj.ccr.2009.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue-penetrating delivery of compounds and nanoparticles into tumors</span></div><div class="casAuthors">Sugahara, Kazuki N.; Teesalu, Tambet; Karmali, Priya Prakash; Kotamraju, Venkata Ramana; Agemy, Lilach; Girard, Olivier M.; Hanahan, Douglas; Mattrey, Robert F.; Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">510-520</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Poor penetration of drugs into tumors is a major obstacle in tumor treatment.  We describe a strategy for peptide-mediated delivery of compds. deep into the tumor parenchyma that uses a tumor-homing peptide, iRGD (CRGDK/RGPD/EC).  I.v. injected compds. coupled to iRGD bound to tumor vessels and spread into the extravascular tumor parenchyma, whereas conventional RGD peptides only delivered the cargo to the blood vessels.  IRGD homes to tumors through a three-step process: the RGD motif mediates binding to αv integrins on tumor endothelium and a proteolytic cleavage then exposes a binding motif for neuropilin-1, which mediates penetration into tissue and cells.  Conjugation to iRGD significantly improved the sensitivity of tumor-imaging agents and enhanced the activity of an antitumor drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9SAZVwScjmLVg90H21EOLACvtfcHk0lhrYwSNCAjqJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eqsbY%253D&md5=f42c01e8e751526318903d28d70ce4c4</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2009.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2009.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DKarmali%26aufirst%3DP.%2BP.%26aulast%3DKotamraju%26aufirst%3DV.%2BR.%26aulast%3DAgemy%26aufirst%3DL.%26aulast%3DGirard%26aufirst%3DO.%2BM.%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DMattrey%26aufirst%3DR.%2BF.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTissue-Penetrating%2520Delivery%2520of%2520Compounds%2520and%2520Nanoparticles%2520into%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D510%26epage%3D520%26doi%3D10.1016%2Fj.ccr.2009.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor-Penetrating Peptides</span>. <i>Front. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">216</span>, <span class="refDoi"> DOI: 10.3389/fonc.2013.00216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3389%2Ffonc.2013.00216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=23986882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC3sbjtlGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=216&author=T.+Teesaluauthor=K.+N.+Sugaharaauthor=E.+Ruoslahti&title=Tumor-Penetrating+Peptides&doi=10.3389%2Ffonc.2013.00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-penetrating peptides</span></div><div class="casAuthors">Teesalu Tambet; Sugahara Kazuki N; Ruoslahti Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">216</span>
        ISSN:<span class="NLM_cas:issn">2234-943X</span>.
    </div><div class="casAbstract">Tumor-homing peptides can be used to deliver drugs into tumors.  Phage library screening in live mice has recently identified homing peptides that specifically recognize the endothelium of tumor vessels, extravasate, and penetrate deep into the extravascular tumor tissue.  The prototypic peptide of this class, iRGD (CRGDKGPDC), contains the integrin-binding RGD motif.  RGD mediates tumor-homing through binding to αv integrins, which are selectively expressed on various cells in tumors, including tumor endothelial cells.  The tumor-penetrating properties of iRGD are mediated by a second sequence motif, R/KXXR/K.  This C-end Rule (or CendR) motif is active only when the second basic residue is exposed at the C-terminus of the peptide.  Proteolytic processing of iRGD in tumors activates the cryptic CendR motif, which then binds to neuropilin-1 activating an endocytic bulk transport pathway through tumor tissue.  Phage screening has also yielded tumor-penetrating peptides that function like iRGD in activating the CendR pathway, but bind to a different primary receptor.  Moreover, novel tumor-homing peptides can be constructed from tumor-homing motifs, CendR elements and protease cleavage sites.  Pathologies other than tumors can be targeted with tissue-penetrating peptides, and the primary receptor can also be a vascular "zip code" of a normal tissue.  The CendR technology provides a solution to a major problem in tumor therapy, poor penetration of drugs into tumors.  The tumor-penetrating peptides are capable of taking a payload deep into tumor tissue in mice, and they also penetrate into human tumors ex vivo.  Targeting with these peptides specifically increases the accumulation in tumors of a variety of drugs and contrast agents, such as doxorubicin, antibodies, and nanoparticle-based compounds.  Remarkably the drug to be targeted does not have to be coupled to the peptide; the bulk transport system activated by the peptide sweeps along any compound that is present in the blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW6rUhtQrVfgHqQV89nF-2fW6udTcc2eY-PkJUuOIdh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbjtlGrtg%253D%253D&md5=5bd13d57c5bc6026c30e04de0ab2d087</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3389%2Ffonc.2013.00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffonc.2013.00216%26sid%3Dliteratum%253Aachs%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor-Penetrating%2520Peptides%26jtitle%3DFront.%2520Oncol.%26date%3D2013%26volume%3D3%26spage%3D216%26doi%3D10.3389%2Ffonc.2013.00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor Penetrating Peptides for Improved Drug Delivery</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.addr.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27040947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=3-12&author=E.+Ruoslahti&title=Tumor+Penetrating+Peptides+for+Improved+Drug+Delivery&doi=10.1016%2Fj.addr.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetrating peptides for improved drug delivery</span></div><div class="casAuthors">Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In vivo screening of phage libraries in tumor-bearing mice has been used to identify peptides that direct phage homing to a tumor.  The power of in vivo phage screening is illustrated by the recent discovery of peptides with unique tumor-penetrating properties.  These peptides activate an endocytic transport pathway related to but distinct from macropinocytosis.  They do so through a complex process that involves binding to a primary, tumor-specific receptor, followed by a proteolytic cleavage, and binding to a second receptor.  The second receptor, neuropilin-1 (or neuropilin-2) activates the transport pathway.  This trans-tissue pathway, dubbed the C-end Rule (CendR) pathway, mediates the extravasation transport through extravascular tumor tissue of payloads ranging from small mol. drugs to nanoparticles.  The CendR technol. provides a soln. to a major problem in tumor therapy, poor penetration of drugs into tumors.  Targeted delivery with tumor-penetrating peptides has been shown to specifically increase the accumulation of drugs, antibodies and nanotherapeutics in exptl. tumors in vivo, and in human tumors ex vivo.  Remarkably the payload does not have to be coupled to the peptide; the peptide activates a bulk transport system that sweeps along a drug present in the blood.  Treatment studies in mice have shown improved anti-tumor efficacy and less damage to normal tissues with drugs ranging from traditional chemotherapeutics to antibodies, and to nanoparticle drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcd2TTUqzLrVg90H21EOLACvtfcHk0lgKH4FgwMc1-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D&md5=83c52c1ec16224278feafb06c8522a1e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor%2520Penetrating%2520Peptides%2520for%2520Improved%2520Drug%2520Delivery%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D3%26epage%3D12%26doi%3D10.1016%2Fj.addr.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aza-Blanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruidiaz, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugahara, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teesalu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">An Endocytosis Pathway Initiated through Neuropilin-1 and Regulated by Nutrient Availability</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4904</span>, <span class="refDoi"> DOI: 10.1038/ncomms5904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fncomms5904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=25277522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4904&author=H.+B.+Pangauthor=G.+B.+Braunauthor=T.+Frimanauthor=P.+Aza-Blancauthor=M.+E.+Ruidiazauthor=K.+N.+Sugaharaauthor=T.+Teesaluauthor=E.+Ruoslahti&title=An+Endocytosis+Pathway+Initiated+through+Neuropilin-1+and+Regulated+by+Nutrient+Availability&doi=10.1038%2Fncomms5904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability</span></div><div class="casAuthors">Pang, Hong-Bo; Braun, Gary B.; Friman, Tomas; Aza-Blanc, Pedro; Ruidiaz, Manuel E.; Sugahara, Kazuki N.; Teesalu, Tambet; Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4904</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropilins (NRPs) are trans-membrane receptors involved in axon guidance and vascular development.  Many growth factors and other signalling mols. bind to NRPs through a carboxy (C)-terminal, basic sequence motif (C-end Rule or CendR motif).  Peptides with this motif (CendR peptides) are taken up into cells by endocytosis.  Tumor-homing CendR peptides penetrate through tumor tissue and have shown utility in enhancing drug delivery into tumors.  Here we show, using RNAi screening and subsequent validation studies, that NRP1-mediated endocytosis of CendR peptides is distinct from known endocytic pathways.  Ultrastructurally, CendR endocytosis resembles macropinocytosis, but is mechanistically different.  We also show that nutrient-sensing networks such as mTOR signalling regulate CendR endocytosis and subsequent intercellular transport of CendR cargo, both of which are stimulated by nutrient depletion.  As CendR is a bulk transport pathway, our results suggest a role for it in nutrient transport; CendR-enhanced drug delivery then makes use of this natural pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ0RdXrbSNI7Vg90H21EOLACvtfcHk0lgKH4FgwMc1-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgsL7O&md5=2f0e203d82fd281cee230d9e3f201f38</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fncomms5904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms5904%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DH.%2BB.%26aulast%3DBraun%26aufirst%3DG.%2BB.%26aulast%3DFriman%26aufirst%3DT.%26aulast%3DAza-Blanc%26aufirst%3DP.%26aulast%3DRuidiaz%26aufirst%3DM.%2BE.%26aulast%3DSugahara%26aufirst%3DK.%2BN.%26aulast%3DTeesalu%26aufirst%3DT.%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DAn%2520Endocytosis%2520Pathway%2520Initiated%2520through%2520Neuropilin-1%2520and%2520Regulated%2520by%2520Nutrient%2520Availability%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D4904%26doi%3D10.1038%2Fncomms5904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siemion, I. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluczyk, A.</span></span> <span> </span><span class="NLM_article-title">Tuftsin: On the 30-Year Anniversary of Victor Najjar’s Discovery</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(99)00019-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2FS0196-9781%2899%2900019-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10465518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFCjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=645-674&author=I.+Z.+Siemionauthor=A.+Kluczyk&title=Tuftsin%3A+On+the+30-Year+Anniversary+of+Victor+Najjar%E2%80%99s+Discovery&doi=10.1016%2FS0196-9781%2899%2900019-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin: On the 30-year anniversary of Victor Najjar's discovery</span></div><div class="casAuthors">Siemion, Ignacy Z.; Kluczyk, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">645-674</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 358 refs.  After a short description of the results of Victor Najjar's research on tuftsin and of the discoveries done by other authors in the early stage of tuftsin investigation, the current state of work on tuftsin is presented, based mainly on the literature published in the years 1984-1997.  The mol. structure, protein sequence, antigenic properties, and its effects on phagocytes are reviewed.  Antimicrobial, and antitumor activities of tuftsin and its therapeutic potentials are also summarized.  The presentation follows this order: the occurrence of tuftsin and retro-tuftsin sequences in proteins, their synthesis and biol., the antigenic properties of tuftsin, its influence on phagocytic cells, and other biol. activities of tuftsin, including antimicrobial, antiviral, antitumor and central effects, and the search for tuftsin superactive analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0uIO4JRKgrVg90H21EOLACvtfcHk0lgKH4FgwMc1-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFCjs78%253D&md5=894964c8ade0168d14ea3a094e6259f5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2899%2900019-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252899%252900019-4%26sid%3Dliteratum%253Aachs%26aulast%3DSiemion%26aufirst%3DI.%2BZ.%26aulast%3DKluczyk%26aufirst%3DA.%26atitle%3DTuftsin%253A%2520On%2520the%252030-Year%2520Anniversary%2520of%2520Victor%2520Najjar%25E2%2580%2599s%2520Discovery%26jtitle%3DPeptides%26date%3D1999%26volume%3D20%26spage%3D645%26epage%3D674%26doi%3D10.1016%2FS0196-9781%2899%2900019-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Wronski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanjappan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pochon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span> <span> </span><span class="NLM_article-title">Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">5702</span>– <span class="NLM_lpage">5710</span>, <span class="refDoi"> DOI: 10.1074/jbc.M511941200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1074%2Fjbc.M511941200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=16371354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=5702-5710&author=M.+A.+von%0AWronskiauthor=N.+Rajuauthor=R.+Pillaiauthor=N.+J.+Bogdanauthor=E.+R.+Marinelliauthor=P.+Nanjappanauthor=K.+Ramalingamauthor=T.+Arunachalamauthor=S.+Eatonauthor=K.+E.+Linderauthor=F.+Yanauthor=S.+Pochonauthor=M.+F.+Tweedleauthor=A.+D.+Nunn&title=Tuftsin+Binds+Neuropilin-1+through+a+Sequence+Similar+to+That+Encoded+by+Exon+8+of+Vascular+Endothelial+Growth+Factor&doi=10.1074%2Fjbc.M511941200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor</span></div><div class="casAuthors">von Wronski, Mathew A.; Raju, Natarajan; Pillai, Radhakrishna; Bogdan, Nancy J.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Ramalingam, Kondareddiar; Arunachalam, Thangavel; Eaton, Steve; Linder, Karen E.; Yan, Feng; Pochon, Sibylle; Tweedle, Michael F.; Nunn, Adrian D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5702-5710</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tuftsin, Thr-Lys-Pro-Arg (TKPR), is an immunostimulatory peptide with reported nervous system effects as well.  The authors unexpectedly found that tuftsin and a higher affinity antagonist, TKPPR, bind selectively to neuropilin-1 and block vascular endothelial growth factor (VEGF) binding to that receptor.  Dimeric and tetrameric forms of TKPPR had greatly increased affinity for neuropilin-1 based on competition binding expts.  On endothelial cells tetrameric TKPPR inhibited the VEGF165-induced autophosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) even though it did not directly inhibit VEGF binding to VEGFR-2.  Homol. between exon 8 of VEGF and TKPPR suggests that the sequence coded for by exon 8 may stabilize VEGF binding to neuropilin-1 to facilitate signaling through VEGFR-2.  Given the overlap between processes involving neuropilin-1 and tuftsin, the authors propose that at least some of the previously reported effects of tuftsin are mediated through neuropilin-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52QmZ9B4Q67Vg90H21EOLACvtfcHk0lgwzEZjaNM0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVejtLw%253D&md5=c8a2c3233068ab1764befd74f0f7b77e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511941200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511941200%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BWronski%26aufirst%3DM.%2BA.%26aulast%3DRaju%26aufirst%3DN.%26aulast%3DPillai%26aufirst%3DR.%26aulast%3DBogdan%26aufirst%3DN.%2BJ.%26aulast%3DMarinelli%26aufirst%3DE.%2BR.%26aulast%3DNanjappan%26aufirst%3DP.%26aulast%3DRamalingam%26aufirst%3DK.%26aulast%3DArunachalam%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DS.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DPochon%26aufirst%3DS.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26atitle%3DTuftsin%2520Binds%2520Neuropilin-1%2520through%2520a%2520Sequence%2520Similar%2520to%2520That%2520Encoded%2520by%2520Exon%25208%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D5702%26epage%3D5710%26doi%3D10.1074%2Fjbc.M511941200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selwood, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsirka, S. E.</span></span> <span> </span><span class="NLM_article-title">Tuftsin Signals through Its Receptor Neuropilin-1 via the Transforming Growth Factor Beta Pathway</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1111/jnc.12404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1111%2Fjnc.12404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24033337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1elurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=394-402&author=J.+C.+Nissenauthor=D.+L.+Selwoodauthor=S.+E.+Tsirka&title=Tuftsin+Signals+through+Its+Receptor+Neuropilin-1+via+the+Transforming+Growth+Factor+Beta+Pathway&doi=10.1111%2Fjnc.12404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway</span></div><div class="casAuthors">Nissen, Jillian C.; Selwood, David L.; Tsirka, Stella E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">394-402</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tuftsin (Thr-Lys-Pro-Arg) is a natural immunomodulating peptide found to stimulate phagocytosis in macrophages/microglia.  Tuftsin binds to the receptor neuropilin-1 (Nrp1) on the surface of cells.  Nrp1 is a single-pass transmembrane protein, but its intracellular C-terminal domain is too small to signal independently.  Instead, it assocs. with a variety of coreceptors.  Despite its long history, the pathway through which tuftsin signals has not been described.  To investigate this question, we employed various inhibitors to Nrp1's coreceptors to det. which route is responsible for tuftsin signaling.  We use the inhibitor EG00229, which prevents tuftsin binding to Nrp1 on the surface of microglia and reverses the anti-inflammatory M2 shift induced by tuftsin.  Furthermore, we demonstrate that blockade of transforming growth factor beta (TGFβ) signaling via TβR1 disrupts the M2 shift similar to EG00229.  We report that tuftsin promotes Smad3 phosphorylation and reduces Akt phosphorylation.  Taken together, our data show that tuftsin signals through Nrp1 and the canonical TGFβ signaling pathway.  Despite the 40-yr history of the tetrapeptide tuftsin (TKPR), a macrophage and microglial activator, its mechanism of action has not been defined.  Here, we report that the tuftsin-mediated anti-inflammatory M2 shift in microglia is caused specifically by tuftsin binding to the receptor neuropilin-1 (Nrp1) and signaling through TGFβ receptor-1, a coreceptor of Nrp1.  We further show that tuftsin signals via the canonical TGFβ pathway and promotes TGFβ release from target cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvj4x2zY4f9LVg90H21EOLACvtfcHk0lgwzEZjaNM0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1elurzL&md5=f28fda0de3faa05b767b1e8c3b048527</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12404%26sid%3Dliteratum%253Aachs%26aulast%3DNissen%26aufirst%3DJ.%2BC.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DTsirka%26aufirst%3DS.%2BE.%26atitle%3DTuftsin%2520Signals%2520through%2520Its%2520Receptor%2520Neuropilin-1%2520via%2520the%2520Transforming%2520Growth%2520Factor%2520Beta%2520Pathway%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26spage%3D394%26epage%3D402%26doi%3D10.1111%2Fjnc.12404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bump, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wleklik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, V. A.</span></span> <span> </span><span class="NLM_article-title">Isolation and Subunit Composition of Tuftsin Receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">7187</span>– <span class="NLM_lpage">7191</span>, <span class="refDoi"> DOI: 10.1073/pnas.83.19.7187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1073%2Fpnas.83.19.7187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=3463958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaL28XlvV2jtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=7187-7191&author=N.+J.+Bumpauthor=J.+Leeauthor=M.+Wleklikauthor=J.+Reichlerauthor=V.+A.+Najjar&title=Isolation+and+Subunit+Composition+of+Tuftsin+Receptor&doi=10.1073%2Fpnas.83.19.7187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and subunit composition of tuftsin receptor</span></div><div class="casAuthors">Bump, Nancy J.; Lee, James; Wleklik, Marek; Reichler, Judith; Najjar, Victor A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7187-91</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Tuftsin (Thr-Lys-Pro-Arg) receptor was purified to apparent homogeneity by affinity chromatog., using a pentapeptide analog (Thr-Lys-Pro-Pro-Arg) that binds the receptor >4 times as avidly as tuftsin.  The analog was covalently linked to a solid support (Affi-Gel 10).  Rabbit peritoneal granulocyte membrane solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate was applied to the affinity column, the column was washed with 0.1 M ammonium carbonate (pH 7.9) and 0.1 M ammonium acetate (pH 5), and bound material was eluted with 20 nM tuftsin or pentapeptide.  The eluate was concd. and subjected to gel filtration; this yielded 1 major peak of [3H]tuftsin-binding activity corresponding to ≈500 kilodaltons (kDa) and a minor peak at ≈250 kDa.  Rechromatog. of either peak resulted in the appearance of the same major and minor peaks.  SDS/PAGE of the affinity-purified material under nonreducing conditions showed only 2 Ag-staining bands.  Electroblotting followed by [3H]tuftsin overlay and fluorog. showed 2 adjacent radioactive bands corresponding in mobility to the Ag-stained bands.  Under reducing conditions, SDS/PAGE yielded mol. mass values of 62 kDa and 52 kDa for the 2 tuftsin receptor subunits.  Electron microscopy revealed a homogeneous population of spherical mols. with diams. of 104 Å.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoajhjEAYhxobVg90H21EOLACvtfcHk0lgwzEZjaNM0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlvV2jtb4%253D&md5=4c6a22dba5ab81e52372045004a4104b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.83.19.7187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.83.19.7187%26sid%3Dliteratum%253Aachs%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWleklik%26aufirst%3DM.%26aulast%3DReichler%26aufirst%3DJ.%26aulast%3DNajjar%26aufirst%3DV.%2BA.%26atitle%3DIsolation%2520and%2520Subunit%2520Composition%2520of%2520Tuftsin%2520Receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D7187%26epage%3D7191%26doi%3D10.1073%2Fpnas.83.19.7187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaszi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remenyi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Conformation, and Immunoreactivity of New Carrier Molecules Based on Repeated Tuftsin-Like Sequence</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1002/bip.20024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fbip.20024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=15048768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1SlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=645-656&author=G.+Mezoauthor=A.+Kalasziauthor=J.+Remenyiauthor=Z.+Majerauthor=A.+Hilbertauthor=O.+Langauthor=L.+Kohidaiauthor=K.+Barnaauthor=D.+Gaalauthor=F.+Hudecz&title=Synthesis%2C+Conformation%2C+and+Immunoreactivity+of+New+Carrier+Molecules+Based+on+Repeated+Tuftsin-Like+Sequence&doi=10.1002%2Fbip.20024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence</span></div><div class="casAuthors">Mezo, Gabor; Kalaszi, Adrian; Remenyi, Judit; Majer, Zsuzsa; Hilbert, Agnes; Lang, Orsolya; Kohidai, Laszlo; Barna, Krisztina; Gaal, Dezso; Hudecz, Ferenc</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">645-656</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sequential oligopeptides based on a pentapeptide (TKPKG) derived from tuftsin with different lengths were synthesized by stepwise solid phase methodol.  These highly sol. oligomers were nontoxic on mouse spleen cells, and other biol. data suggested that tuftsin-like properties were also presented.  The (TKPKG)n (n=2,4,6,8) oligopeptides were not immunogenic; however, they increased sheep red blood cells (SRBC) antigen specific antibody response in mice, demonstrating their immunostimulatory effect.  Chemotactic activity was also found on J774 monocyte cells, while MRC5 fibroblasts were chemotactically nonresponders to the tested forms of tuftsin.  These oligomers showed unordered and flexible structure by CD measurements, confirmed by computer modeling studies indicating also a fairly good accessibility of the ε-amino group of each lysine residue.  Data suggest that these new oligotuftsin derivs. can be considered as promising carriers for synthetic vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4pdG8kKWvVLVg90H21EOLACvtfcHk0li8_sXeY9ePMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1SlsbY%253D&md5=e79fc4c07630c29fb40c0c69771f848e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fbip.20024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20024%26sid%3Dliteratum%253Aachs%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DKalaszi%26aufirst%3DA.%26aulast%3DRemenyi%26aufirst%3DJ.%26aulast%3DMajer%26aufirst%3DZ.%26aulast%3DHilbert%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DO.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DBarna%26aufirst%3DK.%26aulast%3DGaal%26aufirst%3DD.%26aulast%3DHudecz%26aufirst%3DF.%26atitle%3DSynthesis%252C%2520Conformation%252C%2520and%2520Immunoreactivity%2520of%2520New%2520Carrier%2520Molecules%2520Based%2520on%2520Repeated%2520Tuftsin-Like%2520Sequence%26jtitle%3DBiopolymers%26date%3D2004%26volume%3D73%26spage%3D645%26epage%3D656%26doi%3D10.1002%2Fbip.20024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and In Vitro Activity of Novel Drug Delivery Systems Containing Tuftsin Derivatives and Methotrexate</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2260</span>– <span class="NLM_lpage">2269</span>, <span class="refDoi"> DOI: 10.1021/bc800115w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc800115w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSlsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2260-2269&author=K.+B.+Baiauthor=O.+Langauthor=E.+Orbanauthor=R.+Szaboauthor=L.+Kohidaiauthor=F.+Hudeczauthor=G.+Mezo&title=Design%2C+Synthesis%2C+and+In+Vitro+Activity+of+Novel+Drug+Delivery+Systems+Containing+Tuftsin+Derivatives+and+Methotrexate&doi=10.1021%2Fbc800115w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and In Vitro Activity of Novel Drug Delivery Systems Containing Tuftsin Derivatives and Methotrexate</span></div><div class="casAuthors">Bai, Katalin B.; Lang, Orsolya; Orban, Erika; Szabo, Rita; Kohidai, Laszlo; Hudecz, Ferenc; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2260-2269</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During the past decade, biodegradable polymers or oligopeptides recognized by cell-surface receptors have been shown to increase drug specificity, lowering systemic drug toxicity in contrast to small-size fast-acting drugs.  The goal of the present study was to develop anticancer bioconjugates based on chemotactic drug targeting (CDT).  These constructs are composed of methotrexate (Mtx) attached to a tuftsin-like peptide carrier through an enzyme-labile pentapeptide spacer (GFLGC) and several copies of a chemotactic targeting moiety (H-TKPR, For-TKPR, H-TKPKG, and Ac-TKPKG).  Carriers with targeting moieties in the branches were prepd. by solid-phase synthesis using mixed Boc and Fmoc strategies.  The drug mol. connected to an enzyme-labile spacer was attached to the branched oligopeptide in soln.  In vitro chemotaxis, cellular uptake, and cytotoxicity assays were carried out on the MonoMac6 cell line.  The most effective conjugates with H-TKPR or Ac-TKPKG targeting moieties in the branches, which have the most advantageous chemotactic properties, can be internalized rapidly, and these conjugates trigger higher toxic effect than the free drug (Mtx).  The results suggest that our tuftsin-based drug delivery systems might be potential candidates for targeting cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqArpV5Kz8pz7Vg90H21EOLACvtfcHk0li8_sXeY9ePMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSlsrbM&md5=593f340087a796d9c9a11f8156426b8d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbc800115w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800115w%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DK.%2BB.%26aulast%3DLang%26aufirst%3DO.%26aulast%3DOrban%26aufirst%3DE.%26aulast%3DSzabo%26aufirst%3DR.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520In%2520Vitro%2520Activity%2520of%2520Novel%2520Drug%2520Delivery%2520Systems%2520Containing%2520Tuftsin%2520Derivatives%2520and%2520Methotrexate%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2260%26epage%3D2269%26doi%3D10.1021%2Fbc800115w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacsa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grolmusz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vertessy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Enhanced Cellular Uptake of a New, In Silico Identified Antitubercular Candidate by Peptide Conjugation</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1021/bc200221t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200221t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=900-907&author=K.+Horvatiauthor=B.+Bacsaauthor=N.+Szaboauthor=S.+Davidauthor=G.+Mezoauthor=V.+Grolmuszauthor=B.+Vertessyauthor=F.+Hudeczauthor=S.+Bosze&title=Enhanced+Cellular+Uptake+of+a+New%2C+In+Silico+Identified+Antitubercular+Candidate+by+Peptide+Conjugation&doi=10.1021%2Fbc200221t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cellular Uptake of a New, in Silico Identified Antitubercular Candidate by Peptide Conjugation</span></div><div class="casAuthors">Horvati, Kata; Bacsa, Bernadett; Szabo, Nora; David, Sandor; Mezo, Gabor; Grolmusz, Vince; Vertessy, Beata; Hudecz, Ferenc; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">900-907</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis is a successful pathogen, and it can survive in infected macrophages in dormant phase for years and decades.  The therapy of tuberculosis takes at least six months, and the slow-growing bacterium is resistant to many antibiotics.  The development of novel antimicrobials to counter the emergence of bacteria resistant to current therapies is urgently needed.  In silico docking methods and structure-based drug design are useful bioinformatics tools for identifying new agents.  A docking expt. to M. tuberculosis dUTPase enzyme, which plays a key role in the bacterial metab., has resulted in 10 new antitubercular drug candidates.  The uptake of antituberculars by infected macrophages is limited by extracellular diffusion.  The optimization of the cellular uptake by drug delivery systems can decrease the used dosages and the length of the therapy, and it can also enhance the bioavailability of the drug mol.  In this study, improved in vitro efficacy was achieved by attaching the TB5 antitubercular drug candidate to peptide carriers.  As drug delivery components, (i) an antimicrobial granulysin peptide and (ii) a receptor specific tuftsin peptide were used.  An efficient synthetic approach was developed to conjugate the in silico identified TB5 coumarone deriv. to the carrier peptides.  The compds. were effective on M. tuberculosis H37Rv culture in vitro; the chem. linkage did not affect the antimycobacterial activity.  Here, we show that the OT20 tuftsin and GranF2 granulysin peptide conjugates have dramatically enhanced uptake into human MonoMac6 cells.  The TB5-OT20 tuftsin conjugate exhibited significant antimycobacterial activity on M. tuberculosis H37Rv infected MonoMac6 cells and inhibited intracellular bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoASABFeIl9gLVg90H21EOLACvtfcHk0li8_sXeY9ePMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsbk%253D&md5=48bb5b7404aeacd426efc4b79b48fe4d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbc200221t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200221t%26sid%3Dliteratum%253Aachs%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBacsa%26aufirst%3DB.%26aulast%3DSzabo%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DGrolmusz%26aufirst%3DV.%26aulast%3DVertessy%26aufirst%3DB.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DEnhanced%2520Cellular%2520Uptake%2520of%2520a%2520New%252C%2520In%2520Silico%2520Identified%2520Antitubercular%2520Candidate%2520by%2520Peptide%2520Conjugation%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D900%26epage%3D907%26doi%3D10.1021%2Fbc200221t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of New Peptide Conjugates of Antitubercular Drug Candidates-Model Membrane and In Vitro Studies</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2016.07.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.colsurfb.2016.07.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27497074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12kt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2016&pages=106-115&author=A.+Abrahamauthor=Z.+Baranyaiauthor=G.+Gyulaiauthor=E.+Pariauthor=K.+Horvatiauthor=S.+Boszeauthor=E.+Kiss&title=Comparative+Analysis+of+New+Peptide+Conjugates+of+Antitubercular+Drug+Candidates-Model+Membrane+and+In+Vitro+Studies&doi=10.1016%2Fj.colsurfb.2016.07.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of new peptide conjugates of antitubercular drug candidates-Model membrane and in vitro studies</span></div><div class="casAuthors">Abraham, A.; Baranyai, Zs.; Gyulai, G.; Pari, E.; Horvati, K.; Bosze, Sz.; Kiss, E.</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel peptide conjugates of two antitubercular drug candidates were synthesized and characterised using new tuftsin peptide deriv. (OT14) as carrier moiety.  As antitubercular drug candidates two pyridopyrimidine derivs., TB803 (2-allylamino-4-oxopyrido[1,2-a]pyrimidine-3-carbaldehyde) and TB820 (4-oxo-2-(pyrrolidin-1-yl)-pyrido[1,2-a]pyrimidin-3-carbaldehyde) inhibiting vital enzyme of Mycobacterium tuberculosis were applied.  Membrane affinity of the compds. TB803 and TB820 and their peptide conjugates was evaluated using exptl. lipid mono- and bilayer models.  Penetration ability was assessed tensiometrically from Langmuir monolayer study and applying quartz crystal microbalance for the supported lipid bilayer (SLB) system.  Minimal inhibitory concn. (MIC) values remained in a similar micromolar range for both of the conjugates while their cellular uptake rate was improved significantly compared to the drug candidates.  A correlation was found between membrane affinity properties and results of in vitro biol. investigations.  Anal. of phys./structural properties of SLB in contact with bioactive components and visualization of the structural change by at.-force microscopy (AFM) provided information on the type and route of mol. interaction of drug construction with lipid layers.  The possible role of electrostatic interactions between lipid layer and drug candidates was tested in Langmuir-balance expts. using neg. charged lipid mixt. (DPPC + DPPG).  Esp. the peptide conjugates presented increased membrane affinity due to cationic character of the peptide sequence selected for the conjugate formation.  That is supposed to be one reason for the enhanced cellular uptake obsd. in vitro on MonoMac6 cell line.  The conjugation of antitubercular agents to a peptidic carrier is a promising approach to enhance membrane affinity, cellular uptake rate and in vitro selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9jYbH0SnJeLVg90H21EOLACvtfcHk0liFYhpyVV3bBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12kt7bO&md5=ea785da98804f186c1018d622cd0784e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2016.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2016.07.054%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DA.%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DGyulai%26aufirst%3DG.%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DE.%26atitle%3DComparative%2520Analysis%2520of%2520New%2520Peptide%2520Conjugates%2520of%2520Antitubercular%2520Drug%2520Candidates-Model%2520Membrane%2520and%2520In%2520Vitro%2520Studies%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2016%26volume%3D147%26spage%3D106%26epage%3D115%26doi%3D10.1016%2Fj.colsurfb.2016.07.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosatka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senoner, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">In Vitro Biological Evaluation of New Antimycobacterial Salicylanilide-Tuftsin Conjugates</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejmech.2017.03.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28384546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2017&pages=152-173&author=Z.+Baranyaiauthor=M.+Kratkyauthor=R.+Vosatkaauthor=E.+Szaboauthor=Z.+Senonerauthor=S.+Davidauthor=J.+Stolarikovaauthor=J.+Vinsovaauthor=S.+Bosze&title=In+Vitro+Biological+Evaluation+of+New+Antimycobacterial+Salicylanilide-Tuftsin+Conjugates&doi=10.1016%2Fj.ejmech.2017.03.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates</span></div><div class="casAuthors">Baranyai, Zsuzsa; Kratky, Martin; Vosatka, Rudolf; Szabo, Eleonora; Senoner, Zsuzsanna; David, Sandor; Stolarikova, Jirina; Vinsova, Jarmila; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-173</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Tuberculosis is caused by Mycobacterium tuberculosis, an intracellular pathogen that can survive in host cells, mainly in macrophages.  An increase of multidrug-resistant tuberculosis qualifies this infectious disease as a major public health problem worldwide.  The cellular uptake of the antimycobacterial agents by infected host cells is limited.  The authors' approach is to enhance the cellular uptake of the antituberculars by target cell-directed delivery using drug-peptide conjugates to achieve an increased intracellular efficacy.  In this study, salicylanilide derivs. (2-hydroxy-N-phenylbenzamides) with remarkable antimycobacterial activity were conjugated to macrophage receptor specific tuftsin based peptide carriers through oxime bond directly or by insertion of a GFLG tetrapeptide spacer.  The authors have found that the in vitro antimycobacterial activity of the salicylanilides against M. tuberculosis H37Rv is preserved in the conjugates.  While the free drug was ineffective on infected macrophage model, the conjugates were active against the intracellular bacteria.  The fluorescently labeled peptide carriers that were modified with different fatty acid side chains showed outstanding cellular uptake rate to the macrophage model cells.  The conjugation of the salicylanilides to tuftsin based carriers reduced or abolished the in vitro cytostatic activity of the free drugs with the exception of the palmitoylated conjugates.  The conjugates degraded in the presence of rat liver lysosomal homogenate leading to the formation of an oxime bond-linked salicylanilide-amino acid fragment as the smallest active metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaT-ff9Q5ccbVg90H21EOLACvtfcHk0liFYhpyVV3bBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslejtLc%253D&md5=e72e1de7128ca32ee68771705c36b6ae</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.047%26sid%3Dliteratum%253Aachs%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVosatka%26aufirst%3DR.%26aulast%3DSzabo%26aufirst%3DE.%26aulast%3DSenoner%26aufirst%3DZ.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DStolarikova%26aufirst%3DJ.%26aulast%3DVinsova%26aufirst%3DJ.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DIn%2520Vitro%2520Biological%2520Evaluation%2520of%2520New%2520Antimycobacterial%2520Salicylanilide-Tuftsin%2520Conjugates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D133%26spage%3D152%26epage%3D173%26doi%3D10.1016%2Fj.ejmech.2017.03.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span> <span> </span><span class="NLM_article-title">Salicylanilide Ester Prodrugs as Potential Antimicrobial Agents--a Review</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3494</span>– <span class="NLM_lpage">3505</span>, <span class="refDoi"> DOI: 10.2174/138161211798194521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2174%2F138161211798194521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22074422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3494-3505&author=M.+Kratkyauthor=J.+Vinsova&title=Salicylanilide+Ester+Prodrugs+as+Potential+Antimicrobial+Agents%2D%2Da+Review&doi=10.2174%2F138161211798194521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylanilide ester prodrugs as potential antimicrobial agents - a review</span></div><div class="casAuthors">Kratky, Martin; Vinsova, Jarmila</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3494-3505</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Salicylanilides have been a subject of interest in medicinal chem. as a group with a wide range of biol. activities.  The antibacterial (including antimycobacterial) and antifungal activities have come to be viewed as very significant.  The synthesis of new prodrugs to counter a no. of problematic properties of salicylanilides is a current trend.  This article brings together the known basic facts about these prodrugs, particularly about the different mechanisms of the antimicrobial action of salicylanilides, including salicylanilide toxicity and undesired effects.  The largest part of this group consists of antimicrobial salicylanilide esters with different org. acids, e.g. acetates, carbamates, esters with N-protected amino acids, and mutual antibacterial compds. with known antibacterial agents (β-lactames and linezolid), with the activity and structure-activity relationships of these compds. being of particular interest.  This review summarizes the activity of salicylanilides as potential virulence inhibitors attributable to a blockade of the type III secretion pathway.  Many salicylanilide ester derivs. have been demonstrated an effective and promising treatment against pathogenic fungi and bacteria (esp. against Gram-pos., tuberculous and atypical mycobacterial strains), including strains such as methicillin-resistant Staphylococcus aureus and isoniazid-resistant mycobacteria which are resistant to one or more clin. used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri1EWfwbmF6rVg90H21EOLACvtfcHk0liFYhpyVV3bBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVGmsA%253D%253D&md5=d3acf1f46dffce26780fc10b1dc8f7c3</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.2174%2F138161211798194521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211798194521%26sid%3Dliteratum%253Aachs%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVinsova%26aufirst%3DJ.%26atitle%3DSalicylanilide%2520Ester%2520Prodrugs%2520as%2520Potential%2520Antimicrobial%2520Agents--a%2520Review%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D3494%26epage%3D3505%26doi%3D10.2174%2F138161211798194521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arend, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samant, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span> <span> </span><span class="NLM_article-title">Multi-Targeted Therapy of Cancer by Niclosamide: A New Application for an Old Drug</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.canlet.2014.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24732808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXms1Gjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=8-14&author=Y.+Liauthor=P.+K.+Liauthor=M.+J.+Robertsauthor=R.+C.+Arendauthor=R.+S.+Samantauthor=D.+J.+Buchsbaum&title=Multi-Targeted+Therapy+of+Cancer+by+Niclosamide%3A+A+New+Application+for+an+Old+Drug&doi=10.1016%2Fj.canlet.2014.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-targeted therapy of cancer by niclosamide: A new application for an old drug</span></div><div class="casAuthors">Li, Yonghe; Li, Pui-Kai; Roberts, Michael J.; Arend, Rebecca C.; Samant, Rajeev S.; Buchsbaum, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-14</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rapid development of new anticancer drugs that are safe and effective is a common goal shared by basic scientists, clinicians and patients.  The current review discusses one such agent, namely niclosamide, which has been used in the clinic for the treatment of intestinal parasite infections.  Recent studies repeatedly identified niclosamide as a potential anticancer agent by various high-throughput screening campaigns.  Niclosamide not only inhibits the Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways, but also targets mitochondria in cancer cells to induce cell cycle arrest, growth inhibition and apoptosis.  A no. of studies have established the anticancer activities of niclosamide in both in vitro and in vivo models.  Moreover, the inhibitory effects of niclosamide on cancer stem cells provide further evidence for its consideration as a promising drug for cancer therapy.  This article reviews various aspects of niclosamide as they relate to its efficacy against cancer and assocd. mol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAr8M29D4VSrVg90H21EOLACvtfcHk0lgmhE3OXxQvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXms1Gjtbs%253D&md5=0262aa17fe03e265b072f0558e5a2b25</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DRoberts%26aufirst%3DM.%2BJ.%26aulast%3DArend%26aufirst%3DR.%2BC.%26aulast%3DSamant%26aufirst%3DR.%2BS.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26atitle%3DMulti-Targeted%2520Therapy%2520of%2520Cancer%2520by%2520Niclosamide%253A%2520A%2520New%2520Application%2520for%2520an%2520Old%2520Drug%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D349%26spage%3D8%26epage%3D14%26doi%3D10.1016%2Fj.canlet.2014.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premont, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Niclosamide: Beyond an Antihelminthic Drug</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.cellsig.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28389414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt12qurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2018&pages=89-96&author=W.+Chenauthor=R.+A.+Mookauthor=R.+T.+Premontauthor=J.+Wang&title=Niclosamide%3A+Beyond+an+Antihelminthic+Drug&doi=10.1016%2Fj.cellsig.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Niclosamide: Beyond an antihelminthic drug</span></div><div class="casAuthors">Chen, Wei; Mook, Robert A., Jr.; Premont, Richard T.; Wang, Jiangbo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide.  However recent studies have indicated that niclosamide may have broad clin. applications for the treatment of diseases other than those caused by parasites.  These diseases and symptoms may include cancer, bacterial and viral infection, metabolic diseases such as Type II diabetes, NASH and NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-vs.-host disease, and systemic sclerosis.  Among the underlying mechanisms assocd. with the drug actions of niclosamide are uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways.  Here we provide a brief overview of the biol. activities of niclosamide, its potential clin. applications, and its challenges for use as a new therapy for systemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6P0sW9zodbVg90H21EOLACvtfcHk0lgmhE3OXxQvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt12qurk%253D&md5=84f8fcc804e57b07dac47376dbffc35b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DPremont%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DNiclosamide%253A%2520Beyond%2520an%2520Antihelminthic%2520Drug%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D41%26spage%3D89%26epage%3D96%26doi%3D10.1016%2Fj.cellsig.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span> <span> </span><span class="NLM_article-title">Niclosamide, an Old Antihelminthic Agent, Demonstrates Antitumor Activity by Blocking Multiple Signaling Pathways of Cancer Stem Cells</span>. <i>Aizheng</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.5732/cjc.011.10290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.5732%2Fcjc.011.10290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22237038" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=178-184&author=J.+X.+Panauthor=K.+Dingauthor=C.+Y.+Wang&title=Niclosamide%2C+an+Old+Antihelminthic+Agent%2C+Demonstrates+Antitumor+Activity+by+Blocking+Multiple+Signaling+Pathways+of+Cancer+Stem+Cells&doi=10.5732%2Fcjc.011.10290"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.5732%2Fcjc.011.10290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5732%252Fcjc.011.10290%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DJ.%2BX.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DC.%2BY.%26atitle%3DNiclosamide%252C%2520an%2520Old%2520Antihelminthic%2520Agent%252C%2520Demonstrates%2520Antitumor%2520Activity%2520by%2520Blocking%2520Multiple%2520Signaling%2520Pathways%2520of%2520Cancer%2520Stem%2520Cells%26jtitle%3DAizheng%26date%3D2012%26volume%3D31%26spage%3D178%26epage%3D184%26doi%3D10.5732%2Fcjc.011.10290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trageser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogolok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinartz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinhaas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimmers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yachnis, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pincus, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steindler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brustle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffler, B.</span></span> <span> </span><span class="NLM_article-title">Anticancer Effects of Niclosamide in Human Glioblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4124</span>– <span class="NLM_lpage">4136</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-2895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1158%2F1078-0432.CCR-12-2895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=23908450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=4124-4136&author=A.+Wielandauthor=D.+Trageserauthor=S.+Gogolokauthor=R.+Reinartzauthor=H.+Hoferauthor=M.+Kellerauthor=A.+Leinhaasauthor=R.+Schelleauthor=S.+Normannauthor=L.+Klaasauthor=A.+Wahaauthor=P.+Kochauthor=R.+Fimmersauthor=T.+Pietschauthor=A.+T.+Yachnisauthor=D.+W.+Pincusauthor=D.+A.+Steindlerauthor=O.+Brustleauthor=M.+Simonauthor=M.+Glasauthor=B.+Scheffler&title=Anticancer+Effects+of+Niclosamide+in+Human+Glioblastoma&doi=10.1158%2F1078-0432.CCR-12-2895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Effects of Niclosamide in Human Glioblastoma</span></div><div class="casAuthors">Wieland, Anja; Trageser, Daniel; Gogolok, Sabine; Reinartz, Roman; Hoefer, Heike; Keller, Mihaela; Leinhaas, Anke; Schelle, Ramona; Normann, Sabine; Klaas, Lil; Waha, Andreas; Koch, Philipp; Fimmers, Rolf; Pietsch, Torsten; Yachnis, Anthony T.; Pincus, David W.; Steindler, Dennis A.; Bruestle, Oliver; Simon, Matthias; Glas, Martin; Scheffler, Bjoern</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4124-4136</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma is a highly malignant, invariably fatal brain tumor for which effective pharmacotherapy remains an unmet medical need.  Exptl. Design: Screening of a compd. library of 160 synthetic and natural toxic substances identified the antihelmintic niclosamide as a previously unrecognized candidate for clin. development.  Considering the cellular and interindividual heterogeneity of glioblastoma, a portfolio of short-term expanded primary human glioblastoma cells (pGBM; n = 21), common glioma lines (n = 5), and noncancer human control cells (n = 3) was applied as a discovery platform and for preclin. validation.  Pharmacodynamic anal., study of cell-cycle progression, apoptosis, cell migration, proliferation, and on the frequency of multipotent/self-renewing pGBM cells were conducted in vitro, and orthotopic xenotransplantation was used to confirm anticancer effects in vivo.  Results: Niclosamide led to cytostatic, cytotoxic, and antimigratory effects, strongly reduced the frequencies of multipotent/self-renewing cells in vitro, and after exposure significantly diminished the pGBMs' malignant potential in vivo.  Mechanism of action anal. revealed that niclosamide simultaneously inhibited intracellular WNT/CTNNB1-, NOTCH-, mTOR-, and NF-κB signaling cascades.  Furthermore, combinatorial drug testing established that a heterozygous deletion of the NFKBIA locus in glioblastoma samples could serve as a genomic biomarker for predicting a synergistic activity of niclosamide with temozolomide, the current std. in glioblastoma therapy.  Conclusions: Together, our data advocate the use of pGBMs for exploration of compd. libraries to reveal unexpected leads, for example, niclosamide that might be suited for further development toward personalized clin. application.  Clin Cancer Res; 19(15); 4124-36. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRHeuK52g4rVg90H21EOLACvtfcHk0lgmhE3OXxQvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amt7%252FN&md5=2df43b45ff14d3e3d4e88abb782ab67b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-2895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-2895%26sid%3Dliteratum%253Aachs%26aulast%3DWieland%26aufirst%3DA.%26aulast%3DTrageser%26aufirst%3DD.%26aulast%3DGogolok%26aufirst%3DS.%26aulast%3DReinartz%26aufirst%3DR.%26aulast%3DHofer%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DLeinhaas%26aufirst%3DA.%26aulast%3DSchelle%26aufirst%3DR.%26aulast%3DNormann%26aufirst%3DS.%26aulast%3DKlaas%26aufirst%3DL.%26aulast%3DWaha%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DFimmers%26aufirst%3DR.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DYachnis%26aufirst%3DA.%2BT.%26aulast%3DPincus%26aufirst%3DD.%2BW.%26aulast%3DSteindler%26aufirst%3DD.%2BA.%26aulast%3DBrustle%26aufirst%3DO.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DGlas%26aufirst%3DM.%26aulast%3DScheffler%26aufirst%3DB.%26atitle%3DAnticancer%2520Effects%2520of%2520Niclosamide%2520in%2520Human%2520Glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D4124%26epage%3D4136%26doi%3D10.1158%2F1078-0432.CCR-12-2895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsin, A.</span></span> <span> </span><span class="NLM_article-title">Niclosamide Induces Protein Ubiquitination and Inhibits Multiple Pro-Survival Signaling Pathways in the Human Glioblastoma U-87 MG Cell Line</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0184324</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0184324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1371%2Fjournal.pone.0184324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28877265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotV2gsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=B.+Chengauthor=L.+D.+Moralesauthor=Y.+Zhangauthor=S.+Mitoauthor=A.+Tsin&title=Niclosamide+Induces+Protein+Ubiquitination+and+Inhibits+Multiple+Pro-Survival+Signaling+Pathways+in+the+Human+Glioblastoma+U-87+MG+Cell+Line&doi=10.1371%2Fjournal.pone.0184324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line</span></div><div class="casAuthors">Cheng, Benxu; Morales, Liza Doreen; Zhang, Yonghong; Mito, Shizue; Tsin, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0184324/1-e0184324/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Glioblastoma is the most common and lethal malignant primary brain tumor for which the development of efficacious chemotherapeutic agents remains an urgent need.  The anti-helminthic drug niclosamide, which has long been in use to treat tapeworm infections, has recently attracted renewed interest due to its apparent anticancer effects in a variety of in vitro and in vivo cancer models.  However, the mechanism(s) of action remains to be elucidated.  In the present study, we found that niclosamide induced cell toxicity in human glioblastoma cells corresponding with increased protein ubiquitination, ER stress and autophagy.  In addn., niclosamide treatment led to down-regulation of Wnt/β-catenin, PI3K/AKT, MAPK/ERK, and STAT3 pro-survival signal transduction pathways to further reduce U-87 MG cell viability.  Taken together, these results provide new insights into the glioblastoma suppressive capabilities of niclosamide, showing that niclosamide can target multiple major cell signaling pathways simultaneously to effectively promote cell death in U- 87 MG cells.  Niclosamide constitutes a new prospect for a therapeutic treatment against human glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIGXP9I-LRrVg90H21EOLACvtfcHk0lhfa-F_ZtM5nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotV2gsbo%253D&md5=3ef37b4ad9f37c0c7fba4d8a48a640ed</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0184324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0184324%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DMorales%26aufirst%3DL.%2BD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMito%26aufirst%3DS.%26aulast%3DTsin%26aufirst%3DA.%26atitle%3DNiclosamide%2520Induces%2520Protein%2520Ubiquitination%2520and%2520Inhibits%2520Multiple%2520Pro-Survival%2520Signaling%2520Pathways%2520in%2520the%2520Human%2520Glioblastoma%2520U-87%2520MG%2520Cell%2520Line%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0184324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myrberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Design of a Tumor-Homing Cell-Penetrating Peptide</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1021/bc0701139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc0701139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSku77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=70-75&author=H.+Myrbergauthor=L.+Zhangauthor=M.+Maeauthor=U.+Langel&title=Design+of+a+Tumor-Homing+Cell-Penetrating+Peptide&doi=10.1021%2Fbc0701139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Tumor-Homing Cell-Penetrating Peptide</span></div><div class="casAuthors">Myrberg, Helena; Zhang, Lianglin; Maee, Maarja; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-75</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemotherapy is often limited by toxicity to normal cells.  Therefore, an ideal anticancer drug should discriminate between normal tissue and tumors.  This would require a target receptor mol. mostly present in tumors.  The cyclic peptide cCPGPEGAGC (PEGA) is a homing peptide that has previously been shown to accumulate in breast tumor tissue in mice.  PEGA peptide does not cross the plasma membrane per se; however, when attached to the cell-penetrating peptide pVEC, the conjugate is taken up by different breast cancer cells in vitro.  Addnl., the homing capacity of the PEGA-pVEC is conserved in vivo, where the conjugate mainly accumulates in blood vessels in breast tumor tissue and, consequently is taken up.  Furthermore, the authors show that the efficacy of the anticancer drug, chlorambucil, is increased more than 4 times when the drug is conjugated to the PEGA-pVEC chimeric peptide.  These data demonstrate that combining a homing sequence with a cell-penetrating sequence yields a peptide that combines the desirable properties of the parent peptides.  Such peptides may be useful in diagnostics and delivery of therapeutic agents to an intracellular location in a specific tumor target tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHPDCxMIDgLVg90H21EOLACvtfcHk0lgDqYdbVc38Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSku77O&md5=05c03fbf4f62fb4060f94b210e1a49cc</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc0701139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0701139%26sid%3Dliteratum%253Aachs%26aulast%3DMyrberg%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMae%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DDesign%2520of%2520a%2520Tumor-Homing%2520Cell-Penetrating%2520Peptide%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D70%26epage%3D75%26doi%3D10.1021%2Fbc0701139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Maltzhan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karst, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drapkin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, S. N.</span></span> <span> </span><span class="NLM_article-title">Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene Id4</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">147ra112</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1126%2Fscitranslmed.3003778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22896676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC38fosVSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=147ra112&author=Y.+Renauthor=H.+W.+Cheungauthor=G.+von+Maltzhanauthor=A.+Agrawalauthor=G.+S.+Cowleyauthor=B.+A.+Weirauthor=J.+S.+Boehmauthor=P.+Tamayoauthor=A.+M.+Karstauthor=J.+F.+Liuauthor=M.+S.+Hirschauthor=J.+P.+Mesirovauthor=R.+Drapkinauthor=D.+E.+Rootauthor=J.+Loauthor=V.+Fogalauthor=E.+Ruoslahtiauthor=W.+C.+Hahnauthor=S.+N.+Bhatia&title=Targeted+Tumor-Penetrating+siRNA+Nanocomplexes+for+Credentialing+the+Ovarian+Cancer+Oncogene+Id4&doi=10.1126%2Fscitranslmed.3003778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4</span></div><div class="casAuthors">Ren Yin; Cheung Hiu Wing; von Maltzhan Geoffrey; Agrawal Amit; Cowley Glenn S; Weir Barbara A; Boehm Jesse S; Tamayo Pablo; Karst Alison M; Liu Joyce F; Hirsch Michelle S; Mesirov Jill P; Drapkin Ronny; Root David E; Lo Justin; Fogal Valentina; Ruoslahti Erkki; Hahn William C; Bhatia Sangeeta N</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">147</span>),
    <span class="NLM_cas:pages">147ra112</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The comprehensive characterization of a large number of cancer genomes will eventually lead to a compendium of genetic alterations in specific cancers.  Unfortunately, the number and complexity of identified alterations complicate endeavors to identify biologically relevant mutations critical for tumor maintenance because many of these targets are not amenable to manipulation by small molecules or antibodies.  RNA interference provides a direct way to study putative cancer targets; however, specific delivery of therapeutics to the tumor parenchyma remains an intractable problem.  We describe a platform for the discovery and initial validation of cancer targets, composed of a systematic effort to identify amplified and essential genes in human cancer cell lines and tumors partnered with a novel modular delivery technology.  We developed a tumor-penetrating nanocomplex (TPN) that comprised small interfering RNA (siRNA) complexed with a tandem tumor-penetrating and membrane-translocating peptide, which enabled the specific delivery of siRNA deep into the tumor parenchyma.  We used TPN in vivo to evaluate inhibitor of DNA binding 4 (ID4) as a novel oncogene.  Treatment of ovarian tumor-bearing mice with ID4-specific TPN suppressed growth of established tumors and significantly improved survival.  These observations not only credential ID4 as an oncogene in 32% of high-grade ovarian cancers but also provide a framework for the identification, validation, and understanding of potential therapeutic cancer targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTi-ecnajvWRH6CEoQgWY10fW6udTcc2eYSwf_Hsi9Bkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fosVSqtg%253D%253D&md5=19dfb8991167ce0b5fe1ce899d1b985b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003778%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DCheung%26aufirst%3DH.%2BW.%26aulast%3Dvon%2BMaltzhan%26aufirst%3DG.%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DCowley%26aufirst%3DG.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DKarst%26aufirst%3DA.%2BM.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DHirsch%26aufirst%3DM.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DFogal%26aufirst%3DV.%26aulast%3DRuoslahti%26aufirst%3DE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DBhatia%26aufirst%3DS.%2BN.%26atitle%3DTargeted%2520Tumor-Penetrating%2520siRNA%2520Nanocomplexes%2520for%2520Credentialing%2520the%2520Ovarian%2520Cancer%2520Oncogene%2520Id4%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D147ra112%26doi%3D10.1126%2Fscitranslmed.3003778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisp, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savariar, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasgow, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellies, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsien, R. Y.</span></span> <span> </span><span class="NLM_article-title">Dual Targeting of Integrin Alphavbeta3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1514</span>– <span class="NLM_lpage">1525</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-1067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1158%2F1535-7163.MCT-13-1067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24737028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Ojs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1514-1525&author=J.+L.+Crispauthor=E.+N.+Savariarauthor=H.+L.+Glasgowauthor=L.+G.+Elliesauthor=M.+A.+Whitneyauthor=R.+Y.+Tsien&title=Dual+Targeting+of+Integrin+Alphavbeta3+and+Matrix+Metalloproteinase-2+for+Optical+Imaging+of+Tumors+and+Chemotherapeutic+Delivery&doi=10.1158%2F1535-7163.MCT-13-1067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Targeting of Integrin αvβ3 and Matrix Metalloproteinase-2 for Optical Imaging of Tumors and Chemotherapeutic Delivery</span></div><div class="casAuthors">Crisp, Jessica L.; Savariar, Elamprakash N.; Glasgow, Heather L.; Ellies, Lesley G.; Whitney, Michael A.; Tsien, Roger Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1514-1525</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activatable cell-penetrating peptides (ACPP) provide a general strategy for mol. targeting by exploiting the extracellular protease activities assocd. with disease.  Previous work used a matrix metalloproteinase (MMP-2 and 9)-cleavable sequence in the ACPP to target contrast agents for tumor imaging and fluorescence-guided surgery.  To improve specificity and sensitivity for MMP-2, an integrin αvβ3-binding domain, cyclic-RGD, was covalently linked to the ACPP.  This co-targeting strategy relies on the interaction of MMP-2 with integrin αvβ3, which are known to assoc. via the hemopexin domain of MMP-2.  In U87MG glioblastoma cells in culture, dual targeting greatly improved ACPP uptake compared with either MMP or integrin αvβ3 targeting alone.  In vivo, dual-targeted ACPP treatment resulted in tumor contrast of 7.8 ± 1.6, a 10-fold higher tumor fluorescence compared with the neg. control peptide, and increased probe penetration into the core of MDA-MB-231 tumors.  This platform also significantly improved efficacy of the chemotherapeutic monomethylauristatin E (MMAE) in both MDA-MB-231 orthotopic human and syngeneic Py230 murine breast tumors.  Treatment with cyclic-RGD-PLGC(Me)AG-MMAE-ACPP resulted in complete tumor regression in one quarter of MDA-MB-231 tumor-bearing mice, compared with no survival in the control groups.  This rational mechanism for amplified delivery of imaging and potent chemotherapeutic agents avoids the use of antibodies and may be of considerable generality.  Mol Cancer Ther; 13(6); 1514-25. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2Qanxe_4V7Vg90H21EOLACvtfcHk0lgDqYdbVc38Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Ojs7s%253D&md5=bc3b4e5c578ee1745e987b9e0d617575</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-1067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-1067%26sid%3Dliteratum%253Aachs%26aulast%3DCrisp%26aufirst%3DJ.%2BL.%26aulast%3DSavariar%26aufirst%3DE.%2BN.%26aulast%3DGlasgow%26aufirst%3DH.%2BL.%26aulast%3DEllies%26aufirst%3DL.%2BG.%26aulast%3DWhitney%26aufirst%3DM.%2BA.%26aulast%3DTsien%26aufirst%3DR.%2BY.%26atitle%3DDual%2520Targeting%2520of%2520Integrin%2520Alphavbeta3%2520and%2520Matrix%2520Metalloproteinase-2%2520for%2520Optical%2520Imaging%2520of%2520Tumors%2520and%2520Chemotherapeutic%2520Delivery%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D1514%26epage%3D1525%26doi%3D10.1158%2F1535-7163.MCT-13-1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span> <span> </span><span class="NLM_article-title">Paclitaxel Loaded Liposomes Decorated with a Multifunctional Tandem Peptide for Glioma Targeting</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4835</span>– <span class="NLM_lpage">4847</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.02.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.biomaterials.2014.02.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24651033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2qtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=4835-4847&author=Y.+Liuauthor=R.+Ranauthor=J.+Chenauthor=Q.+Kuangauthor=J.+Tangauthor=L.+Meiauthor=Q.+Zhangauthor=H.+Gaoauthor=Z.+Zhangauthor=Q.+He&title=Paclitaxel+Loaded+Liposomes+Decorated+with+a+Multifunctional+Tandem+Peptide+for+Glioma+Targeting&doi=10.1016%2Fj.biomaterials.2014.02.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting</span></div><div class="casAuthors">Liu, Yayuan; Ran, Rui; Chen, Jiantao; Kuang, Qifang; Tang, Jie; Mei, Ling; Zhang, Qianyu; Gao, Huile; Zhang, Zhirong; He, Qin</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4835-4847</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The treatment of glioma is a great challenge because of the existence of the blood-brain barrier (BBB).  In order to reduce toxicity to the normal brain tissue and achieve efficient treatment, it is also important for drugs to specifically accumulate in the glioma foci and penetrate into the tumor core after entering into the brain.  In this study, a specific ligand cyclic RGD peptide was conjugated to a cell penetrating peptide R8 to develop a multifunctional peptide R8-RGD.  R8-RGD increased the cellular uptake of liposomes by 2-fold and nearly 30-fold compared to sep. R8 and RGD resp., and displayed effective penetration of three-dimensional glioma spheroids and BBB model in vitro.  In vivo studies showed that R8-RGD-lipo could be efficiently delivered into the brain and selectively accumulated in the glioma foci after systemic administration in C6 glioma bearing mice.  When paclitaxel (PTX) was loaded in liposomes, R8-RGD-lipo could induce the strongest inhibition and apoptosis against C6 cells and finally achieved the longest survival in intracranial C6 glioma bearing mice.  In conclusion, all the results indicated that the tandem peptide R8-RGD was a promising ligand possessing multi functions including BBB transporting, glioma targeting and tumor penetrating.  And R8-RGD-lipo was proved to be a potential anti-glioma drug delivery system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO-NfIUqmT0rVg90H21EOLACvtfcHk0lh2T6DsxLiN0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2qtLo%253D&md5=d9a0215c7f77ab2c4f7012ba848b3686</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.02.031%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRan%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DQ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DPaclitaxel%2520Loaded%2520Liposomes%2520Decorated%2520with%2520a%2520Multifunctional%2520Tandem%2520Peptide%2520for%2520Glioma%2520Targeting%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D4835%26epage%3D4847%26doi%3D10.1016%2Fj.biomaterials.2014.02.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parente, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piarulli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neundorf, I.</span></span> <span> </span><span class="NLM_article-title">Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2011</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2lsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2011-2022&author=L.+Feniauthor=S.+Parenteauthor=C.+Robertauthor=S.+Gazzolaauthor=D.+Arosioauthor=U.+Piarulliauthor=I.+Neundorf&title=Kiss+and+Run%3A+Promoting+Effective+and+Targeted+Cellular+Uptake+of+a+Drug+Delivery+Vehicle+Composed+of+an+Integrin-Targeting+Diketopiperazine+Peptidomimetic+and+a+Cell-Penetrating+Peptide&doi=10.1021%2Facs.bioconjchem.9b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide</span></div><div class="casAuthors">Feni, Lucia; Parente, Sara; Robert, Clemence; Gazzola, Silvia; Arosio, Daniela; Piarulli, Umberto; Neundorf, Ines</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2011-2022</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) have emerged as powerful tools in terms of drug delivery.  Those short, often cationic peptides are characterized by their usually low toxicity and their ability to transport diverse cargos inside almost any kinds of cells.  Still, one major drawback is their nonselective uptake making their application in targeted cancer therapies questionable.  In this work, we aimed to combine the power of a CPP (sC18) with an integrin-targeting unit (c[DKP-f3-RGD]).  The latter is composed of the Arg-Gly-Asp peptide sequence cyclized via a diketopiperazine scaffold and is characterized by its high selectivity toward integrin αvβ3.  The two parts were linked via copper-catalyzed alkyne-azide click reaction (CuAAC), while the CPP was addnl. functionalized with either a fluorescent dye or the anticancer drug daunorubicin.  Both functionalities allowed a careful biol. evaluation of these novel peptide-conjugates regarding their cellular uptake mechanism, as well as cytotoxicity in αvβ3 integrin receptor expressing cells vs. cells that do not express αvβ3.  Our results show that the uptake follows a "kiss-and-run"-like model, in which the conjugates first target and recognize the receptor, but translocate mainly by CPP mediation.  Thereby, we obsd. significantly more pronounced toxic effects in αvβ3 expressing U87 cells compared to HT-29 and MCF-7 cells, when the cells were exposed to the substances with only very short contact times (15 min).  All in all, we present new concepts for the design of cancer selective peptide-drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52geONXxf1rVg90H21EOLACvtfcHk0lh2T6DsxLiN0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2lsLnL&md5=7fd7487362f162c12a84139697c35575</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00292%26sid%3Dliteratum%253Aachs%26aulast%3DFeni%26aufirst%3DL.%26aulast%3DParente%26aufirst%3DS.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DGazzola%26aufirst%3DS.%26aulast%3DArosio%26aufirst%3DD.%26aulast%3DPiarulli%26aufirst%3DU.%26aulast%3DNeundorf%26aufirst%3DI.%26atitle%3DKiss%2520and%2520Run%253A%2520Promoting%2520Effective%2520and%2520Targeted%2520Cellular%2520Uptake%2520of%2520a%2520Drug%2520Delivery%2520Vehicle%2520Composed%2520of%2520an%2520Integrin-Targeting%2520Diketopiperazine%2520Peptidomimetic%2520and%2520a%2520Cell-Penetrating%2520Peptide%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2011%26epage%3D2022%26doi%3D10.1021%2Facs.bioconjchem.9b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwala, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkwood, J. M.</span></span> <span> </span><span class="NLM_article-title">Temozolomide, a Novel Alkylating Agent with Activity in the Central Nervous System, May Improve the Treatment of Advanced Metastatic Melanoma</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.5-2-144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1634%2Ftheoncologist.5-2-144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10794805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Wmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=144-151&author=S.+S.+Agarwalaauthor=J.+M.+Kirkwood&title=Temozolomide%2C+a+Novel+Alkylating+Agent+with+Activity+in+the+Central+Nervous+System%2C+May+Improve+the+Treatment+of+Advanced+Metastatic+Melanoma&doi=10.1634%2Ftheoncologist.5-2-144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma</span></div><div class="casAuthors">Agarwala, Sanjiv S.; Kirkwood, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-151</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review with 46 refs.  Temozolomide (TMZ) is the first new chemotherapy agent to be approved for the treatment of high-grade malignant gliomas in more than 20 yr.  This novel oral alkylating agent has demonstrated promising activity not only in brain tumors, but in a variety of solid tumors, including malignant melanoma.  TMZ is 100% bioavailable when taken orally and, because of its small size and lipophilic properties, it is able to cross the blood-brain barrier.  Concns. in the central nervous system are approx. 30% of plasma concns.  Once it has entered the central nervous system, TMZ can be spontaneously converted to the active metabolite.  These pharmacol. properties make it an ideal agent for treating central nervous system malignancies.  In patients with advanced metastatic melanoma, brain metastases are a major cause of treatment failure.  In this setting, TMZ has been shown to be as effective as dacarbazine, with a similar safety profile.  More importantly, there is evidence to suggest that TMZ-treated patients have a lower incidence of central nervous system relapse compared with dacarbazine-treated patients.  Therefore, TMZ is actively being investigated for the treatment and prevention of brain metastases in melanoma patients.  TMZ may become an important part of treatment regimens for advanced metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxC74OlKZMBbVg90H21EOLACvtfcHk0lh2T6DsxLiN0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Wmsr8%253D&md5=43ae5fb41b1efa83547a03072bb9eeee</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.5-2-144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.5-2-144%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwala%26aufirst%3DS.%2BS.%26aulast%3DKirkwood%26aufirst%3DJ.%2BM.%26atitle%3DTemozolomide%252C%2520a%2520Novel%2520Alkylating%2520Agent%2520with%2520Activity%2520in%2520the%2520Central%2520Nervous%2520System%252C%2520May%2520Improve%2520the%2520Treatment%2520of%2520Advanced%2520Metastatic%2520Melanoma%26jtitle%3DOncologist%26date%3D2000%26volume%3D5%26spage%3D144%26epage%3D151%26doi%3D10.1634%2Ftheoncologist.5-2-144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranyai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinsova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senoner, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolarikova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Combating Highly Resistant Emerging Pathogen Mycobacterium Abscessus and Mycobacterium Tuberculosis with Novel Salicylanilide Esters and Carbamates</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejmech.2015.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=26210507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1eltbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=692-704&author=Z.+Baranyaiauthor=M.+Kratkyauthor=J.+Vinsovaauthor=N.+Szaboauthor=Z.+Senonerauthor=K.+Horvatiauthor=J.+Stolarikovaauthor=S.+Davidauthor=S.+Bosze&title=Combating+Highly+Resistant+Emerging+Pathogen+Mycobacterium+Abscessus+and+Mycobacterium+Tuberculosis+with+Novel+Salicylanilide+Esters+and+Carbamates&doi=10.1016%2Fj.ejmech.2015.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates</span></div><div class="casAuthors">Baranyai, Zsuzsa; Kratky, Martin; Vinsova, Jarmila; Szabo, Nora; Senoner, Zsuzsanna; Horvati, Kata; Stolarikova, Jirina; David, Sandor; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">692-704</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the Mycobacterium genus over one hundred species are already described and new ones are periodically reported.  Species that form colonies in a week are classified as rapid growers, those requiring longer periods (up to three months) are the mostly pathogenic slow growers.  More recently, new emerging species have been identified to lengthen the list, all rapid growers.  Of these, Mycobacterium abscessus is also an intracellular pathogen and it is the most chemotherapy-resistant rapid-growing mycobacterium.  In addn., the cases of multidrug-resistant Mycobacterium tuberculosis infection are also increasing.  Therefore there is an urgent need to find new active mols. against these threatening strains.  Based on previous results, a series of salicylanilides, salicylanilide 5-chloropyrazinoates and carbamates was designed, synthesized and characterized.  The compds. were evaluated for their in vitro activity on M. abscessus, susceptible M. tuberculosis H37Rv, multidrug-resistant (MDR) M. tuberculosis MDR A8, M. tuberculosis MDR 9449/2006 and on the extremely-resistant Praha 131 (XDR) strains.  All derivs. exhibited a significant activity with min. inhibitory concns. (MICs) in the low micromolar range.  Eight salicylanilide carbamates and two salicylanilide esters exhibited an excellent in vitro activity on M. abscessus with MICs from 0.2 to 2.1 μM, thus being more effective than ciprofloxacin and gentamicin.  This finding is potentially promising, particularly, as M. abscessus is a threateningly chemotherapy-resistant species.  M. tuberculosis H37Rv was inhibited with MICs from 0.2 μM, and eleven compds. have lower MICs than isoniazid.  Salicylanilide esters and carbamates were found that they were effective also on MDR and XDR M. tuberculosis strains with MICs ≥1.0 μM.  The in vitro cytotoxicity (IC50) was also detd. on human MonoMac-6 cells, and selectivity index (SI) of the compds. was established.  In general, salicylanilide derivs. substituted by halogens on both salicyl and aniline rings showed better activity, than 4-benzoylaniline derivs.  The ester or carbamate bond formation of parent salicylanilides mostly retained or improved antimycobacterial potency with moderate selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTzdur-j287Vg90H21EOLACvtfcHk0lidhlI20ETJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1eltbjL&md5=ee9a776f1ae6887528ea77e115f5f4c0</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaranyai%26aufirst%3DZ.%26aulast%3DKratky%26aufirst%3DM.%26aulast%3DVinsova%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DN.%26aulast%3DSenoner%26aufirst%3DZ.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DStolarikova%26aufirst%3DJ.%26aulast%3DDavid%26aufirst%3DS.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DCombating%2520Highly%2520Resistant%2520Emerging%2520Pathogen%2520Mycobacterium%2520Abscessus%2520and%2520Mycobacterium%2520Tuberculosis%2520with%2520Novel%2520Salicylanilide%2520Esters%2520and%2520Carbamates%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D692%26epage%3D704%26doi%3D10.1016%2Fj.ejmech.2015.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harashima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiura, Y.</span></span> <span> </span><span class="NLM_article-title">Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1011</span>, <span class="refDoi"> DOI: 10.1021/bc015508l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc015508l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1005-1011&author=S.+Futakiauthor=W.+Ohashiauthor=T.+Suzukiauthor=M.+Niwaauthor=S.+Tanakaauthor=K.+Uedaauthor=H.+Harashimaauthor=Y.+Sugiura&title=Stearylated+Arginine-Rich+Peptides%3A+A+New+Class+of+Transfection+Systems&doi=10.1021%2Fbc015508l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems</span></div><div class="casAuthors">Futaki, Shiroh; Ohashi, Wakana; Suzuki, Tomoki; Niwa, Miki; Tanaka, Seigo; Ueda, Kunihiro; Harashima, Hideyoshi; Sugiura, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1005-1011</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Membrane-permeable arginine-rich peptides, such as HIV-1 Tat-(48-60), HIV-1 Rev-(34-50), and flock house virus (FHV) coat-(35-49), have been shown to possess the ability to transfect COS-7 cells with luciferase-coding plasmid as efficiently as polyarginine (MW 5000-15 000) and polylysine (MW 9800).  Not only these virus-derived cationic peptides but also oligoarginines of 4-16 residues were found to be able to transfect cells.  In the case of the Tat, FHV, and octaarginine peptides, N-terminal stearylation of the peptides increases the transfection efficiency by approx. 100 times to reach the same order of magnitude as that of LipofectAMINE, one of the most efficient com. available transfection agents. Also, a certain correlation was obsd. between the transfection efficiency of stearyl-(Arg)n peptides (stearyl-Rn: n = 4, 8, 12, 16) and the membrane permeability of the corresponding (Arg)n peptides (Rn).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_RsRM5TN0krVg90H21EOLACvtfcHk0lidhlI20ETJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVWmtrk%253D&md5=13da6d6a424ef70b2dc1495a20614c50</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fbc015508l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc015508l%26sid%3Dliteratum%253Aachs%26aulast%3DFutaki%26aufirst%3DS.%26aulast%3DOhashi%26aufirst%3DW.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNiwa%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DHarashima%26aufirst%3DH.%26aulast%3DSugiura%26aufirst%3DY.%26atitle%3DStearylated%2520Arginine-Rich%2520Peptides%253A%2520A%2520New%2520Class%2520of%2520Transfection%2520Systems%26jtitle%3DBioconjugate%2520Chem.%26date%3D2001%26volume%3D12%26spage%3D1005%26epage%3D1011%26doi%3D10.1021%2Fbc015508l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andaloussi, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghloul, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guterstam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzumanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gait, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallbrink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Pepfect 14, a Novel Cell-Penetrating Peptide for Oligonucleotide Delivery in Solution and as Solid Formulation</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">5284</span>– <span class="NLM_lpage">5298</span>, <span class="refDoi"> DOI: 10.1093/nar/gkr072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1093%2Fnar%2Fgkr072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=21345932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=5284-5298&author=K.+Ezzatauthor=S.+E.+Andaloussiauthor=E.+M.+Zaghloulauthor=T.+Lehtoauthor=S.+Lindbergauthor=P.+M.+Morenoauthor=J.+R.+Violaauthor=T.+Magdyauthor=R.+Abdoauthor=P.+Guterstamauthor=R.+Sillardauthor=S.+M.+Hammondauthor=M.+J.+Woodauthor=A.+A.+Arzumanovauthor=M.+J.+Gaitauthor=C.+I.+Smithauthor=M.+Hallbrinkauthor=U.+Langel&title=Pepfect+14%2C+a+Novel+Cell-Penetrating+Peptide+for+Oligonucleotide+Delivery+in+Solution+and+as+Solid+Formulation&doi=10.1093%2Fnar%2Fgkr072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span></div><div class="casAuthors">Ezzat, Kariem; El Andaloussi, Samir; Zaghloul, Eman M.; Lehto, Taavi; Lindberg, Staffan; Moreno, Pedro M. D.; Viola, Joana R.; Magdy, Tarek; Abdo, Rania; Guterstam, Peter; Sillard, Rannar; Hammond, Suzan M.; Wood, Matthew J. A.; Arzumanov, Andrey A.; Gait, Michael J.; Smith, C. I. Edvard; Haellbrink, Mattias; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5284-5298</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splicing.  Recently, several of these debilitating disorders have been shown to be amenable for splice-correcting oligonucleotides (SCOs) that modify splicing patterns and restore the phenotype in exptl. models.  However, translational approaches are required to transform SCOs into usable drug products.  In this study, we present a new cell-penetrating peptide, PepFect14 (PF14), which efficiently delivers SCOs to different cell models including HeLa pLuc705 and mdx mouse myotubes; a cell culture model of Duchenne's muscular dystrophy (DMD).  Non-covalent PF14-SCO nanocomplexes induce splice-correction at rates higher than the com. available lipid-based vector Lipofectamine 2000 (LF2000) and remain active in the presence of serum.  Furthermore, we demonstrate the feasibility of incorporating this delivery system into solid formulations that could be suitable for several therapeutic applications.  Solid dispersion technique is utilized and the formed solid formulations are as active as the freshly prepd. nanocomplexes in soln. even when stored at an elevated temps. for several weeks.  In contrast, LF2000 drastically loses activity after being subjected to same procedure.  This shows that using PF14 is a very promising translational approach for the delivery of SCOs in different pharmaceutical forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamzA5Sq7uFrVg90H21EOLACvtfcHk0ljUMxG2BlnZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D&md5=64e66305efb772c25386977d53802340</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr072%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DAndaloussi%26aufirst%3DS.%2BE.%26aulast%3DZaghloul%26aufirst%3DE.%2BM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DP.%2BM.%26aulast%3DViola%26aufirst%3DJ.%2BR.%26aulast%3DMagdy%26aufirst%3DT.%26aulast%3DAbdo%26aufirst%3DR.%26aulast%3DGuterstam%26aufirst%3DP.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DHammond%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DM.%2BJ.%26aulast%3DArzumanov%26aufirst%3DA.%2BA.%26aulast%3DGait%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26aulast%3DHallbrink%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPepfect%252014%252C%2520a%2520Novel%2520Cell-Penetrating%2520Peptide%2520for%2520Oligonucleotide%2520Delivery%2520in%2520Solution%2520and%2520as%2520Solid%2520Formulation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3D5284%26epage%3D5298%26doi%3D10.1093%2Fnar%2Fgkr072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnoller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribranska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Nanoencapsulation of Antitubercular Drug Isoniazid and Its Lipopeptide Conjugate</span>. <i>J. Dispersion Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1728</span>– <span class="NLM_lpage">1734</span>, <span class="refDoi"> DOI: 10.1080/01932691.2011.616128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1080%2F01932691.2011.616128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGlsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1728-1734&author=E.+Kissauthor=D.+Schnollerauthor=K.+Pribranskaauthor=K.+Hillauthor=C.+B.+Penzesauthor=K.+Horvatiauthor=S.+Bosze&title=Nanoencapsulation+of+Antitubercular+Drug+Isoniazid+and+Its+Lipopeptide+Conjugate&doi=10.1080%2F01932691.2011.616128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoencapsulation of Antitubercular Drug Isoniazid and Its Lipopeptide Conjugate</span></div><div class="casAuthors">Kiss, E.; Schnoeller, D.; Pribranska, K.; Hill, K.; Penzes, Cs. B.; Horvati, K.; Bosze, Sz.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dispersion Science and Technology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1728-1734</span>CODEN:
                <span class="NLM_cas:coden">JDTEDS</span>;
        ISSN:<span class="NLM_cas:issn">0193-2691</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Isoniazid (INH) is a first line drug for treatment of the widespread deadly disease caused by Mycobacterium tuberculosis.  Peptide conjugate of INH was designed and synthesized for targeted and receptor-mediated cellular uptake of INH.  Chem. compn., hydrophobicity (n-octanol/water partition coeff.), and membrane affinity (using a Langmuir lipid monolayer as a model system) of the conjugate were characterized.  Hydrophilicity of the drug was remarkably decreased by the conjugation which resulted in improved interaction with lipid layer and allowed its efficient encapsulation into polylactic/glycolic acid nanoparticles enhancing the bioavailability of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuAf4HLJNJhrVg90H21EOLACvtfcHk0ljUMxG2BlnZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGlsrjL&md5=85496fc2e16555789e7c906a2d365494</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1080%2F01932691.2011.616128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01932691.2011.616128%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DE.%26aulast%3DSchnoller%26aufirst%3DD.%26aulast%3DPribranska%26aufirst%3DK.%26aulast%3DHill%26aufirst%3DK.%26aulast%3DPenzes%26aufirst%3DC.%2BB.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DNanoencapsulation%2520of%2520Antitubercular%2520Drug%2520Isoniazid%2520and%2520Its%2520Lipopeptide%2520Conjugate%26jtitle%3DJ.%2520Dispersion%2520Sci.%2520Technol.%26date%3D2011%26volume%3D32%26spage%3D1728%26epage%3D1734%26doi%3D10.1080%2F01932691.2011.616128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span> <span> </span><span class="NLM_article-title">Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3893</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1021/ja00119a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00119a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=3893-3899&author=J.+Shaoauthor=J.+P.+Tam&title=Unprotected+Peptides+as+Building+Blocks+for+the+Synthesis+of+Peptide+Dendrimers+with+Oxime%2C+Hydrazone%2C+and+Thiazolidine+Linkages&doi=10.1021%2Fja00119a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Unprotected Peptides as Building Blocks for the Synthesis of Peptide Dendrimers with Oxime, Hydrazone, and Thiazolidine Linkages</span></div><div class="casAuthors">Shao, Jun; Tam, James P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3893-9</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general approach for forming peptide dendrimers with oxime, hydrazone, and thiazolidine linkages was developed using unprotected peptides as building blocks and selective ligation between an aldehyde and a weak base.  To illustrate the generality of this approach, a branched lysine core matrix with an aldehyde was used to ligate four copies of unprotected peptides contg. a weak nucleophilic base such as aminooxy, hydrazide, or cysteine 1,2-aminothiol groups at their N-termini to form synthetic branched proteins.  Various parameters affecting the ligations were studied, and optimal conditions gave 12-27-fold rate increases and shortened the reaction time from 24-60 to 2-8 h.  Among the three reactions studied, ligation by thiazolidine appeared to be superior to ligation by oxime or hydrazone in reaction rate and product stability.  The purified dendrimeric products gave single peaks on reverse phase HPLC and size exclusion HPLC.  Their macromol. structures were also characterized by mass spectrometry and amino acid anal.  CD spectra of the dendrimers showed that they have an increased ordered helical structure.  Ligation reactions using a mutually reactive weak base and aldehyde pair should provide a useful approach for the synthesis of peptide dendrimers and artificial proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9c17gwrdT7Vg90H21EOLACvtfcHk0ljUMxG2BlnZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVajtb8%253D&md5=6480b4f8c75ce105b1baff1bb3e65075</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja00119a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00119a001%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DJ.%2BP.%26atitle%3DUnprotected%2520Peptides%2520as%2520Building%2520Blocks%2520for%2520the%2520Synthesis%2520of%2520Peptide%2520Dendrimers%2520with%2520Oxime%252C%2520Hydrazone%252C%2520and%2520Thiazolidine%2520Linkages%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D3893%26epage%3D3899%26doi%3D10.1021%2Fja00119a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naqvi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzow, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finucane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagra, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishfaq, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosabowski, J.</span></span> <span> </span><span class="NLM_article-title">Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking In Vitro and In Vivo</span>. <i>Cancer Biother. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1089/cbr.2009.0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1089%2Fcbr.2009.0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=20187801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ktl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=89-95&author=S.+A.+Naqviauthor=T.+Matzowauthor=C.+Finucaneauthor=S.+A.+Nagraauthor=M.+M.+Ishfaqauthor=S.+J.+Matherauthor=J.+Sosabowski&title=Insertion+of+a+Lysosomal+Enzyme+Cleavage+Site+into+the+Sequence+of+a+Radiolabeled+Neuropeptide+Influences+Cell+Trafficking+In+Vitro+and+In+Vivo&doi=10.1089%2Fcbr.2009.0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo</span></div><div class="casAuthors">Naqvi Syed Ali Raza; Matzow Torkjel; Finucane Ciara; Nagra Saeed A; Ishfaq Malik M; Mather Stephen J; Sosabowski Jane</div><div class="citationInfo"><span class="NLM_cas:title">Cancer biotherapy & radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-95</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Radiolabeled neuropeptides are widely explored for targeting tumours for either imaging or radiotherapeutic purposes.  After binding to their receptors, these peptides are rapidly internalized into lysosomes, where they are degraded by proteolytic enzymes, such as cathepsins.  The aim of this study was to investigate the effect of the inclusion of specific cleavage sites for cathepsin B into the peptide sequence.  The cleavage site, GFLG, together with a series of dipeptides for pharmacokinetic modification of radiometabolites, were, therefore, inserted into a peptide that binds to the gastrin/CCK2 receptor.  The receptor binding of the peptides was explored in AR42J cells, rates of internalization, and externalization of the radionuclide were measured and the nature of the radiometabolites explored.  The effects of the modifications on biodistribution in tumor-bearing mice was explored by high-resolution single-photon emission computed tomography imaging.  Differences in rates of externalization from tumor cells in vitro and in the rates of washout from tumor and kidney in vivo were observed.  These results indicate that insertion of an enzymatic cleavage site, such as that for cathepsin B, into a neuropeptide appears to have an influence on the intracellular processing, which results in a change in the rate of egress of radioactivity from target and nontarget tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKTaXFsO12OJSWdIdmEou5fW6udTcc2eaQSSOcYEiBq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ktl2itw%253D%253D&md5=dfc6b613726ce09cc9b68291c5a60340</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2009.0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2009.0666%26sid%3Dliteratum%253Aachs%26aulast%3DNaqvi%26aufirst%3DS.%2BA.%26aulast%3DMatzow%26aufirst%3DT.%26aulast%3DFinucane%26aufirst%3DC.%26aulast%3DNagra%26aufirst%3DS.%2BA.%26aulast%3DIshfaq%26aufirst%3DM.%2BM.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DSosabowski%26aufirst%3DJ.%26atitle%3DInsertion%2520of%2520a%2520Lysosomal%2520Enzyme%2520Cleavage%2520Site%2520into%2520the%2520Sequence%2520of%2520a%2520Radiolabeled%2520Neuropeptide%2520Influences%2520Cell%2520Trafficking%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2010%26volume%3D25%26spage%3D89%26epage%3D95%26doi%3D10.1089%2Fcbr.2009.0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vrettos, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzakos, A. G.</span></span> <span> </span><span class="NLM_article-title">On the Design Principles of Peptide-Drug Conjugates for Targeted Drug Delivery to the Malignant Tumor Site</span>. <i>Beilstein J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">930</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.3762/bjoc.14.80</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3762%2Fbjoc.14.80" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29765474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOnsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=930-954&author=E.+I.+Vrettosauthor=G.+Mezoauthor=A.+G.+Tzakos&title=On+the+Design+Principles+of+Peptide-Drug+Conjugates+for+Targeted+Drug+Delivery+to+the+Malignant+Tumor+Site&doi=10.3762%2Fbjoc.14.80"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site</span></div><div class="casAuthors">Vrettos, Eirinaios I.; Mezo, Gabor; Tzakos, Andreas G.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">930-954</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030.  To effectively combat the menace of cancer, a variety of strategies have been exploited.  Among them, the development of peptide-drug conjugates (PDCs) is considered as an inextricable part of this armamentarium and is continuously explored as a viable approach to target malignant tumors.  The general architecture of PDCs consists of three building blocks: the tumor-homing peptide, the cytotoxic agent and the biodegradable connecting linker.  The aim of the current review is to provide a spherical perspective on the basic principles governing PDCs, as also the methodol. to construct them.  We aim to offer basic and integral knowledge on the rational design towards the construction of PDCs through analyzing each building block, as also to highlight the overall progress of this rapidly growing field.  Therefore, we focus on several intriguing examples from the recent literature, including important PDCs that have progressed to phase III clin. trials.  Last, we address possible difficulties that may emerge during the synthesis of PDCs, as also report ways to overcome them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRxpOdZLKXfrVg90H21EOLACvtfcHk0lgFFnaocf7MPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOnsLvP&md5=595fce13e61b3e6f58a8ae6969e8b2c8</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.14.80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.14.80%26sid%3Dliteratum%253Aachs%26aulast%3DVrettos%26aufirst%3DE.%2BI.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTzakos%26aufirst%3DA.%2BG.%26atitle%3DOn%2520the%2520Design%2520Principles%2520of%2520Peptide-Drug%2520Conjugates%2520for%2520Targeted%2520Drug%2520Delivery%2520to%2520the%2520Malignant%2520Tumor%2520Site%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D14%26spage%3D930%26epage%3D954%26doi%3D10.3762%2Fbjoc.14.80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. F.</span></span> <span> </span><span class="NLM_article-title">Antitumor Imidazotetrazines. 41. Conjugation of the Antitumor Agents Mitozolomide and Temozolomide to Peptides and Lexitropsins Bearing DNA Major and Minor Groove-Binding Structural Motifs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5458</span>– <span class="NLM_lpage">5470</span>, <span class="refDoi"> DOI: 10.1021/jm020936d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020936d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlyht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5458-5470&author=J.+Arrowsmithauthor=S.+A.+Jenningsauthor=A.+S.+Clarkauthor=M.+F.+Stevens&title=Antitumor+Imidazotetrazines.+41.+Conjugation+of+the+Antitumor+Agents+Mitozolomide+and+Temozolomide+to+Peptides+and+Lexitropsins+Bearing+DNA+Major+and+Minor+Groove-Binding+Structural+Motifs&doi=10.1021%2Fjm020936d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Imidazotetrazines. 41. Conjugation of the Antitumor Agents Mitozolomide and Temozolomide to Peptides and Lexitropsins Bearing DNA Major and Minor Groove-Binding Structural Motifs</span></div><div class="casAuthors">Arrowsmith, Jill; Jennings, Sharon A.; Clark, Alan S.; Stevens, Malcolm F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5458-5470</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carboxylic acids derived from the amido groups of the antitumor agents mitozolomide and temozolomide have been conjugated to simple amino acids and peptides by carbodiimide coupling. Solid-state peptide synthesis has been applied to link the acids to DNA major groove-binding peptidic motifs known to adopt α-helical conformations.  Attachment of the acids to pyrrole and imidazole polyamidic lexitropsins gave a series of potential DNA minor groove-binding ligands.  In vitro biol. evaluation of a limited no. of these novel conjugates failed to demonstrate any enhanced growth-inhibitory activity compared to the unconjugated drugs; sites of alkylation at tracts of multiple guanines were also unaffected.  Attachment of addnl. residues at C-8 of the imidazotetrazines did not perturb the chem. of activation of the bicyclic nucleus, and biol. sequelae can be rationalized by invoking the liberation of a common, diffusible, reactive chem. intermediate, the methanediazonium ion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEh6WwILUpnbVg90H21EOLACvtfcHk0lgFFnaocf7MPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlyht74%253D&md5=078cdc0e831e5fe3878d177fc6d5f8e7</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm020936d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020936d%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DJ.%26aulast%3DJennings%26aufirst%3DS.%2BA.%26aulast%3DClark%26aufirst%3DA.%2BS.%26aulast%3DStevens%26aufirst%3DM.%2BF.%26atitle%3DAntitumor%2520Imidazotetrazines.%252041.%2520Conjugation%2520of%2520the%2520Antitumor%2520Agents%2520Mitozolomide%2520and%2520Temozolomide%2520to%2520Peptides%2520and%2520Lexitropsins%2520Bearing%2520DNA%2520Major%2520and%2520Minor%2520Groove-Binding%2520Structural%2520Motifs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5458%26epage%3D5470%26doi%3D10.1021%2Fjm020936d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emrick, T.</span></span> <span> </span><span class="NLM_article-title">Versatile Synthesis of Polymer-Temozolomide Conjugates</span>. <i>ACS Macro Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/acsmacrolett.7b00007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmacrolett.7b00007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1agsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=215-218&author=M.+Skinnerauthor=S.+M.+Wardauthor=T.+Emrick&title=Versatile+Synthesis+of+Polymer-Temozolomide+Conjugates&doi=10.1021%2Facsmacrolett.7b00007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Versatile Synthesis of Polymer-Temozolomide Conjugates</span></div><div class="casAuthors">Skinner, Matthew; Ward, Sarah M.; Emrick, Todd</div><div class="citationInfo"><span class="NLM_cas:title">ACS Macro Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-218</span>CODEN:
                <span class="NLM_cas:coden">AMLCCD</span>;
        ISSN:<span class="NLM_cas:issn">2161-1653</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new and versatile synthesis was developed to produce polymer prodrugs composed of poly(2-methacryloyloxyethyl phosphorylcholine) (polyMPC) conjugated covalently to the glioblastoma drug Temozolomide (TMZ).  Through a controlled free radical copolymn. of a TMZ-substituted methacrylate and MPC, water-sol. polyMPC-TMZ conjugates were realized with TMZ loadings of >50 mol %.  After polymn., the structural fidelity of the pendent TMZ moieties was confirmed by NMR and UV-vis spectroscopy, while mol. wt. estn. by gel permeation chromatog. (GPC) confirmed the desired control over the polymn., with isolated polymer-TMZ conjugates exhibiting narrow mol. wt. distributions.  This synthetic design opens new possibilities for formulating numerous types of polymeric TMZ-based structures that are of interest for treating glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZFjd-Sd5RY7Vg90H21EOLACvtfcHk0ljzpC0GeJXuyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1agsLk%253D&md5=b85a474a521c65cb2a8bc409d9a23b7b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facsmacrolett.7b00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmacrolett.7b00007%26sid%3Dliteratum%253Aachs%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DS.%2BM.%26aulast%3DEmrick%26aufirst%3DT.%26atitle%3DVersatile%2520Synthesis%2520of%2520Polymer-Temozolomide%2520Conjugates%26jtitle%3DACS%2520Macro%2520Lett.%26date%3D2017%26volume%3D6%26spage%3D215%26epage%3D218%26doi%3D10.1021%2Facsmacrolett.7b00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toniolo, C. F. F.</span>; <span class="NLM_string-name">Woody, R. W.</span></span> <span> </span><span class="NLM_article-title">Electronic Circular Dichroism of Peptides</span>. In  <i>Comprehensive Chiroptical Spectroscopy: Applications in Stereochemical Analysis of Synthetic Compounds, Natural Products, and Biomolecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berova, N.</span>, <span class="NLM_string-name">Polavarapu, P. L.</span>, <span class="NLM_string-name">Nakanishi, K.</span>, <span class="NLM_string-name">Woody, R. W.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_year">2012</span>; Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">544</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2F9781118120392.ch15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=499-544&author=C.+F.+F.+Toniolo&author=R.+W.+Woodyauthor=N.+Berova&author=P.+L.+Polavarapu&author=K.+Nakanishi&author=R.+W.+Woody&title=Comprehensive+Chiroptical+Spectroscopy%3A+Applications+in+Stereochemical+Analysis+of+Synthetic+Compounds%2C+Natural+Products%2C+and+Biomolecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2F9781118120392.ch15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118120392.ch15%26sid%3Dliteratum%253Aachs%26aulast%3DToniolo%26aufirst%3DC.%2BF.%2BF.%26atitle%3DElectronic%2520Circular%2520Dichroism%2520of%2520Peptides%26btitle%3DComprehensive%2520Chiroptical%2520Spectroscopy%253A%2520Applications%2520in%2520Stereochemical%2520Analysis%2520of%2520Synthetic%2520Compounds%252C%2520Natural%2520Products%252C%2520and%2520Biomolecules%26aulast%3DBerova%26aufirst%3DN.%26pub%3DWiley%26date%3D2012%26volume%3D2%26spage%3D499%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woody, R. W.</span></span> <span> </span><span class="NLM_article-title">Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">8234</span>– <span class="NLM_lpage">8245</span>, <span class="refDoi"> DOI: 10.1021/ja901218m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja901218m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtleltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=8234-8245&author=R.+W.+Woody&title=Circular+Dichroism+Spectrum+of+Peptides+in+the+Poly%28Pro%29II+Conformation&doi=10.1021%2Fja901218m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Circular Dichroism Spectrum of Peptides in the Poly(Pro)II Conformation</span></div><div class="casAuthors">Woody, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8234-8245</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The poly(Pro)II (PII) conformation is increasingly recognized as an important element in peptide and protein conformation.  CD is one of the most useful methods for detecting and characterizing PII.  Although the std. exciton-based model for predicting peptide CD spectra works well for α-helixes and β-sheets, it fails to reproduce the PII CD spectrum because it does not account for mixing of the nπ* and ππ* transitions with transitions in the deep UV, which is significant for the PII conformation.  In this work, the exciton model is extended to include this mixing, using ab initio-derived bond polarizability tensors to calc. the contributions of the high-energy transitions.  The strong neg. 195-nm and weaker pos. 220-nm CD bands of PII are reproduced for (Ala)n conformers in the PII region of the Ramachandran map.  For the canonical PII conformation from fiber diffraction of poly(Pro)II (-77, +146), the results are poor, but conformations with less neg. φ (∼ -60°) and more pos. ψ (≥160°) give spectra showing the PII characteristics.  The CD of (Pro)n is not reproduced by the calcns., probably because variations in (φ,Ψ), ring puckering, and cis-trans isomerism are not included in the model The extended model also gives improved results for α-helical polypeptides, leading to increased amplitude for the 205-nm band and decreased amplitude for a neg. band predicted near 180 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFoF4RrL40KLVg90H21EOLACvtfcHk0ljzpC0GeJXuyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtleltrs%253D&md5=8ff00394c461ee2a815ededda8168a06</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fja901218m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja901218m%26sid%3Dliteratum%253Aachs%26aulast%3DWoody%26aufirst%3DR.%2BW.%26atitle%3DCircular%2520Dichroism%2520Spectrum%2520of%2520Peptides%2520in%2520the%2520Poly%2528Pro%2529II%2520Conformation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D8234%26epage%3D8245%26doi%3D10.1021%2Fja901218m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zsila, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majer, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uray, K.</span></span> <span> </span><span class="NLM_article-title">Tailoring Uptake Efficacy of HSV-1 gD Derived Carrier Peptides</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">721</span>, <span class="refDoi"> DOI: 10.3390/biom10050721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fbiom10050721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFChsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=721&author=S.+Boszeauthor=F.+Zsilaauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=Z.+Majerauthor=F.+Hudeczauthor=K.+Uray&title=Tailoring+Uptake+Efficacy+of+HSV-1+gD+Derived+Carrier+Peptides&doi=10.3390%2Fbiom10050721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Tailoring uptake efficacy of HSV-1 gD tailoring uptake efficacy of Hsv-1 GD derived carrier peptides</span></div><div class="casAuthors">Bosze, Szilvia; Zsila, Ferenc; Biri-Kovacs, Beata; Szeder, Balint; Majer, Zsuzsa; Hudecz, Ferenc; Uray, Katalin</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Regions of the Herpes simplex virus-1 (HSV-1) glycoprotein D (gD) were chosen to design carrier peptides based on the known tertiary structure of the virus entry receptor complexes.  These complexes consist of the following: HSV-1 gD-nectin-1 and HSV-1 gD-herpesvirus entry mediator (HVEM).  Three sets of peptides were synthesized with sequences covering the (i) N-terminal HVEM- and nectin-1 binding region -5-42, (ii) the 181-216 medium region contg. nectin-1 binding sequences and (iii) the C-terminal nectin-1 binding region 214-255.  The carrier candidates were prepd. with acetylated and 5(6)-carboxyfluorescein labeled N-termini.  The peptides were chem. characterised and their conformational features in soln. were also detd.  In vitro internalisation profile and intracellular localisation were evaluated on SH-SY5Y neuroblastoma cells.  Peptide originated from the C-terminal region 224-247 of the HSV-1 gD showed remarkable internalisation compared to the other peptides with low to moderate entry.  Electronic CD secondary structure studies of the peptides revealed that the most effectively internalised peptides exhibit high helical propensity at increasing TFE concns.  We proved that oligopeptides derived from the nectin-1 binding region are promising candidates-with possibility of Lys237Arg and/or Trp241Phe substitutions-for side-reaction free conjugation of bioactive compds.-drugs or gene therapy agents-as cargos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpFf4GZ9IzLVg90H21EOLACvtfcHk0ljzpC0GeJXuyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFChsbrI&md5=18b7b467a6a4c6389fde07fda20fe931</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3390%2Fbiom10050721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10050721%26sid%3Dliteratum%253Aachs%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DZsila%26aufirst%3DF.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DMajer%26aufirst%3DZ.%26aulast%3DHudecz%26aufirst%3DF.%26aulast%3DUray%26aufirst%3DK.%26atitle%3DTailoring%2520Uptake%2520Efficacy%2520of%2520HSV-1%2520gD%2520Derived%2520Carrier%2520Peptides%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26spage%3D721%26doi%3D10.3390%2Fbiom10050721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, M.</span></span> <span> </span><span class="NLM_article-title">About TFE: Old and New Findings</span>. <i>Curr. Protein Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.2174/1389203720666190214152439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2174%2F1389203720666190214152439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30767740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVGht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=425-451&author=M.+Vincenziauthor=F.+A.+Mercurioauthor=M.+Leone&title=About+TFE%3A+Old+and+New+Findings&doi=10.2174%2F1389203720666190214152439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">About TFE: Old and New Findings</span></div><div class="casAuthors">Vincenzi, Marian; Mercurio, Flavia A.; Leone, Marilisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">425-451</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The fluorinated alc. 2,2,2-Trifluoroethanol (TFE) has been implemented for many decades now in conformational studies of proteins and peptides.  In peptides, which are often disordered in aq. solns., TFE acts as secondary structure stabilizer and primarily induces an α -helical conformation.  The exact mechanism through which TFE plays its stabilizing roles is still debated and direct and indirect routes, relying either on straight interaction between TFE and mols. or indirect pathways based on perturbation of solvation sphere, have been proposed.  Another still unanswered question is the capacity of TFE to favor in peptides a bioactive or a native-like conformation rather than simply stimulate the raise of secondary structure elements that reflect only the inherent propensity of a specific amino-acid sequence.  In protein studies, TFE destroys unique protein tertiary structure and often leads to the formation of non-native secondary structure elements, but, interestingly, gives some hints about early folding intermediates.  In this review, we will summarize proposed mechanisms of TFE actions.  We will also describe several examples, in which TFE has been successfully used to reveal structural properties of different mol. systems, including antimicrobial and aggregation-prone peptides, as well as globular folded and intrinsically disordered proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBTMk3S3Vx6LVg90H21EOLACvtfcHk0lhMc4rpaFsUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVGht7fI&md5=4ebf31c9bc3368a1c51d07586b69dfec</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F1389203720666190214152439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203720666190214152439%26sid%3Dliteratum%253Aachs%26aulast%3DVincenzi%26aufirst%3DM.%26aulast%3DMercurio%26aufirst%3DF.%2BA.%26aulast%3DLeone%26aufirst%3DM.%26atitle%3DAbout%2520TFE%253A%2520Old%2520and%2520New%2520Findings%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D425%26epage%3D451%26doi%3D10.2174%2F1389203720666190214152439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2</span>. <i>Probiotics Antimicrob. Proteins</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1007/s12602-017-9335-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs12602-017-9335-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29043494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=118-127&author=J.+Yanauthor=X.+Liangauthor=C.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=K.+Wangauthor=L.+Zhao&title=Influence+of+Proline+Substitution+on+the+Bioactivity+of+Mammalian-Derived+Antimicrobial+Peptide+NK-2&doi=10.1007%2Fs12602-017-9335-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2</span></div><div class="casAuthors">Yan, Jiexi; Liang, Xiaolei; Liu, Chang; Cheng, Yuemei; Zhou, Lanxia; Wang, Kairong; Zhao, Li</div><div class="citationInfo"><span class="NLM_cas:title">Probiotics and Antimicrobial Proteins</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-127</span>CODEN:
                <span class="NLM_cas:coden">PAPREP</span>;
        ISSN:<span class="NLM_cas:issn">1867-1306</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Multidrug-resistant bacteria are emerging as a global threat, making the search for alternative compds. urgent.  Antimicrobial peptides (AMPs) became a promising hotspot due to their distinct action mechanism and possibility to be used as an alternative or complement to traditional antibiotics.  However, gaining a better understanding about the relationship between antimicrobial peptides structure and its bioactivity is crucial for the development of next generation of antimicrobial agents.  NK-2, derived from mammalian protein NK-lysin, has potent antitumor and bactericidal abilities.  As proline was considered to be an effective α-helix breaker due to its restricted conformation, to better comprehend the effects of proline in the structure-activity relationship of NK-2, we constructed two NK-2 analogs.  We examd. the biol. activities of NK-2 and its proline substitution analogs and analyzed the resulting conformational changes.  Our results showed that introducing proline into the primary sequence of NK-2 significantly decreased the antitumor, antibacterial, and cytotoxic effects, as well as DNA binding activity by changing the α-helix content.  However, α-helical content was not the only detg. factor, the position of proline inserted was also crit.  This study will allow for clearer insight into the role of proline in structure and bioactivity of NK-2 and provide a foundation for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXX60Rzle7qLVg90H21EOLACvtfcHk0lhMc4rpaFsUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsr3P&md5=494febc701ee5a918b7a91427c7725f3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs12602-017-9335-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12602-017-9335-1%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DInfluence%2520of%2520Proline%2520Substitution%2520on%2520the%2520Bioactivity%2520of%2520Mammalian-Derived%2520Antimicrobial%2520Peptide%2520NK-2%26jtitle%3DProbiotics%2520Antimicrob.%2520Proteins%26date%3D2018%26volume%3D10%26spage%3D118%26epage%3D127%26doi%3D10.1007%2Fs12602-017-9335-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitaku, S.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Secondary Structure Breakers in Soluble Proteins</span>. <i>Biophysics (Biophys. Soc. Jpn.)</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.2142/biophysics.1.55</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.2142%2Fbiophysics.1.55" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2lurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=55-65&author=K.+Imaiauthor=S.+Mitaku&title=Mechanisms+of+Secondary+Structure+Breakers+in+Soluble+Proteins&doi=10.2142%2Fbiophysics.1.55"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of secondary structure breakers in soluble proteins</span></div><div class="casAuthors">Imai, Kenichiro; Mitaku, Shigeki</div><div class="citationInfo"><span class="NLM_cas:title">Biophysics (Biophysical Society of Japan)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">BBSJC3</span>;
        ISSN:<span class="NLM_cas:issn">1349-2942</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society of Japan</span>)
        </div><div class="casAbstract">The sequences of proteins contain various signals for structural stability and function.  Membrane proteins, for example, have clear signals for helical structure characterized by a cluster of hydrophobic residues sandwiched between clusters of amphiphilic residues.  However, the distinct physicochem. signals for secondary structures in sol. proteins remain unclear.  Therefore, despite a long history of investigation, the accuracy of secondary structure prediction is not sufficiently high.  In contrast, very clear signals for secondary structure breakpoints (breakers) have been established.  These signals include the presence of Pro residues, Gly residues, or clusters of a combination of Pro and Gly residues.  Pro residues are too rigid to be incorporated into a secondary structure, whereas Gly residues are so flexible that the local structure becomes unstable in a cluster.  Breaking signals of secondary structure put strong limitations on the tertiary structures of proteins.  Here, in addn. to Pro and Gly clusters, clusters of residues with amphiphilic side-chains which have both a polar group and a flexible hydrocarbon (e.g., Arg, Lys, His, Glu, and Gln residues) were found to be a novel type of secondary structure breaker.  These secondary structure breakers were found to depend on specific environmental factors.  Such conditions included the av. hydrophobicity, the helical periodicity, the d. of Ser and Thr residues, and the presence of Trp and Tyr clusters.  Principal component anal. of environmental factors was conducted in order to identify candidate breakers in the secondary structure breaking regions.  Predicted breakers were located in breaking regions with an accuracy of 72%.  Taking the loop core into consideration, almost 90% of the predicted breakers were located in the loop segments.  When the migration effect of the breaking point was taken into account, the loop segments with the predicted breakers covered 2/3 of all loop segments.  The possibility of secondary structure prediction based on secondary structure breakers was discussed.  By combining the effects of primary factors (Pro, Gly, and amphiphilic residues) and several environmental factors, a method was developed for accurately predicting secondary structure breakers.  The system of this method is available on the Internet at the URL: http://bp.nuap.nagoya-u.ac.jp/sosui/sosuibreaker/sosuibreaker_submit.html.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo27FHdHa66O7Vg90H21EOLACvtfcHk0lhMc4rpaFsUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2lurrL&md5=47a29e985cace9329e2aea0e723ac67d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.2142%2Fbiophysics.1.55&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2142%252Fbiophysics.1.55%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DK.%26aulast%3DMitaku%26aufirst%3DS.%26atitle%3DMechanisms%2520of%2520Secondary%2520Structure%2520Breakers%2520in%2520Soluble%2520Proteins%26jtitle%3DBiophysics%2520%2528Biophys.%2520Soc.%2520Jpn.%2529%26date%3D2005%26volume%3D1%26spage%3D55%26epage%3D65%26doi%3D10.2142%2Fbiophysics.1.55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mindell, J. A.</span></span> <span> </span><span class="NLM_article-title">Lysosomal Acidification Mechanisms</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-012110-142317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1146%2Fannurev-physiol-012110-142317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=22335796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvFynsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=69-86&author=J.+A.+Mindell&title=Lysosomal+Acidification+Mechanisms&doi=10.1146%2Fannurev-physiol-012110-142317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal acidification mechanisms</span></div><div class="casAuthors">Mindell, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-86</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysosomes, the terminal organelles on the endocytic pathway, digest macromols. and make their components available to the cell as nutrients.  Hydrolytic enzymes specific to a wide range of targets reside within the lysosome; these enzymes are activated by the highly acidic pH (between 4.5 and 5.0) in the organelles' interior.  Lysosomes generate and maintain their pH gradients by using the activity of a proton-pumping V-type ATPase, which uses metabolic energy in the form of ATP to pump protons into the lysosome lumen.  Because this activity separates elec. charge and generates a transmembrane voltage, another ion must move to dissipate this voltage for net pumping to occur.  This so-called counterion may be either a cation (moving out of the lysosome) or an anion (moving into the lysosome).  Recent data support the involvement of ClC-7, a Cl-/H+ antiporter, in this process, although many open questions remain as to this transporter's involvement.  Although functional results also point to a cation transporter, its mol. identity remains uncertain.  Both the V-ATPase and the counterion transporter are likely to be important players in the mechanisms detg. the steady-state pH of the lysosome interior.  Exciting new results suggest that lysosomal pH may be dynamically regulated in some cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhQ7yyHPp6nrVg90H21EOLACvtfcHk0lhMc4rpaFsUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvFynsbo%253D&md5=c9a157aa4b4c9c432ee4e26e4d3bdd13</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-012110-142317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-012110-142317%26sid%3Dliteratum%253Aachs%26aulast%3DMindell%26aufirst%3DJ.%2BA.%26atitle%3DLysosomal%2520Acidification%2520Mechanisms%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2012%26volume%3D74%26spage%3D69%26epage%3D86%26doi%3D10.1146%2Fannurev-physiol-012110-142317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orban, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlage, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulic, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansorge, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M?ller, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manea, M.</span></span> <span> </span><span class="NLM_article-title">In Vitro Degradation and Antitumor Activity of Oxime Bond-Linked Daunorubicin-GnRH-III Bioconjugates and DNA-Binding Properties of Daunorubicin-Amino Acid Metabolites</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">469</span>– <span class="NLM_lpage">483</span>, <span class="refDoi"> DOI: 10.1007/s00726-010-0766-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs00726-010-0766-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=20953647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=469-483&author=E.+Orbanauthor=G.+Mezoauthor=P.+Schlageauthor=G.+Csikauthor=Z.+Kulicauthor=P.+Ansorgeauthor=E.+Fellingerauthor=H.+M.+M%3Fllerauthor=M.+Manea&title=In+Vitro+Degradation+and+Antitumor+Activity+of+Oxime+Bond-Linked+Daunorubicin-GnRH-III+Bioconjugates+and+DNA-Binding+Properties+of+Daunorubicin-Amino+Acid+Metabolites&doi=10.1007%2Fs00726-010-0766-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites</span></div><div class="casAuthors">Orban, Erika; Mezo, Gabor; Schlage, Pascal; Csik, Gabriella; Kulic, Zarko; Ansorge, Philipp; Fellinger, Erzsebet; Moeller, Heiko Michael; Manea, Marilena</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-483</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Bioconjugates with receptor-mediated tumor-targeting functions and carrying cytotoxic agents should enable the specific delivery of chemotherapeutics to malignant tissues, thus increasing their local efficacy while limiting the peripheral toxicity.  In the present study, gonadotropin-releasing hormone III (GnRH-III; Glp-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2) was employed as a targeting moiety to which daunorubicin was attached via oxime bond, either directly or by insertion of a GFLG or YRRL tetrapeptide spacer.  The in vitro antitumor activity of the bioconjugates was detd. on MCF-7 human breast and HT-29 human colon cancer cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.  Their degrdn./stability (1) in human serum, (2) in the presence of cathepsin B and (3) in rat liver lysosomal homogenate was analyzed by liq. chromatog. in combination with mass spectrometry.  The results show that (1) all synthesized bioconjugates have in vitro antitumor effect, (2) they are stable in human serum at least for 24 h, except for the compd. contg. an YRRL spacer and (3) they are hydrolyzed by cathepsin B and in the lysosomal homogenate.  To investigate the relationship between the in vitro antitumor activity and the structure of the bioconjugates, the smallest metabolites produced in the lysosomal homogenate were synthesized and their binding to DNA was assessed by fluorescence spectroscopy.  Our data indicate that the incorporation of a peptide spacer in the structure of oxime bond-linked daunorubicin-GnRH-III bioconjugates is not required for their antitumor activity.  Moreover, the antitumor activity is influenced by the structure of the metabolites (daunorubicin-amino acid derivs.) and their DNA-binding properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1eA6n7rBhLVg90H21EOLACvtfcHk0lhKec5OLucfoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGgsb4%253D&md5=0b6f89a0f7f9a916ea0f9de7e377f99f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs00726-010-0766-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-010-0766-1%26sid%3Dliteratum%253Aachs%26aulast%3DOrban%26aufirst%3DE.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DSchlage%26aufirst%3DP.%26aulast%3DCsik%26aufirst%3DG.%26aulast%3DKulic%26aufirst%3DZ.%26aulast%3DAnsorge%26aufirst%3DP.%26aulast%3DFellinger%26aufirst%3DE.%26aulast%3DM%253Fller%26aufirst%3DH.%2BM.%26aulast%3DManea%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Degradation%2520and%2520Antitumor%2520Activity%2520of%2520Oxime%2520Bond-Linked%2520Daunorubicin-GnRH-III%2520Bioconjugates%2520and%2520DNA-Binding%2520Properties%2520of%2520Daunorubicin-Amino%2520Acid%2520Metabolites%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D41%26spage%3D469%26epage%3D483%26doi%3D10.1007%2Fs00726-010-0766-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyzos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, L. M.</span></span> <span> </span><span class="NLM_article-title">Tumorigenicity and Metastasis of Human Breast Carcinoma Cell Lines in Nude Mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=2297709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADyaK3c7isVansA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1990&pages=717-721&author=J.+E.+Priceauthor=A.+Polyzosauthor=R.+D.+Zhangauthor=L.+M.+Daniels&title=Tumorigenicity+and+Metastasis+of+Human+Breast+Carcinoma+Cell+Lines+in+Nude+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice</span></div><div class="casAuthors">Price J E; Polyzos A; Zhang R D; Daniels L M</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">717-21</span>
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">There are few reports describing experimental models of the growth and metastasis of human breast carcinomas.  This article discusses the tumorigenic and metastatic properties of two estrogen receptor-negative breast carcinomas injected into nude mice.  Tumor growth in the mammary fatpad (m.f.p.) and the subcutis was compared in female nude mice.  The injection of 10(5) viable cells of two human breast carcinoma cell lines (MDA-MB-231 and MDA-MB-435) gave a 100% tumor take rate in the m.f.p., whereas only 40% of the s.c. injections produced tumors and these occurred several weeks after the appearance of the m.f.p. tumors.  Thus, the m.f.p. of nude mice is a favorable site for the growth of human breast carcinomas.  MDA-MB-435 tumors produced distant metastases in 80% to 100% of recipients.  The most common sites for metastasis were the lymph nodes and lungs, with a lower incidence of metastases in muscle (chest wall and thigh), heart, and brain.  New variant cell lines were isolated from metastases in the lungs, brain, and heart.  All the cell lines were tumorigenic in the m.f.p., and the lung- and heart-derived metastasis lines produced slightly more lung metastases than the original cell line.  However, the brain metastasis variant produced significantly fewer lung metastases.  Intravenous inoculation of the spontaneous metastasis-derived cell lines produced few lung colonies.  Only cell variants isolated from experimental lung metastases showed enhanced lung colonization potential when reinjected i.v.  Our results suggest that the estrogen receptor-negative MDA-MB-435 cell line injected in the m.f.p. of nude mice could be a valuable tool for analysis of the cellular and molecular basis of the metastasis of advanced breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCYThNdIE9DEH3Rlp_k91zfW6udTcc2ebh4kjoPJe9y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7isVansA%253D%253D&md5=7e2d4690d050a7d5fcbf5114220dca42</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DJ.%2BE.%26aulast%3DPolyzos%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%2BD.%26aulast%3DDaniels%26aufirst%3DL.%2BM.%26atitle%3DTumorigenicity%2520and%2520Metastasis%2520of%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Lines%2520in%2520Nude%2520Mice%26jtitle%3DCancer%2520Res.%26date%3D1990%26volume%3D50%26spage%3D717%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cailleau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciger, Q. V.</span></span> <span> </span><span class="NLM_article-title">Long-Term Human Breast Carcinoma Cell Lines of Metastatic Origin: Preliminary Characterization</span>. <i>In Vitro</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">911</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1007/BF02616120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2FBF02616120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=730202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADyaE1M%252FoslCqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1978&pages=911-915&author=R.+Cailleauauthor=M.+Oliveauthor=Q.+V.+Cruciger&title=Long-Term+Human+Breast+Carcinoma+Cell+Lines+of+Metastatic+Origin%3A+Preliminary+Characterization&doi=10.1007%2FBF02616120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization</span></div><div class="casAuthors">Cailleau R; Olive M; Cruciger Q V</div><div class="citationInfo"><span class="NLM_cas:title">In vitro</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-5</span>
        ISSN:<span class="NLM_cas:issn">0073-5655</span>.
    </div><div class="casAbstract">Nineteen human breast carcinoma cell lines have been established as continuous cultures during the past 6 years in our laboratory.  This preliminary report is designed to list the lines by their designated code numbers (MDA-MB) and present a brief summary of their morphological, cytogenetic and biochemical characteristics.  Sixteen of our lines were obtained from pleural effusions, two from brain metastases, and one from pericardial fluid.  All lines have been shown to be distinct entities and are uncontaminated by HeLa cells or each other.  A lq marker chromosome is present in all but one of the lines examined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwc_MDwhbdp5agfuraLLzSfW6udTcc2ebh4kjoPJe9y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1M%252FoslCqtQ%253D%253D&md5=f7f96fa1a76a2728e60c1c369157d9ba</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1007%2FBF02616120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02616120%26sid%3Dliteratum%253Aachs%26aulast%3DCailleau%26aufirst%3DR.%26aulast%3DOlive%26aufirst%3DM.%26aulast%3DCruciger%26aufirst%3DQ.%2BV.%26atitle%3DLong-Term%2520Human%2520Breast%2520Carcinoma%2520Cell%2520Lines%2520of%2520Metastatic%2520Origin%253A%2520Preliminary%2520Characterization%26jtitle%3DIn%2520Vitro%26date%3D1978%26volume%3D14%26spage%3D911%26epage%3D915%26doi%3D10.1007%2FBF02616120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirks, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faries, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varella-Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kniss, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nims, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capes-Davis, A.</span></span> <span> </span><span class="NLM_article-title">Authentication of M14 Melanoma Cell Line Proves Misidentification of MDA-MB-435 Breast Cancer Cell Line</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1002/ijc.31067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fijc.31067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28940260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1alsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2018&pages=561-572&author=C.+Korchauthor=E.+M.+Hallauthor=W.+G.+Dirksauthor=M.+Ewingauthor=M.+Fariesauthor=M.+Varella-Garciaauthor=S.+Robinsonauthor=D.+Stortsauthor=J.+A.+Turnerauthor=Y.+Wangauthor=E.+C.+Burnettauthor=L.+Healyauthor=D.+Knissauthor=R.+M.+Neveauthor=R.+W.+Nimsauthor=Y.+A.+Reidauthor=W.+A.+Robinsonauthor=A.+Capes-Davis&title=Authentication+of+M14+Melanoma+Cell+Line+Proves+Misidentification+of+MDA-MB-435+Breast+Cancer+Cell+Line&doi=10.1002%2Fijc.31067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line</span></div><div class="casAuthors">Korch, Christopher; Hall, Erin M.; Dirks, Wilhelm G.; Ewing, Margaret; Faries, Mark; Varella-Garcia, Marileila; Robinson, Steven; Storts, Douglas; Turner, Jacqueline A.; Wang, Ying; Burnett, Edward C.; Healy, Lyn; Kniss, Douglas; Neve, Richard M.; Nims, Raymond W.; Reid, Yvonne A.; Robinson, William A.; Capes-Davis, Amanda</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A variety of anal. approaches have indicated that melanoma cell line UCLA-SO-M14 (M14) and breast carcinoma cell line MDA-MB-435 originate from a common donor.  This indicates that at some point in the past, one of these cell lines became misidentified, meaning that it ceased to correspond to the reported donor and instead became falsely identified (through cross-contamination or other means) as a cell line from a different donor.  Initial studies concluded that MDA-MB-435 was the misidentified cell line and M14 was the authentic cell line, although contradictory evidence has been published, resulting in further confusion.  To address this question, we obtained early samples of the melanoma cell line (M14), a lymphoblastoid cell line from the same donor (ML14), and donor serum preserved at the originator's institution.  M14 samples were cryopreserved in Dec. 1975, before MDA-MB-435 cells were established in culture.  Through a series of mol. characterizations, including short tandem repeat (STR) profiling and cytogenetic anal., we demonstrated that later samples of M14 and MDA-MB-435 correspond to samples of M14 frozen in 1975, to the lymphoblastoid cell line ML14, and to the melanoma donor's STR profile, sex and blood type.  This work demonstrates conclusively that M14 is the authentic cell line and MDA-MB-435 is misidentified.  With clear provenance information and authentication testing of early samples, it is possible to resolve debates regarding the origins of problematic cell lines that are widely used in cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbh0oUjT06OLVg90H21EOLACvtfcHk0lj58RimsfjI_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1alsLzL&md5=e2b359c4465cc1cb89cc694d0f17f800</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fijc.31067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31067%26sid%3Dliteratum%253Aachs%26aulast%3DKorch%26aufirst%3DC.%26aulast%3DHall%26aufirst%3DE.%2BM.%26aulast%3DDirks%26aufirst%3DW.%2BG.%26aulast%3DEwing%26aufirst%3DM.%26aulast%3DFaries%26aufirst%3DM.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DStorts%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBurnett%26aufirst%3DE.%2BC.%26aulast%3DHealy%26aufirst%3DL.%26aulast%3DKniss%26aufirst%3DD.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DNims%26aufirst%3DR.%2BW.%26aulast%3DReid%26aufirst%3DY.%2BA.%26aulast%3DRobinson%26aufirst%3DW.%2BA.%26aulast%3DCapes-Davis%26aufirst%3DA.%26atitle%3DAuthentication%2520of%2520M14%2520Melanoma%2520Cell%2520Line%2520Proves%2520Misidentification%2520of%2520MDA-MB-435%2520Breast%2520Cancer%2520Cell%2520Line%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2018%26volume%3D142%26spage%3D561%26epage%3D572%26doi%3D10.1002%2Fijc.31067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapuvari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span> <span> </span><span class="NLM_article-title">Improved in Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4763</span>, <span class="refDoi"> DOI: 10.3390/ijms20194763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms20194763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVWgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=4763&author=I.+Randelovicauthor=S.+Schusterauthor=B.+Kapuvariauthor=G.+Fossatiauthor=C.+Steinkuhlerauthor=G.+Mezoauthor=J.+Tovari&title=Improved+in+Vivo+Anti-Tumor+and+Anti-Metastatic+Effect+of+GnRH-III-Daunorubicin+Analogs+on+Colorectal+and+Breast+Carcinoma+Bearing+Mice&doi=10.3390%2Fijms20194763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Improved in vivo anti-tumor and anti-metastatic effect of GnRH-III-daunorubicin analogs on colorectal and breast carcinoma bearing mice</span></div><div class="casAuthors">Randelovic, Ivan; Schuster, Sabine; Kapuvari, Bence; Fossati, Gianluca; Steinkuhler, Christian; Mezo, Gabor; Tovari, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4763</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Among various homing devices, gonadotropin-releasing hormone-III (GnRH-III) peptide represents a suitable targeting moiety for drug delivery systems.  The anti-tumor activity of the previously developed GnRH-III-[4Lys(Bu),8Lys(Dau = Aoa)] conjugate and the novel synthesized GnRH-III-[2ΔHis,3d-Tic,4Lys(Bu),8Lys(Dau = Aoa)] conjugate, contg. the anti-cancer drug daunorubicin, were evaluated.  Here, we demonstrate that both GnRH-III-Dau conjugates possess an efficient growth inhibitory effect on more than 20 cancer cell lines, whereby the biol. activity is strongly connected to the expression of gonadotropin-releasing hormone receptors (GnRH-R).  The novel conjugate showed a higher in vitro anti-proliferative activity and a higher uptake capacity.  Moreover, the treatment with GnRH-III-Dau conjugates cause a significant in vivo tumor growth and metastases inhibitory effect in three different orthotopic models, including 4T1 mice and MDA-MB-231 human breast carcinoma, as well as HT-29 human colorectal cancer bearing BALB/s and SCID mice, while toxic side-effects were substantially reduced in comparison to the treatment with the free drug.  These findings illustrate that our novel lead compd. is a highly promising candidate for targeted tumor therapy in both colon cancer and metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2QyO2YJrgdbVg90H21EOLACvtfcHk0lj58RimsfjI_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVWgs74%253D&md5=068322b233f70d77d0ac12ded68b4e63</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fijms20194763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20194763%26sid%3Dliteratum%253Aachs%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DKapuvari%26aufirst%3DB.%26aulast%3DFossati%26aufirst%3DG.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTovari%26aufirst%3DJ.%26atitle%3DImproved%2520in%2520Vivo%2520Anti-Tumor%2520and%2520Anti-Metastatic%2520Effect%2520of%2520GnRH-III-Daunorubicin%2520Analogs%2520on%2520Colorectal%2520and%2520Breast%2520Carcinoma%2520Bearing%2520Mice%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D4763%26doi%3D10.3390%2Fijms20194763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripodi, A. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span> <span> </span><span class="NLM_article-title">In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1879</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1007/s12253-019-00773-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs12253-019-00773-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31820302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCjs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&pages=1879-1892&author=A.+A.+P.+Tripodiauthor=I.+Randelovicauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=G.+Mezoauthor=J.+Tovari&title=In+Vivo+Tumor+Growth+Inhibition+and+Antiangiogenic+Effect+of+Cyclic+NGR+Peptide-Daunorubicin+Conjugates+Developed+for+Targeted+Drug+Delivery&doi=10.1007%2Fs12253-019-00773-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery</span></div><div class="casAuthors">Tripodi, Andrea Angelo Pierluigi; Randjelovic, Ivan; Biri-Kovacs, Beata; Szeder, Balint; Mezo, Gabor; Tovari, Jozsef</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1879-1892</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Among various homing devices, peptides contg. the NGR tripeptide sequence represent a promising approach to selectively recognize CD13 receptor isoforms on the surface of tumor cells.  They have been successfully used for the delivery of various chemotherapeutic drugs to tumor vessels.  Here, we report on the murine plasma stability, in vitro and in vivo antitumor activity of our recently described bioconjugates contg. daunorubicin as payload.  Furthermore, CD13 expression of KS Kaposi's Sarcoma cell line and HT-29 human colon carcinoma cell line was investigated.  Flow cytometry studies confirm the fast cellular uptake resulting in the rapid delivery of the active metabolite Dau = Aoa-Gly-OH to tumor cells.  The increased in vitro antitumor effect might be explained by the faster rearrangement from NGR to isoDGR in case of conjugate 2 (Dau = Aoa-GFLGK(c[NleNGRE]-GG)-NH2) in comparison with conjugate 1 (Dau = Aoa-GFLGK(c[KNGRE]-GG)-NH2).  Nevertheless, results indicated that both conjugates showed significant effect on inhibition of proliferation in the primary tumor and also on blood vessel formation making them a potential candidate for targeting angiogenesis processes in tumors where CD13 and integrins are involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuuR3Awl8OLVg90H21EOLACvtfcHk0ljAgkToK4aGAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCjs7zE&md5=9587fd214003a7c590147b47ad499c1d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs12253-019-00773-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-019-00773-3%26sid%3Dliteratum%253Aachs%26aulast%3DTripodi%26aufirst%3DA.%2BA.%2BP.%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DMezo%26aufirst%3DG.%26aulast%3DTovari%26aufirst%3DJ.%26atitle%3DIn%2520Vivo%2520Tumor%2520Growth%2520Inhibition%2520and%2520Antiangiogenic%2520Effect%2520of%2520Cyclic%2520NGR%2520Peptide-Daunorubicin%2520Conjugates%2520Developed%2520for%2520Targeted%2520Drug%2520Delivery%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2020%26volume%3D26%26spage%3D1879%26epage%3D1892%26doi%3D10.1007%2Fs12253-019-00773-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dokus, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randelovic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohidai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to Panc-1 Pancreatic Cancer</span>. <i>Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">576</span>, <span class="refDoi"> DOI: 10.3390/pharmaceutics12060576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fpharmaceutics12060576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFGnsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=576&author=L.+E.+Dokusauthor=E.+Lajkoauthor=I.+Randelovicauthor=D.+Mezoauthor=G.+Schlosserauthor=L.+Kohidaiauthor=J.+Tovariauthor=G.+Mezo&title=Phage+Display-Based+Homing+Peptide-Daunomycin+Conjugates+for+Selective+Drug+Targeting+to+Panc-1+Pancreatic+Cancer&doi=10.3390%2Fpharmaceutics12060576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to PANC-1 pancreatic cancer</span></div><div class="casAuthors">Dokus, Levente E.; Lajko, Eszter; Randelovic, Ivan; Mezo, Diana; Schlosser, Gitta; Kohidai, Laszlo; Tovari, Jozsef; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576</span>CODEN:
                <span class="NLM_cas:coden">PHARK5</span>;
        ISSN:<span class="NLM_cas:issn">1999-4923</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and dangerous cancerous diseases, leading to a high rate of mortality.  Therefore, the development of new, more efficient treatment approaches is necessary to cure this illness.  Peptide-based drug targeting provides a new tool for this purpose.  Previously, a hexapeptide Cys-Lys-Ala-Ala-Lys-Asn (CKAAKN) was applied efficiently as the homing device for drug-loaded nanostructures in PDAC cells.  In this research, Cys was replaced by Ser in the sequence and this new SKAAKN targeting moiety was used in conjugates contg. daunomycin (Dau).  Five different structures were developed and tested.  The results indicated that linear versions with one Dau were not effective on PANC-1 cells in vitro; however, branched conjugates with two Dau mols. showed significant antitumor activity.  Differences in the antitumor effect of the conjugates could be explained with the different cellular uptake and lysosomal degrdn.  The most efficient conjugate was Dau=Aoa-GFLG-K(Dau=Aoa)SKAAKN-OH (conjugate 4) that also showed significant tumor growth inhibition on s.c. implanted PANC-1 tumor-bearing mice with negligible side effects.  Our novel results suggest that peptide-based drug delivery systems could be a promising tool for the treatment of pancreatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHefZ-MzGahLVg90H21EOLACvtfcHk0ljAgkToK4aGAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFGnsbzP&md5=bb8a2a924ee2244cc4e62d8e3d5b6e55</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3390%2Fpharmaceutics12060576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpharmaceutics12060576%26sid%3Dliteratum%253Aachs%26aulast%3DDokus%26aufirst%3DL.%2BE.%26aulast%3DLajko%26aufirst%3DE.%26aulast%3DRandelovic%26aufirst%3DI.%26aulast%3DMezo%26aufirst%3DD.%26aulast%3DSchlosser%26aufirst%3DG.%26aulast%3DKohidai%26aufirst%3DL.%26aulast%3DTovari%26aufirst%3DJ.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DPhage%2520Display-Based%2520Homing%2520Peptide-Daunomycin%2520Conjugates%2520for%2520Selective%2520Drug%2520Targeting%2520to%2520Panc-1%2520Pancreatic%2520Cancer%26jtitle%3DPharmaceutics%26date%3D2020%26volume%3D12%26spage%3D576%26doi%3D10.3390%2Fpharmaceutics12060576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casey, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, J.</span></span> <span> </span><span class="NLM_article-title">Sensors and Regulators of Intracellular Ph</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1038/nrm2820</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fnrm2820" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=19997129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=50-61&author=J.+R.+Caseyauthor=S.+Grinsteinauthor=J.+Orlowski&title=Sensors+and+Regulators+of+Intracellular+Ph&doi=10.1038%2Fnrm2820"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Sensors and regulators of intracellular pH</span></div><div class="casAuthors">Casey, Joseph R.; Grinstein, Sergio; Orlowski, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-61</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protons dictate the charge and structure of macromols. and are used as energy currency by eukaryotic cells.  The unique function of individual organelles therefore depends on the establishment and stringent maintenance of a distinct pH.  This, in turn, requires a means to sense the prevailing pH and to respond to deviations from the norm with effective mechanisms to transport, produce, or consume proton equiv.  A dynamic, finely tuned balance between proton-extruding and proton-importing processes underlies pH homeostasis not only in the cytosol, but in other cellular compartments as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0tc-Hhm3bxLVg90H21EOLACvtfcHk0ljAgkToK4aGAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqtL3K&md5=e2812e3d37793d358456b4f3e0ee3f8c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fnrm2820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2820%26sid%3Dliteratum%253Aachs%26aulast%3DCasey%26aufirst%3DJ.%2BR.%26aulast%3DGrinstein%26aufirst%3DS.%26aulast%3DOrlowski%26aufirst%3DJ.%26atitle%3DSensors%2520and%2520Regulators%2520of%2520Intracellular%2520Ph%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D50%26epage%3D61%26doi%3D10.1038%2Fnrm2820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adorjan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mezo, G.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationship of HER2 Receptor Targeting Peptide and Its Derivatives in Targeted Tumor Therapy</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">183</span>, <span class="refDoi"> DOI: 10.3390/biom10020183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fbiom10020183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslCjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=183&author=B.+Biri-Kovacsauthor=A.+Adorjanauthor=I.+Szaboauthor=B.+Szederauthor=S.+Boszeauthor=G.+Mezo&title=Structure-Activity+Relationship+of+HER2+Receptor+Targeting+Peptide+and+Its+Derivatives+in+Targeted+Tumor+Therapy&doi=10.3390%2Fbiom10020183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of HER2 receptor targeting peptide and its derivatives in targeted tumor therapy</span></div><div class="casAuthors">Biri-Kovacs, Beata; Adorjan, Afrodite; Szabo, Ildiko; Szeder, Balint; Bosze, Szilvia; Mezo, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Human epidermal growth factor (HER2) is a transmembrane tyrosine kinase receptor that is frequently overexpressed in breast cancer.  Its increased level prognoses a poor patient outcome and a high mortality rate.  Despite the widening spectrum of therapies that are becoming available to treat HER2+ breast cancer, its side effects and resistance still make this protein a valuable object of research in targeted tumor therapy.  The role of tumor-targeting peptides has become more and more prominent in the last few decades due to their simple synthesis and pharmakokinetic properties.  Here, we examine two fluorescently-labeled HER2-specific peptides and their combined analogs that are developed to target the extracellular region of HER2.  The peptides are investigated on breast cancer cell lines with different HER2 expression profiles.  Moreover, their extracellular localization and specificity are confirmed by flow cytometry and confocal microscopy.  Therefore, a new, combined HER2 binding conjugate is obtained that interacts with HER2-overexpressing cells with high affinity and specificity.  Furthermore, secondary structure prediction reveals that the a-helical content of the peptides is assocd. with their receptor recognition.  This highly specific conjugate can be used as a starting point for diagnostical or drug-targeting purposes in upcoming studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Rnc3wzfxF7Vg90H21EOLACvtfcHk0ljAgkToK4aGAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslCjurc%253D&md5=49813039f8199847316480ac4abb74d0</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3390%2Fbiom10020183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10020183%26sid%3Dliteratum%253Aachs%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DAdorjan%26aufirst%3DA.%26aulast%3DSzabo%26aufirst%3DI.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DMezo%26aufirst%3DG.%26atitle%3DStructure-Activity%2520Relationship%2520of%2520HER2%2520Receptor%2520Targeting%2520Peptide%2520and%2520Its%2520Derivatives%2520in%2520Targeted%2520Tumor%2520Therapy%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26spage%3D183%26doi%3D10.3390%2Fbiom10020183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joliot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallerla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burlina, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagan, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative Fluorescence Spectroscopy and Flow Cytometry Analyses of Cell-Penetrating Peptides Internalization Pathways: Optimization, Pitfalls, Comparison with Mass Spectrometry Quantification</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">36938</span>, <span class="refDoi"> DOI: 10.1038/srep36938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1038%2Fsrep36938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=27841303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGitr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36938&author=F.+Illienauthor=N.+Rodriguezauthor=M.+Amouraauthor=A.+Joliotauthor=M.+Pallerlaauthor=S.+Cribierauthor=F.+Burlinaauthor=S.+Sagan&title=Quantitative+Fluorescence+Spectroscopy+and+Flow+Cytometry+Analyses+of+Cell-Penetrating+Peptides+Internalization+Pathways%3A+Optimization%2C+Pitfalls%2C+Comparison+with+Mass+Spectrometry+Quantification&doi=10.1038%2Fsrep36938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantification</span></div><div class="casAuthors">Illien, Francoise; Rodriguez, Nicolas; Amoura, Mehdi; Joliot, Alain; Pallerla, Manjula; Cribier, Sophie; Burlina, Fabienne; Sagan, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36938</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of cell-penetrating peptides entry into cells is unclear, preventing the development of more efficient vectors for biotechnol. or therapeutic purposes.  Here, we developed a protocol relying on fluorometry to distinguish endocytosis from direct membrane translocation, using Penetratin, TAT and R9.  The quantities of internalized CPPs measured by fluorometry in cell lysates converge with those obtained by our previously reported mass spectrometry quantification method.  By contrast, flow cytometry quantification faces several limitations due to fluorescence quenching processes that depend on the cell line and occur at peptide/cell ratio >6.108 for CF-Penetratin.  The anal. of cellular internalization of a doubly labeled fluorescent and biotinylated Penetratin analog by the two independent techniques, fluorometry and mass spectrometry, gave consistent results at the quant. and qual. levels.  Both techniques revealed the use of two alternative translocation and endocytosis pathways, whose relative efficacy depends on cell-surface sugars and peptide concn.  We confirmed that Penetratin translocates at low concn. and uses endocytosis at high μM concns.  We further demonstrate that the hydrophobic/hydrophilic nature of the N-terminal extremity impacts on the internalization efficiency of CPPs.  We expect these results and the assocd. protocols to help unraveling the translocation pathway to the cytosol of cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwTCm2jxX937Vg90H21EOLACvtfcHk0lgWhQyexSz5DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGitr%252FN&md5=ee292e6cfee9f70ab9630d2413258ac5</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fsrep36938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36938%26sid%3Dliteratum%253Aachs%26aulast%3DIllien%26aufirst%3DF.%26aulast%3DRodriguez%26aufirst%3DN.%26aulast%3DAmoura%26aufirst%3DM.%26aulast%3DJoliot%26aufirst%3DA.%26aulast%3DPallerla%26aufirst%3DM.%26aulast%3DCribier%26aufirst%3DS.%26aulast%3DBurlina%26aufirst%3DF.%26aulast%3DSagan%26aufirst%3DS.%26atitle%3DQuantitative%2520Fluorescence%2520Spectroscopy%2520and%2520Flow%2520Cytometry%2520Analyses%2520of%2520Cell-Penetrating%2520Peptides%2520Internalization%2520Pathways%253A%2520Optimization%252C%2520Pitfalls%252C%2520Comparison%2520with%2520Mass%2520Spectrometry%2520Quantification%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36938%26doi%3D10.1038%2Fsrep36938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyulai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span> <span> </span><span class="NLM_article-title">Membrane Affinity and Fluorescent Labelling: Comparative Study of Monolayer Interaction, Cellular Uptake and Cytotoxicity Profile of Carboxyfluorescein-Conjugated Cationic Peptides</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1557</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1007/s00726-018-2630-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2Fs00726-018-2630-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30099595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFSqtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1557-1571&author=E.+Kissauthor=G.+Gyulaiauthor=E.+Pariauthor=K.+Horvatiauthor=S.+Bosze&title=Membrane+Affinity+and+Fluorescent+Labelling%3A+Comparative+Study+of+Monolayer+Interaction%2C+Cellular+Uptake+and+Cytotoxicity+Profile+of+Carboxyfluorescein-Conjugated+Cationic+Peptides&doi=10.1007%2Fs00726-018-2630-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane affinity and fluorescent labelling: comparative study of monolayer interaction, cellular uptake and cytotoxicity profile of carboxyfluorescein-conjugated cationic peptides</span></div><div class="casAuthors">Kiss, Eva; Gyulai, Gergo; Pari, Edit; Horvati, Kata; Bosze, Szilvia</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1557-1571</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">Fluorescent labeling is a common approach to reveal the mol. details of cellular uptake, internalisation, transport, distribution processes in biol. systems.  A representative set of seven cationic peptides-including cell-penetrating peptides as well as antimicrobial peptides and synthetic derivs.-was selected for our comparative study.  Membrane affinity of the peptides and their 5(6)-carboxyfluorescein (Cf) derivs. was detd. quant. and compared applying Langmuir monolayer of zwitterionic (DPPC) and neg. charged (DPPC + DPPG) lipids as cell membrane models.  The interaction with neutral lipid layer is mainly governed by the overall hydrophobicity of the mol. which is remarkably increased by Cf-conjugation for the most hydrophobic Magainin, Melittin and Transportan.  A significantly enhanced membrane affinity was detected in neg. charged lipid model monolayer for all of the peptides since the combination of electrostatic and hydrophobic interaction is active in that case.  This effect might also responsible for the obsd. high in vitro internalisation rate of Penetratin and Dhvar4, while according to in vitro studies they did not cause damage of cell membrane.  From the expts. with the given seven cationic peptides, it can be concluded that the Cf-conjugation alters the degree of membrane interaction of such peptides which are moderately hydrophobic and highly charged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTNxF1mGvPJbVg90H21EOLACvtfcHk0lgWhQyexSz5DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFSqtrnI&md5=82f6c7e49bb7cc951e52c6963fd47775</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1007%2Fs00726-018-2630-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-018-2630-7%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DE.%26aulast%3DGyulai%26aufirst%3DG.%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26atitle%3DMembrane%2520Affinity%2520and%2520Fluorescent%2520Labelling%253A%2520Comparative%2520Study%2520of%2520Monolayer%2520Interaction%252C%2520Cellular%2520Uptake%2520and%2520Cytotoxicity%2520Profile%2520of%2520Carboxyfluorescein-Conjugated%2520Cationic%2520Peptides%26jtitle%3DAmino%2520Acids%26date%3D2018%26volume%3D50%26spage%3D1557%26epage%3D1571%26doi%3D10.1007%2Fs00726-018-2630-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ü.</span></span> <i>CPP, Cell-Penetrating Peptides</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">2019</span>; pp  <span class="NLM_fpage">XII</span>, 470.<span class="refDoi"> DOI: 10.1007/978-981-13-8747-0</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1007%2F978-981-13-8747-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=XII&author=%C3%9C.+Langel&title=CPP%2C+Cell-Penetrating+Peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2F978-981-13-8747-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-981-13-8747-0%26sid%3Dliteratum%253Aachs%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26btitle%3DCPP%252C%2520Cell-Penetrating%2520Peptides%26pub%3DSpringer%26date%3D2019%26spage%3DXII%26doi%3D10.1007%2F978-981-13-8747-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staerk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H. M.</span></span> <span> </span><span class="NLM_article-title">Fluorophore Labeling of a Cell-Penetrating Peptide Induces Differential Effects on Its Cellular Distribution and Affects Cell Viability</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1859</i></span>,  <span class="NLM_fpage">2483</span>– <span class="NLM_lpage">2494</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2017.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.bbamem.2017.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=28919344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SitLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1859&publication_year=2017&pages=2483-2494&author=D.+Birchauthor=M.+V.+Christensenauthor=D.+Staerkauthor=H.+Franzykauthor=H.+M.+Nielsen&title=Fluorophore+Labeling+of+a+Cell-Penetrating+Peptide+Induces+Differential+Effects+on+Its+Cellular+Distribution+and+Affects+Cell+Viability&doi=10.1016%2Fj.bbamem.2017.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorophore labeling of a cell-penetrating peptide induces differential effects on its cellular distribution and affects cell viability</span></div><div class="casAuthors">Birch, Ditlev; Christensen, Malene Vinther; Staerk, Dan; Franzyk, Henrik; Nielsen, Hanne Moerck</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1859</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2483-2494</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-penetrating peptides constitute efficient delivery vectors, and studies of their uptake and mechanism of translocation typically involve fluorophore-labeled conjugates.  In the present study, the influence of a no. of specific fluorophores on the physico-chem. properties and uptake-related characteristics of penetratin were studied.  An array of seven fluorophores belonging to distinct structural classes was examd., and the impact of fluorophore labeling on intracellular distribution and cytotoxicity was correlated to the physico-chem. properties of the conjugates.  Exposure of several mammalian cell types to fluorophore-penetratin conjugates revealed a strong structure-dependent redn. in viability (1.5- to 20-fold lower IC50 values as compared to those of non-labeled penetratin).  Also, the degree of less severe effects on membrane integrity, as well as intracellular distribution patterns differed among the conjugates.  Overall, neutral hydrophobic fluorophores or neg. charged fluorophores conferred less cytotoxicity as compared to the effect exerted by pos. charged, hydrophobic fluorophores.  The latter conjugates, however, exhibited less membrane assocn. and more clearly defined intracellular distribution patterns.  Thus, selection of the appropriate flurophore is crit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuUABBhzCZLVg90H21EOLACvtfcHk0lhUoSeetuR7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SitLjE&md5=fecd160ea4a85fb30ff21a78ec68db30</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2017.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2017.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DD.%26aulast%3DChristensen%26aufirst%3DM.%2BV.%26aulast%3DStaerk%26aufirst%3DD.%26aulast%3DFranzyk%26aufirst%3DH.%26aulast%3DNielsen%26aufirst%3DH.%2BM.%26atitle%3DFluorophore%2520Labeling%2520of%2520a%2520Cell-Penetrating%2520Peptide%2520Induces%2520Differential%2520Effects%2520on%2520Its%2520Cellular%2520Distribution%2520and%2520Affects%2520Cell%2520Viability%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2017%26volume%3D1859%26spage%3D2483%26epage%3D2494%26doi%3D10.1016%2Fj.bbamem.2017.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Ardoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lostale-Seijo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, J.</span></span> <span> </span><span class="NLM_article-title">Where in the Cell Is Our Cargo? Methods Currently Used to Study Intracellular Cytosolic Localisation</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1002/cbic.201800390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fcbic.201800390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=30178574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1CgsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=488-498&author=A.+Mendez-Ardoyauthor=I.+Lostale-Seijoauthor=J.+Montenegro&title=Where+in+the+Cell+Is+Our+Cargo%3F+Methods+Currently+Used+to+Study+Intracellular+Cytosolic+Localisation&doi=10.1002%2Fcbic.201800390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Where in the Cell Is our Cargo? Methods Currently Used To Study Intracellular Cytosolic Localisation</span></div><div class="casAuthors">Mendez-Ardoy, Alejandro; Lostale-Seijo, Irene; Montenegro, Javier</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-498</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The internalisation and delivery of active substances into cells is a field of growing interest for chem. biol. and therapeutics.  As we move from small-mol.-based drugs towards bigger cargos, such as antibodies, enzymes, nucleases or nucleic acids, the development of efficient delivery systems becomes crit. for their practical application.  Different strategies and synthetic carriers have been developed; these include cationic lipids, gold nanoparticles, polymers, cell-penetrating peptides (CPPs), protein surface modification etc.  However, all of these methodologies still present limitations relating to the precise targeting of the different intracellular compartments and, in particular, difficulties in access to the cellular cytosol.  Addnl., the precise quantification of the cellular uptake of a compd. is not enough to demonstrate delivery and/or functional activity.  Therefore, methods to det. cellular distributions of cargos and carriers are of crit. importance for identifying the barriers that are blocking the activity.  Herein we survey the different techniques that can currently be used to track and to monitor the subcellular localisation of the synthetic compds. that we deliver inside cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgcISUGrv1x7Vg90H21EOLACvtfcHk0lhUoSeetuR7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1CgsrjE&md5=63251bf2420cf2977e977c52207d25b4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800390%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Ardoy%26aufirst%3DA.%26aulast%3DLostale-Seijo%26aufirst%3DI.%26aulast%3DMontenegro%26aufirst%3DJ.%26atitle%3DWhere%2520in%2520the%2520Cell%2520Is%2520Our%2520Cargo%253F%2520Methods%2520Currently%2520Used%2520to%2520Study%2520Intracellular%2520Cytosolic%2520Localisation%26jtitle%3DChemBioChem%26date%3D2019%26volume%3D20%26spage%3D488%26epage%3D498%26doi%3D10.1002%2Fcbic.201800390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sani, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, F.</span></span> <span> </span><span class="NLM_article-title">Lipid Matrix Plays a Role in Abeta Fibril Kinetics and Morphology</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>585</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2011.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.febslet.2011.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=21320494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsF2jurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=749-754&author=M.+A.+Saniauthor=J.+D.+Gehmanauthor=F.+Separovic&title=Lipid+Matrix+Plays+a+Role+in+Abeta+Fibril+Kinetics+and+Morphology&doi=10.1016%2Fj.febslet.2011.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid matrix plays a role in Abeta fibril kinetics and morphology</span></div><div class="casAuthors">Sani, Marc-Antoine; Gehman, John D.; Separovic, Frances</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-754</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While neuronal membranes are proposed to be the primary target of amyloid plaques, the effect of phospholipids on fibril formation kinetics and morphol. has not yet been resolved.  We report that interaction of various compns. with neuronal mimics promoted different processes of fibril formation; neg. charged surfaces increased the lag time and elongation rate in thioflavin T assays, while brain total lipid ext. had an opposite effect compared to that in the absence of lipid.  Electron microscopy showed thin and elongated fibrils when the peptide was incubated with anionic lipids, while neutral surfaces promoted coarse and small fibrils.  CD and thioflavin T assays confirmed an initially unstructured peptide, and measured its transition to an aggregated beta-sheet conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfD1-zxKZgg7Vg90H21EOLACvtfcHk0lhUoSeetuR7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsF2jurk%253D&md5=ac9e49ee4e1078f6f543df0eab649d10</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DSani%26aufirst%3DM.%2BA.%26aulast%3DGehman%26aufirst%3DJ.%2BD.%26aulast%3DSeparovic%26aufirst%3DF.%26atitle%3DLipid%2520Matrix%2520Plays%2520a%2520Role%2520in%2520Abeta%2520Fibril%2520Kinetics%2520and%2520Morphology%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D749%26epage%3D754%26doi%3D10.1016%2Fj.febslet.2011.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandrino, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochelavicius, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobre, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, O. N.,  Jr</span></span> <span> </span><span class="NLM_article-title">The Prion Fragment Prp106–127 Adopts a Secondary Structure Typical of Aggregated Fibrils in Langmuir Monolayers of Brain Lipid Extract</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">104930</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2020.104930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.chemphyslip.2020.104930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=32470442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2020&pages=104930&author=B.+Sandrinoauthor=K.+Jochelaviciusauthor=D.+Volpatiauthor=S.+C.+Barbosaauthor=T.+M.+Nobreauthor=O.+N.+Oliveira&title=The+Prion+Fragment+Prp106%E2%80%93127+Adopts+a+Secondary+Structure+Typical+of+Aggregated+Fibrils+in+Langmuir+Monolayers+of+Brain+Lipid+Extract&doi=10.1016%2Fj.chemphyslip.2020.104930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The prion fragment PrP106-127 adopts a secondary structure typical of aggregated fibrils in langmuir monolayers of brain lipid extract</span></div><div class="casAuthors">Sandrino, B.; Jochelavicius, K.; Volpati, D.; Barbosa, S. C.; Nobre, T. M.; Oliveira, O. N. Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104930</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Understanding protein aggregation is essential to unveil mol. mechanisms assocd. with neurodegenerative diseases such as Alzheimer's, Huntington's and spongiform encephalopathy, particularly to det. the role of interaction with cell membranes.  In this study, we employ Langmuir monolayers as cell membrane models to mimic interaction with the peptide KTNMHKHMAGAAAAGAVVGGLG-OH, a fragment from the human prion protein including residues 106-127, believed to be involved in protein aggregation.  Using in situ polarization-modulated IR reflection adsorption spectroscopy (PM-IRRAS) for Langmuir monolayers and FTIR for solid films, we found that PrP106-127 adopts mainly β-sheets, random coils and β-turns in Langmuir monolayers and in Langmuir-Blodgett (LB) and cast films.  This also applies to monolayers and solid films made with PrP106-127 and a brain total lipid ext. (BTLE).  In contrast, some α-helixes are obsd. in the secondary structure of PrP106-127 in monolayers, and esp. in solid films, of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC).  In summary, in a model representing brain cells (BTLE), the secondary structure of PrP106-127 is typical of fiber aggregates, while aggregation is unlikely if PrP106-127 interacts with a membrane model (DOPC) characteristic of mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kGwa2c5JGrVg90H21EOLACvtfcHk0lhUoSeetuR7eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjsL%252FP&md5=17e9082ed9a3e424d4f5b833d14ca1be</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2020.104930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2020.104930%26sid%3Dliteratum%253Aachs%26aulast%3DSandrino%26aufirst%3DB.%26aulast%3DJochelavicius%26aufirst%3DK.%26aulast%3DVolpati%26aufirst%3DD.%26aulast%3DBarbosa%26aufirst%3DS.%2BC.%26aulast%3DNobre%26aufirst%3DT.%2BM.%26aulast%3DOliveira%26aufirst%3DO.%2BN.%26atitle%3DThe%2520Prion%2520Fragment%2520Prp106%25E2%2580%2593127%2520Adopts%2520a%2520Secondary%2520Structure%2520Typical%2520of%2520Aggregated%2520Fibrils%2520in%2520Langmuir%2520Monolayers%2520of%2520Brain%2520Lipid%2520Extract%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2020%26volume%3D230%26spage%3D104930%26doi%3D10.1016%2Fj.chemphyslip.2020.104930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pari, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvati, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biri-Kovacs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zsila, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, E.</span></span> <span> </span><span class="NLM_article-title">Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2197</span>, <span class="refDoi"> DOI: 10.3390/ijms21062197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3390%2Fijms21062197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVejsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=2197&author=E.+Pariauthor=K.+Horvatiauthor=S.+Boszeauthor=B.+Biri-Kovacsauthor=B.+Szederauthor=F.+Zsilaauthor=E.+Kiss&title=Drug+Conjugation+Induced+Modulation+of+Structural+and+Membrane+Interaction+Features+of+Cationic+Cell-Permeable+Peptides&doi=10.3390%2Fijms21062197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Drug conjugation induced modulation of structural and membrane interaction features of cationic cell-permeable peptides</span></div><div class="casAuthors">Pari, Edit; Horvati, Kata; Bosze, Szilvia; Biri-Kovacs, Beata; Szeder, Balint; Zsila, Ferenc; Kiss, Eva</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2197</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cell-penetrating peptides might have great potential for enhancing the therapeutic effect of drug mols. against such dangerous pathogens as Mycobacterium tuberculosis (Mtb), which causes a major health problem worldwide.  A set of cationic cell-penetration peptides with various hydrophobicity were selected and synthesized as drug carrier of isoniazid (INH), a first-line antibacterial agent against tuberculosis.  Mol. interactions between the peptides and their INH-conjugates with cell-membrane-forming lipid layers composed of DPPC and mycolic acid (a characteristic component of Mtb cell wall) were evaluated, using the Langmuir balance technique.  Secondary structure of the INH conjugates was analyzed and compared to that of the native peptides by CD spectroscopic expts. performed in aq. and membrane mimetic environment.  A correlation was found between the conjugation induced conformational and membrane affinity changes of the INH-peptide conjugates.  The degree and mode of interaction were also characterized by AFM imaging of penetrated lipid layers.  In vitro biol. evaluation was performed with Penetratin and Transportan conjugates.  Results showed similar internalization rate into EBC-1 human squamous cell carcinoma, but markedly different subcellular localization and activity on intracellular Mtb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwni53JmX97Vg90H21EOLACvtfcHk0lizBOuXx0oggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVejsb7L&md5=d5de492802b38dc4263265d408372c79</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.3390%2Fijms21062197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21062197%26sid%3Dliteratum%253Aachs%26aulast%3DPari%26aufirst%3DE.%26aulast%3DHorvati%26aufirst%3DK.%26aulast%3DBosze%26aufirst%3DS.%26aulast%3DBiri-Kovacs%26aufirst%3DB.%26aulast%3DSzeder%26aufirst%3DB.%26aulast%3DZsila%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DE.%26atitle%3DDrug%2520Conjugation%2520Induced%2520Modulation%2520of%2520Structural%2520and%2520Membrane%2520Interaction%2520Features%2520of%2520Cationic%2520Cell-Permeable%2520Peptides%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D2197%26doi%3D10.3390%2Fijms21062197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bicker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortuna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcão, A.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Models and Their Relevance for a Successful Development of CNS Drug Delivery Systems: A Review</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.ejpb.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=24686194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=409-432&author=J.+Bickerauthor=G.+Alvesauthor=A.+Fortunaauthor=A.+Falc%C3%A3o&title=Blood-Brain+Barrier+Models+and+Their+Relevance+for+a+Successful+Development+of+CNS+Drug+Delivery+Systems%3A+A+Review&doi=10.1016%2Fj.ejpb.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review</span></div><div class="casAuthors">Bicker, Joana; Alves, Gilberto; Fortuna, Ana; Falcao, Amilcar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-432</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  During the research and development of new drugs directed at the central nervous system, there is a considerable attrition rate caused by their hampered access to the brain by the blood-brain barrier.  Throughout the years, several in vitro models have been developed in an attempt to mimic crit. functionalities of the blood-brain barrier and reliably predict the permeability of drug candidates.  However, the current challenge lies in developing a model that retains fundamental blood-brain barrier characteristics and simultaneously remains compatible with the high throughput demands of pharmaceutical industries.  This review firstly describes the roles of all elements of the neurovascular unit and their influence on drug brain penetration.  In vitro models, including non-cell based and cell-based models, and in vivo models are herein presented, with a particular emphasis on their methodol. aspects.  Lastly, their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph-OEiYO0znrVg90H21EOLACvtfcHk0lizBOuXx0oggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWgu7Y%253D&md5=73c2d2182182626c039ccb469b65eec4</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBicker%26aufirst%3DJ.%26aulast%3DAlves%26aufirst%3DG.%26aulast%3DFortuna%26aufirst%3DA.%26aulast%3DFalc%25C3%25A3o%26aufirst%3DA.%26atitle%3DBlood-Brain%2520Barrier%2520Models%2520and%2520Their%2520Relevance%2520for%2520a%2520Successful%2520Development%2520of%2520CNS%2520Drug%2520Delivery%2520Systems%253A%2520A%2520Review%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2014%26volume%3D87%26spage%3D409%26epage%3D432%26doi%3D10.1016%2Fj.ejpb.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cukierman, E.</span></span> <span> </span><span class="NLM_article-title">Modeling Tissue Morphogenesis and Cancer in 3D</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1016%2Fj.cell.2007.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=17719539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVels77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2007&pages=601-610&author=K.+M.+Yamadaauthor=E.+Cukierman&title=Modeling+Tissue+Morphogenesis+and+Cancer+in+3D&doi=10.1016%2Fj.cell.2007.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling tissue morphogenesis and cancer in 3D</span></div><div class="casAuthors">Yamada, Kenneth M.; Cukierman, Edna</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Three-dimensional (3D) in vitro models span the gap between two-dimensional cell cultures and whole-animal systems.  By mimicking features of the in vivo environment and taking advantage of the same tools used to study cells in traditional cell culture, 3D models provide unique perspectives on the behavior of stem cells, developing tissues and organs, and tumors.  These models may help to accelerate translational research in cancer biol. and tissue engineering.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorQ_LEDS99G7Vg90H21EOLACvtfcHk0lizBOuXx0oggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVels77F&md5=6822cdd35eeb4b3413fd4ea9ad66b689</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BM.%26aulast%3DCukierman%26aufirst%3DE.%26atitle%3DModeling%2520Tissue%2520Morphogenesis%2520and%2520Cancer%2520in%25203D%26jtitle%3DCell%26date%3D2007%26volume%3D130%26spage%3D601%26epage%3D610%26doi%3D10.1016%2Fj.cell.2007.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, S. A.</span></span> <span> </span><span class="NLM_article-title">Three-Dimensional In Vitro Cell Culture Models in Drug Discovery and Drug Repositioning</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">6</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.3389%2Ffphar.2018.00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=29410625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKrs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=6&author=S.+A.+Langhans&title=Three-Dimensional+In+Vitro+Cell+Culture+Models+in+Drug+Discovery+and+Drug+Repositioning&doi=10.3389%2Ffphar.2018.00006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional in vitro cell culture models in drug discovery and drug repositioning</span></div><div class="casAuthors">Langhans, Sigrid A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6/1-6/14</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Drug development is a lengthy and costly process that proceeds through several stages from target identification to lead discovery and optimization, preclin. validation and clin. trials culminating in approval for clin. use.  An important step in this process is high-throughput screening (HTS) of small compd. libraries for lead identification.  Currently, themajority of cell-based HTS is being carried out on cultured cells propagated in two-dimensions (2D) on plastic surfaces optimized for tissue culture.  At the same time, compelling evidence suggests that cells cultured in these non-physiol. conditions are not representative of cells residing in the complex microenvironment of a tissue.  This discrepancy is thought to be a significant contributor to the high failure rate in drug discovery, where only a low percentage of drugs investigated ever make it through the gamut of testing and approval to the market.  Thus, three-dimensional (3D) cell culture technologies that more closely resemble in vivo cell environments are now being pursued with intensity as they are expected to accommodate better precision in drug discovery.  Here we will review common approaches to 3D culture, discuss the significance of 3D cultures in drug resistance and drug repositioning and address some of the challenges of applying 3D cell cultures to high-throughput drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw5NAwsfOLKrVg90H21EOLACvtfcHk0lj4nPgZIycoSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKrs7%252FP&md5=79c9604de826fc9e3850978df741468f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00006%26sid%3Dliteratum%253Aachs%26aulast%3DLanghans%26aufirst%3DS.%2BA.%26atitle%3DThree-Dimensional%2520In%2520Vitro%2520Cell%2520Culture%2520Models%2520in%2520Drug%2520Discovery%2520and%2520Drug%2520Repositioning%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D6%26doi%3D10.3389%2Ffphar.2018.00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, T. A.</span></span> <span> </span><span class="NLM_article-title">A Set of Constructed Type Spectra for the Practical Estimation of Peptide Secondary Structure from Circular Dichroism</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1006/abio.1997.2355</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1006%2Fabio.1997.2355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=9398343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADyaK2sXnvVOjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=1997&pages=36-40&author=J.+Reedauthor=T.+A.+Reed&title=A+Set+of+Constructed+Type+Spectra+for+the+Practical+Estimation+of+Peptide+Secondary+Structure+from+Circular+Dichroism&doi=10.1006%2Fabio.1997.2355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A set of constructed type spectra for the practical estimation of peptide secondary structure from circular dichroism</span></div><div class="casAuthors">Reed, Jennifer; Reed, Thomas Arnold</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-40</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">While reliable methods have been developed for the estn. of globular protein secondary structure content from their far UV CD spectra, these are not suitable for the anal. of simple peptides.  Model peptides have been measured in purely α-helical, β-sheet, and coil form, and are often used for fitting the CD spectra of peptides, but these are mainly derived from homopolymers and exhibit side-chain-dependent characteristics that do not accurately represent the situation in natural sequences.  We have attempted to reduce the side-chain bias inherent in these spectra by constructing a series of frequency-weighted "av." spectra from all available data on model peptides.  These have proved quite satisfactory in estg. the secondary structure of a no. of peptides.  A computer program incorporating these spectra has been developed for practical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSVhnf5TB-LVg90H21EOLACvtfcHk0lj4nPgZIycoSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnvVOjtbY%253D&md5=7e0175339e8fc187b56d7b6331354ef7</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1006%2Fabio.1997.2355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1997.2355%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DT.%2BA.%26atitle%3DA%2520Set%2520of%2520Constructed%2520Type%2520Spectra%2520for%2520the%2520Practical%2520Estimation%2520of%2520Peptide%2520Secondary%2520Structure%2520from%2520Circular%2520Dichroism%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D254%26spage%3D36%26epage%3D40%26doi%3D10.1006%2Fabio.1997.2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manolios, N.</span></span> <span> </span><span class="NLM_article-title">Kinetic and Conformational Properties of a Novel T-Cell Antigen Receptor Transmembrane Peptide in Model Membranes</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1002/psc.987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.1002%2Fpsc.987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=18240131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVSktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=714-724&author=M.+A.+Amonauthor=M.+Aliauthor=V.+Benderauthor=K.+Hallauthor=M.+I.+Aguilarauthor=J.+Aldrich-Wrightauthor=N.+Manolios&title=Kinetic+and+Conformational+Properties+of+a+Novel+T-Cell+Antigen+Receptor+Transmembrane+Peptide+in+Model+Membranes&doi=10.1002%2Fpsc.987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes</span></div><div class="casAuthors">Amon, Michael A.; Ali, Marina; Bender, Veronika; Hall, Kristopher; Aguilar, Marie-Isabel; Aldrich-Wright, Janice; Manolios, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">714-724</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Core peptide (CP; GLRILLLKV) is a 9-amino acid peptide derived from the transmembrane sequence of the T-cell antigen receptor (TCR) α-subunit.  CP inhibits T-cell activation both in vitro and in vivo by disruption of the TCR at the membrane level.  To elucidate CP interactions with lipids, surface plasmon resonance (SPR) and CD were used to examine CP binding and secondary structure in the presence of either the anionic dimyristoyl-L-α-phosphatidyl-DL-glycerol (DMPG), or the zwitterionic dimyristoyl-L-α-phosphatidyl choline (DMPC).  Using lipid monolayers and bilayers, SPR expts. demonstrated that irreversible peptide-lipid binding required the hydrophobic interior provided by a membrane bilayer.  The importance of electrostatic interactions between CP and phospholipids was highlighted on lipid monolayers as CP bound reversibly to anionic DMPG monolayers, with no detectable binding obsd. on neutral DMPC monolayers.  CD revealed a dose-dependent conformational change of CP from a dominantly random coil structure to that of β-structure as the concn. of lipid increased relative to CP.  This occurred only in the presence of the anionic DMPG at a lipid: peptide molar ratio of 1.6: 1 as no conformational change was obsd. when the zwitterionic DMPC was tested up to a lipid: peptide ratio of 8.4: 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ZRRmn2yl8LVg90H21EOLACvtfcHk0lj4nPgZIycoSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVSktLg%253D&md5=ddb04ab43e3d6c4bd32e9b728d601135</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1002%2Fpsc.987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.987%26sid%3Dliteratum%253Aachs%26aulast%3DAmon%26aufirst%3DM.%2BA.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DK.%26aulast%3DAguilar%26aufirst%3DM.%2BI.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%26aulast%3DManolios%26aufirst%3DN.%26atitle%3DKinetic%2520and%2520Conformational%2520Properties%2520of%2520a%2520Novel%2520T-Cell%2520Antigen%2520Receptor%2520Transmembrane%2520Peptide%2520in%2520Model%2520Membranes%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2008%26volume%3D14%26spage%3D714%26epage%3D724%26doi%3D10.1002%2Fpsc.987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggiali, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitaker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kievit, R.</span></span> <span> </span><span class="NLM_article-title">Raincloud Plots: A Multi-Platform Tool for Robust Data Visualization [Version 1; Peer Review: 2 Approved]</span>. <i>Wellcome Open Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">63</span>, <span class="refDoi"> DOI: 10.12688/wellcomeopenres.15191.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=10.12688%2Fwellcomeopenres.15191.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=31069261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=63&author=M.+Allenauthor=D.+Poggialiauthor=K.+Whitakerauthor=T.+Marshallauthor=R.+Kievit&title=Raincloud+Plots%3A+A+Multi-Platform+Tool+for+Robust+Data+Visualization+%5BVersion+1%3B+Peer+Review%3A+2+Approved%5D&doi=10.12688%2Fwellcomeopenres.15191.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Raincloud plots: a multi-platform tool for robust data visualization</span></div><div class="casAuthors">Allen Micah; Allen Micah; Whitaker Kirstie; Allen Micah; Poggiali Davide; Poggiali Davide; Whitaker Kirstie; Marshall Tom Rhys; Marshall Tom Rhys; Kievit Rogier A; Kievit Rogier A</div><div class="citationInfo"><span class="NLM_cas:title">Wellcome open research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63</span>
        ISSN:<span class="NLM_cas:issn">2398-502X</span>.
    </div><div class="casAbstract">Across scientific disciplines, there is a rapidly growing recognition of the need for more statistically robust, transparent approaches to data visualization.  Complementary to this, many scientists have called for plotting tools that accurately and transparently convey key aspects of statistical effects and raw data with minimal distortion.  Previously common approaches, such as plotting conditional mean or median barplots together with error-bars have been criticized for distorting effect size, hiding underlying patterns in the raw data, and obscuring the assumptions upon which the most commonly used statistical tests are based.  Here we describe a data visualization approach which overcomes these issues, providing maximal statistical information while preserving the desired 'inference at a glance' nature of barplots and other similar visualization devices.  These "raincloud plots" can visualize raw data, probability density, and key summary statistics such as median, mean, and relevant confidence intervals in an appealing and flexible format with minimal redundancy.  In this tutorial paper, we provide basic demonstrations of the strength of raincloud plots and similar approaches, outline potential modifications for their optimal use, and provide open-source code for their streamlined implementation in R, Python and Matlab ( https://github.com/RainCloudPlots/RainCloudPlots).  Readers can investigate the R and Python tutorials interactively in the browser using Binder by Project Jupyter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvxyxWUQf3XoJKJbLTgsvCfW6udTcc2eaqq_tPd8QR6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jvVeitQ%253D%253D&md5=a24a8c463d5b6536940d02728e19c898</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.12688%2Fwellcomeopenres.15191.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Fwellcomeopenres.15191.1%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DPoggiali%26aufirst%3DD.%26aulast%3DWhitaker%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DT.%26aulast%3DKievit%26aufirst%3DR.%26atitle%3DRaincloud%2520Plots%253A%2520A%2520Multi-Platform%2520Tool%2520for%2520Robust%2520Data%2520Visualization%2520%255BVersion%25201%253B%2520Peer%2520Review%253A%25202%2520Approved%255D%26jtitle%3DWellcome%2520Open%2520Res.%26date%3D2019%26volume%3D4%26spage%3D63%26doi%3D10.12688%2Fwellcomeopenres.15191.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zar, J. H.</span></span> In  <i>Biostatistical Analysis</i>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Zar, J. H.</span></span>, Ed.; <span class="NLM_publisher-name">Pearson Educations</span>: <span class="NLM_publisher-loc">Upper Saddle River, NJ</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+H.+Zarauthor=J.+H.+Zar&title=Biostatistical+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZar%26aufirst%3DJ.%2BH.%26btitle%3DBiostatistical%2520Analysis%26aulast%3DZar%26aufirst%3DJ.%2BH.%26pub%3DPearson%2520Educations%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">R Core Team</span>. <span> </span><span class="NLM_article-title">The R Project for Statistical
Computing</span>. <a href="https://www.r-project.org/" class="extLink">https://www.r-project.org/</a> (accessed Feb 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=R+Core+Team.+The+R+Project+for+Statistical%0AComputing.+https%3A%2F%2Fwww.r-project.org%2F+%28accessed+Feb+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520R%2520Project%2520for%2520Statistical%250AComputing" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohlert, T.</span></span> <span> </span><span class="NLM_article-title">The Pairwise Multiple Comparison of Mean Ranks Package (Pmcmr)</span>. <a href="https://cran.r-project.org/web/packages/PMCMR/vignettes/PMCMR.pdf" class="extLink">https://cran.r-project.org/web/packages/PMCMR/vignettes/PMCMR.pdf</a> (accessed Feb 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pohlert%2C+T.+The+Pairwise+Multiple+Comparison+of+Mean+Ranks+Package+%28Pmcmr%29.+https%3A%2F%2Fcran.r-project.org%2Fweb%2Fpackages%2FPMCMR%2Fvignettes%2FPMCMR.pdf+%28accessed+Feb+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPohlert%26aufirst%3DT.%26atitle%3DThe%2520Pairwise%2520Multiple%2520Comparison%2520of%2520Mean%2520Ranks%2520Package%2520%2528Pmcmr%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01399">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17840"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01399?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01399</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Monitoring of the conjugation reactions, characterization of TMZA, characterization of the compounds, analytical RP-HPLC chromatograms of lead compounds, stability study of the conjugates, digestion profile of conjugates in rat liver lysosomal homogenate and LC-MS analysis, <i>in vitro</i> cytostatic and cytotoxic activity, determination of the pH dependence of the fluorescence intensity, cellular uptake studies, confocal microscopy studies, in vitro BBB model studies, and spheroid studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula string (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular formula string (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_003.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_001.pdf">jm0c01399_si_001.pdf (5.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_002.csv">jm0c01399_si_002.csv (15.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01399/suppl_file/jm0c01399_si_003.xlsx">jm0c01399_si_003.xlsx (14.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01399&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01399%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01399" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                12MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e11815c8832458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
